data_2mvo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mvo _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.7 tttm . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 112.327 0.491 . . . . 3.02 112.327 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -148.61 152.91 37.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.823 -0.626 . . . . 0.28999999999999998 110.903 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -97.56 129.07 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.468 -0.567 . . . . 0.16 109.468 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.1 tt -129.34 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.892 0.377 . . . . 1.1799999999999999 110.938 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -150.48 167.87 25.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.59 0.709 . . . . 0.78000000000000003 111.654 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.5 -34.62 64.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.724 . . . . 1.1000000000000001 111.118 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.02 86.53 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 121.021 -0.272 . . . . 1.0600000000000001 110.727 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -66.36 -46.61 76.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.38 111.282 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.07 -8.79 55.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.671 0.989 . . . . 1.72 113.671 -174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.69 -153.79 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.419 -0.586 . . . . 1.0900000000000001 109.419 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -56.77 -21.42 28.32 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.571 0.623 . . . . 4.0999999999999996 112.4 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -59.2 -20.09 50.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.498 0.555 . . . . 2.2799999999999998 112.498 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.7 t-105 -55.81 111.94 3.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 119.121 -0.466 . . . . 0.20999999999999999 110.205 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -89.55 -13.25 2.84 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.904 1.736 . . . . 0.29999999999999999 114.164 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -87.8 143.62 27.04 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.228 0.537 . . . . 1.04 111.627 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.4 p -67.99 -36.76 80.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.345 -0.843 . . . . 1.01 110.817 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.67 129.39 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.272 -1.01 . . . . 1.03 108.272 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.92 -32.94 72.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.023 0.379 . . . . 1.8 112.023 -169.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -147.02 174.37 11.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.406 -0.518 . . . . 0.59999999999999998 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.05 34.31 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.832 -1.307 . . . . 0.10000000000000001 109.832 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.3 m -109.93 141.58 42.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.598 -0.354 . . . . 1.02 110.349 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.64 137.23 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -148.01 143.79 27.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.432 0.634 . . . . 2.1800000000000002 112.127 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.011 -0.995 . . . . 0.35999999999999999 109.492 172.545 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.11 -0.33 . . . . 1.1000000000000001 110.11 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.32 157.14 43.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.448 0.642 . . . . 1.05 111.396 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -114.03 127.75 56.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.799 -1.091 . . . . 0.13 109.932 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -108.51 130.48 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.325 -0.62 . . . . 1.04 109.325 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.41 154.8 37.0 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.655 -0.418 . . . . 1.01 110.625 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.66 -26.49 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.509 1.473 . . . . 0.17999999999999999 113.225 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -63.96 -12.79 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.816 0.673 . . . . 0.17999999999999999 112.816 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.52 10.43 65.48 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 122.151 -0.343 . . . . 0.17000000000000001 112.92 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.7 m -99.37 139.36 35.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.233 -0.655 . . . . 1.04 109.233 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.8 m -105.02 130.91 53.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.297 0.57 . . . . 1.0 110.056 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -116.68 147.54 41.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.14000000000000001 108.992 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.41 126.08 34.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.94999999999999996 110.771 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.04 -50.93 6.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.347 -0.388 . . . . 1.03 110.637 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -103.11 166.58 10.35 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.643 0.735 . . . . 0.38 112.019 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.6 -41.16 69.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.39 -0.823 . . . . 2.2000000000000002 112.209 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -63.94 -42.8 97.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.689 -0.404 . . . . 3.04 111.398 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.28 78.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.862 0.363 . . . . 1.05 110.907 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.56 -40.92 98.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 2.0699999999999998 110.394 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.85 -33.93 71.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 3.1699999999999999 111.288 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.66 0.44 8.72 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.083 0.771 . . . . 1.0 113.083 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.12 23.43 63.53 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.826 -0.43 . . . . 0.53000000000000003 113.203 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -84.89 142.64 39.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 108.938 -0.764 . . . . 0.64000000000000001 108.938 171.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.09 148.83 51.25 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.182 1.255 . . . . 1.1499999999999999 111.281 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 158.91 30.44 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.376 1.384 . . . . 0.53000000000000003 112.301 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.96 -11.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 119.033 -0.508 . . . . 1.01 112.345 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 t -43.83 -39.65 6.06 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 115.559 1.689 . . . . 1.0800000000000001 115.559 -172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.98 -31.95 96.62 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 CA-C-N 122.31 1.861 . . . . 0.32000000000000001 112.395 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.1 pt -98.9 1.49 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 113.008 0.744 . . . . 1.05 113.008 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -79.59 136.77 36.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.34 0.518 . . . . 3.79 110.545 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 1.05 111.356 -178.177 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 33.2 mt . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 121.05 0.452 . . . . 1.1000000000000001 109.915 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -61.83 138.81 58.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.93999999999999995 112.092 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -95.99 11.55 33.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.173 -0.921 . . . . 1.1000000000000001 112.103 171.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -42.41 30.65 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.876 -0.515 . . . . 0.20999999999999999 112.632 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.5 81.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.996 0.427 . . . . 1.02 110.78 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.55 -41.94 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.03 110.47 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.97 -44.04 94.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 1.04 110.464 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.05 -43.73 91.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.924 -0.311 . . . . 1.3700000000000001 110.562 -176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 39.0 m -60.9 -47.52 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.586 -0.446 . . . . 1.04 110.597 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.3 m -62.84 -40.12 96.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.58 -0.448 . . . . 1.05 110.921 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.83 -39.63 89.74 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.969 -0.292 . . . . 1.0700000000000001 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -58.77 -42.58 89.26 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.777 -0.369 . . . . 2.5600000000000001 110.241 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.97 -39.55 95.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.97999999999999998 111.03 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.1 m -59.99 -25.31 65.16 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.238 -0.437 . . . . 0.32000000000000001 112.144 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.139 0 C-N-CA 121.116 -0.564 . . . . 0.60999999999999999 112.614 -179.756 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 pttt . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -143.8 153.12 42.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.581 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -97.3 123.95 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.18 151.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.092 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.0 p -147.79 165.81 29.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.871 0.843 . . . . 0.0 112.061 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -55.62 -34.28 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.38 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.15 90.42 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.785 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -66.38 -46.59 76.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.904 0.383 . . . . 0.0 111.241 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -81.88 -16.64 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.06 -148.3 0.3 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -56.03 -21.25 20.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.196 0.907 . . . . 0.0 112.368 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.0 tp -56.54 -27.83 58.52 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -55.73 111.89 3.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.42 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -89.53 -13.15 2.87 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.766 1.644 . . . . 0.0 114.167 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.31 145.33 25.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.284 0.564 . . . . 0.0 111.813 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.8 p -69.37 -37.16 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.647 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.42 129.65 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.12 -32.77 73.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -168.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -148.55 175.1 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.09 34.38 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 m -107.88 141.1 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.81 137.71 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.45 143.73 30.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 112.06 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.684 173.008 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.222 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.7 157.79 42.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.437 0.637 . . . . 0.0 111.452 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -114.05 127.47 55.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.025 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.17 130.91 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.37 155.25 36.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.735 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.39 -26.74 9.01 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.595 1.53 . . . . 0.0 113.127 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -64.5 -11.82 37.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.55 9.28 66.85 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.543 -0.361 . . . . 0.0 112.911 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.1 m -99.45 140.83 33.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -105.04 131.08 53.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.235 0.54 . . . . 0.0 110.118 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -116.22 148.09 40.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.997 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.35 127.93 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -86.79 -51.8 5.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -103.2 167.49 9.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 112.059 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.106 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -63.23 -41.91 99.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.207 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.04 79.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 110.92 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.77 -41.27 99.16 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.282 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -58.77 -33.99 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.409 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.44 7.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.05 23.46 63.61 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.964 -0.353 . . . . 0.0 113.265 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -84.9 143.16 39.79 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.469 0.635 . . . . 0.0 109.303 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.84 149.07 47.18 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.246 1.297 . . . . 0.0 111.458 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.05 154.88 29.57 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.403 1.402 . . . . 0.0 112.702 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 91.6 mt -61.67 -14.95 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.132 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 t -44.12 -39.05 5.64 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.31 -31.38 94.95 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.306 1.859 . . . . 0.0 112.373 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.4 pt -98.76 7.03 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -78.09 142.03 38.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.447 0.567 . . . . 0.0 110.546 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.3 mt . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.3 m -64.54 141.01 58.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.003 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.8 9.71 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.095 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.04 -44.06 32.34 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.87 -0.519 . . . . 0.0 112.64 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 -47.57 85.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.795 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.43 -42.11 91.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 tp -60.09 -43.89 95.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -58.97 -43.27 91.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.595 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 m -60.87 -47.92 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.588 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.1 m -62.9 -39.84 95.76 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.923 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.81 -39.1 87.69 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.909 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.85 -42.65 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.247 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.88 -39.45 94.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.916 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.7 m -60.05 -25.24 65.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.83 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.6 -179.031 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -148.83 152.72 36.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -92.22 126.74 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.7 tp -126.86 145.73 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.589 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -150.41 161.71 41.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.687 0.756 . . . . 0.0 112.484 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -55.57 -34.97 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.542 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.24 88.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.039 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -71.69 -46.65 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.054 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mp -72.45 -25.76 61.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.13 -147.71 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -55.99 -21.59 22.0 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.367 0.985 . . . . 0.0 112.352 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.93 -25.32 63.37 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 47.0 t-105 -55.8 110.45 2.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.409 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.5 -13.27 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 114.158 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.7 145.76 24.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.304 0.573 . . . . 0.0 111.927 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 p -69.39 -36.86 77.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.67 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.12 129.48 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -61.58 -33.24 73.53 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.98 175.01 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.01 34.26 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 m -106.94 137.56 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.48 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -147.97 144.05 27.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.397 0.617 . . . . 0.0 112.299 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.644 169.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.692 0.282 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -133.16 158.64 43.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.619 0.724 . . . . 0.0 111.886 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -114.08 128.65 56.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.848 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.84 131.37 58.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.14 155.53 36.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.781 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.71 -27.06 10.34 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.533 1.489 . . . . 0.0 113.079 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 p30 -63.99 -12.41 37.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.47 9.69 66.52 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.912 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.8 m -99.37 139.94 34.29 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m -103.54 129.55 50.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -114.69 150.56 35.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.073 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.44 126.06 34.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.311 . . . . 0.0 110.377 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.4 mt -82.99 -51.93 7.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.466 . . . . 0.0 110.187 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -109.18 166.84 10.55 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 111.761 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -52.41 -33.66 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.866 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -61.83 -48.65 79.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 110.775 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.45 -35.1 75.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.243 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.44 -41.2 98.56 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.243 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.04 -33.96 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.47 0.31 8.65 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.14 23.41 63.54 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.963 -0.354 . . . . 0.0 113.244 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -89.0 143.13 30.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 117.465 0.633 . . . . 0.0 109.421 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.14 148.39 44.31 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.256 1.304 . . . . 0.0 111.249 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.4 157.07 32.93 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.387 1.391 . . . . 0.0 112.625 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.61 -13.46 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 119.135 -0.46 . . . . 0.0 112.228 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.5 t -44.0 -39.44 6.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.37 -31.29 94.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 CA-C-N 122.336 1.87 . . . . 0.0 112.387 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.7 pt -98.83 7.83 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -77.34 140.67 40.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.341 -178.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.3 mt . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.984 0.421 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -64.93 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.848 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.55 8.24 39.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.193 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.91 -44.45 31.69 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.85 -0.531 . . . . 0.0 112.922 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.68 76.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.268 0.534 . . . . 0.0 110.778 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.3 tp -59.24 -42.29 90.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.474 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.39 -42.99 97.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.53 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.9 t -59.55 -44.9 93.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.49 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.34 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.552 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.7 m -63.22 -40.04 96.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.31 -39.55 87.4 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.785 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -58.62 -42.77 88.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.09 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.4 m -60.49 -25.16 65.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.993 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.66 -179.298 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -144.55 153.14 41.51 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.271 172.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -93.19 126.57 38.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.8 tp -126.71 142.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.0 p -145.86 164.54 31.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.594 0.711 . . . . 0.0 111.929 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -55.57 -35.52 65.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.154 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.19 85.76 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.603 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -66.33 -46.63 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.577 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.3 mt -91.08 -8.13 49.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 60.93 -146.44 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -57.15 -24.04 51.5 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.306 0.957 . . . . 0.0 112.476 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.16 -22.37 60.84 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -55.85 107.41 0.88 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.228 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.48 -13.27 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.812 1.674 . . . . 0.0 114.174 -174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.72 145.04 26.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.19 0.519 . . . . 0.0 111.66 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 p -69.04 -36.88 78.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.725 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.72 130.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.92 -32.69 73.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -169.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.78 174.43 11.83 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.734 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -107.82 139.97 41.62 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.612 -0.346 . . . . 0.0 110.071 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.49 134.84 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -145.95 142.64 28.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.425 0.631 . . . . 0.0 111.991 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.891 170.438 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.581 0.229 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.8 158.71 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.555 0.693 . . . . 0.0 111.931 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -114.05 129.04 56.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.898 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.9 131.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.61 155.13 36.72 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.749 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.37 -27.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.625 1.55 . . . . 0.0 113.152 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -64.36 -11.65 34.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.68 10.46 67.3 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.84 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.8 m -99.34 139.32 35.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.0 m -103.04 129.96 49.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.346 0.593 . . . . 0.0 110.023 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.47 150.89 37.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.188 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.39 128.88 35.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.697 0.284 . . . . 0.0 110.725 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.6 mt -87.98 -57.12 3.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.094 0.473 . . . . 0.0 110.434 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -105.1 159.14 16.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -47.44 -35.26 8.28 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.095 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -61.64 -44.45 96.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.08 -37.36 74.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.392 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -63.94 -39.22 93.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.026 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.5 -34.02 70.47 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.041 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 0.79 10.04 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.4 63.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.877 -0.402 . . . . 0.0 113.319 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -90.48 143.2 28.91 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.576 0.688 . . . . 0.0 109.668 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.11 148.1 39.14 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.267 1.311 . . . . 0.0 111.271 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.98 158.84 34.37 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.366 1.377 . . . . 0.0 112.939 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 112' ' ' ILE . 88.9 mt -61.13 -11.54 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.353 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.8 t -43.83 -39.82 6.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.39 -32.11 96.01 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 CA-C-N 122.364 1.88 . . . . 0.0 112.433 -174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 23.1 pt -98.74 5.18 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -79.41 135.66 36.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.477 0.581 . . . . 0.0 110.772 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.077 0.465 . . . . 0.0 111.668 -177.701 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.9 mt . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 121.141 0.496 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 139.83 58.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.068 -174.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.99 9.43 37.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.053 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.16 31.73 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.827 -0.546 . . . . 0.0 112.913 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.1 75.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.313 0.557 . . . . 0.0 110.78 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.06 -41.58 88.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.36 -43.76 96.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -60.04 -44.15 94.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.601 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.0 m -60.56 -47.03 87.98 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.504 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.8 m -63.31 -40.4 97.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.68 -38.34 84.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.954 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.5 -42.58 87.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.55 -38.54 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.5 m -59.95 -25.23 65.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.91 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.168 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.676 179.403 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -149.03 150.71 33.26 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.792 168.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -92.59 124.82 36.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 tp -125.83 145.17 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -150.38 162.43 40.56 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.795 0.807 . . . . 0.0 112.419 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.95 -35.18 66.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.537 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.5 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.056 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.93 -46.65 51.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.078 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.17 -147.03 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.8 -22.0 22.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.38 0.991 . . . . 0.0 112.468 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.41 -24.91 63.87 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -55.89 110.98 2.64 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.357 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -89.55 -13.13 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.731 1.621 . . . . 0.0 114.108 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.42 145.47 24.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.191 0.52 . . . . 0.0 111.921 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.2 p -69.58 -37.03 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.663 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.11 129.34 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.97 -33.47 74.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -169.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -147.5 174.36 11.79 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.712 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.02 34.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.7 m -108.08 139.95 41.98 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.7 pt -109.36 139.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -148.01 145.44 28.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 112.303 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.3 m . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.695 173.29 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.24 157.27 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 111.458 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -114.17 128.07 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.946 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.98 130.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.22 155.59 36.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.802 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.47 -26.88 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.473 1.449 . . . . 0.0 113.097 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -64.31 -12.24 39.94 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.43 9.49 66.85 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.927 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.9 m -99.39 140.01 34.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 m -104.36 130.8 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.322 0.582 . . . . 0.0 110.087 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -116.18 148.24 40.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.082 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.4 128.3 35.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.692 0.282 . . . . 0.0 110.722 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.8 mt -87.58 -51.14 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -103.04 166.41 10.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.665 0.745 . . . . 0.0 112.037 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -55.33 -40.16 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.129 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -63.76 -42.06 97.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.334 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.61 -36.32 78.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.29 -41.44 98.98 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.306 176.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -59.2 -33.86 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.317 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.1 -1.54 10.28 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.45 63.67 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.897 -0.391 . . . . 0.0 113.238 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -84.99 134.36 41.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.133 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.33 148.1 91.46 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.062 1.174 . . . . 0.0 111.235 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 157.97 30.36 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.315 1.343 . . . . 0.0 112.302 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 112' ' ' ILE . 91.0 mt -62.07 -11.75 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.256 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.0 t -43.79 -40.05 6.61 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.29 -32.28 96.55 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 CA-C-N 122.25 1.839 . . . . 0.0 112.417 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.7 pt -98.84 7.66 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.03 140.22 40.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.527 0.603 . . . . 0.0 110.399 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 111.82 -176.238 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 84.2 mt . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 121.08 0.466 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.4 m -65.01 140.81 58.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.951 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.95 9.27 36.28 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.139 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.01 -45.18 32.86 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.837 -0.54 . . . . 0.0 112.766 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.04 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.162 0.481 . . . . 0.0 110.707 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.1 tp -59.35 -42.35 91.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -43.31 94.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -58.81 -44.46 90.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.45 -47.34 86.53 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.568 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.3 m -62.51 -40.49 96.89 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.842 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.68 -39.41 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.858 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -58.8 -42.83 90.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 110.277 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.57 -38.21 90.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.191 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.8 m -60.08 -25.14 65.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.957 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.61 179.761 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -143.59 153.08 42.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.412 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.28 123.63 36.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 tp -125.45 145.77 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.484 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.0 p -148.48 162.94 38.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.776 0.798 . . . . 0.0 112.262 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -56.54 -34.76 67.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.478 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.55 91.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.067 -176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -69.24 -46.72 66.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 0.0 111.032 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.7 -25.12 61.12 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.39 -148.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -55.37 -20.6 12.37 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.352 0.978 . . . . 0.0 112.417 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.75 -23.41 63.2 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -55.9 112.89 4.84 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.326 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.53 -13.24 2.85 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.863 1.709 . . . . 0.0 114.157 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -93.27 145.81 24.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.184 0.516 . . . . 0.0 111.722 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.96 -36.72 75.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.648 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.77 130.35 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -64.41 -30.59 71.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -150.64 176.86 10.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.725 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.66 162.07 34.41 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -107.47 139.84 41.35 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.7 pt -109.22 137.48 41.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -144.91 144.09 30.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.279 0.561 . . . . 0.0 112.008 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.712 173.459 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.24 157.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.344 0.592 . . . . 0.0 111.372 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.4 t80 -114.05 127.06 55.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.129 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.7 130.69 58.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.91 155.75 36.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.729 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.51 -26.68 9.25 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.44 1.427 . . . . 0.0 113.126 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -64.18 -12.56 41.46 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.96 9.17 66.17 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.911 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.4 m -99.41 139.35 35.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.412 0.606 . . . . 0.0 109.396 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.8 m -103.46 131.91 50.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.058 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.36 129.24 35.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.695 0.283 . . . . 0.0 110.796 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 mt -88.3 -51.88 5.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -103.6 167.6 9.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.615 0.721 . . . . 0.0 111.959 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -55.47 -40.32 71.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.975 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -63.3 -41.56 98.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.326 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.71 79.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.832 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.04 -40.89 99.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.859 0.361 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.51 -34.07 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.714 0.292 . . . . 0.0 111.303 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.01 1.97 7.87 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.51 63.61 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.27 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -84.75 143.18 40.25 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.45 150.99 47.22 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.278 1.319 . . . . 0.0 111.931 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.89 151.97 36.2 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.299 1.332 . . . . 0.0 112.925 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 91.4 mt -61.99 -13.31 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.2 t -46.76 -35.27 4.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.09 -33.78 97.73 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 CA-C-N 123.038 2.121 . . . . 0.0 112.039 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 18.6 pt -98.94 7.77 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -77.26 142.3 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.684 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.152 0.501 . . . . 0.0 111.435 -178.124 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.6 mt . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -62.1 140.51 58.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.179 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.48 6.98 47.13 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.241 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.21 -44.84 34.56 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.84 -0.538 . . . . 0.0 112.629 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.67 84.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.153 0.477 . . . . 0.0 110.74 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.59 -42.23 92.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.456 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.11 -43.81 95.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.453 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -59.21 -43.35 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.641 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.54 -47.95 83.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.563 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.8 m -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.772 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.75 -39.0 87.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.8 -42.94 90.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.301 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.159 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.02 -25.3 65.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.772 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.224 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.911 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -145.62 153.12 40.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.589 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -90.87 123.71 34.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.9 tp -124.55 146.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -148.99 161.62 41.55 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.804 0.811 . . . . 0.0 112.437 -173.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -56.45 -34.78 67.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.34 91.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.106 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.25 -46.72 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.04 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -72.5 -28.99 63.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.82 -141.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -54.0 -28.33 37.36 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.797 1.181 . . . . 0.0 112.058 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.96 -26.92 50.2 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -55.82 109.97 1.98 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.709 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -89.56 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.828 1.685 . . . . 0.0 114.108 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.2 mt -91.24 145.88 24.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 111.819 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -69.82 -37.11 76.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.623 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.49 129.95 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -64.38 -31.0 72.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -168.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -149.53 176.73 10.36 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.615 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.01 34.28 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -106.99 140.39 39.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 pt -109.51 138.66 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -144.96 144.15 30.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.568 . . . . 0.0 111.946 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.7 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.815 173.69 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.711 0.291 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.34 155.78 41.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.308 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -114.16 127.52 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.139 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.5 131.12 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 36.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.852 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.2 -26.99 8.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.537 1.491 . . . . 0.0 113.106 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -64.8 -11.19 34.15 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 9.47 66.9 Favored Glycine 0 CA--C 1.537 1.422 0 O-C-N 122.104 -0.372 . . . . 0.0 112.921 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.0 m -99.44 138.95 35.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.86 130.96 50.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.209 0.528 . . . . 0.0 110.003 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.96 148.06 41.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.235 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.33 127.05 35.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.691 0.282 . . . . 0.0 110.714 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -85.22 -50.91 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.976 0.417 . . . . 0.0 110.332 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.92 167.65 9.57 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.67 0.748 . . . . 0.0 111.921 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -58.22 -37.54 75.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.076 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.77 -41.18 98.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.199 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.39 -36.94 79.27 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.33 -40.11 96.42 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.458 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -58.57 -33.94 70.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.157 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.24 1.59 7.41 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.51 63.58 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.946 -0.364 . . . . 0.0 113.253 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -86.59 143.19 35.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 117.498 0.649 . . . . 0.0 109.386 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.18 152.24 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.297 1.331 . . . . 0.0 111.349 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.04 157.84 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.297 1.331 . . . . 0.0 112.431 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 112' ' ' ILE . 81.4 mt -62.91 -10.12 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 t -43.84 -39.6 6.0 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -172.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.8 -33.72 98.62 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 CA-C-N 122.385 1.887 . . . . 0.0 112.232 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 23.8 pt -98.9 7.44 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -77.61 139.3 39.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.336 0.516 . . . . 0.0 110.474 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 111.398 -177.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -59.53 139.2 57.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.9 mt -94.92 6.28 49.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.314 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -44.2 37.86 Favored Glycine 0 CA--C 1.526 0.758 0 O-C-N 121.873 -0.517 . . . . 0.0 112.741 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 -47.84 83.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.243 0.521 . . . . 0.0 110.76 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.89 -42.43 93.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.57 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.0 tp -60.41 -43.03 97.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.523 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.2 t -58.91 -43.97 91.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.764 0.316 . . . . 0.0 110.531 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.13 -47.78 84.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.583 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.7 m -62.65 -40.56 97.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.802 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.019 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.31 -43.65 88.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.247 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.13 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.085 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.12 -25.14 65.23 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.09 0 C-N-CA 121.351 -0.452 . . . . 0.0 112.665 -179.672 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 mttt . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -148.83 150.81 33.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.15 126.09 39.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 tp -125.57 144.42 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.465 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 160.47 43.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.724 0.774 . . . . 0.0 112.356 -173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.66 -34.74 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.525 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.76 90.71 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.116 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -70.59 -46.54 63.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.171 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.36 -25.05 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.87 -148.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -55.7 -20.48 14.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.271 0.941 . . . . 0.0 112.367 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.75 -24.3 63.94 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -55.85 112.89 4.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.264 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -89.54 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.812 1.675 . . . . 0.0 114.144 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.82 144.87 25.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 111.656 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.7 p -69.09 -37.41 78.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.585 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -64.27 129.77 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.08 -33.6 74.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -147.58 174.61 11.59 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.879 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 161.98 34.23 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.5 m -107.45 139.98 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 pt -109.58 138.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.79 145.9 31.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.24 0.543 . . . . 0.0 111.918 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.768 173.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 155.6 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.389 0.614 . . . . 0.0 111.405 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -114.1 127.54 55.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.134 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.15 130.9 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.35 155.91 35.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.838 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.61 -25.82 8.37 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.453 1.435 . . . . 0.0 113.139 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -65.23 -11.8 44.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.76 67.73 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 122.055 -0.403 . . . . 0.0 112.964 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.6 m -99.52 139.37 35.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.5 m -104.09 132.93 49.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 109.889 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -118.26 151.27 37.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.54 125.02 34.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.691 0.281 . . . . 0.0 110.646 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.9 mt -83.45 -50.33 8.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 109.918 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -103.27 167.56 9.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.574 0.702 . . . . 0.0 111.502 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.3 -38.8 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.954 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.93 -43.02 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.441 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.68 79.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 110.723 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -63.33 -41.42 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.278 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -58.6 -32.79 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.514 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 2.38 6.27 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.09 23.48 63.51 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.176 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.76 142.4 45.39 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 153.83 76.58 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 121.316 1.344 . . . . 0.0 111.737 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.06 151.58 27.29 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.375 1.383 . . . . 0.0 112.509 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 92.9 mt -64.02 -16.57 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.223 -0.418 . . . . 0.0 111.878 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.2 t -46.73 -35.26 4.84 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.38 -32.63 96.6 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 CA-C-N 123.155 2.163 . . . . 0.0 111.935 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.0 pt -98.75 6.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -78.28 138.79 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.305 0.502 . . . . 0.0 110.74 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 121.162 0.506 . . . . 0.0 111.718 -177.282 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.1 0.476 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m -60.34 138.47 57.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.993 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -95.24 7.33 46.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.27 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -43.11 36.88 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.755 -0.591 . . . . 0.0 112.63 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.62 80.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.061 0.43 . . . . 0.0 110.781 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 tp -59.86 -42.51 93.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.23 -43.17 96.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.475 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 t -59.24 -43.95 92.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.547 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.0 m -59.93 -47.58 85.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.576 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.3 m -62.67 -40.95 98.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.04 -38.35 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.628 0.252 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.47 -43.7 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 110.2 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.88 -39.28 93.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.902 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.9 m -60.05 -25.16 65.13 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.841 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.189 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.842 -179.113 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mttp . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -152.1 151.45 31.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -93.37 127.33 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 tp -127.73 145.46 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.509 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -150.48 160.89 43.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.734 0.778 . . . . 0.0 112.387 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -55.54 -34.94 65.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.12 89.99 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.031 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.16 -46.67 60.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.063 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.45 -26.78 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.79 -145.39 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -55.56 -23.27 25.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.486 1.039 . . . . 0.0 112.285 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.0 -23.57 63.76 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -55.86 111.13 2.8 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.37 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -89.53 -13.18 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.845 1.697 . . . . 0.0 114.056 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.06 145.36 25.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 111.964 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.5 p -70.03 -37.29 75.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.535 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.65 129.59 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.84 -33.97 75.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.042 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -148.42 175.03 11.46 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.601 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.79 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -108.15 138.68 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 pt -106.81 134.37 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.32 145.18 30.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.417 0.627 . . . . 0.0 111.994 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.006 170.014 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.22 156.35 42.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.464 0.649 . . . . 0.0 111.814 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -114.04 128.0 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.795 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.51 131.77 56.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.16 155.4 36.46 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.834 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.73 -27.1 10.46 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.62 1.546 . . . . 0.0 113.092 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -64.49 -11.69 36.43 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.55 66.63 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.936 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -99.42 140.29 33.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.7 m -103.75 129.23 51.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 110.093 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -114.79 151.88 33.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.04 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.3 124.93 33.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 110.43 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.2 -47.42 14.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.152 0.501 . . . . 0.0 109.809 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -115.36 167.62 10.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -53.84 -33.81 57.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.716 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -61.18 -49.01 78.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.323 0.582 . . . . 0.0 110.637 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.86 -37.39 76.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.09 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -61.42 -42.16 98.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.014 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -57.74 -33.96 69.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.8 9.18 3.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.5 63.6 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 122.177 -0.327 . . . . 0.0 113.358 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -97.01 112.08 59.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.366 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -54.78 150.4 36.85 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.472 1.204 . . . . 0.0 111.592 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.45 158.88 55.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.266 1.311 . . . . 0.0 112.391 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 112' ' ' ILE . 76.6 mt -61.59 -10.81 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 t -44.21 -38.92 5.64 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -172.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.92 -33.59 98.74 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.612 1.968 . . . . 0.0 112.21 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.9 pt -98.81 6.75 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -77.45 141.59 39.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.497 0.589 . . . . 0.0 110.796 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.416 -179.411 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 121.156 0.503 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -62.79 138.79 58.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.168 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -96.2 11.18 35.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.953 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -44.59 31.1 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.825 -0.547 . . . . 0.0 112.851 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.58 77.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.313 0.557 . . . . 0.0 110.797 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.15 -42.05 89.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -60.38 -43.69 96.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.656 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.9 p -60.61 -42.56 97.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.721 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.09 -47.18 87.52 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.642 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.1 m -63.09 -40.54 97.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.08 -39.46 86.15 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.799 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -58.76 -42.88 89.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.297 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.96 -39.28 91.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.055 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.6 m -59.93 -25.29 65.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.013 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.622 179.88 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.7 mttp . . . . . 0 N--CA 1.464 0.263 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -149.61 151.1 33.23 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.866 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -93.76 126.99 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 tp -128.25 145.95 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.144 -0.223 . . . . 0.0 110.597 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.39 161.23 42.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.695 0.76 . . . . 0.0 112.502 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -55.99 -34.82 66.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.535 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.54 86.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.07 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.33 -46.64 54.69 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.012 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.71 -26.19 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.56 -146.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -54.1 -28.1 37.2 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.412 1.006 . . . . 0.0 111.952 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.2 tp -53.97 -26.54 26.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -55.69 111.09 2.72 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.318 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.69 -13.1 2.81 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.771 1.647 . . . . 0.0 114.197 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.82 145.36 25.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.204 0.526 . . . . 0.0 111.84 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.8 p -69.22 -37.12 77.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.62 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.36 129.23 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.66 -34.04 75.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.8 174.84 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.471 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.03 34.29 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -108.09 137.81 45.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 pt -106.82 133.15 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -146.81 147.17 30.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.469 0.652 . . . . 0.0 111.93 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.742 167.79 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.66 158.62 42.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.57 0.7 . . . . 0.0 111.938 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -114.09 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.767 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.55 131.45 57.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.14 155.21 36.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.823 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.69 -27.05 10.25 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.599 1.533 . . . . 0.0 113.103 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.1 p30 -64.11 -12.17 36.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.19 10.05 66.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.889 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 m -99.4 139.9 34.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.24 129.53 50.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.302 0.572 . . . . 0.0 110.124 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -114.58 149.41 36.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.038 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.32 126.17 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.821 0.343 . . . . 0.0 110.439 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.5 mt -83.71 -51.75 6.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -111.93 167.63 10.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.7 0.762 . . . . 0.0 111.924 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.92 -34.22 54.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -60.77 -47.07 88.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.325 0.584 . . . . 0.0 110.459 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.406 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.25 -41.25 98.27 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.236 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -59.49 -34.0 72.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.259 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.34 -2.88 12.0 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.53 63.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 122.128 -0.358 . . . . 0.0 113.166 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -88.93 143.2 31.08 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 117.454 0.627 . . . . 0.0 109.566 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.42 148.11 37.64 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.203 1.269 . . . . 0.0 111.324 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -76.09 158.78 37.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.368 1.378 . . . . 0.0 112.684 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.77 -12.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 119.013 -0.518 . . . . 0.0 112.28 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.8 t -43.76 -39.64 5.88 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.44 -31.91 95.56 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 CA-C-N 122.35 1.875 . . . . 0.0 112.432 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 20.0 pt -98.84 6.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -77.57 137.54 38.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.54 0.609 . . . . 0.0 110.453 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 111.778 -176.148 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 121.099 0.476 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.0 m -65.03 140.88 58.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.055 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.43 8.63 39.82 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.14 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.1 -43.67 32.56 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.897 -0.502 . . . . 0.0 112.745 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.45 -49.48 77.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.161 0.48 . . . . 0.0 110.84 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 29.9 tp -58.82 -42.0 88.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.476 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.82 -44.22 94.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.484 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -59.96 -43.9 94.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.666 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.1 m -60.5 -46.75 88.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.449 . . . . 0.0 110.58 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.5 m -63.14 -41.35 99.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.01 -39.4 85.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.746 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.33 -42.39 91.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.56 -39.69 94.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -63.12 -25.18 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.144 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.144 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.636 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -139.01 152.81 47.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.656 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -93.87 126.21 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 tp -124.91 144.85 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.9 p -150.38 160.82 43.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.673 0.749 . . . . 0.0 112.447 -173.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -55.64 -34.68 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.567 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.64 -42.17 87.69 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.104 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -73.64 -46.61 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.375 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.36 -27.78 63.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.4 -142.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -54.11 -28.88 42.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.683 1.129 . . . . 0.0 111.883 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -56.98 -24.77 55.78 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -55.91 107.49 0.9 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.368 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -87.2 -13.24 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.703 1.602 . . . . 0.0 114.136 -175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.0 mt -89.59 145.56 25.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.559 . . . . 0.0 111.94 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.3 p -69.85 -37.28 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.719 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.15 130.13 30.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.02 -33.4 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.043 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -147.01 174.55 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.667 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.72 162.09 34.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -107.92 140.58 40.83 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.539 -0.389 . . . . 0.0 110.112 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.96 135.36 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.36 143.57 31.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.295 0.569 . . . . 0.0 112.151 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.672 173.765 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.8 m -131.86 155.23 41.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 111.225 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -114.1 128.04 56.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.031 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.97 131.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.52 155.32 36.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.75 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.42 -26.54 8.83 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.565 1.51 . . . . 0.0 113.111 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -64.43 -12.17 40.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.36 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.92 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.9 m -99.41 140.01 34.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.6 m -104.73 130.92 52.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 110.095 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -116.32 148.41 40.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.0 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.28 124.94 33.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.767 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 mt -82.18 -48.5 11.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 0.0 109.982 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.5 p30 -108.39 167.63 9.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.47 0.653 . . . . 0.0 111.606 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -55.03 -40.99 70.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.979 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -63.42 -42.47 98.72 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.37 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.27 78.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.077 0.465 . . . . 0.0 110.616 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -62.32 -41.7 98.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.944 0.402 . . . . 0.0 110.213 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -57.69 -33.07 67.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.495 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.79 9.92 3.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.47 63.67 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.359 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -94.64 112.03 56.33 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.097 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.39 153.41 40.97 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.183 1.255 . . . . 0.0 111.569 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.35 158.84 56.0 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.263 1.309 . . . . 0.0 112.283 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.408 HG22 HD13 ' A' ' 112' ' ' ILE . 74.7 mt -62.75 -9.92 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.8 t -44.43 -38.69 5.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.93 -33.14 98.55 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 CA-C-N 122.474 1.919 . . . . 0.0 112.329 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.8 pt -98.91 6.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -77.53 140.84 39.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.479 0.581 . . . . 0.0 110.522 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 -178.286 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.9 mt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.156 0.503 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -65.08 140.89 58.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.89 9.55 38.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.13 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -45.86 32.97 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.841 -0.537 . . . . 0.0 112.838 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.79 87.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.237 0.518 . . . . 0.0 110.822 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.492 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.465 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -58.65 -43.13 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.662 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.91 -47.74 85.03 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.584 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.4 m -62.62 -40.11 95.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.856 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.97 -39.93 87.33 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.788 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.82 -43.64 90.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.292 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.58 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.334 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.92 -25.23 64.98 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.117 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.709 178.084 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.9 mttm . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -151.18 152.57 33.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -95.91 128.57 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 tp -128.0 145.0 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -150.12 161.63 42.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.706 0.765 . . . . 0.0 112.466 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.69 -34.42 65.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.547 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.39 90.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.104 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -69.89 -46.76 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.953 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.91 -25.67 61.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.9 -147.61 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -55.92 -21.16 19.02 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.34 0.973 . . . . 0.0 112.292 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.87 -23.43 63.43 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -55.75 113.08 5.06 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.3 -176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -89.67 -13.25 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.752 1.635 . . . . 0.0 114.306 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -94.15 147.31 23.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.173 0.511 . . . . 0.0 111.915 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.0 p -69.58 -36.4 76.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.728 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.69 128.22 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.88 -33.93 75.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -148.61 174.94 11.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.557 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 162.07 34.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 m -108.58 140.47 41.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.611 -0.346 . . . . 0.0 110.076 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 pt -108.47 136.77 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.35 143.56 31.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.391 0.615 . . . . 0.0 111.941 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.744 173.033 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.576 0.227 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.54 154.64 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.498 0.666 . . . . 0.0 111.491 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -114.04 127.91 56.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.801 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.31 131.86 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.48 155.17 36.68 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.821 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.7 -26.87 10.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.629 1.553 . . . . 0.0 113.018 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -64.22 -12.16 38.13 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.72 10.37 67.31 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 121.491 -0.385 . . . . 0.0 112.832 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 m -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.6 m -101.52 130.43 47.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.261 0.553 . . . . 0.0 109.943 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.65 147.23 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.813 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.31 124.99 33.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 110.794 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.93 -48.27 11.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -112.55 167.58 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.614 0.721 . . . . 0.0 112.004 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -53.79 -40.76 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.151 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -63.36 -41.11 98.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.252 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.47 -38.61 77.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.695 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.16 -40.71 98.33 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.412 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -58.01 -33.88 69.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.314 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.89 7.53 4.7 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.48 63.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.227 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -94.49 111.99 55.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.361 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.72 151.51 31.75 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.189 1.259 . . . . 0.0 111.358 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.1 158.98 45.04 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.476 1.451 . . . . 0.0 112.705 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 112' ' ' ILE . 80.1 mt -59.64 -12.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.344 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 t -43.36 -40.71 6.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -58.05 -30.04 88.9 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 122.507 1.931 . . . . 0.0 112.703 -173.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.8 pt -98.9 7.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -68.58 149.18 49.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.742 0.701 . . . . 0.0 110.801 -176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 111.626 -178.104 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 121.046 0.45 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -69.27 141.46 54.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.997 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.4 mt -91.87 5.83 48.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.318 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.89 -43.74 39.82 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.792 -0.567 . . . . 0.0 112.543 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.94 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 110.78 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.62 -42.77 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.18 -42.89 95.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.435 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 m -59.54 -43.69 93.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.687 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.4 m -61.37 -47.82 84.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.605 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.6 m -63.56 -39.62 94.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.939 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.19 -38.74 87.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.936 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.36 -43.2 88.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.894 0.378 . . . . 0.0 110.222 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.76 -39.68 94.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.893 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.2 m -60.07 -25.2 65.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.631 -179.36 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.2 tttp . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -145.61 153.15 40.74 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.056 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -95.02 128.25 41.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tp -126.57 141.49 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.0 p -144.23 164.66 30.08 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.595 0.712 . . . . 0.0 111.865 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -55.69 -36.15 66.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.322 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.04 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.765 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -70.63 -46.58 63.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.936 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.0 mt -85.03 -9.45 58.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.7 -151.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -56.03 -20.08 15.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.914 0.779 . . . . 0.0 112.366 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -57.54 -25.79 60.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.1 t-105 -55.79 107.18 0.81 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.27 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.21 -13.17 4.51 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.832 1.688 . . . . 0.0 114.068 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -88.21 145.69 25.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.36 0.6 . . . . 0.0 112.062 -174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.3 p -69.83 -36.89 75.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.72 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.22 129.01 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.67 -32.43 72.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -146.78 174.35 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.652 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -107.81 140.32 41.07 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.625 -0.338 . . . . 0.0 110.1 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 pt -109.34 137.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -148.04 146.45 28.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.384 0.611 . . . . 0.0 112.067 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.8 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.722 173.451 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.52 156.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.328 0.585 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -114.08 128.35 56.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.069 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.18 130.76 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.32 155.32 36.53 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.762 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.49 -26.8 9.35 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.495 1.463 . . . . 0.0 113.064 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -63.88 -12.71 39.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.84 9.68 65.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 122.071 -0.393 . . . . 0.0 112.91 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m -99.43 139.72 34.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -104.47 131.62 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 0.0 110.09 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.81 149.31 41.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.18 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.36 128.22 35.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.704 0.288 . . . . 0.0 110.648 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.87 -52.66 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.478 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -103.12 167.61 9.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.598 0.714 . . . . 0.0 112.117 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.86 -40.46 69.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.148 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -63.88 -42.03 97.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.301 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.11 79.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.12 -41.02 99.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.288 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.13 -33.94 71.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.638 0.256 . . . . 0.0 111.317 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.66 -1.7 12.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.44 63.72 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.907 -0.385 . . . . 0.0 113.16 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -83.2 135.86 44.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.207 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.07 147.85 94.32 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.053 1.168 . . . . 0.0 111.27 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.07 158.87 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.445 1.43 . . . . 0.0 112.481 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 112' ' ' ILE . 86.9 mt -62.31 -10.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 t -43.64 -40.03 6.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.14 -32.19 96.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.293 1.855 . . . . 0.0 112.605 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 pt -98.96 7.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 149.81 42.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.718 0.69 . . . . 0.0 110.882 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 172.868 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.043 0.449 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -59.79 137.09 58.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.275 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.5 mt -99.16 6.81 46.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.304 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.65 -43.55 37.42 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.822 -0.549 . . . . 0.0 112.771 -173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.93 75.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.248 0.524 . . . . 0.0 110.814 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.55 -42.15 91.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.7 tp -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.494 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.55 -43.31 93.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.595 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.6 m -60.99 -48.0 83.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.594 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.1 m -63.11 -40.48 97.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.805 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.09 -38.96 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.958 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -58.51 -43.76 89.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.368 . . . . 0.0 110.2 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.01 -39.55 95.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.988 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.94 -25.33 65.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.032 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.192 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.554 -179.686 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -150.6 147.51 27.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.79 167.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -98.96 126.35 44.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 tt -132.04 152.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.276 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.8 p -150.44 166.41 30.19 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.683 0.754 . . . . 0.0 111.82 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -55.61 -34.6 65.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.238 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.68 88.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.743 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -66.23 -46.49 76.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.368 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.73 -14.74 47.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.47 -148.99 0.28 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.26 -20.85 20.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.105 0.866 . . . . 0.0 112.343 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.47 -23.28 57.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -55.83 113.46 5.75 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.427 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -89.61 -13.2 2.82 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.786 1.658 . . . . 0.0 114.086 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.07 144.9 24.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.243 0.544 . . . . 0.0 111.875 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.1 p -68.65 -37.15 79.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.627 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.32 130.36 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -63.9 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -168.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -152.98 177.26 10.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.662 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.08 34.33 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m -108.17 141.49 39.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 pt -108.95 136.77 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -139.78 140.31 36.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.444 0.64 . . . . 0.0 111.949 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.108 170.72 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 159.0 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.459 0.647 . . . . 0.0 111.402 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -114.09 126.54 55.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.78 129.68 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.89 155.79 36.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.676 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.85 -26.84 10.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.541 1.494 . . . . 0.0 113.109 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -63.88 -12.86 40.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.83 66.43 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.886 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -99.34 139.74 34.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -104.84 129.07 53.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.013 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -114.07 149.64 35.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.008 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.45 128.98 35.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.723 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.4 mt -88.54 -52.16 5.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.445 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p30 -103.22 167.41 9.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 112.192 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -55.43 -40.4 71.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.063 -173.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -62.85 -41.7 99.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.67 80.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 0.0 110.958 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.81 -41.35 99.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.312 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.37 -33.97 71.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.71 0.291 . . . . 0.0 111.346 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.99 -1.07 10.82 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.49 63.64 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.093 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -83.2 143.15 44.78 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.528 0.664 . . . . 0.0 109.251 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.02 147.77 55.47 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.235 1.29 . . . . 0.0 111.379 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.14 154.77 29.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.332 1.354 . . . . 0.0 112.772 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.64 -16.63 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.021 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 t -44.46 -38.53 5.58 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.99 -31.89 96.54 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.383 1.887 . . . . 0.0 112.193 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.4 pt -98.05 3.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -78.18 135.66 37.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.47 0.577 . . . . 0.0 110.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.189 0.519 . . . . 0.0 111.862 -175.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.5 mt . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.975 0.416 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 140.39 58.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.126 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.5 mt -95.3 9.72 38.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.1 171.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.13 -44.05 33.12 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.845 -0.534 . . . . 0.0 112.648 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.78 84.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.121 0.46 . . . . 0.0 110.666 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.6 tp -59.32 -42.06 90.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 110.51 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -60.01 -44.4 94.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.496 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 m -59.2 -42.69 91.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.63 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.61 -47.97 83.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.641 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.8 m -62.86 -40.15 96.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.729 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.72 -39.0 86.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -58.66 -42.65 88.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.29 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.13 -39.12 93.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.96 -25.19 65.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.869 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.252 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.475 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.6 tttm . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -150.2 147.95 28.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.952 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -96.79 127.37 42.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 tp -128.0 143.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.984 -176.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.5 p -143.88 164.82 29.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.516 0.674 . . . . 0.0 111.552 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -55.55 -36.22 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.163 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.52 84.29 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.766 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -70.44 -45.06 66.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.3 mt -87.23 -8.68 56.56 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.78 -149.57 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -55.76 -21.74 20.55 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.036 0.834 . . . . 0.0 112.336 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -56.42 -28.07 58.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -55.69 107.25 0.82 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.397 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.34 -13.18 4.4 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.755 1.637 . . . . 0.0 114.15 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.73 145.05 26.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.82 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -69.55 -37.5 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.509 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.7 m -63.68 129.72 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.22 -33.44 75.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.16 173.14 12.79 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.709 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 161.99 34.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m -108.13 139.58 42.58 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.575 -0.368 . . . . 0.0 110.082 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 pt -107.58 136.18 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.34 143.69 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.462 0.649 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.143 171.017 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.03 157.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.413 0.625 . . . . 0.0 111.412 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -114.07 127.02 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.933 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.02 131.03 58.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -101.18 155.96 35.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.812 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.51 -26.67 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.503 1.469 . . . . 0.0 113.19 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -64.96 -11.58 40.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.94 9.62 67.7 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.944 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.5 m -99.43 139.9 34.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -104.58 130.57 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.1 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.54 148.02 40.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.005 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.36 127.53 35.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.762 0.315 . . . . 0.0 110.835 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.16 -50.46 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.344 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -105.66 167.6 9.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.637 0.732 . . . . 0.0 111.95 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.33 -40.74 71.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.159 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -64.09 -40.94 97.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.288 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.98 -37.66 77.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.57 -40.36 96.77 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.342 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -58.26 -34.02 70.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.211 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.62 1.82 7.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.92 23.55 63.77 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.986 -0.341 . . . . 0.0 113.227 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -88.24 125.99 62.12 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.219 172.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.68 152.48 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 CA-C-N 120.614 1.255 . . . . 0.0 111.372 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.07 158.01 30.45 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.357 1.371 . . . . 0.0 112.344 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.421 HG21 HD12 ' A' ' 112' ' ' ILE . 85.3 mt -62.04 -11.18 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.993 -0.527 . . . . 0.0 112.291 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 t -44.09 -39.64 6.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.68 -32.45 95.8 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-N 122.296 1.856 . . . . 0.0 112.401 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.8 pt -98.82 7.69 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -77.8 139.95 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.458 0.572 . . . . 0.0 110.398 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -177.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.1 mt . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 121.056 0.455 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -64.63 140.99 58.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.109 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -93.9 8.53 40.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.16 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.88 -44.16 31.27 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 121.808 -0.557 . . . . 0.0 112.764 -173.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.18 82.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.136 0.468 . . . . 0.0 110.759 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 32.8 tp -59.5 -41.99 91.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.464 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.7 m -59.18 -43.52 92.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.597 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.2 m -61.02 -47.5 86.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.651 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.9 m -62.99 -40.08 96.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.815 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.65 -39.67 89.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -58.65 -42.41 88.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.342 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.97 -39.2 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.025 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.9 m -60.01 -25.22 65.12 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.938 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.16 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.644 -179.774 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.4 tttp . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -146.46 153.04 39.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.917 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -91.98 125.6 36.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 tp -123.26 144.31 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.3 p -150.06 160.51 43.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.614 0.721 . . . . 0.0 112.299 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.57 -34.28 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.545 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.25 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.059 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -70.74 -46.66 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -73.57 -23.24 59.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.25 -150.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.08 -26.59 27.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.112 0.869 . . . . 0.0 111.797 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -53.06 -28.28 24.02 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -55.77 107.13 0.79 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.189 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.22 -13.29 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.757 1.638 . . . . 0.0 114.113 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.31 144.43 28.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.202 0.525 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -68.17 -37.13 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.777 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.16 129.76 31.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -61.76 -32.95 73.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -147.1 174.55 11.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.07 34.34 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -107.51 138.46 43.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.659 -0.318 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -108.98 132.83 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -148.07 144.91 28.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.38 0.61 . . . . 0.0 112.27 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.4 m . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.465 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.672 0.273 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.72 158.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.614 0.721 . . . . 0.0 111.921 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.15 129.18 56.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.879 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.88 131.73 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.66 155.15 36.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.666 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -48.85 -25.75 8.88 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.487 1.458 . . . . 0.0 113.104 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.1 p30 -65.27 -11.74 44.44 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.38 67.6 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.847 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.9 m -99.4 138.63 36.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 m -103.18 129.37 50.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.231 0.538 . . . . 0.0 110.067 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -114.14 148.83 36.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.024 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.28 125.93 34.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.325 . . . . 0.0 110.409 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.05 -51.38 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -112.38 167.59 10.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.658 0.742 . . . . 0.0 112.012 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -52.32 -34.02 45.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.777 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -61.71 -47.43 85.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.9 -34.29 74.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.424 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -62.31 -41.14 98.28 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.131 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -59.08 -34.01 71.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.064 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.09 -3.35 12.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.46 63.71 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.65 -0.309 . . . . 0.0 113.242 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -89.75 143.2 29.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.393 0.597 . . . . 0.0 109.593 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 150.17 47.42 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.242 1.295 . . . . 0.0 111.265 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.97 158.94 30.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.373 1.382 . . . . 0.0 112.783 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 92.5 mt -60.02 -14.0 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.159 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.5 t -42.97 -41.33 6.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -61.76 -27.41 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 CA-C-N 122.039 1.764 . . . . 0.0 112.656 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.5 pt -98.8 6.64 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -75.87 143.38 41.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.884 0.766 . . . . 0.0 110.828 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.812 176.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 87.3 mt . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 121.15 0.5 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -64.08 140.88 58.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.238 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.3 mt -95.11 10.86 34.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.053 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.7 -45.44 30.76 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.8 -0.563 . . . . 0.0 112.877 -173.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.85 -48.48 81.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.263 0.531 . . . . 0.0 110.835 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.2 tp -59.31 -42.1 90.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.463 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.8 tp -59.59 -44.17 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -59.82 -44.2 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.599 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.9 m -60.27 -46.29 90.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.565 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.6 m -62.35 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.976 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.0 -39.61 86.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.677 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.51 -41.97 91.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.05 -39.72 93.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.97 -25.21 65.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.794 177.322 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 tttt . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -143.95 150.01 37.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -126.87 146.69 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.713 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.7 p -150.52 160.55 43.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.691 0.758 . . . . 0.0 112.305 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -55.48 -34.84 64.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.477 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.14 90.54 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.183 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -70.08 -46.58 64.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.287 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.12 -25.7 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.23 -148.64 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.25 -20.06 16.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.3 0.954 . . . . 0.0 112.429 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.5 -24.17 63.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -55.88 112.59 4.49 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.32 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.52 -13.24 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.754 1.636 . . . . 0.0 114.166 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.3 mt -90.9 145.21 24.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.532 . . . . 0.0 111.883 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.03 -37.5 78.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.58 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.88 129.94 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -62.34 -33.59 75.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.95 174.49 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.765 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.06 34.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -108.09 140.07 41.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.16 136.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.74 144.12 39.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.583 . . . . 0.0 111.988 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.695 172.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.685 0.279 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.36 156.77 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.367 0.603 . . . . 0.0 111.306 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -114.08 126.47 55.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.048 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.27 130.49 57.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.28 155.83 35.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.819 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.52 -26.68 9.28 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.588 1.525 . . . . 0.0 113.105 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.3 p30 -64.74 -11.91 41.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.23 67.12 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 122.123 -0.361 . . . . 0.0 112.913 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.6 m -99.39 140.14 34.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.85 130.46 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.17 0.509 . . . . 0.0 110.102 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.69 149.06 38.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.106 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.28 126.93 35.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.696 0.284 . . . . 0.0 110.805 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.36 -50.52 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.965 0.412 . . . . 0.0 110.226 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.34 167.6 9.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 111.687 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -56.75 -38.37 72.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.062 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -64.79 -41.79 95.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.548 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.88 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.811 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.05 -52.09 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.338 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.67 -20.27 66.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.06 9.85 3.37 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.55 63.32 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 122.28 -0.262 . . . . 0.0 113.456 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -96.98 112.97 62.18 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -54.27 152.72 24.43 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 CA-C-N 120.577 1.242 . . . . 0.0 111.7 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.02 158.98 30.7 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.457 1.438 . . . . 0.0 112.75 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.29 -10.68 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.302 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.3 t -42.19 -41.81 5.47 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.14 -30.19 81.91 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 122.004 1.752 . . . . 0.0 112.612 -173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.7 pt -98.87 5.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -75.63 143.03 42.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.835 0.743 . . . . 0.0 110.555 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.897 0.379 . . . . 0.0 111.105 -179.402 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 45.4 mt . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.968 0.413 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -63.49 140.63 58.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.015 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -93.16 9.81 34.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.121 171.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.78 -44.14 30.51 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.858 -0.526 . . . . 0.0 112.757 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.17 82.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.161 0.481 . . . . 0.0 110.707 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.21 -41.89 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 110.458 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.48 -44.47 95.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.7 p -59.76 -40.86 89.58 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.649 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.9 m -61.66 -48.57 80.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.601 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.9 m -62.6 -40.28 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.727 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.44 -39.49 87.69 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -58.58 -43.0 89.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.315 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.07 -39.47 92.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.91 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -60.1 -25.23 65.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.794 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.643 -179.058 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -148.05 153.21 38.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.576 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -90.53 125.21 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 tp -126.05 147.12 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.23 162.1 41.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.783 0.801 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.62 -35.05 65.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.414 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.05 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.134 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.0 -46.64 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.257 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.56 -26.61 60.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.46 -146.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -56.18 -20.12 16.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.495 1.043 . . . . 0.0 112.463 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.27 -25.13 63.83 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.1 t-105 -55.87 111.76 3.52 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.572 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.63 -13.23 2.8 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.858 1.705 . . . . 0.0 114.096 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.8 mt -90.6 145.57 24.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.177 0.513 . . . . 0.0 111.953 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.8 p -69.71 -37.43 76.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.555 174.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.76 128.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.75 -33.99 75.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.068 -169.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.25 174.82 11.26 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.503 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.76 162.04 34.29 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 m -106.76 139.72 40.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.9 pt -108.16 135.77 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -146.19 141.03 27.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.375 0.607 . . . . 0.0 112.181 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.055 170.814 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.323 0 CA-C-O 120.754 0.312 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.06 155.81 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.554 0.692 . . . . 0.0 111.783 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -114.18 130.24 56.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.81 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.6 t -109.51 131.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.47 155.35 36.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.851 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.68 -27.33 10.73 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.605 1.537 . . . . 0.0 113.09 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -64.04 -12.03 34.78 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 10.24 66.49 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 122.153 -0.342 . . . . 0.0 112.896 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 57.4 m -99.43 139.11 35.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.48 130.49 49.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 109.993 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.62 150.88 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.141 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.34 124.9 33.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 mt -79.85 -47.13 15.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 109.793 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -114.89 166.27 11.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.358 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -52.9 -34.53 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.735 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -61.01 -49.05 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.747 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.12 76.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -61.66 -42.31 98.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.998 0.427 . . . . 0.0 110.089 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -58.23 -33.17 69.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.358 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.16 9.77 2.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.51 63.42 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.18 -0.325 . . . . 0.0 113.38 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -97.55 111.96 60.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.339 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -54.46 150.94 32.29 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.116 1.21 . . . . 0.0 111.654 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.81 158.9 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.325 1.35 . . . . 0.0 112.477 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 112' ' ' ILE . 75.3 mt -61.9 -10.62 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 t -44.41 -38.83 5.89 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -58.79 -32.49 97.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 CA-C-N 122.472 1.919 . . . . 0.0 112.462 -175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.0 pt -98.83 7.55 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -76.45 137.34 39.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.495 0.588 . . . . 0.0 110.478 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.636 -175.9 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 121.086 0.469 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -63.1 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.842 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.52 9.27 35.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.098 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.8 31.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.838 -0.539 . . . . 0.0 112.852 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.323 0.562 . . . . 0.0 110.752 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.8 tp -59.1 -42.35 90.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.17 -43.24 95.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.473 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.7 m -59.24 -43.64 92.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.628 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.75 -47.63 85.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.538 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.5 m -63.22 -39.69 95.33 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.088 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.11 -39.49 86.36 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.724 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -58.75 -43.09 90.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.04 -38.62 89.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.8 m -59.89 -25.33 65.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.997 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.648 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 tttt . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -147.01 146.82 30.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.835 169.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -93.75 125.71 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 tp -126.2 144.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.514 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.3 p -150.42 158.9 44.67 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.566 0.698 . . . . 0.0 112.388 -173.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -55.54 -34.6 64.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.438 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.74 89.41 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.09 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -70.39 -46.64 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.259 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.68 -26.27 62.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.66 -147.17 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.85 -22.03 22.95 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.38 0.991 . . . . 0.0 112.286 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.53 -20.53 63.34 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -55.82 118.45 20.15 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.247 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -89.69 -13.3 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.807 1.671 . . . . 0.0 114.157 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.62 145.21 27.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.34 0.59 . . . . 0.0 112.101 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.2 p -67.31 -37.8 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.464 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.77 128.6 26.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.11 -33.91 75.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -147.99 173.87 12.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.778 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.01 34.23 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 m -108.92 139.09 44.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.611 -0.347 . . . . 0.0 110.105 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.51 134.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.11 144.56 38.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.233 0.54 . . . . 0.0 111.995 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.396 172.047 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.1 158.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.353 0.596 . . . . 0.0 111.557 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -114.1 126.85 55.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.039 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.47 129.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.5 155.45 36.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.647 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.49 -26.59 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.589 1.526 . . . . 0.0 113.115 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -63.95 -12.77 40.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.88 67.09 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 122.09 -0.381 . . . . 0.0 112.924 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 m -99.34 139.38 35.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 m -104.87 130.18 53.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 109.972 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -114.9 148.65 38.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.9 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.4 127.74 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.694 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -86.82 -50.53 6.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.285 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -103.43 167.12 10.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.627 0.727 . . . . 0.0 111.956 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.37 -39.88 73.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.999 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.18 -41.89 99.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.271 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.19 79.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.899 0.381 . . . . 0.0 110.968 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.97 -40.55 98.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.43 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -58.63 -34.04 70.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.721 0.296 . . . . 0.0 111.329 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.21 0.96 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.49 63.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.969 -0.35 . . . . 0.0 113.191 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -83.21 143.15 44.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.03 152.66 68.01 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.262 1.308 . . . . 0.0 111.752 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.1 153.54 28.55 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.454 1.436 . . . . 0.0 112.725 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.02 -18.98 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.779 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 t -46.6 -36.82 7.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.57 -29.01 83.58 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 CA-C-N 122.997 2.106 . . . . 0.0 112.103 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.6 pt -98.89 2.17 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 143.3 45.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.103 0.865 . . . . 0.0 110.204 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.776 -175.382 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.7 mt . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.042 0.448 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -72.25 141.37 48.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.694 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -91.68 8.5 36.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.163 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.54 -43.15 36.09 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.749 -0.595 . . . . 0.0 112.327 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.72 88.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.788 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.01 -41.68 88.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.035 0.445 . . . . 0.0 110.463 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.64 -45.2 92.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.474 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.3 p -59.73 -41.05 90.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.69 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.62 -47.76 83.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.707 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.0 m -62.67 -40.35 96.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.839 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -60.18 -39.87 88.0 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.751 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -59.44 -42.05 91.04 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.424 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.05 -38.72 89.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.107 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -59.97 -25.28 65.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.867 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.703 179.195 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -142.34 153.21 43.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.763 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.88 126.0 39.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 173.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tp -124.79 141.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.5 p -143.46 163.37 33.29 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.594 0.711 . . . . 0.0 111.755 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.54 -35.53 65.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.216 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.19 85.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.729 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.44 -46.65 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.826 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.5 mt -87.02 -8.69 56.91 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 61.66 -145.37 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.0 -28.44 37.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.29 0.95 . . . . 0.0 111.92 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.33 -25.58 35.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -55.92 107.17 0.8 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.372 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.02 -13.17 3.89 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.833 1.689 . . . . 0.0 114.129 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -89.67 145.89 24.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.315 0.579 . . . . 0.0 111.821 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.1 p -69.63 -37.1 76.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.723 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.77 129.64 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -64.31 -30.14 71.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -150.26 174.62 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.662 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.5 m -107.89 140.94 40.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.629 -0.336 . . . . 0.0 110.102 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 pt -108.87 136.08 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -143.55 143.88 31.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 111.824 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.701 174.157 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.06 156.73 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.599 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -114.06 126.95 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.236 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.06 130.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.4 156.22 35.49 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.658 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.2 -26.73 8.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.509 1.473 . . . . 0.0 113.105 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 p30 -65.11 -11.46 40.13 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 8.51 67.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.85 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -99.47 138.48 36.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.1 m -103.7 131.0 51.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 109.865 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -115.97 149.76 38.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.979 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.38 127.23 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.674 0.273 . . . . 0.0 110.752 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -86.68 -51.02 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.941 0.4 . . . . 0.0 110.181 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -103.25 167.61 9.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.644 0.735 . . . . 0.0 111.944 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.79 -39.04 76.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.944 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -62.76 -41.27 99.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.151 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.87 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.072 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.2 -40.55 97.81 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.389 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -58.86 -34.01 71.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.689 0.281 . . . . 0.0 111.241 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.21 -1.79 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.54 63.41 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.07 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -82.09 143.19 48.8 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 109.516 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 153.47 73.84 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.366 1.378 . . . . 0.0 111.811 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.12 151.89 27.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.538 1.492 . . . . 0.0 112.66 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 90.2 mt -64.28 -18.62 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 119.015 -0.517 . . . . 0.0 111.672 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.3 t -45.12 -37.34 4.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -171.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.01 -32.11 96.95 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 CA-C-N 122.529 1.939 . . . . 0.0 112.102 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.8 pt -97.06 3.68 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.38 139.37 39.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.439 0.563 . . . . 0.0 110.331 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.38 -177.915 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.054 0.454 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -63.29 140.8 58.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.236 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.5 mt -94.41 9.87 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.059 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.02 -45.26 32.94 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.845 -0.534 . . . . 0.0 112.735 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.3 85.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.175 0.488 . . . . 0.0 110.759 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.8 tp -59.47 -41.95 90.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.602 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.64 -44.61 93.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -59.07 -43.37 91.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.66 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.59 -47.28 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 110.626 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.9 m -62.7 -41.53 99.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.794 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.16 -37.43 82.88 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.69 -43.86 90.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 110.197 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -36.24 82.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.84 -25.16 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.069 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.86 178.645 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 78.5 m80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.515 -0.55 . . . . 44.149999999999999 109.515 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -123.66 132.2 53.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 43.490000000000002 110.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -127.1 149.05 50.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 42.210000000000001 110.525 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -111.73 136.8 50.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 42.020000000000003 110.318 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -117.62 132.48 56.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.27 -0.423 . . . . 41.270000000000003 110.549 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -60.68 -39.76 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 40.939999999999998 110.86 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.2 m -59.52 156.26 13.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 41.219999999999999 110.872 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -63.18 161.83 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 40.869999999999997 110.768 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.26 -165.94 21.28 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.961 -0.856 . . . . 40.770000000000003 110.961 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.6 mt -76.69 145.78 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 40.200000000000003 110.584 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.98 165.46 27.16 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 40.340000000000003 110.424 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.96 -20.8 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.361 1.374 . . . . 40.719999999999999 113.098 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -55.26 -36.12 65.75 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.128 -0.229 . . . . 39.210000000000001 111.187 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.67 178.07 42.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 38.079999999999998 110.938 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -58.74 -40.29 83.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 36.880000000000003 110.799 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.27 -173.42 55.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.778 -0.929 . . . . 35.579999999999998 110.778 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.1 mtm -136.44 153.6 51.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 33.780000000000001 110.551 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -99.69 150.45 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 32.969999999999999 110.196 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -56.38 -38.59 71.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 31.789999999999999 110.961 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.7 m -129.22 136.98 50.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.525 -0.307 . . . . 30.41 110.516 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.5 51.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 29.609999999999999 110.337 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.02 129.23 38.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 28.710000000000001 110.49 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.52 81.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 28.640000000000001 111.421 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -125.76 137.48 53.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.352 . . . . 27.399999999999999 110.68 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -133.93 162.68 31.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 26.629999999999999 110.359 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.56 139.35 32.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 27.050000000000001 110.829 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -70.19 142.37 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 25.98 110.538 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -122.56 140.53 52.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 26.07 110.281 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -136.58 153.8 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.366 . . . . 25.510000000000002 110.625 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 93.0 mmm -123.33 145.41 48.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 25.850000000000001 109.951 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.53 114.03 25.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 25.91 110.849 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -125.29 99.82 33.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.091 -0.504 . . . . 25.899999999999999 110.05 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -88.37 123.9 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.549 1.499 . . . . 26.289999999999999 112.42 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -61.27 -34.68 75.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 27.399999999999999 111.452 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.85 128.06 36.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 27.800000000000001 110.637 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.9 166.26 35.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.802 -0.919 . . . . 28.449999999999999 110.802 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -129.65 162.03 29.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 30.289999999999999 110.62 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -132.24 -35.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 30.91 111.128 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.44 -35.58 68.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.641 -0.254 . . . . 29.710000000000001 111.278 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -55.57 149.26 14.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.403 . . . . 31.09 110.879 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.01 -36.2 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 30.129999999999999 111.435 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -78.83 149.15 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 28.109999999999999 110.641 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -109.52 148.16 31.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 27.43 110.196 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.86 -37.9 94.89 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.392 -0.683 . . . . 25.800000000000001 111.392 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.29 171.09 51.49 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.763 -0.935 . . . . 23.100000000000001 110.763 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.31 176.23 38.46 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.118 -0.793 . . . . 20.710000000000001 111.118 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -59.62 -34.53 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.518 0.199 . . . . 18.449999999999999 111.434 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.7 144.23 27.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 15.94 110.901 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -69.85 143.35 91.98 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 13.49 110.1 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.8 -169.98 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.228 1.285 . . . . 11.73 111.714 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.42 131.83 52.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.952 0.406 . . . . 7.9299999999999997 110.556 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.39 -37.18 79.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.539 . . . . 6.9299999999999997 111.299 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -99.59 136.6 39.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 6.0899999999999999 110.655 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -74.78 -49.2 4.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.992 -0.528 . . . . 1.5900000000000001 112.228 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.19 128.14 16.51 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.203 1.268 . . . . 1.1399999999999999 112.112 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -90.29 133.85 32.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.548 -0.739 . . . . 1.3300000000000001 109.386 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.22 155.42 9.26 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.034 1.156 . . . . 0.97999999999999998 111.482 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.1 151.64 89.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.393 -0.367 . . . . 1.2 110.224 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.63 157.76 48.12 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.191 1.261 . . . . 0.90000000000000002 111.532 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -55.82 120.1 30.55 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.897 -0.573 . . . . 1.6899999999999999 109.956 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.04 119.89 4.03 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.134 1.223 . . . . 0.88 113.441 -169.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -77.75 158.11 29.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.686 -1.227 . . . . 1.4299999999999999 107.686 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -56.57 125.55 22.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.16 -0.616 . . . . 1.95 110.971 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 63.58 24.03 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.45 -0.796 . . . . 2.3999999999999999 112.705 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -159.14 141.82 14.14 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.319 -0.553 . . . . 3.02 112.327 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -148.61 152.91 37.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.823 -0.626 . . . . 0.28999999999999998 110.903 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -97.56 129.07 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.468 -0.567 . . . . 0.16 109.468 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.1 tt -129.34 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.892 0.377 . . . . 1.1799999999999999 110.938 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -150.48 167.87 25.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.59 0.709 . . . . 0.78000000000000003 111.654 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.5 -34.62 64.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.724 . . . . 1.1000000000000001 111.118 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.02 86.53 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 121.021 -0.272 . . . . 1.0600000000000001 110.727 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -66.36 -46.61 76.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.38 111.282 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.07 -8.79 55.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.671 0.989 . . . . 1.72 113.671 -174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.69 -153.79 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.419 -0.586 . . . . 1.0900000000000001 109.419 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -56.77 -21.42 28.32 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.571 0.623 . . . . 4.0999999999999996 112.4 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -59.2 -20.09 50.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.498 0.555 . . . . 2.2799999999999998 112.498 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.7 t-105 -55.81 111.94 3.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 119.121 -0.466 . . . . 0.20999999999999999 110.205 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -89.55 -13.25 2.84 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.904 1.736 . . . . 0.29999999999999999 114.164 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -87.8 143.62 27.04 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.228 0.537 . . . . 1.04 111.627 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.4 p -67.99 -36.76 80.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.345 -0.843 . . . . 1.01 110.817 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.67 129.39 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.272 -1.01 . . . . 1.03 108.272 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.92 -32.94 72.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.023 0.379 . . . . 1.8 112.023 -169.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -147.02 174.37 11.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.406 -0.518 . . . . 0.59999999999999998 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.05 34.31 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.832 -1.307 . . . . 0.10000000000000001 109.832 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.3 m -109.93 141.58 42.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.598 -0.354 . . . . 1.02 110.349 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.64 137.23 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -148.01 143.79 27.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.432 0.634 . . . . 2.1800000000000002 112.127 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.9 m -105.81 119.74 39.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.011 -0.995 . . . . 0.35999999999999999 109.492 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.91 156.63 69.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.539 -0.3 . . . . 1.3799999999999999 111.061 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.07 -19.84 4.58 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.446 1.431 . . . . 1.1299999999999999 113.223 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.4 m -79.65 3.06 20.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.358 0.873 . . . . 2.0499999999999998 113.358 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 62.98 39.5 10.17 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.1 0.476 . . . . 2.0499999999999998 110.852 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.27 127.11 55.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.215 -0.661 . . . . 2.2400000000000002 109.215 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.05 121.07 36.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.11 -0.33 . . . . 1.1000000000000001 110.11 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.32 157.14 43.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.448 0.642 . . . . 1.05 111.396 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -114.03 127.75 56.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.799 -1.091 . . . . 0.13 109.932 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -108.51 130.48 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.325 -0.62 . . . . 1.04 109.325 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.41 154.8 37.0 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.655 -0.418 . . . . 1.01 110.625 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.66 -26.49 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.509 1.473 . . . . 0.17999999999999999 113.225 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -63.96 -12.79 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.816 0.673 . . . . 0.17999999999999999 112.816 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.52 10.43 65.48 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 122.151 -0.343 . . . . 0.17000000000000001 112.92 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.7 m -99.37 139.36 35.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.233 -0.655 . . . . 1.04 109.233 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.8 m -105.02 130.91 53.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.297 0.57 . . . . 1.0 110.056 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -116.68 147.54 41.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.14000000000000001 108.992 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.41 126.08 34.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.94999999999999996 110.771 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.04 -50.93 6.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.347 -0.388 . . . . 1.03 110.637 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -103.11 166.58 10.35 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.643 0.735 . . . . 0.38 112.019 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.6 -41.16 69.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.39 -0.823 . . . . 2.2000000000000002 112.209 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -63.94 -42.8 97.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.689 -0.404 . . . . 3.04 111.398 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.28 78.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.862 0.363 . . . . 1.05 110.907 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.56 -40.92 98.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 2.0699999999999998 110.394 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.85 -33.93 71.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 3.1699999999999999 111.288 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.66 0.44 8.72 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.083 0.771 . . . . 1.0 113.083 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.12 23.43 63.53 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.826 -0.43 . . . . 0.53000000000000003 113.203 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -84.89 142.64 39.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 108.938 -0.764 . . . . 0.64000000000000001 108.938 171.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.09 148.83 51.25 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.182 1.255 . . . . 1.1499999999999999 111.281 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 158.91 30.44 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.376 1.384 . . . . 0.53000000000000003 112.301 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.96 -11.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 119.033 -0.508 . . . . 1.01 112.345 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 t -43.83 -39.65 6.06 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 115.559 1.689 . . . . 1.0800000000000001 115.559 -172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.98 -31.95 96.62 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 CA-C-N 122.31 1.861 . . . . 0.32000000000000001 112.395 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.1 pt -98.9 1.49 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 113.008 0.744 . . . . 1.05 113.008 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -79.59 136.77 36.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.34 0.518 . . . . 3.79 110.545 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.76 136.29 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 1.05 111.356 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -95.12 139.91 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.869 -0.605 . . . . 3.0499999999999998 109.858 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.34 166.01 19.63 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.473 -0.651 . . . . 1.03 111.473 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 m -57.85 -38.53 75.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.967 -0.293 . . . . 2.9399999999999999 110.767 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.19 166.11 26.12 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.602 -0.999 . . . . 2.0899999999999999 110.602 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.9 58.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.042 -0.599 . . . . 2.2400000000000002 111.987 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.57 -123.91 30.1 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.568 -0.613 . . . . 1.27 111.568 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -108.96 158.99 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 1.54 110.867 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 33.2 mt -73.5 128.7 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.712 -0.676 . . . . 1.1000000000000001 109.915 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -61.83 138.81 58.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.93999999999999995 112.092 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -95.99 11.55 33.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.173 -0.921 . . . . 1.1000000000000001 112.103 171.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -42.41 30.65 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.876 -0.515 . . . . 0.20999999999999999 112.632 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.5 81.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.996 0.427 . . . . 1.02 110.78 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.55 -41.94 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.03 110.47 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.97 -44.04 94.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 1.04 110.464 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.05 -43.73 91.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.924 -0.311 . . . . 1.3700000000000001 110.562 -176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 39.0 m -60.9 -47.52 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.586 -0.446 . . . . 1.04 110.597 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.3 m -62.84 -40.12 96.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.58 -0.448 . . . . 1.05 110.921 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.83 -39.63 89.74 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.969 -0.292 . . . . 1.0700000000000001 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -58.77 -42.58 89.26 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.777 -0.369 . . . . 2.5600000000000001 110.241 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.97 -39.55 95.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.97999999999999998 111.03 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.1 m -59.99 -25.31 65.16 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.238 -0.437 . . . . 0.32000000000000001 112.144 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.25 22.99 61.84 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.116 -0.564 . . . . 0.60999999999999999 112.614 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -71.4 134.27 46.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 117.462 0.631 . . . . 4.46 110.532 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.924 -1.486 . . . . 2.6299999999999999 110.913 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -125.36 135.77 52.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.44 134.66 53.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -124.23 135.4 53.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.515 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -123.97 135.21 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -121.91 129.81 52.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.521 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m -65.05 156.29 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m -61.99 153.14 30.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.36 -177.19 49.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.46 143.27 26.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.338 . . . . 0.0 110.408 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.44 151.94 90.21 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.561 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -88.33 168.23 6.31 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.728 1.619 . . . . 0.0 112.313 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -124.55 151.66 44.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.305 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.43 138.94 47.35 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -134.84 147.86 50.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.0 110.521 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.6 -177.87 52.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -97.29 131.45 43.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.704 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -131.09 147.37 52.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -99.58 133.34 44.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.492 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -127.95 162.3 27.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 147.2 53.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.424 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 142.82 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.554 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.11 43.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -87.54 141.01 28.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.31 151.65 38.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.54 141.79 35.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.432 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -67.76 140.42 56.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.524 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -114.78 151.6 33.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.584 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -124.32 136.06 53.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -124.67 155.17 39.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.523 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.24 119.18 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.555 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.7 p -64.26 152.9 87.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.549 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -82.4 -176.08 2.79 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.483 1.455 . . . . 0.0 112.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -98.2 167.19 11.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.779 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.7 mt -94.5 142.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.06 51.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.8 t -72.55 144.11 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -137.34 162.24 34.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -80.75 169.5 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.43 139.71 49.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.54 162.7 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -132.11 135.35 46.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -139.9 160.22 40.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.09 -177.12 51.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.04 176.49 53.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.37 -173.84 37.84 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -76.67 141.41 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 110.224 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.41 29.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.275 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.29 147.31 76.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.351 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -91.54 176.95 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.759 1.639 . . . . 0.0 112.344 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.58 152.74 44.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.223 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -100.68 135.35 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.648 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -124.78 157.35 35.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.518 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -56.16 159.63 5.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.17 128.32 16.79 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.417 1.411 . . . . 0.0 112.278 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.32 140.23 27.04 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.383 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -52.17 150.72 18.64 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.111 1.207 . . . . 0.0 111.53 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.12 153.89 83.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.484 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.25 149.96 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.233 1.289 . . . . 0.0 111.46 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.2 p -55.93 139.45 70.64 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.091 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.16 119.86 3.98 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.173 1.249 . . . . 0.0 113.112 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -80.36 162.1 24.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.2 p -54.13 125.65 19.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 111.711 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 63.77 12.65 6.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 171.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -159.77 162.33 34.84 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -143.8 153.12 42.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.581 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -97.3 123.95 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.18 151.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.092 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.0 p -147.79 165.81 29.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.871 0.843 . . . . 0.0 112.061 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -55.62 -34.28 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.38 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.15 90.42 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.785 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -66.38 -46.59 76.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.904 0.383 . . . . 0.0 111.241 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -81.88 -16.64 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.06 -148.3 0.3 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -56.03 -21.25 20.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.196 0.907 . . . . 0.0 112.368 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.0 tp -56.54 -27.83 58.52 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -55.73 111.89 3.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.42 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -89.53 -13.15 2.87 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.766 1.644 . . . . 0.0 114.167 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.31 145.33 25.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.284 0.564 . . . . 0.0 111.813 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.8 p -69.37 -37.16 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.647 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.42 129.65 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.12 -32.77 73.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -168.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -148.55 175.1 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.09 34.38 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 m -107.88 141.1 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.81 137.71 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.45 143.73 30.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 112.06 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 m -108.25 121.21 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.684 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -81.98 155.89 69.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.906 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.46 -19.99 7.91 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.366 1.377 . . . . 0.0 113.286 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -81.04 3.0 24.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 69.25 35.79 2.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 111.023 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -113.37 127.42 56.12 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.75 124.08 39.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.288 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.7 157.79 42.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.437 0.637 . . . . 0.0 111.452 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -114.05 127.47 55.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.025 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.17 130.91 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.37 155.25 36.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.735 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.39 -26.74 9.01 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.595 1.53 . . . . 0.0 113.127 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -64.5 -11.82 37.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.55 9.28 66.85 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.543 -0.361 . . . . 0.0 112.911 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.1 m -99.45 140.83 33.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -105.04 131.08 53.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.235 0.54 . . . . 0.0 110.118 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -116.22 148.09 40.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.997 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.35 127.93 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -86.79 -51.8 5.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -103.2 167.49 9.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 112.059 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.106 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -63.23 -41.91 99.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.207 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.34 -37.04 79.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 110.92 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.77 -41.27 99.16 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.282 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -58.77 -33.99 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.409 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.44 7.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.05 23.46 63.61 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.964 -0.353 . . . . 0.0 113.265 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -84.9 143.16 39.79 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.469 0.635 . . . . 0.0 109.303 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.84 149.07 47.18 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.246 1.297 . . . . 0.0 111.458 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.05 154.88 29.57 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.403 1.402 . . . . 0.0 112.702 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 91.6 mt -61.67 -14.95 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.132 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 t -44.12 -39.05 5.64 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.31 -31.38 94.95 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.306 1.859 . . . . 0.0 112.373 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.4 pt -98.76 7.03 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -78.09 142.03 38.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.447 0.567 . . . . 0.0 110.546 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.68 137.33 32.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -97.24 139.97 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.045 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.87 167.38 19.69 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.494 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -57.97 -39.0 77.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.619 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.44 165.22 25.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.05 27.44 60.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.27 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.6 -123.8 31.54 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -106.55 154.61 20.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 110.926 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.3 mt -76.75 130.28 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.025 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.3 m -64.54 141.01 58.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.003 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.8 9.71 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.095 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.04 -44.06 32.34 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.87 -0.519 . . . . 0.0 112.64 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 -47.57 85.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.795 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.43 -42.11 91.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 tp -60.09 -43.89 95.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -58.97 -43.27 91.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.595 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 m -60.87 -47.92 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.588 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.1 m -62.9 -39.84 95.76 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.923 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.81 -39.1 87.69 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.909 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.85 -42.65 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.247 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.88 -39.45 94.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.916 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.7 m -60.05 -25.24 65.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.83 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.78 22.85 48.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.6 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -88.37 133.06 34.19 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.437 0.618 . . . . 0.0 110.451 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 CA-C-O 117.945 -1.475 . . . . 0.0 110.964 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -121.02 143.09 49.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -121.23 137.52 54.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.431 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -123.51 143.23 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -109.15 137.99 46.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.515 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -129.52 150.49 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m -117.05 146.85 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.2 p -142.62 163.38 32.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.472 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.68 -178.93 52.58 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.4 mt -96.12 141.14 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.65 159.0 74.28 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.466 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -86.24 109.99 0.99 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.591 1.527 . . . . 0.0 112.266 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -125.88 147.32 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.51 117.35 0.68 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.1 p -142.85 159.88 41.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 0.0 110.498 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.36 140.43 30.78 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.8 mtt -130.05 153.74 48.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.518 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -98.85 146.02 26.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -103.17 148.9 25.2 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.5 p -123.31 162.79 22.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.441 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 145.43 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.599 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.91 154.56 43.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 143.5 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -82.77 132.98 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.4 141.5 44.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.22 143.46 44.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.647 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -128.57 143.56 50.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -75.9 145.37 40.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.725 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -123.57 145.15 49.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.4 mtp -119.83 150.31 40.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.56 144.11 54.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.671 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 p -107.13 159.62 29.37 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.408 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.56 -178.9 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.486 1.457 . . . . 0.0 112.312 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -67.38 145.4 55.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.686 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.5 tp -96.8 133.2 41.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.415 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.63 -177.03 51.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.3 m -93.56 144.52 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.589 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.2 119.28 21.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -66.71 148.31 52.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.748 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -69.15 -174.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -59.96 132.51 54.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.634 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.52 152.49 20.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 p -77.95 168.72 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.27 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.93 142.38 44.96 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -140.01 2.84 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.18 -166.95 23.42 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -53.04 155.63 2.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 111.491 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.01 152.78 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.816 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -55.77 159.68 5.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -59.99 172.09 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.402 1.402 . . . . 0.0 112.175 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.06 152.59 43.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.775 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -120.89 153.78 36.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.38 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -56.76 145.77 28.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 m -72.22 159.57 85.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.29 138.32 23.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.35 1.366 . . . . 0.0 112.265 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.26 142.82 28.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.379 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.23 154.01 11.83 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.069 1.179 . . . . 0.0 111.316 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.99 151.31 89.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.505 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -60.58 148.13 92.26 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.119 1.212 . . . . 0.0 111.236 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.5 p -55.92 131.98 73.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.09 119.88 4.01 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.171 1.247 . . . . 0.0 113.489 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.7 p -82.61 157.09 23.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 167.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 p -57.49 125.49 23.12 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.828 -172.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 63.57 21.61 12.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.786 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.7 144.21 14.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.404 0.547 . . . . 0.0 112.251 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -148.83 152.72 36.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -92.22 126.74 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.7 tp -126.86 145.73 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.589 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -150.41 161.71 41.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.687 0.756 . . . . 0.0 112.484 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -55.57 -34.97 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.542 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.24 88.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.039 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -71.69 -46.65 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.054 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mp -72.45 -25.76 61.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.13 -147.71 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -55.99 -21.59 22.0 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.367 0.985 . . . . 0.0 112.352 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.93 -25.32 63.37 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 47.0 t-105 -55.8 110.45 2.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.409 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.5 -13.27 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 114.158 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.7 145.76 24.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.304 0.573 . . . . 0.0 111.927 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 p -69.39 -36.86 77.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.67 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.12 129.48 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -61.58 -33.24 73.53 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.98 175.01 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.01 34.26 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 m -106.94 137.56 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.48 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -147.97 144.05 27.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.397 0.617 . . . . 0.0 112.299 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m -102.51 118.52 37.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.644 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.7 mt -87.66 159.03 50.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.489 -172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.18 -14.46 8.85 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.359 1.373 . . . . 0.0 113.133 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.0 m -78.62 2.98 17.55 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 63.05 44.49 5.84 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.137 0.494 . . . . 0.0 110.349 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -135.17 142.95 46.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.511 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.45 121.28 41.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.692 0.282 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -133.16 158.64 43.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.619 0.724 . . . . 0.0 111.886 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -114.08 128.65 56.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.848 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.84 131.37 58.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.14 155.53 36.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.781 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.71 -27.06 10.34 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.533 1.489 . . . . 0.0 113.079 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 p30 -63.99 -12.41 37.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.47 9.69 66.52 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.912 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.8 m -99.37 139.94 34.29 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m -103.54 129.55 50.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -114.69 150.56 35.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.073 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.44 126.06 34.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.311 . . . . 0.0 110.377 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.4 mt -82.99 -51.93 7.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.466 . . . . 0.0 110.187 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -109.18 166.84 10.55 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 111.761 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -52.41 -33.66 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.866 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -61.83 -48.65 79.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 110.775 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.45 -35.1 75.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.243 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.44 -41.2 98.56 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.243 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.04 -33.96 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.47 0.31 8.65 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.14 23.41 63.54 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.963 -0.354 . . . . 0.0 113.244 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -89.0 143.13 30.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 117.465 0.633 . . . . 0.0 109.421 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.14 148.39 44.31 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.256 1.304 . . . . 0.0 111.249 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.4 157.07 32.93 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.387 1.391 . . . . 0.0 112.625 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.61 -13.46 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 119.135 -0.46 . . . . 0.0 112.228 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.5 t -44.0 -39.44 6.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.37 -31.29 94.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 CA-C-N 122.336 1.87 . . . . 0.0 112.387 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.7 pt -98.83 7.83 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -77.34 140.67 40.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.66 139.84 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.341 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -93.35 139.88 30.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.824 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.22 167.3 17.98 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -58.38 -39.07 78.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.646 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.04 164.91 26.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.92 29.18 59.43 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.171 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.51 -120.45 21.74 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.51 157.68 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.001 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.27 132.78 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.127 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -64.93 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.848 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.55 8.24 39.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.193 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.91 -44.45 31.69 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.85 -0.531 . . . . 0.0 112.922 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.68 76.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.268 0.534 . . . . 0.0 110.778 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.3 tp -59.24 -42.29 90.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.474 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.39 -42.99 97.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.53 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.9 t -59.55 -44.9 93.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.49 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.34 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.552 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.7 m -63.22 -40.04 96.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.31 -39.55 87.4 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.785 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -58.62 -42.77 88.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.09 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.4 m -60.49 -25.16 65.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.993 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 22.88 50.62 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.66 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -85.99 134.89 33.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.412 0.606 . . . . 0.0 110.503 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.734 0 CA-C-O 118.057 -1.413 . . . . 0.0 110.96 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.1 141.03 49.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.518 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.96 137.01 54.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.454 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.46 144.33 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -118.78 139.0 52.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -112.02 140.05 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.456 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t -116.14 142.39 46.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.6 p -140.43 161.55 37.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.0 -178.25 38.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.5 tp -102.32 129.16 48.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.314 . . . . 0.0 110.502 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.87 158.22 68.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.586 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.67 130.65 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.622 1.548 . . . . 0.0 112.118 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -124.05 146.51 48.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.51 -176.85 48.24 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -138.88 156.3 47.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.281 . . . . 0.0 110.568 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.19 -176.65 35.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -129.32 152.43 48.89 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -95.75 135.38 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -124.25 158.65 31.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.399 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.4 m -72.25 134.88 45.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.308 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.56 159.42 43.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.652 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.18 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.523 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 146.62 26.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.737 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -128.26 138.63 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.493 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -57.54 152.84 14.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -72.47 143.13 48.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.643 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -105.98 160.05 15.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.27 165.25 26.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -125.87 171.94 10.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.509 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 mtt -106.2 158.81 16.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.692 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.78 145.32 56.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.772 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -67.62 153.98 94.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.722 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.66 -174.94 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.593 1.528 . . . . 0.0 112.341 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.44 124.96 30.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.5 150.48 28.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.6 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.71 156.83 7.22 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -122.88 170.06 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.341 . . . . 0.0 110.472 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -57.47 149.74 20.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.517 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -71.04 171.49 10.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.162 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.02 149.48 47.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.881 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -62.89 152.95 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.484 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -73.08 148.25 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.688 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -122.3 169.43 10.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.526 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.21 -170.42 27.14 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.44 121.57 20.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.88 -170.67 44.34 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -56.84 154.01 9.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.748 0.309 . . . . 0.0 110.592 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.26 147.91 15.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.851 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.57 133.58 85.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.25 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.51 -169.96 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.206 1.271 . . . . 0.0 111.626 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.25 159.13 4.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.369 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -60.71 150.15 33.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.027 0.441 . . . . 0.0 110.689 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -129.95 150.25 51.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.232 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.73 167.67 0.37 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.503 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -50.45 128.0 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.093 1.195 . . . . 0.0 112.001 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.47 120.92 68.93 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.382 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 153.27 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 120.884 1.352 . . . . 0.0 111.128 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.05 151.35 90.11 Favored Pre-proline 0 C--N 1.33 -0.283 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.427 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -81.45 163.91 19.15 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.358 1.372 . . . . 0.0 111.51 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -55.98 139.89 70.29 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.063 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.09 119.91 4.02 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.075 1.184 . . . . 0.0 113.033 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -75.69 160.06 30.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.8 m -54.0 125.62 19.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.76 10.84 5.42 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 171.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -159.7 159.53 33.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -144.55 153.14 41.51 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.271 172.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -93.19 126.57 38.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.8 tp -126.71 142.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.0 p -145.86 164.54 31.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.594 0.711 . . . . 0.0 111.929 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -55.57 -35.52 65.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.154 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.19 85.76 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.603 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -66.33 -46.63 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.577 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.3 mt -91.08 -8.13 49.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 60.93 -146.44 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -57.15 -24.04 51.5 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.306 0.957 . . . . 0.0 112.476 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.16 -22.37 60.84 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -55.85 107.41 0.88 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.228 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.48 -13.27 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.812 1.674 . . . . 0.0 114.174 -174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.72 145.04 26.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.19 0.519 . . . . 0.0 111.66 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 p -69.04 -36.88 78.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.725 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.72 130.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.92 -32.69 73.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -169.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.78 174.43 11.83 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.734 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -107.82 139.97 41.62 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.612 -0.346 . . . . 0.0 110.071 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.49 134.84 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -145.95 142.64 28.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.425 0.631 . . . . 0.0 111.991 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.62 119.48 38.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.891 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.5 mt -87.55 156.49 53.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.189 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.01 -18.01 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.307 1.338 . . . . 0.0 113.28 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -76.93 0.0 22.63 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 67.36 44.21 1.84 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.072 0.463 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -135.12 145.25 47.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.457 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.58 123.25 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.655 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.8 158.71 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.555 0.693 . . . . 0.0 111.931 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -114.05 129.04 56.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.898 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.9 131.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.61 155.13 36.72 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.749 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.37 -27.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.625 1.55 . . . . 0.0 113.152 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -64.36 -11.65 34.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.68 10.46 67.3 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.84 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.8 m -99.34 139.32 35.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.0 m -103.04 129.96 49.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.346 0.593 . . . . 0.0 110.023 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.47 150.89 37.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.188 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.39 128.88 35.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.697 0.284 . . . . 0.0 110.725 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.6 mt -87.98 -57.12 3.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.094 0.473 . . . . 0.0 110.434 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -105.1 159.14 16.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -47.44 -35.26 8.28 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.095 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -61.64 -44.45 96.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.08 -37.36 74.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.392 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -63.94 -39.22 93.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.026 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.5 -34.02 70.47 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.041 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 0.79 10.04 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.4 63.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.877 -0.402 . . . . 0.0 113.319 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -90.48 143.2 28.91 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.576 0.688 . . . . 0.0 109.668 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.11 148.1 39.14 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.267 1.311 . . . . 0.0 111.271 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.98 158.84 34.37 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.366 1.377 . . . . 0.0 112.939 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 112' ' ' ILE . 88.9 mt -61.13 -11.54 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.353 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.8 t -43.83 -39.82 6.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.39 -32.11 96.01 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 CA-C-N 122.364 1.88 . . . . 0.0 112.433 -174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 23.1 pt -98.74 5.18 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -79.41 135.66 36.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.477 0.581 . . . . 0.0 110.772 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.41 149.61 33.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.077 0.465 . . . . 0.0 111.668 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -85.88 142.3 28.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.467 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.08 159.41 18.84 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 m -57.33 -39.16 75.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.742 0.306 . . . . 0.0 110.686 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.44 163.98 28.1 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.52 34.15 50.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.012 -0.614 . . . . 0.0 111.73 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.38 -119.96 9.82 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.676 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -104.39 159.95 15.3 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.528 -0.396 . . . . 0.0 110.383 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.9 mt -76.45 129.94 36.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.141 0.496 . . . . 0.0 110.357 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 139.83 58.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.068 -174.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.99 9.43 37.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.053 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.16 31.73 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.827 -0.546 . . . . 0.0 112.913 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.1 75.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.313 0.557 . . . . 0.0 110.78 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.06 -41.58 88.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.36 -43.76 96.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -60.04 -44.15 94.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.601 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.0 m -60.56 -47.03 87.98 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.504 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.8 m -63.31 -40.4 97.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.68 -38.34 84.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.954 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.5 -42.58 87.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.55 -38.54 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.5 m -59.95 -25.23 65.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.91 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.73 22.86 22.59 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.676 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.1 133.68 40.22 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.433 0.617 . . . . 0.0 110.495 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.91 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -124.65 136.12 53.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.379 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -121.69 144.48 48.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.622 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -113.68 140.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.425 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -119.49 133.51 55.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.48 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -124.3 137.1 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.507 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -116.22 143.57 45.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -61.6 154.98 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.614 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.19 -174.36 38.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.68 129.98 45.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.9 142.65 97.54 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.17 130.14 2.45 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.656 1.571 . . . . 0.0 112.203 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -60.66 144.51 51.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.653 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.2 -175.27 48.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.0 m -62.1 157.12 19.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.58 144.09 38.01 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.1 161.59 28.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -88.5 149.08 23.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.25 142.83 41.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -124.25 163.14 22.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.75 145.01 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.534 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.07 144.79 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.591 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.5 154.24 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 134.17 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.629 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -105.66 133.1 50.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.97 139.6 39.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -62.27 149.33 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -98.53 145.76 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.57 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -131.06 172.02 12.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.11 145.78 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.72 140.87 58.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.655 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -132.57 162.85 54.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.407 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -82.98 110.0 1.77 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.496 1.464 . . . . 0.0 112.205 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -150.03 165.36 32.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.5 tp -104.1 126.87 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.419 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -178.33 46.14 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.3 p -124.76 158.85 32.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.809 0.338 . . . . 0.0 110.32 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -75.69 136.85 40.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.0 137.53 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.57 133.17 42.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.627 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -149.98 167.54 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -136.21 127.25 27.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.983 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -129.99 160.54 33.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.05 165.99 36.59 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 -178.26 40.88 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.68 -172.23 47.46 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -57.81 146.95 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.718 0.294 . . . . 0.0 110.461 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.07 157.5 44.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.716 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.74 155.78 59.16 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 131.39 39.01 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.36 1.373 . . . . 0.0 111.74 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.67 164.25 32.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.64 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -90.8 159.91 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.382 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -140.59 159.24 42.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.912 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -66.83 153.84 93.2 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.17 150.41 7.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.25 1.3 . . . . 0.0 112.172 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.33 143.59 29.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.382 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.23 160.89 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.068 1.179 . . . . 0.0 111.303 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.94 153.86 83.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.579 -176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.95 151.2 44.8 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.298 1.332 . . . . 0.0 111.59 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -56.04 129.7 73.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.992 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.22 119.95 3.98 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.21 1.273 . . . . 0.0 113.252 -170.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.7 p -74.74 160.65 30.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 166.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -55.06 125.43 20.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.083 -172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p30 63.22 13.4 6.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.219 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -146.28 154.58 41.86 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.29 0.495 . . . . 0.0 111.834 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -149.03 150.71 33.26 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.792 168.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -92.59 124.82 36.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 tp -125.83 145.17 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -150.38 162.43 40.56 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.795 0.807 . . . . 0.0 112.419 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.95 -35.18 66.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.537 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.5 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.056 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.93 -46.65 51.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.078 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.17 -147.03 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.8 -22.0 22.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.38 0.991 . . . . 0.0 112.468 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.41 -24.91 63.87 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -55.89 110.98 2.64 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.357 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -89.55 -13.13 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.731 1.621 . . . . 0.0 114.108 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.42 145.47 24.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.191 0.52 . . . . 0.0 111.921 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.2 p -69.58 -37.03 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.663 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.11 129.34 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.97 -33.47 74.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -169.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -147.5 174.36 11.79 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.712 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.02 34.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.7 m -108.08 139.95 41.98 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.7 pt -109.36 139.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -148.01 145.44 28.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 112.303 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.3 m -108.6 124.02 49.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.695 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -85.92 156.38 58.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.005 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.12 -20.4 7.51 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.405 1.403 . . . . 0.0 113.177 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.9 p -79.23 3.01 19.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 63.74 39.67 8.34 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 121.085 0.469 . . . . 0.0 110.83 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -114.85 128.62 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.51 123.73 40.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.163 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.24 157.27 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 111.458 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -114.17 128.07 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.946 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.98 130.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.22 155.59 36.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.802 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.47 -26.88 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.473 1.449 . . . . 0.0 113.097 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -64.31 -12.24 39.94 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.43 9.49 66.85 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.927 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.9 m -99.39 140.01 34.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 m -104.36 130.8 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.322 0.582 . . . . 0.0 110.087 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -116.18 148.24 40.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.082 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.4 128.3 35.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.692 0.282 . . . . 0.0 110.722 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.8 mt -87.58 -51.14 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -103.04 166.41 10.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.665 0.745 . . . . 0.0 112.037 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -55.33 -40.16 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.129 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -63.76 -42.06 97.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.334 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.61 -36.32 78.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.29 -41.44 98.98 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.306 176.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -59.2 -33.86 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.317 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.1 -1.54 10.28 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.45 63.67 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.897 -0.391 . . . . 0.0 113.238 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -84.99 134.36 41.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.133 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.33 148.1 91.46 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.062 1.174 . . . . 0.0 111.235 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 157.97 30.36 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.315 1.343 . . . . 0.0 112.302 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 112' ' ' ILE . 91.0 mt -62.07 -11.75 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.256 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.0 t -43.79 -40.05 6.61 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.29 -32.28 96.55 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 CA-C-N 122.25 1.839 . . . . 0.0 112.417 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.7 pt -98.84 7.66 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.03 140.22 40.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.527 0.603 . . . . 0.0 110.399 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.42 26.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 111.82 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.46 139.94 36.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.58 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.61 166.5 18.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 m -57.64 -39.15 76.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.592 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.99 166.82 28.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.14 55.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.11 -119.98 12.81 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.43 159.29 15.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.061 0.458 . . . . 0.0 111.059 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 84.2 mt -78.85 133.44 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.269 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.4 m -65.01 140.81 58.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.951 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.95 9.27 36.28 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.139 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.01 -45.18 32.86 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.837 -0.54 . . . . 0.0 112.766 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.04 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.162 0.481 . . . . 0.0 110.707 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.1 tp -59.35 -42.35 91.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -43.31 94.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -58.81 -44.46 90.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.45 -47.34 86.53 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.568 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.3 m -62.51 -40.49 96.89 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.842 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.68 -39.41 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.858 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -58.8 -42.83 90.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 110.277 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.57 -38.21 90.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.191 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.8 m -60.08 -25.14 65.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.957 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.72 23.01 60.74 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.61 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -85.0 133.56 34.25 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.427 0.613 . . . . 0.0 110.501 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 118.032 -1.426 . . . . 0.0 110.961 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -116.87 137.56 52.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.437 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -124.23 142.9 50.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.469 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.99 137.77 52.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.419 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -128.9 137.26 51.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.462 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -116.3 137.86 51.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.1 m -63.78 154.28 33.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -123.06 141.66 51.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.89 -176.7 50.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.6 tp -99.34 128.4 45.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.22 153.19 90.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.626 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -86.24 -177.57 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.566 1.511 . . . . 0.0 112.071 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -63.75 143.42 57.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.402 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.06 -175.11 44.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.0 m -63.95 156.46 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 0.0 110.525 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.69 -176.1 36.1 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -127.4 158.16 38.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.779 0.323 . . . . 0.0 110.494 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -73.2 138.52 45.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.503 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -93.82 138.98 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.486 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m -121.94 143.27 49.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.53 147.97 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.575 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.29 158.67 43.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 147.62 25.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -84.15 153.71 23.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -131.7 164.74 25.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.543 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.18 144.16 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -123.87 141.29 52.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -104.36 147.61 27.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.623 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -122.02 144.31 48.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -115.56 146.22 41.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.258 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.31 120.64 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.538 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 m -61.76 152.78 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.581 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.28 -175.03 2.02 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.624 1.549 . . . . 0.0 112.235 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -67.34 148.02 52.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.61 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.59 143.79 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.426 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.43 -139.96 3.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -76.31 166.02 24.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.813 0.34 . . . . 0.0 110.508 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -60.92 142.44 56.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -150.03 -173.26 4.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.05 153.57 11.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -55.85 154.88 6.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.015 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.53 175.79 9.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.724 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.6 p -74.78 165.57 25.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.499 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.28 -174.23 43.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.9 -174.31 48.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.69 49.71 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -58.48 149.68 24.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.747 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.22 10.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -55.0 163.08 1.61 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 140.95 95.21 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.312 1.342 . . . . 0.0 112.112 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -173.67 2.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.615 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -79.7 157.87 27.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -63.88 139.21 58.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.798 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.92 167.5 19.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.674 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.28 147.18 8.87 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.327 1.352 . . . . 0.0 112.017 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.22 142.2 28.32 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.786 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.22 160.98 2.87 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.167 1.245 . . . . 0.0 111.289 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.93 152.97 85.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.453 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.86 155.29 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.274 1.316 . . . . 0.0 111.576 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -55.88 142.15 64.95 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.19 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.07 119.93 4.03 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.168 1.245 . . . . 0.0 113.049 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -79.96 161.57 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -53.84 125.64 19.29 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.826 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 63.83 9.63 4.61 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -159.77 163.87 34.26 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -143.59 153.08 42.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.412 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.28 123.63 36.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 tp -125.45 145.77 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.484 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.0 p -148.48 162.94 38.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.776 0.798 . . . . 0.0 112.262 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -56.54 -34.76 67.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.478 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.55 91.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.067 -176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -69.24 -46.72 66.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 0.0 111.032 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.7 -25.12 61.12 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.39 -148.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -55.37 -20.6 12.37 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.352 0.978 . . . . 0.0 112.417 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.75 -23.41 63.2 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -55.9 112.89 4.84 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.326 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.53 -13.24 2.85 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.863 1.709 . . . . 0.0 114.157 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -93.27 145.81 24.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.184 0.516 . . . . 0.0 111.722 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.96 -36.72 75.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.648 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.77 130.35 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -64.41 -30.59 71.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -150.64 176.86 10.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.725 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.66 162.07 34.41 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -107.47 139.84 41.35 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.7 pt -109.22 137.48 41.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -144.91 144.09 30.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.279 0.561 . . . . 0.0 112.008 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.6 m -108.65 122.74 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.712 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -83.13 158.82 63.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.001 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.57 -21.51 10.91 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.401 1.4 . . . . 0.0 113.159 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.0 p -79.51 3.0 20.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 63.71 40.51 7.74 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.233 0.539 . . . . 0.0 110.62 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -114.41 128.6 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.01 124.11 38.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.362 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.24 157.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.344 0.592 . . . . 0.0 111.372 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.4 t80 -114.05 127.06 55.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.129 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.7 130.69 58.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.91 155.75 36.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.729 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.51 -26.68 9.25 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.44 1.427 . . . . 0.0 113.126 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -64.18 -12.56 41.46 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.96 9.17 66.17 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.911 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.4 m -99.41 139.35 35.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.412 0.606 . . . . 0.0 109.396 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.8 m -103.46 131.91 50.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.058 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.36 129.24 35.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.695 0.283 . . . . 0.0 110.796 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 mt -88.3 -51.88 5.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -103.6 167.6 9.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.615 0.721 . . . . 0.0 111.959 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -55.47 -40.32 71.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.975 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -63.3 -41.56 98.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.326 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.71 79.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.832 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.04 -40.89 99.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.859 0.361 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.51 -34.07 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.714 0.292 . . . . 0.0 111.303 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.01 1.97 7.87 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.51 63.61 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.27 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -84.75 143.18 40.25 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.45 150.99 47.22 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.278 1.319 . . . . 0.0 111.931 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.89 151.97 36.2 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.299 1.332 . . . . 0.0 112.925 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 91.4 mt -61.99 -13.31 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.2 t -46.76 -35.27 4.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.09 -33.78 97.73 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 CA-C-N 123.038 2.121 . . . . 0.0 112.039 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 18.6 pt -98.94 7.77 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -77.26 142.3 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.684 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.44 139.51 30.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.152 0.501 . . . . 0.0 111.435 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -104.05 142.44 34.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.168 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.37 151.35 19.36 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.81 -40.88 81.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.58 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.68 171.76 19.5 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.57 -120.53 23.23 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.45 -120.02 1.73 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.44 152.94 21.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.01 128.03 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -62.1 140.51 58.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.179 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.48 6.98 47.13 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.241 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.21 -44.84 34.56 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.84 -0.538 . . . . 0.0 112.629 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.67 84.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.153 0.477 . . . . 0.0 110.74 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.59 -42.23 92.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.456 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.11 -43.81 95.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.453 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -59.21 -43.35 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.641 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.54 -47.95 83.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.563 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.8 m -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.772 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.75 -39.0 87.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.8 -42.94 90.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.301 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.159 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.02 -25.3 65.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.772 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.19 -18.14 54.73 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.911 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.19 145.51 25.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.672 0.736 . . . . 0.0 110.633 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.82 0 CA-C-O 118.065 -1.408 . . . . 0.0 110.965 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.88 140.64 49.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -123.33 135.85 54.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.69 147.17 47.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -112.32 139.26 48.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.54 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.52 140.49 49.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.394 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -117.93 143.64 46.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.502 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -68.92 161.94 27.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.13 -171.81 40.28 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.11 143.67 27.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.331 . . . . 0.0 110.333 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.28 151.03 91.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.559 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -89.49 -178.48 1.73 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.697 1.598 . . . . 0.0 112.343 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.63 145.55 49.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.106 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.43 -172.26 44.65 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 142.65 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.429 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.6 -176.23 50.93 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -126.42 164.42 21.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 110.321 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -83.39 140.17 32.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.551 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -115.02 157.9 22.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.598 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -133.58 158.91 41.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 141.46 56.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.613 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.43 144.59 53.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.23 144.81 56.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.402 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -88.3 133.9 33.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -122.28 157.58 31.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.393 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -70.63 140.34 51.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.393 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 -123.06 152.42 41.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.741 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -106.91 155.11 20.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -103.59 131.53 50.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.69 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.98 165.95 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.382 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -62.17 147.12 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.3 m -58.17 151.93 44.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.52 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.37 174.86 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.7 1.6 . . . . 0.0 112.378 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -67.27 151.93 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.556 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.3 mt -78.99 144.92 34.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.398 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.76 126.72 41.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -127.47 164.6 21.55 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -80.63 109.15 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 0.0 110.276 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -150.1 -176.12 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.697 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.75 156.83 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.364 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.76 121.99 19.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.567 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -133.74 -176.25 4.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -72.37 165.89 23.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.57 -175.7 43.88 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.89 -173.49 49.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.14 -170.67 45.19 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -57.43 149.83 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.533 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.69 149.5 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.768 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.51 155.12 30.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.679 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.93 -169.99 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.325 1.35 . . . . 0.0 112.044 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.97 167.88 19.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -57.27 164.18 1.89 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -55.89 143.83 30.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.035 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -139.74 167.06 19.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.626 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.33 148.21 7.85 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.396 1.397 . . . . 0.0 111.994 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.73 142.05 28.91 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.701 -0.666 . . . . 0.0 109.592 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.29 160.96 2.96 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.125 1.217 . . . . 0.0 111.427 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.05 152.39 87.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.375 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.1 150.83 34.07 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.304 1.336 . . . . 0.0 111.499 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.7 m -55.99 136.93 73.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.079 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.1 119.9 4.01 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.124 1.216 . . . . 0.0 113.262 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 p -78.68 162.64 26.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -53.82 125.52 18.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 111.751 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.8 12.88 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 171.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -159.82 165.73 31.74 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -145.62 153.12 40.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.589 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -90.87 123.71 34.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.9 tp -124.55 146.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -148.99 161.62 41.55 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.804 0.811 . . . . 0.0 112.437 -173.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -56.45 -34.78 67.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.34 91.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.106 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.25 -46.72 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.04 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -72.5 -28.99 63.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.82 -141.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -54.0 -28.33 37.36 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.797 1.181 . . . . 0.0 112.058 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.96 -26.92 50.2 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -55.82 109.97 1.98 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.709 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -89.56 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.828 1.685 . . . . 0.0 114.108 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.2 mt -91.24 145.88 24.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 111.819 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -69.82 -37.11 76.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.623 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.49 129.95 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -64.38 -31.0 72.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -168.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -149.53 176.73 10.36 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.615 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.01 34.28 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -106.99 140.39 39.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 pt -109.51 138.66 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -144.96 144.15 30.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.568 . . . . 0.0 111.946 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.7 m -109.52 122.8 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.815 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -82.51 158.21 66.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.856 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.53 -21.53 19.06 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.451 1.434 . . . . 0.0 112.913 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 t -78.2 3.12 16.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 63.57 40.91 7.69 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 121.297 0.57 . . . . 0.0 110.668 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.65 128.3 56.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.03 125.68 39.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.343 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.34 155.78 41.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.308 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -114.16 127.52 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.139 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.5 131.12 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 36.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.852 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.2 -26.99 8.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.537 1.491 . . . . 0.0 113.106 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -64.8 -11.19 34.15 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 9.47 66.9 Favored Glycine 0 CA--C 1.537 1.422 0 O-C-N 122.104 -0.372 . . . . 0.0 112.921 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.0 m -99.44 138.95 35.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.86 130.96 50.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.209 0.528 . . . . 0.0 110.003 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.96 148.06 41.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.235 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.33 127.05 35.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.691 0.282 . . . . 0.0 110.714 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -85.22 -50.91 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.976 0.417 . . . . 0.0 110.332 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.92 167.65 9.57 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.67 0.748 . . . . 0.0 111.921 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -58.22 -37.54 75.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.076 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.77 -41.18 98.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.199 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.39 -36.94 79.27 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.33 -40.11 96.42 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.458 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -58.57 -33.94 70.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.157 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.24 1.59 7.41 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.51 63.58 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.946 -0.364 . . . . 0.0 113.253 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -86.59 143.19 35.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 117.498 0.649 . . . . 0.0 109.386 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.18 152.24 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.297 1.331 . . . . 0.0 111.349 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.04 157.84 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.297 1.331 . . . . 0.0 112.431 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 112' ' ' ILE . 81.4 mt -62.91 -10.12 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 t -43.84 -39.6 6.0 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -172.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.8 -33.72 98.62 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 CA-C-N 122.385 1.887 . . . . 0.0 112.232 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 23.8 pt -98.9 7.44 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -77.61 139.3 39.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.336 0.516 . . . . 0.0 110.474 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.28 136.49 32.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 111.398 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -99.38 140.37 33.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.107 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.29 167.21 20.21 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.533 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 m -58.13 -38.51 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.29 . . . . 0.0 110.713 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.52 165.78 26.01 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.95 59.29 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.181 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.07 -123.59 30.37 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -107.83 159.7 16.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.21 129.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.213 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -59.53 139.2 57.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.9 mt -94.92 6.28 49.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.314 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -44.2 37.86 Favored Glycine 0 CA--C 1.526 0.758 0 O-C-N 121.873 -0.517 . . . . 0.0 112.741 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 -47.84 83.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.243 0.521 . . . . 0.0 110.76 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.89 -42.43 93.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.57 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.0 tp -60.41 -43.03 97.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.523 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.2 t -58.91 -43.97 91.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.764 0.316 . . . . 0.0 110.531 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.13 -47.78 84.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.583 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.7 m -62.65 -40.56 97.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.802 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.019 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.31 -43.65 88.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.247 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.13 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.085 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.12 -25.14 65.23 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.92 23.01 39.98 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.351 -0.452 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -103.19 145.62 29.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.43 0.615 . . . . 0.0 110.322 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 CA-C-O 118.059 -1.412 . . . . 0.0 110.924 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -128.85 146.64 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -113.06 141.68 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -110.84 138.71 46.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.492 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -130.36 166.03 21.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.434 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -111.29 137.44 49.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.411 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.2 m -63.59 154.47 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.679 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -121.13 148.94 43.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.02 138.99 49.16 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.3 mt -98.29 140.8 32.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 110.7 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.53 154.79 94.0 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.509 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.21 112.75 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.282 1.321 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -123.76 153.35 41.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.457 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.66 -176.78 51.33 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -117.75 143.13 46.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.551 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 178.23 24.57 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt -123.45 148.54 46.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.81 0.338 . . . . 0.0 110.557 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -135.99 159.91 40.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -106.87 146.26 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -139.59 159.55 41.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.95 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.14 139.56 50.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.685 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 145.0 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.575 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -77.18 131.91 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.366 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.88 146.11 42.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.633 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.27 154.74 29.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -148.77 159.7 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.716 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.59 131.85 51.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -118.35 139.91 50.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.405 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.27 158.32 37.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.486 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -77.65 173.11 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.653 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 m -67.55 150.7 97.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.366 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -89.92 174.56 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.701 1.6 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.18 147.22 52.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.309 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.92 126.65 39.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.55 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.36 -172.58 44.5 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 m -73.02 141.6 47.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.753 0.311 . . . . 0.0 110.36 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -58.57 133.77 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -69.83 150.35 46.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.732 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.44 157.72 10.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.373 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.5 117.44 15.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.619 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -100.88 171.19 7.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.703 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.2 m -62.31 144.35 55.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.363 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.41 34.24 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 -170.68 46.82 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.15 -164.42 24.48 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -57.14 140.4 49.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.55 150.17 23.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -57.02 155.76 15.13 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.6 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.5 -170.0 0.61 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 112.32 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 151.04 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -126.14 168.74 13.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.425 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -65.53 142.6 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.605 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -66.64 153.55 93.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.608 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.58 146.28 54.35 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.324 1.349 . . . . 0.0 111.896 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.31 141.58 27.67 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.48 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 160.88 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.103 1.202 . . . . 0.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.04 153.79 83.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.457 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.42 148.63 43.37 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.215 1.276 . . . . 0.0 111.475 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.9 p -56.01 129.88 73.06 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.042 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.11 119.88 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.139 1.226 . . . . 0.0 113.455 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.6 p -76.37 159.7 30.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -56.07 125.56 22.13 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.109 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.66 14.32 8.06 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -150.92 149.86 30.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.612 0.642 . . . . 0.0 112.252 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -148.83 150.81 33.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.15 126.09 39.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 tp -125.57 144.42 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.465 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 160.47 43.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.724 0.774 . . . . 0.0 112.356 -173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.66 -34.74 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.525 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.76 90.71 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.116 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -70.59 -46.54 63.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.171 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.36 -25.05 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.87 -148.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -55.7 -20.48 14.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.271 0.941 . . . . 0.0 112.367 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.75 -24.3 63.94 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -55.85 112.89 4.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.264 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -89.54 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.812 1.675 . . . . 0.0 114.144 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.82 144.87 25.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 111.656 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.7 p -69.09 -37.41 78.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.585 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -64.27 129.77 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.08 -33.6 74.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -147.58 174.61 11.59 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.879 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 161.98 34.23 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.5 m -107.45 139.98 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 pt -109.58 138.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.79 145.9 31.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.24 0.543 . . . . 0.0 111.918 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.7 m -108.68 120.11 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.768 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.8 mt -81.44 155.63 71.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.89 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.7 -20.15 8.9 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.372 1.381 . . . . 0.0 113.278 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.4 m -80.98 3.02 24.4 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.2 t0 69.01 37.2 2.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.87 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -114.34 127.95 56.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.3 122.14 37.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.204 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 155.6 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.389 0.614 . . . . 0.0 111.405 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -114.1 127.54 55.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.134 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.15 130.9 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.35 155.91 35.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.838 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.61 -25.82 8.37 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.453 1.435 . . . . 0.0 113.139 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -65.23 -11.8 44.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.76 67.73 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 122.055 -0.403 . . . . 0.0 112.964 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.6 m -99.52 139.37 35.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.5 m -104.09 132.93 49.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 109.889 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -118.26 151.27 37.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.54 125.02 34.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.691 0.281 . . . . 0.0 110.646 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.9 mt -83.45 -50.33 8.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 109.918 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -103.27 167.56 9.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.574 0.702 . . . . 0.0 111.502 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.3 -38.8 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.954 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.93 -43.02 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.441 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.68 79.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 110.723 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -63.33 -41.42 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.278 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -58.6 -32.79 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.514 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 2.38 6.27 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.09 23.48 63.51 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.176 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.76 142.4 45.39 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 153.83 76.58 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 121.316 1.344 . . . . 0.0 111.737 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.06 151.58 27.29 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.375 1.383 . . . . 0.0 112.509 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 92.9 mt -64.02 -16.57 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.223 -0.418 . . . . 0.0 111.878 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.2 t -46.73 -35.26 4.84 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.38 -32.63 96.6 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 CA-C-N 123.155 2.163 . . . . 0.0 111.935 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.0 pt -98.75 6.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -78.28 138.79 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.305 0.502 . . . . 0.0 110.74 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -83.93 138.11 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.162 0.506 . . . . 0.0 111.718 -177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -98.23 139.98 33.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.13 144.54 16.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -57.17 -40.0 76.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.8 169.45 19.14 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.18 -119.95 20.66 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.67 -119.95 1.71 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.58 150.6 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.272 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.61 126.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.192 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m -60.34 138.47 57.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.993 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -95.24 7.33 46.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.27 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -43.11 36.88 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.755 -0.591 . . . . 0.0 112.63 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.62 80.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.061 0.43 . . . . 0.0 110.781 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 tp -59.86 -42.51 93.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.23 -43.17 96.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.475 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 t -59.24 -43.95 92.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.547 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.0 m -59.93 -47.58 85.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.576 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.3 m -62.67 -40.95 98.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.04 -38.35 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.628 0.252 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.47 -43.7 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 110.2 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.88 -39.28 93.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.902 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.9 m -60.05 -25.16 65.13 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.841 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.35 44.62 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.842 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.68 145.37 24.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.722 0.761 . . . . 0.0 110.598 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.732 0 CA-C-O 118.035 -1.425 . . . . 0.0 110.987 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.28 139.68 50.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.465 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -119.99 141.52 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -115.23 138.84 50.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.509 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -123.85 145.8 48.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.54 140.0 48.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.4 m -61.27 153.88 25.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t -123.31 145.2 48.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.25 -176.99 51.64 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.67 139.6 30.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.601 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.47 155.07 93.1 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.601 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.92 119.93 6.78 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.37 1.38 . . . . 0.0 111.939 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -150.0 166.01 30.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -175.46 50.49 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -113.94 143.34 44.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.553 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.85 -175.54 37.72 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtt -110.59 144.39 39.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.388 . . . . 0.0 110.528 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -116.81 148.8 40.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.497 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -56.98 146.05 28.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.9 p -122.03 162.12 21.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.514 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.71 49.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 148.23 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.621 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.66 145.7 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.532 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.24 151.79 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.9 134.81 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.416 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -106.85 156.83 18.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.592 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -147.32 162.61 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.43 151.53 27.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.634 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -129.62 159.76 35.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.395 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.5 mtp -99.25 141.04 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.636 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -87.37 172.26 9.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -65.17 153.22 89.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.528 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.2 155.9 14.71 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.544 1.496 . . . . 0.0 112.328 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -68.05 149.01 50.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.572 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.35 144.29 28.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.456 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.08 -140.0 2.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -72.44 169.56 16.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.317 . . . . 0.0 110.436 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -55.23 145.37 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -150.1 167.5 26.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.473 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.16 153.39 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.57 122.77 21.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.691 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -128.64 144.07 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.339 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 p -71.47 162.38 29.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.332 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.33 178.73 53.76 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.48 -171.91 47.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.26 -156.37 6.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -55.47 148.86 14.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.73 145.28 29.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.2 157.54 89.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.686 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.49 -169.97 0.74 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.396 1.397 . . . . 0.0 112.216 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -172.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -56.08 169.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.776 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -116.78 147.17 42.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.793 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -70.95 163.91 60.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.23 162.11 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.416 1.411 . . . . 0.0 112.131 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.27 142.42 28.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.391 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.23 160.8 3.04 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.15 1.233 . . . . 0.0 111.41 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.98 154.25 82.3 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.717 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.96 151.62 67.99 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.246 1.297 . . . . 0.0 111.425 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -55.83 135.65 72.6 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -80.21 119.96 3.99 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.289 1.326 . . . . 0.0 113.311 -170.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -82.89 158.02 22.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -56.79 125.46 22.49 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.856 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 63.55 14.96 8.48 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -152.08 151.21 30.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.65 0.659 . . . . 0.0 112.205 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -152.1 151.45 31.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -93.37 127.33 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 tp -127.73 145.46 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.509 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -150.48 160.89 43.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.734 0.778 . . . . 0.0 112.387 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -55.54 -34.94 65.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.12 89.99 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.031 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.16 -46.67 60.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.063 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.45 -26.78 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.79 -145.39 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -55.56 -23.27 25.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.486 1.039 . . . . 0.0 112.285 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.0 -23.57 63.76 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -55.86 111.13 2.8 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.37 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -89.53 -13.18 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.845 1.697 . . . . 0.0 114.056 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.06 145.36 25.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 111.964 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.5 p -70.03 -37.29 75.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.535 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.65 129.59 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.84 -33.97 75.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.042 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -148.42 175.03 11.46 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.601 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.79 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -108.15 138.68 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 pt -106.81 134.37 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.32 145.18 30.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.417 0.627 . . . . 0.0 111.994 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.6 m -102.47 118.55 37.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.006 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt -81.92 156.37 69.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.267 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.9 -16.78 12.42 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.398 1.399 . . . . 0.0 113.016 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -79.93 3.08 21.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 63.88 47.4 3.52 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -131.4 136.33 47.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.463 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.25 120.43 35.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.624 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.22 156.35 42.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.464 0.649 . . . . 0.0 111.814 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -114.04 128.0 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.795 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.51 131.77 56.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.16 155.4 36.46 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.834 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.73 -27.1 10.46 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.62 1.546 . . . . 0.0 113.092 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -64.49 -11.69 36.43 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.55 66.63 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.936 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -99.42 140.29 33.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.7 m -103.75 129.23 51.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 110.093 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -114.79 151.88 33.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.04 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.3 124.93 33.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 110.43 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.2 -47.42 14.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.152 0.501 . . . . 0.0 109.809 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -115.36 167.62 10.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -53.84 -33.81 57.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.716 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -61.18 -49.01 78.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.323 0.582 . . . . 0.0 110.637 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.86 -37.39 76.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.09 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -61.42 -42.16 98.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.014 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -57.74 -33.96 69.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.8 9.18 3.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.5 63.6 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 122.177 -0.327 . . . . 0.0 113.358 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -97.01 112.08 59.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.366 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -54.78 150.4 36.85 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.472 1.204 . . . . 0.0 111.592 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.45 158.88 55.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.266 1.311 . . . . 0.0 112.391 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 112' ' ' ILE . 76.6 mt -61.59 -10.81 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 t -44.21 -38.92 5.64 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -172.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.92 -33.59 98.74 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.612 1.968 . . . . 0.0 112.21 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.9 pt -98.81 6.75 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -77.45 141.59 39.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.497 0.589 . . . . 0.0 110.796 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.67 146.49 36.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.416 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -86.82 155.12 20.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.967 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.97 -167.6 36.09 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.894 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 m -57.7 -48.86 78.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.09 114.94 0.63 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.271 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.43 34.13 88.41 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.084 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.39 154.85 26.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.18 142.87 39.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.62 128.43 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.156 0.503 . . . . 0.0 110.116 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -62.79 138.79 58.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.168 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -96.2 11.18 35.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.953 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -44.59 31.1 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.825 -0.547 . . . . 0.0 112.851 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.58 77.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.313 0.557 . . . . 0.0 110.797 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.15 -42.05 89.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -60.38 -43.69 96.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.656 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.9 p -60.61 -42.56 97.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.721 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.09 -47.18 87.52 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.642 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.1 m -63.09 -40.54 97.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.08 -39.46 86.15 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.799 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -58.76 -42.88 89.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.297 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.96 -39.28 91.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.055 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.6 m -59.93 -25.29 65.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.013 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.83 60.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.622 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.95 133.59 36.88 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.451 0.626 . . . . 0.0 110.551 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.808 0 CA-C-O 118.045 -1.419 . . . . 0.0 110.988 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.83 135.21 52.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.491 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -129.14 148.92 51.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -111.93 140.72 46.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.527 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -112.61 139.81 47.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -120.96 132.75 55.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.506 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 m -63.44 156.07 27.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.9 p -68.69 162.55 25.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.556 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.35 -177.86 51.94 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -100.14 131.15 46.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.445 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.1 163.69 36.28 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.5 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.01 158.97 27.36 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.366 1.378 . . . . 0.0 111.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.58 146.84 47.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.542 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 -177.48 40.41 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 143.12 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.13 -176.59 50.76 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.5 mtp -108.35 144.15 36.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 110.52 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -79.4 135.06 36.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -57.7 144.72 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -134.38 158.8 42.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 148.71 42.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.624 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.17 147.47 30.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.4 146.76 25.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -86.88 155.49 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.431 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -95.01 131.5 40.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -63.66 145.26 56.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -140.18 165.04 28.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.993 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -109.45 146.2 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.401 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.54 133.35 35.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.403 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.8 149.6 47.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -57.17 154.79 19.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.46 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.96 129.53 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.299 1.333 . . . . 0.0 111.993 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -67.2 149.51 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.773 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.87 148.45 27.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.14 -177.93 51.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -123.08 167.78 13.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 110.474 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -66.31 179.93 0.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -71.44 170.17 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -82.62 174.65 10.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -73.95 -174.1 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.832 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.84 151.86 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -71.19 136.2 47.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.74 -150.05 9.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.82 -173.65 47.48 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.86 179.36 53.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -126.5 157.16 39.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 110.432 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.75 149.63 21.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.246 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.56 134.48 82.22 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.278 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.7 -169.97 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.821 1.681 . . . . 0.0 112.274 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.4 -173.97 2.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.262 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -107.5 139.41 42.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.499 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -103.5 142.79 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.635 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 p -70.43 154.11 94.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.09 139.8 33.81 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.379 1.386 . . . . 0.0 112.094 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.29 143.01 28.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.316 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.2 158.83 4.76 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.14 1.227 . . . . 0.0 111.294 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 mt -64.0 149.85 92.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.531 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -63.63 146.16 92.22 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.171 1.247 . . . . 0.0 111.135 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.7 p -55.94 137.6 72.49 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.111 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.2 119.94 3.99 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.172 1.248 . . . . 0.0 113.385 -170.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.8 p -81.59 158.73 24.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 167.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -56.87 125.44 22.51 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.967 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 m120 63.64 14.07 7.84 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -151.72 150.77 30.58 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.59 0.632 . . . . 0.0 112.208 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -149.61 151.1 33.23 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.866 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -93.76 126.99 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 tp -128.25 145.95 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.144 -0.223 . . . . 0.0 110.597 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.39 161.23 42.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.695 0.76 . . . . 0.0 112.502 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -55.99 -34.82 66.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.535 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.54 86.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.07 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.33 -46.64 54.69 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.012 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.71 -26.19 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.56 -146.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -54.1 -28.1 37.2 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.412 1.006 . . . . 0.0 111.952 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.2 tp -53.97 -26.54 26.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -55.69 111.09 2.72 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.318 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.69 -13.1 2.81 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.771 1.647 . . . . 0.0 114.197 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.82 145.36 25.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.204 0.526 . . . . 0.0 111.84 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.8 p -69.22 -37.12 77.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.62 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.36 129.23 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.66 -34.04 75.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.8 174.84 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.471 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.03 34.29 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -108.09 137.81 45.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 pt -106.82 133.15 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -146.81 147.17 30.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.469 0.652 . . . . 0.0 111.93 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.2 m -102.48 120.49 40.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.742 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.6 mt -87.67 156.97 52.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.353 -173.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.73 -16.27 5.48 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.511 1.474 . . . . 0.0 113.183 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.6 m -77.54 3.0 14.67 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 62.99 43.62 6.51 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -135.13 145.79 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.618 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.55 42.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 110.774 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.66 158.62 42.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.57 0.7 . . . . 0.0 111.938 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -114.09 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.767 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.55 131.45 57.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.14 155.21 36.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.823 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.69 -27.05 10.25 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.599 1.533 . . . . 0.0 113.103 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.1 p30 -64.11 -12.17 36.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.19 10.05 66.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.889 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 m -99.4 139.9 34.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.24 129.53 50.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.302 0.572 . . . . 0.0 110.124 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -114.58 149.41 36.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.038 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.32 126.17 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.821 0.343 . . . . 0.0 110.439 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.5 mt -83.71 -51.75 6.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -111.93 167.63 10.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.7 0.762 . . . . 0.0 111.924 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.92 -34.22 54.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -60.77 -47.07 88.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.325 0.584 . . . . 0.0 110.459 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.406 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.25 -41.25 98.27 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.236 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -59.49 -34.0 72.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.259 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.34 -2.88 12.0 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.53 63.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 122.128 -0.358 . . . . 0.0 113.166 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -88.93 143.2 31.08 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 117.454 0.627 . . . . 0.0 109.566 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.42 148.11 37.64 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.203 1.269 . . . . 0.0 111.324 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -76.09 158.78 37.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.368 1.378 . . . . 0.0 112.684 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.77 -12.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 119.013 -0.518 . . . . 0.0 112.28 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.8 t -43.76 -39.64 5.88 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.44 -31.91 95.56 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 CA-C-N 122.35 1.875 . . . . 0.0 112.432 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 20.0 pt -98.84 6.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -77.57 137.54 38.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.54 0.609 . . . . 0.0 110.453 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.95 142.88 31.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.58 140.0 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.846 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.35 150.34 18.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -57.5 -41.15 80.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.35 171.83 23.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.26 -120.05 20.09 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.95 -119.89 1.55 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.66 150.5 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.9 mt -79.58 129.16 37.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.468 -174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.0 m -65.03 140.88 58.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.055 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.43 8.63 39.82 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.14 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.1 -43.67 32.56 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.897 -0.502 . . . . 0.0 112.745 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.45 -49.48 77.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.161 0.48 . . . . 0.0 110.84 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 29.9 tp -58.82 -42.0 88.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.476 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.82 -44.22 94.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.484 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -59.96 -43.9 94.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.666 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.1 m -60.5 -46.75 88.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.449 . . . . 0.0 110.58 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.5 m -63.14 -41.35 99.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.01 -39.4 85.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.746 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.33 -42.39 91.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.56 -39.69 94.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -63.12 -25.18 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.144 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.86 22.95 40.41 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.636 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.65 144.92 25.67 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.43 0.615 . . . . 0.0 110.503 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.998 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -117.69 139.47 50.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.52 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -120.99 142.79 49.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.12 138.72 50.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.424 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -122.15 144.41 48.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.491 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.79 139.49 49.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.415 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.2 p -134.99 160.03 39.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.621 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.9 p -67.93 163.77 21.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.79 -176.92 51.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.78 142.94 26.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.81 154.69 85.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.66 133.83 41.3 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.8 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -123.08 152.46 41.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.439 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.82 -176.67 51.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p -69.17 159.91 32.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.597 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.82 -175.09 45.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.4 135.78 40.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -134.18 134.76 42.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.603 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.51 144.16 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -122.16 160.15 25.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.12 157.12 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.62 141.61 56.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.03 158.41 44.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.561 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -66.66 139.81 57.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -102.2 133.91 46.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.726 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -102.38 146.09 28.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.392 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -54.42 147.45 13.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.258 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -68.11 147.91 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -119.6 145.41 46.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.9 mtp -117.62 166.14 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -61.32 145.03 52.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.8 p -62.15 152.45 78.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -86.47 -174.97 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.679 1.586 . . . . 0.0 112.297 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.59 123.83 27.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.5 mt -81.77 144.11 31.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.553 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.78 -139.95 2.77 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.7 t -59.0 167.04 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -61.55 144.04 55.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.39 -179.96 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.737 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -63.03 150.8 41.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.655 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -59.06 151.04 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.85 136.96 58.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.559 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 p -82.63 166.8 18.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.641 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.5 -167.3 28.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.36 -177.0 36.72 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.09 -177.51 51.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 168.69 23.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.3 . . . . 0.0 110.713 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 144.68 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.639 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 156.74 64.83 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.23 173.98 7.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.233 1.289 . . . . 0.0 111.944 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 142.7 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.686 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.38 164.82 26.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.447 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -147.01 157.02 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.9 m -80.98 153.15 72.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.339 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.33 162.19 10.27 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.204 1.269 . . . . 0.0 111.63 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.35 141.0 27.13 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.42 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.32 153.48 13.15 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.102 1.201 . . . . 0.0 111.336 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.11 153.77 84.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.325 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.63 145.85 53.26 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.157 1.238 . . . . 0.0 111.133 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.5 m -55.89 139.38 70.41 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.146 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.07 119.81 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.109 1.206 . . . . 0.0 113.1 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.9 p -84.04 159.69 21.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 p -55.54 125.59 21.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.026 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 63.43 14.12 7.69 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.265 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -157.08 144.18 18.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -139.01 152.81 47.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.656 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -93.87 126.21 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 tp -124.91 144.85 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.9 p -150.38 160.82 43.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.673 0.749 . . . . 0.0 112.447 -173.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -55.64 -34.68 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.567 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.64 -42.17 87.69 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.104 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -73.64 -46.61 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.375 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.36 -27.78 63.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.4 -142.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -54.11 -28.88 42.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.683 1.129 . . . . 0.0 111.883 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -56.98 -24.77 55.78 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -55.91 107.49 0.9 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.368 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -87.2 -13.24 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.703 1.602 . . . . 0.0 114.136 -175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.0 mt -89.59 145.56 25.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.559 . . . . 0.0 111.94 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.3 p -69.85 -37.28 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.719 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.15 130.13 30.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.02 -33.4 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.043 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -147.01 174.55 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.667 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.72 162.09 34.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -107.92 140.58 40.83 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.539 -0.389 . . . . 0.0 110.112 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.96 135.36 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.36 143.57 31.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.295 0.569 . . . . 0.0 112.151 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.7 m -108.59 121.8 45.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -83.28 158.97 63.0 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.955 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.35 -18.46 18.98 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.386 1.391 . . . . 0.0 113.099 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.8 m -80.32 3.07 22.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 63.9 41.48 6.64 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 0.0 110.545 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -116.4 128.46 55.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.259 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.03 123.74 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.387 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.8 m -131.86 155.23 41.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 111.225 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -114.1 128.04 56.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.031 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.97 131.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.52 155.32 36.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.75 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.42 -26.54 8.83 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.565 1.51 . . . . 0.0 113.111 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -64.43 -12.17 40.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.36 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.92 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.9 m -99.41 140.01 34.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.6 m -104.73 130.92 52.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 110.095 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -116.32 148.41 40.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.0 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.28 124.94 33.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.767 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 mt -82.18 -48.5 11.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 0.0 109.982 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.5 p30 -108.39 167.63 9.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.47 0.653 . . . . 0.0 111.606 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -55.03 -40.99 70.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.979 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -63.42 -42.47 98.72 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.37 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.27 78.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.077 0.465 . . . . 0.0 110.616 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -62.32 -41.7 98.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.944 0.402 . . . . 0.0 110.213 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -57.69 -33.07 67.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.495 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.79 9.92 3.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.47 63.67 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.359 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -94.64 112.03 56.33 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.097 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.39 153.41 40.97 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.183 1.255 . . . . 0.0 111.569 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.35 158.84 56.0 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.263 1.309 . . . . 0.0 112.283 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.408 HG22 HD13 ' A' ' 112' ' ' ILE . 74.7 mt -62.75 -9.92 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.8 t -44.43 -38.69 5.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.93 -33.14 98.55 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 CA-C-N 122.474 1.919 . . . . 0.0 112.329 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.8 pt -98.91 6.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -77.53 140.84 39.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.479 0.581 . . . . 0.0 110.522 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.09 141.89 29.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -97.86 139.88 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.777 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.09 169.68 20.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 86.3 p -60.83 -35.13 75.73 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.087 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.17 164.24 26.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.61 27.51 63.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.05 -122.05 27.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -104.29 156.71 17.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.023 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.9 mt -78.74 133.12 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.53 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -65.08 140.89 58.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.89 9.55 38.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.13 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -45.86 32.97 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.841 -0.537 . . . . 0.0 112.838 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.79 87.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.237 0.518 . . . . 0.0 110.822 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.492 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.465 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -58.65 -43.13 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.662 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.91 -47.74 85.03 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.584 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.4 m -62.62 -40.11 95.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.856 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.97 -39.93 87.33 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.788 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.82 -43.64 90.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.292 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.58 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.334 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.92 -25.23 64.98 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.95 23.01 62.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.709 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.43 142.81 47.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.497 0.648 . . . . 0.0 110.988 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.801 0 CA-C-O 118.107 -1.385 . . . . 0.0 110.975 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.43 140.0 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.452 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.42 139.04 51.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.453 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -121.03 141.7 50.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.51 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -123.31 133.78 54.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.487 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -125.52 136.37 53.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.45 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m -119.72 147.55 44.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -121.87 144.36 48.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.58 -177.74 33.95 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.3 tp -100.78 131.7 46.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 0.0 110.529 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.53 159.72 40.89 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.52 151.7 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.492 1.461 . . . . 0.0 112.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -150.02 163.04 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.635 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.97 -177.43 51.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 m -62.99 154.5 30.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 110.561 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.8 43.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.9 153.44 35.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 110.402 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -93.44 142.5 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.697 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.84 156.64 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.371 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -78.29 159.57 28.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.02 156.98 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 146.0 27.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.479 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.34 144.81 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.632 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -122.87 148.09 45.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.343 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -106.12 133.89 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.465 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -110.94 152.35 26.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -79.63 147.53 32.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -138.11 165.1 27.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.148 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.82 141.74 40.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.434 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.5 mtm -94.4 144.2 25.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.559 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -147.7 173.66 12.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 m -62.72 152.93 80.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.54 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.25 156.55 14.73 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.536 1.49 . . . . 0.0 112.246 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.12 145.62 54.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -88.51 144.62 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.469 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.24 146.35 43.38 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 t -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.745 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -69.38 -178.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -65.35 127.62 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.657 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -150.01 -179.66 7.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.806 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.06 150.81 32.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.47 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -71.6 145.41 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.552 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -122.55 166.09 15.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.88 -169.94 39.8 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.31 -176.34 44.36 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.92 -168.7 19.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.0 146.22 27.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.15 146.56 50.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.92 153.8 83.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.522 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.85 166.91 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.343 1.362 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.07 55.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -125.95 146.92 49.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.65 147.06 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -104.72 99.94 20.98 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.427 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.22 162.1 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.427 1.418 . . . . 0.0 112.125 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.57 142.5 31.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.311 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.32 155.29 9.69 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.025 1.15 . . . . 0.0 111.257 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 mt -64.04 150.36 92.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.292 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 146.23 96.49 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.125 1.217 . . . . 0.0 111.158 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 p -55.94 138.87 71.48 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.08 119.83 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.195 1.263 . . . . 0.0 113.212 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.8 p -87.01 158.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 167.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -57.22 125.54 23.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.85 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.7 m120 63.56 15.05 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -150.03 148.27 28.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.585 0.63 . . . . 0.0 112.28 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -151.18 152.57 33.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -95.91 128.57 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 tp -128.0 145.0 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -150.12 161.63 42.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.706 0.765 . . . . 0.0 112.466 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.69 -34.42 65.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.547 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.39 90.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.104 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -69.89 -46.76 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.953 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.91 -25.67 61.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.9 -147.61 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -55.92 -21.16 19.02 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.34 0.973 . . . . 0.0 112.292 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.87 -23.43 63.43 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -55.75 113.08 5.06 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.3 -176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -89.67 -13.25 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.752 1.635 . . . . 0.0 114.306 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -94.15 147.31 23.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.173 0.511 . . . . 0.0 111.915 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.0 p -69.58 -36.4 76.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.728 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.69 128.22 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.88 -33.93 75.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -148.61 174.94 11.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.557 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 162.07 34.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.2 m -108.58 140.47 41.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.611 -0.346 . . . . 0.0 110.076 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 pt -108.47 136.77 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.35 143.56 31.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.391 0.615 . . . . 0.0 111.941 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 m -110.19 122.61 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.744 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.0 mt -83.02 157.78 65.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.34 -22.29 15.56 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.433 1.422 . . . . 0.0 113.012 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -79.37 3.02 19.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 63.82 39.98 7.93 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.254 0.55 . . . . 0.0 110.811 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -110.53 128.01 55.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.76 122.56 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.508 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.54 154.64 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.498 0.666 . . . . 0.0 111.491 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -114.04 127.91 56.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.801 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.31 131.86 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.48 155.17 36.68 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.821 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.7 -26.87 10.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.629 1.553 . . . . 0.0 113.018 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -64.22 -12.16 38.13 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.72 10.37 67.31 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 121.491 -0.385 . . . . 0.0 112.832 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 m -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.6 m -101.52 130.43 47.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.261 0.553 . . . . 0.0 109.943 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.65 147.23 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.813 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.31 124.99 33.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 110.794 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.93 -48.27 11.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -112.55 167.58 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.614 0.721 . . . . 0.0 112.004 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -53.79 -40.76 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.151 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -63.36 -41.11 98.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.252 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.47 -38.61 77.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.695 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.16 -40.71 98.33 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.412 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -58.01 -33.88 69.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.314 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.89 7.53 4.7 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.48 63.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.227 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -94.49 111.99 55.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.361 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.72 151.51 31.75 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.189 1.259 . . . . 0.0 111.358 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.1 158.98 45.04 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.476 1.451 . . . . 0.0 112.705 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 112' ' ' ILE . 80.1 mt -59.64 -12.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.344 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 t -43.36 -40.71 6.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -58.05 -30.04 88.9 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 122.507 1.931 . . . . 0.0 112.703 -173.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.8 pt -98.9 7.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -68.58 149.18 49.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.742 0.701 . . . . 0.0 110.801 -176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.53 143.15 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 111.626 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -96.74 139.96 32.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.696 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.8 155.39 17.75 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.2 p -58.87 -34.58 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.022 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.11 158.09 24.13 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.23 25.74 61.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.437 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.02 18.68 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 117.359 0.58 . . . . 0.0 111.68 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.47 156.33 18.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 0.0 110.685 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 74.6 mt -86.13 132.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.046 0.45 . . . . 0.0 110.254 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -69.27 141.46 54.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.997 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.4 mt -91.87 5.83 48.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.318 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.89 -43.74 39.82 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.792 -0.567 . . . . 0.0 112.543 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.94 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 110.78 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.62 -42.77 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.18 -42.89 95.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.435 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 m -59.54 -43.69 93.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.687 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.4 m -61.37 -47.82 84.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.605 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.6 m -63.56 -39.62 94.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.939 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.19 -38.74 87.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.936 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.36 -43.2 88.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.894 0.378 . . . . 0.0 110.222 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.76 -39.68 94.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.893 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.2 m -60.07 -25.2 65.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 22.95 54.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.631 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -84.05 133.75 34.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.465 0.633 . . . . 0.0 110.641 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 117.937 -1.48 . . . . 0.0 111.021 179.855 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -120.74 142.65 49.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.526 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.76 137.84 51.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.399 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -120.29 140.46 51.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -120.38 141.02 50.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.435 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -122.9 132.91 54.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t -121.4 142.68 49.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m -63.45 155.73 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.76 -176.17 38.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 tp -100.09 128.54 46.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.04 163.81 45.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.567 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.92 159.59 24.82 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.343 1.362 . . . . 0.0 111.803 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.55 141.88 58.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.658 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.61 -174.87 47.32 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.5 p -131.34 156.28 45.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.733 0.301 . . . . 0.0 110.485 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.49 179.23 50.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.2 mtp -133.52 159.22 41.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.514 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.78 140.61 48.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.91 151.38 36.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.761 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -124.65 141.38 52.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.195 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.16 107.73 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.629 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.07 157.13 42.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.457 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.8 105.0 11.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.294 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -137.14 144.09 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -121.45 154.64 36.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.035 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -142.52 169.07 18.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -148.23 164.11 34.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.428 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.13 141.08 40.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.742 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -131.94 156.86 45.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.394 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.0 mtt -102.1 141.58 34.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -88.51 118.28 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -137.85 160.13 65.93 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.11 -174.94 2.02 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.509 1.473 . . . . 0.0 112.115 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.63 128.39 34.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.567 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.9 tp -100.48 130.22 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.626 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.1 -173.93 50.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 m -72.05 135.94 46.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.719 0.295 . . . . 0.0 110.464 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.44 157.41 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.738 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.0 150.16 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.98 145.75 45.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.477 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -72.55 172.17 11.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.915 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -135.16 171.47 14.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.97 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 m -71.22 140.16 50.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.419 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.49 -177.32 50.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.27 -140.02 3.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.62 -174.35 49.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -57.96 148.78 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.719 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 151.8 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.553 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.96 159.06 6.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.758 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.91 -179.0 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.298 1.332 . . . . 0.0 111.998 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.61 158.77 43.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.74 140.83 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.434 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -64.7 141.26 58.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.576 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -127.55 162.41 49.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.67 128.16 23.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.24 1.293 . . . . 0.0 111.642 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.41 139.45 26.77 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.573 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -52.24 155.5 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.053 1.169 . . . . 0.0 111.262 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.01 152.73 86.82 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.24 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.56 154.6 71.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.111 1.207 . . . . 0.0 111.122 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.6 m -55.96 130.76 73.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.231 -0.414 . . . . 0.0 109.974 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.07 119.87 4.02 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.111 1.207 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -83.99 159.0 21.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.9 m -55.07 125.51 20.79 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.025 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.2 p30 63.35 16.46 9.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.224 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -154.99 141.56 18.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.293 0.497 . . . . 0.0 112.254 -175.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -145.61 153.15 40.74 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.056 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -95.02 128.25 41.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tp -126.57 141.49 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.0 p -144.23 164.66 30.08 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.595 0.712 . . . . 0.0 111.865 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -55.69 -36.15 66.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.322 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.04 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.765 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -70.63 -46.58 63.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.936 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.0 mt -85.03 -9.45 58.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.7 -151.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -56.03 -20.08 15.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.914 0.779 . . . . 0.0 112.366 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -57.54 -25.79 60.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.1 t-105 -55.79 107.18 0.81 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.27 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.21 -13.17 4.51 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.832 1.688 . . . . 0.0 114.068 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -88.21 145.69 25.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.36 0.6 . . . . 0.0 112.062 -174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.3 p -69.83 -36.89 75.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.72 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.22 129.01 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.67 -32.43 72.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -146.78 174.35 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.652 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -107.81 140.32 41.07 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.625 -0.338 . . . . 0.0 110.1 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 pt -109.34 137.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -148.04 146.45 28.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.384 0.611 . . . . 0.0 112.067 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.8 m -109.47 125.58 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.722 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.93 160.41 55.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.058 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.15 -20.93 8.44 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.453 1.436 . . . . 0.0 113.177 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -80.08 3.07 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 62.87 40.12 9.95 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.143 0.497 . . . . 0.0 110.692 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -112.61 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.97 121.97 37.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.322 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.52 156.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.328 0.585 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -114.08 128.35 56.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.069 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.18 130.76 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.32 155.32 36.53 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.762 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.49 -26.8 9.35 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.495 1.463 . . . . 0.0 113.064 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -63.88 -12.71 39.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.84 9.68 65.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 122.071 -0.393 . . . . 0.0 112.91 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m -99.43 139.72 34.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -104.47 131.62 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 0.0 110.09 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.81 149.31 41.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.18 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.36 128.22 35.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.704 0.288 . . . . 0.0 110.648 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.87 -52.66 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.478 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -103.12 167.61 9.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.598 0.714 . . . . 0.0 112.117 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.86 -40.46 69.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.148 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -63.88 -42.03 97.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.301 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.11 79.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -63.12 -41.02 99.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.288 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.13 -33.94 71.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.638 0.256 . . . . 0.0 111.317 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.66 -1.7 12.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.44 63.72 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.907 -0.385 . . . . 0.0 113.16 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -83.2 135.86 44.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.207 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.07 147.85 94.32 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.053 1.168 . . . . 0.0 111.27 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.07 158.87 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.445 1.43 . . . . 0.0 112.481 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 112' ' ' ILE . 86.9 mt -62.31 -10.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.2 t -43.64 -40.03 6.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.14 -32.19 96.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.293 1.855 . . . . 0.0 112.605 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 pt -98.96 7.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 149.81 42.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.718 0.69 . . . . 0.0 110.882 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.19 138.43 32.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 172.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.22 139.87 32.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.01 16.15 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.0 p -61.75 -34.77 76.43 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.194 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.46 135.89 11.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.31 -36.67 3.56 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.03 -59.96 0.35 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 141.06 42.36 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.8 -0.235 . . . . 0.0 110.785 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.6 mt -81.3 133.86 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.043 0.449 . . . . 0.0 109.798 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -59.79 137.09 58.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.275 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.5 mt -99.16 6.81 46.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.304 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.65 -43.55 37.42 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.822 -0.549 . . . . 0.0 112.771 -173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.93 75.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.248 0.524 . . . . 0.0 110.814 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.55 -42.15 91.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.7 tp -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.494 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.55 -43.31 93.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.595 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.6 m -60.99 -48.0 83.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.594 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.1 m -63.11 -40.48 97.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.805 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.09 -38.96 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.958 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -58.51 -43.76 89.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.368 . . . . 0.0 110.2 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.01 -39.55 95.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.988 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.94 -25.33 65.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.032 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.6 22.97 61.09 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.554 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -75.8 134.53 40.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.454 0.627 . . . . 0.0 110.525 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.886 -1.508 . . . . 0.0 111.036 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.97 139.99 50.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -124.57 135.56 53.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -128.69 148.42 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.346 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -110.4 138.92 46.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.628 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -118.48 143.09 46.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.365 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m -117.56 147.3 42.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.562 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.7 p -140.92 162.53 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.61 -177.98 52.17 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.93 141.49 28.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.557 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.64 163.65 43.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.465 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.97 175.76 0.89 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.327 1.351 . . . . 0.0 111.969 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -61.52 147.63 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.374 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.63 -176.78 28.17 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -117.76 144.08 45.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 0.0 110.463 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.02 -175.51 35.82 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 44.4 ttm -98.36 135.67 39.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.34 . . . . 0.0 110.599 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -89.87 146.48 24.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -99.14 139.35 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.536 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -122.85 163.26 20.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.7 147.29 42.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.25 146.58 38.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.566 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 147.36 38.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.554 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -66.73 147.84 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.068 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.69 164.59 27.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.484 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -95.36 149.69 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.617 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -127.09 140.99 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -108.05 147.72 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.494 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.97 147.58 49.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -117.69 151.72 36.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.463 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.56 143.59 56.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.0 m -113.09 159.98 32.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.99 -178.82 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.349 1.366 . . . . 0.0 111.973 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -67.28 147.12 53.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.7 tt -94.5 127.75 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.29 -175.19 38.36 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 m -79.34 137.22 37.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.786 0.326 . . . . 0.0 110.609 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.69 144.42 55.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.543 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -147.83 170.43 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.82 144.57 56.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.628 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -65.91 144.85 56.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.619 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -133.31 167.23 20.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -79.05 163.2 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.483 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.9 144.75 48.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 -173.91 37.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.98 -178.49 51.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.45 142.64 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 110.405 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.33 144.77 45.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.241 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.44 148.83 97.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.247 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.95 -171.0 0.45 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.779 1.653 . . . . 0.0 112.077 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.96 145.36 55.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.145 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -115.8 120.34 38.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.667 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -131.46 146.99 52.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.228 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 m -64.92 151.29 93.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.078 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.83 128.13 23.42 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.084 1.189 . . . . 0.0 111.704 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.38 139.62 26.85 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.51 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.33 140.74 52.13 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.061 1.174 . . . . 0.0 111.25 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.12 153.67 84.61 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 143.26 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.048 1.166 . . . . 0.0 110.85 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -55.82 144.65 55.91 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.197 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.68 119.78 6.46 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 120.864 1.043 . . . . 0.0 112.825 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -98.34 156.86 16.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -56.31 125.5 22.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.192 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.7 m120 63.63 10.93 5.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -149.09 148.06 29.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.834 0.743 . . . . 0.0 112.845 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -150.6 147.51 27.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.79 167.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -98.96 126.35 44.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 tt -132.04 152.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.276 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.8 p -150.44 166.41 30.19 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.683 0.754 . . . . 0.0 111.82 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -55.61 -34.6 65.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.238 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.68 88.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.743 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -66.23 -46.49 76.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.368 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -84.73 -14.74 47.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.47 -148.99 0.28 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.26 -20.85 20.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.105 0.866 . . . . 0.0 112.343 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.47 -23.28 57.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -55.83 113.46 5.75 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.427 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -89.61 -13.2 2.82 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.786 1.658 . . . . 0.0 114.086 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.07 144.9 24.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.243 0.544 . . . . 0.0 111.875 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.1 p -68.65 -37.15 79.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.627 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.32 130.36 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -63.9 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -168.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -152.98 177.26 10.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.662 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.08 34.33 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m -108.17 141.49 39.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 pt -108.95 136.77 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -139.78 140.31 36.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.444 0.64 . . . . 0.0 111.949 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.7 m -108.48 118.51 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.108 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.6 157.63 52.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.402 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -49.32 -20.74 3.94 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.344 1.363 . . . . 0.0 113.0 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -75.93 3.39 10.27 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 p30 54.04 34.59 20.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.009 0.923 . . . . 0.0 111.773 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -109.12 133.28 53.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.07 123.94 40.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.093 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 159.0 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.459 0.647 . . . . 0.0 111.402 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -114.09 126.54 55.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.78 129.68 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.89 155.79 36.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.676 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.85 -26.84 10.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.541 1.494 . . . . 0.0 113.109 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -63.88 -12.86 40.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.83 66.43 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.886 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -99.34 139.74 34.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -104.84 129.07 53.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.013 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -114.07 149.64 35.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.008 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.45 128.98 35.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.723 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.4 mt -88.54 -52.16 5.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.445 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p30 -103.22 167.41 9.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 112.192 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -55.43 -40.4 71.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.063 -173.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -62.85 -41.7 99.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.67 80.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 0.0 110.958 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.81 -41.35 99.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.312 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.37 -33.97 71.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.71 0.291 . . . . 0.0 111.346 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.99 -1.07 10.82 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.49 63.64 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.093 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -83.2 143.15 44.78 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.528 0.664 . . . . 0.0 109.251 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.02 147.77 55.47 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.235 1.29 . . . . 0.0 111.379 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.14 154.77 29.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.332 1.354 . . . . 0.0 112.772 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.64 -16.63 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.021 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 t -44.46 -38.53 5.58 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.99 -31.89 96.54 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.383 1.887 . . . . 0.0 112.193 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.4 pt -98.05 3.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -78.18 135.66 37.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.47 0.577 . . . . 0.0 110.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.81 146.57 35.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.189 0.519 . . . . 0.0 111.862 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -92.14 140.5 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.685 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.84 157.23 18.68 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.1 p -59.13 -35.27 73.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.936 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.42 160.37 26.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.68 30.27 56.48 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.184 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.96 -119.92 14.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.41 157.58 17.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.298 . . . . 0.0 110.405 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.79 130.06 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.416 . . . . 0.0 110.348 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 140.39 58.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.126 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.5 mt -95.3 9.72 38.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.1 171.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.13 -44.05 33.12 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.845 -0.534 . . . . 0.0 112.648 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.78 84.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.121 0.46 . . . . 0.0 110.666 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.6 tp -59.32 -42.06 90.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 110.51 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -60.01 -44.4 94.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.496 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 m -59.2 -42.69 91.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.63 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.61 -47.97 83.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.641 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.8 m -62.86 -40.15 96.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.729 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.72 -39.0 86.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -58.66 -42.65 88.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.29 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.13 -39.12 93.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.96 -25.19 65.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.869 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.94 4.6 55.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -101.4 145.03 29.48 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.078 0.939 . . . . 0.0 110.551 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.957 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.44 140.09 50.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -117.03 138.99 51.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.0 143.56 49.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -118.99 131.54 56.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -126.93 149.02 50.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.43 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.9 m -61.0 154.46 22.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.421 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -119.78 148.27 43.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.511 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.35 -173.97 50.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.1 tp -95.45 131.12 41.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.67 142.65 98.02 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -88.83 -174.94 1.11 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.636 1.557 . . . . 0.0 112.127 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -55.7 150.9 11.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.034 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.32 32.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -114.34 141.6 47.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 110.62 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 -174.03 49.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.7 mtm -107.17 153.84 22.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.481 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -69.84 132.9 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.672 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.29 143.95 47.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -121.63 138.75 54.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.99 145.63 56.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.617 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.97 145.48 52.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.408 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.71 154.85 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -92.35 155.32 17.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -94.17 130.42 40.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -114.34 160.09 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -117.23 153.42 32.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.247 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -55.86 141.37 39.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -132.44 167.67 19.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.493 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -97.73 144.65 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -68.98 139.75 55.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -133.09 162.55 56.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.86 -174.99 2.35 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.454 1.436 . . . . 0.0 112.093 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -73.55 176.26 6.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.766 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.64 128.73 44.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.4 -173.74 48.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -79.58 165.56 22.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.691 0.282 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -61.13 135.35 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.79 140.12 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.4 123.62 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.433 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.72 134.96 56.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 0.0 110.54 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -100.74 151.17 21.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.2 p -80.55 166.47 21.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.327 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.35 178.45 51.62 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.0 -165.52 27.5 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -167.89 28.59 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -56.06 144.71 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 110.859 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.27 151.6 24.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.67 155.0 23.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.93 171.21 3.07 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.243 1.295 . . . . 0.0 111.903 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.42 160.83 39.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.714 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -105.25 145.13 31.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.296 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -104.11 142.89 33.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.263 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 m -81.81 160.41 63.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -48.5 128.84 18.68 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.448 1.432 . . . . 0.0 112.082 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.34 139.63 26.91 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.544 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -52.33 159.96 3.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.182 1.255 . . . . 0.0 111.796 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -64.05 159.84 52.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.5 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.9 148.21 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.098 1.199 . . . . 0.0 110.833 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -55.86 143.72 59.88 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.453 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.42 119.86 7.39 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.139 1.226 . . . . 0.0 112.509 -172.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -124.37 143.73 50.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -55.82 125.59 21.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.25 -170.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.4 p30 63.35 12.45 6.25 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.537 168.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -150.41 138.13 19.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.666 0.666 . . . . 0.0 112.669 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -150.2 147.95 28.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.952 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -96.79 127.37 42.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 tp -128.0 143.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.984 -176.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.5 p -143.88 164.82 29.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.516 0.674 . . . . 0.0 111.552 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -55.55 -36.22 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.163 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.52 84.29 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.766 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -70.44 -45.06 66.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.3 mt -87.23 -8.68 56.56 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.78 -149.57 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -55.76 -21.74 20.55 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.036 0.834 . . . . 0.0 112.336 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -56.42 -28.07 58.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -55.69 107.25 0.82 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.397 -176.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.34 -13.18 4.4 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.755 1.637 . . . . 0.0 114.15 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.73 145.05 26.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.82 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -69.55 -37.5 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.509 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.7 m -63.68 129.72 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.22 -33.44 75.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.16 173.14 12.79 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.709 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 161.99 34.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m -108.13 139.58 42.58 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.575 -0.368 . . . . 0.0 110.082 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 pt -107.58 136.18 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.34 143.69 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.462 0.649 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 m -106.62 118.61 37.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.143 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.75 160.03 47.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.148 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.42 -17.92 7.27 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.452 1.434 . . . . 0.0 113.52 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.4 p -80.08 2.89 22.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 t0 67.66 33.51 4.94 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.904 0.32 . . . . 0.0 111.486 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -121.5 138.89 54.1 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.57 128.28 44.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.237 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.03 157.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.413 0.625 . . . . 0.0 111.412 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -114.07 127.02 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.933 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.02 131.03 58.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -101.18 155.96 35.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.812 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.51 -26.67 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.503 1.469 . . . . 0.0 113.19 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -64.96 -11.58 40.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.94 9.62 67.7 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.944 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.5 m -99.43 139.9 34.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -104.58 130.57 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.1 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.54 148.02 40.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.005 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.36 127.53 35.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.762 0.315 . . . . 0.0 110.835 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.16 -50.46 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.344 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -105.66 167.6 9.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.637 0.732 . . . . 0.0 111.95 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.33 -40.74 71.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.159 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -64.09 -40.94 97.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.288 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.98 -37.66 77.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.57 -40.36 96.77 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.342 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -58.26 -34.02 70.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.211 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.62 1.82 7.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.92 23.55 63.77 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.986 -0.341 . . . . 0.0 113.227 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -88.24 125.99 62.12 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.219 172.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.68 152.48 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 CA-C-N 120.614 1.255 . . . . 0.0 111.372 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.07 158.01 30.45 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.357 1.371 . . . . 0.0 112.344 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.421 HG21 HD12 ' A' ' 112' ' ' ILE . 85.3 mt -62.04 -11.18 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.993 -0.527 . . . . 0.0 112.291 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 t -44.09 -39.64 6.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.68 -32.45 95.8 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-N 122.296 1.856 . . . . 0.0 112.401 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.8 pt -98.82 7.69 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -77.8 139.95 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.458 0.572 . . . . 0.0 110.398 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.93 143.11 29.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -91.66 139.97 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.849 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.5 168.83 19.95 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 m -58.39 -38.79 78.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.733 0.301 . . . . 0.0 110.709 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.49 166.43 26.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.61 29.67 59.28 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.127 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.27 -120.04 19.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -104.21 157.77 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 0.0 111.031 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.1 mt -79.05 132.81 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.514 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -64.63 140.99 58.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.109 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -93.9 8.53 40.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.16 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.88 -44.16 31.27 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 121.808 -0.557 . . . . 0.0 112.764 -173.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.18 82.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.136 0.468 . . . . 0.0 110.759 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 32.8 tp -59.5 -41.99 91.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.464 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.7 m -59.18 -43.52 92.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.597 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.2 m -61.02 -47.5 86.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.651 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.9 m -62.99 -40.08 96.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.815 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.65 -39.67 89.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -58.65 -42.41 88.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.342 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.97 -39.2 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.025 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.9 m -60.01 -25.22 65.12 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.938 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.77 23.0 43.95 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.644 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -77.27 134.26 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.455 0.627 . . . . 0.0 110.359 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.818 0 CA-C-O 117.968 -1.462 . . . . 0.0 111.024 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.98 133.7 53.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -128.01 141.85 51.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.406 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -123.22 140.49 52.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.505 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -111.38 138.59 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.99 132.52 53.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.4 t -120.34 142.61 48.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.499 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 t -120.27 141.31 50.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.0 -176.39 50.0 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.37 140.86 29.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.754 0.312 . . . . 0.0 110.425 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.02 142.83 97.56 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.47 -174.95 0.81 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.741 1.628 . . . . 0.0 112.14 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -58.91 148.76 29.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.315 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.66 124.22 32.93 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -147.84 163.53 36.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 110.427 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 115.68 8.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -133.97 162.14 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -78.6 165.67 23.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.948 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -61.53 143.1 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.314 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -122.34 164.8 17.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.493 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.47 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.617 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.24 147.85 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.537 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.13 146.86 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.92 150.61 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.66 142.64 38.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.68 154.21 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.62 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -70.21 146.14 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -86.5 138.31 31.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -117.13 142.27 47.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.462 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.42 146.0 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.641 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -144.68 160.69 40.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.555 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -56.73 154.28 18.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.51 136.48 31.11 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.359 1.373 . . . . 0.0 112.083 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -137.41 169.23 18.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.82 145.03 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.19 -174.37 50.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -134.24 165.64 24.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 110.618 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -63.2 168.79 3.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -70.22 138.42 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -150.0 155.14 39.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.335 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -73.19 169.95 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.439 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -94.95 113.06 24.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.845 0.355 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -131.74 162.68 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.51 137.57 30.99 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.0 -169.63 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.94 -149.92 0.46 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.42 150.46 11.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.27 162.3 6.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -54.12 163.85 1.13 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.05 168.81 5.48 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.403 1.402 . . . . 0.0 112.243 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.95 156.28 28.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.796 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -113.84 174.62 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -56.84 145.43 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.724 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -65.04 112.69 8.73 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.52 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.12 159.77 45.16 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.266 1.311 . . . . 0.0 111.636 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -90.31 140.96 27.18 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.359 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.36 134.96 53.2 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.083 1.188 . . . . 0.0 111.561 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.0 152.4 87.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.99 142.93 99.02 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.248 1.299 . . . . 0.0 111.201 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.0 p -55.88 137.05 72.57 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.098 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.21 119.91 3.97 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.123 1.216 . . . . 0.0 113.334 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -85.19 157.04 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -57.32 125.54 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.794 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.58 21.12 12.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.82 173.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -159.69 142.71 14.02 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.336 0.516 . . . . 0.0 112.274 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -146.46 153.04 39.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.917 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -91.98 125.6 36.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 tp -123.26 144.31 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.3 p -150.06 160.51 43.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.614 0.721 . . . . 0.0 112.299 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.57 -34.28 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.545 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.25 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.059 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -70.74 -46.66 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -73.57 -23.24 59.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.25 -150.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.08 -26.59 27.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.112 0.869 . . . . 0.0 111.797 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -53.06 -28.28 24.02 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -55.77 107.13 0.79 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.189 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.22 -13.29 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.757 1.638 . . . . 0.0 114.113 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.31 144.43 28.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.202 0.525 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -68.17 -37.13 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.777 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.16 129.76 31.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -61.76 -32.95 73.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -147.1 174.55 11.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.07 34.34 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -107.51 138.46 43.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.659 -0.318 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -108.98 132.83 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -148.07 144.91 28.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.38 0.61 . . . . 0.0 112.27 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.4 m -102.45 118.73 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.65 158.06 51.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.545 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.37 -18.26 5.19 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.417 1.411 . . . . 0.0 113.327 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.6 p -77.5 3.03 14.48 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 63.18 45.53 5.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.073 0.463 . . . . 0.0 110.638 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -135.2 144.66 47.07 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.571 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.84 120.46 40.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.72 158.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.614 0.721 . . . . 0.0 111.921 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.15 129.18 56.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.879 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.88 131.73 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.66 155.15 36.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.666 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -48.85 -25.75 8.88 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.487 1.458 . . . . 0.0 113.104 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.1 p30 -65.27 -11.74 44.44 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.38 67.6 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.847 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.9 m -99.4 138.63 36.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 m -103.18 129.37 50.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.231 0.538 . . . . 0.0 110.067 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -114.14 148.83 36.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.024 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.28 125.93 34.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.325 . . . . 0.0 110.409 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.05 -51.38 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -112.38 167.59 10.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.658 0.742 . . . . 0.0 112.012 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -52.32 -34.02 45.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.777 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -61.71 -47.43 85.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.9 -34.29 74.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.424 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -62.31 -41.14 98.28 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.131 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -59.08 -34.01 71.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.064 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.09 -3.35 12.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.46 63.71 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.65 -0.309 . . . . 0.0 113.242 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -89.75 143.2 29.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.393 0.597 . . . . 0.0 109.593 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 150.17 47.42 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.242 1.295 . . . . 0.0 111.265 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.97 158.94 30.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.373 1.382 . . . . 0.0 112.783 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 92.5 mt -60.02 -14.0 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.159 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.5 t -42.97 -41.33 6.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -61.76 -27.41 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 CA-C-N 122.039 1.764 . . . . 0.0 112.656 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.5 pt -98.8 6.64 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -75.87 143.38 41.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.884 0.766 . . . . 0.0 110.828 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.73 150.99 30.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.812 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -81.28 139.79 35.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.066 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.98 172.58 34.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 m -62.83 -35.9 81.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.643 0.259 . . . . 0.0 111.535 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.76 110.06 3.24 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.864 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 49.98 26.9 9.15 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.617 -0.325 . . . . 0.0 112.639 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.6 -60.07 4.73 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.14 145.87 35.02 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.639 -0.33 . . . . 0.0 110.361 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 87.3 mt -73.07 133.47 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.15 0.5 . . . . 0.0 110.476 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -64.08 140.88 58.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.238 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.3 mt -95.11 10.86 34.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.053 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.7 -45.44 30.76 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.8 -0.563 . . . . 0.0 112.877 -173.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.85 -48.48 81.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.263 0.531 . . . . 0.0 110.835 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 31.2 tp -59.31 -42.1 90.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.463 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.8 tp -59.59 -44.17 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -59.82 -44.2 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.599 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.9 m -60.27 -46.29 90.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.565 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.6 m -62.35 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.976 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.0 -39.61 86.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.677 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.51 -41.97 91.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.05 -39.72 93.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.97 -25.21 65.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.0 60.0 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.794 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -53.65 141.74 25.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.487 0.643 . . . . 0.0 111.416 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.985 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -122.5 129.18 51.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.423 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -135.14 157.71 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.541 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -111.88 138.89 47.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.41 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.72 138.91 50.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -126.01 134.95 51.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.325 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.7 t -118.52 141.78 48.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.603 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 t -126.22 144.15 50.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.369 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 179.76 52.73 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.3 mt -98.6 139.28 34.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.53 142.98 84.59 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -89.16 132.16 2.23 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.573 1.515 . . . . 0.0 112.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -150.01 162.48 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.51 -166.44 41.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.8 p -132.0 156.77 45.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.496 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.67 -174.89 50.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.6 mtt -107.69 160.09 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.383 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -68.33 125.21 25.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.423 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -126.68 143.61 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.512 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 t -75.23 152.86 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.302 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.09 56.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.596 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.08 155.25 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.4 144.75 56.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.436 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -80.13 138.1 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.634 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.88 154.89 36.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.517 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.02 146.0 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -143.62 160.17 41.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.007 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -116.72 157.26 25.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.556 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -106.13 134.21 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -99.18 146.77 25.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -74.8 179.58 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.726 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.9 p -61.05 157.49 41.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.473 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.96 159.84 24.08 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.289 1.326 . . . . 0.0 112.041 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -76.06 -174.57 2.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 tt -91.66 130.03 37.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.911 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.46 138.45 36.68 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -136.49 161.14 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.618 0.247 . . . . 0.0 110.658 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -81.63 108.52 15.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.654 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -145.1 176.31 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.444 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.14 147.21 48.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.339 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -57.67 136.47 56.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 110.638 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -140.64 -173.28 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.584 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -56.58 177.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.494 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.44 179.98 32.12 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.37 -155.83 7.5 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.16 -174.95 44.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.96 142.47 55.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.85 151.23 42.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.648 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.85 161.94 4.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.91 145.5 98.14 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.322 1.348 . . . . 0.0 112.003 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.06 40.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.505 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.43 133.21 36.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -126.08 152.41 45.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.9 m -61.44 157.71 43.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.38 137.01 25.36 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.306 1.338 . . . . 0.0 112.238 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -90.34 142.64 28.51 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.717 -0.658 . . . . 0.0 109.646 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.33 160.92 3.03 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.221 1.281 . . . . 0.0 111.377 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.3 mt -63.9 153.3 84.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.74 150.5 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.42 1.414 . . . . 0.0 111.172 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.3 p -55.99 134.85 73.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.066 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.05 119.8 4.01 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.236 1.291 . . . . 0.0 113.059 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -75.97 157.59 32.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 168.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.1 m -54.74 125.58 20.56 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.239 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.2 p30 63.31 16.28 9.34 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.295 171.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -153.83 140.65 19.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -143.95 150.01 37.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -126.87 146.69 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.713 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.7 p -150.52 160.55 43.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.691 0.758 . . . . 0.0 112.305 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -55.48 -34.84 64.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.477 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.14 90.54 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.183 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -70.08 -46.58 64.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.287 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.12 -25.7 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.23 -148.64 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.25 -20.06 16.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.3 0.954 . . . . 0.0 112.429 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.5 -24.17 63.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -55.88 112.59 4.49 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.32 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.52 -13.24 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.754 1.636 . . . . 0.0 114.166 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.3 mt -90.9 145.21 24.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.532 . . . . 0.0 111.883 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.03 -37.5 78.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.58 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.88 129.94 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -62.34 -33.59 75.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.95 174.49 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.765 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.06 34.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -108.09 140.07 41.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.16 136.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.74 144.12 39.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.583 . . . . 0.0 111.988 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.18 118.53 36.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.695 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -83.12 156.77 66.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.061 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.01 -18.29 16.59 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.403 1.402 . . . . 0.0 113.055 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -80.11 3.1 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 64.1 40.78 6.75 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.178 0.514 . . . . 0.0 110.559 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -115.68 128.11 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.78 124.22 40.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.262 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.36 156.77 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.367 0.603 . . . . 0.0 111.306 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -114.08 126.47 55.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.048 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.27 130.49 57.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.28 155.83 35.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.819 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.52 -26.68 9.28 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.588 1.525 . . . . 0.0 113.105 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.3 p30 -64.74 -11.91 41.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.23 67.12 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 122.123 -0.361 . . . . 0.0 112.913 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.6 m -99.39 140.14 34.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.85 130.46 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.17 0.509 . . . . 0.0 110.102 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.69 149.06 38.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.106 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.28 126.93 35.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.696 0.284 . . . . 0.0 110.805 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.36 -50.52 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.965 0.412 . . . . 0.0 110.226 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.34 167.6 9.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 111.687 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -56.75 -38.37 72.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.062 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -64.79 -41.79 95.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.548 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.88 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.811 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.05 -52.09 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.338 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.67 -20.27 66.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.06 9.85 3.37 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.55 63.32 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 122.28 -0.262 . . . . 0.0 113.456 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -96.98 112.97 62.18 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -54.27 152.72 24.43 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 CA-C-N 120.577 1.242 . . . . 0.0 111.7 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.02 158.98 30.7 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.457 1.438 . . . . 0.0 112.75 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.29 -10.68 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.302 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.3 t -42.19 -41.81 5.47 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.14 -30.19 81.91 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 122.004 1.752 . . . . 0.0 112.612 -173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.7 pt -98.87 5.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -75.63 143.03 42.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.835 0.743 . . . . 0.0 110.555 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.91 138.53 31.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.897 0.379 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -92.56 139.89 30.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.53 169.52 19.47 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -58.33 -39.07 78.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.706 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.35 165.65 26.3 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.32 28.68 59.51 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.204 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.53 -121.44 25.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.67 155.11 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.991 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.58 129.94 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.019 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -63.49 140.63 58.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.015 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -93.16 9.81 34.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.121 171.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.78 -44.14 30.51 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.858 -0.526 . . . . 0.0 112.757 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.17 82.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.161 0.481 . . . . 0.0 110.707 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.21 -41.89 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 110.458 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.48 -44.47 95.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.7 p -59.76 -40.86 89.58 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.649 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.9 m -61.66 -48.57 80.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.601 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.9 m -62.6 -40.28 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.727 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.44 -39.49 87.69 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -58.58 -43.0 89.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.315 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.07 -39.47 92.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.91 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -60.1 -25.23 65.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.794 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.94 22.95 24.22 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.643 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -88.71 145.9 25.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.474 0.637 . . . . 0.0 110.311 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.911 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.42 139.71 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.466 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -120.67 141.83 50.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -114.67 137.67 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.453 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -128.17 137.05 51.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.467 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -119.68 141.44 49.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.419 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.1 m -119.19 149.3 41.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.561 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 t -70.71 149.54 46.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.67 141.46 43.99 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.67 135.07 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.352 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 142.5 83.59 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -90.97 111.29 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.744 1.629 . . . . 0.0 112.494 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.94 132.75 43.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.312 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 -173.06 35.96 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -119.92 147.82 44.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.692 0.282 . . . . 0.0 110.459 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.78 -178.1 51.13 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.65 155.38 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.81 0.338 . . . . 0.0 110.484 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -80.23 133.47 36.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.507 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -68.22 142.94 55.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.51 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -136.14 157.06 47.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.836 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.83 146.66 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.645 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.93 146.78 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.57 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 144.18 54.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -98.1 152.68 19.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -132.94 164.03 27.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.404 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.57 143.24 36.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -63.74 145.7 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -99.55 125.62 45.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -127.93 138.79 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.5 mtp -126.39 162.62 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.599 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -72.33 -175.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.611 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -57.15 153.11 26.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 176.05 9.33 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.459 1.439 . . . . 0.0 112.271 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.87 123.97 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 mp -76.8 152.92 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.415 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.24 150.95 14.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.7 p -121.07 170.13 9.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.744 0.307 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.82 127.64 33.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.471 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.0 145.17 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -137.86 175.31 9.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -59.7 150.42 27.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.461 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.16 141.48 49.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.547 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -124.81 168.35 13.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.538 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.73 -165.99 19.2 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 147.93 19.13 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.33 -158.29 9.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.74 146.35 31.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.423 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 147.4 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.02 153.61 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.491 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.28 174.24 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.349 1.366 . . . . 0.0 112.194 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.58 150.24 24.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -109.06 138.66 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.591 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -63.35 147.79 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 m -116.82 156.09 48.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.375 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.23 135.46 59.93 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.227 1.285 . . . . 0.0 111.858 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.34 141.39 32.54 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.246 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.33 149.97 21.4 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.15 1.233 . . . . 0.0 111.636 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.97 154.58 81.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.01 146.82 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.196 1.264 . . . . 0.0 111.174 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.5 m -55.82 139.81 69.18 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.241 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.17 119.92 3.99 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.142 1.228 . . . . 0.0 113.131 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -88.42 159.85 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 168.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 p -54.71 125.61 20.62 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.702 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 63.72 15.66 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 170.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -159.8 158.81 31.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -148.05 153.21 38.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.576 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -90.53 125.21 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 tp -126.05 147.12 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.23 162.1 41.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.783 0.801 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.62 -35.05 65.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.414 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.05 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.134 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.0 -46.64 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.257 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.56 -26.61 60.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 70.46 -146.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -56.18 -20.12 16.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.495 1.043 . . . . 0.0 112.463 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.27 -25.13 63.83 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.1 t-105 -55.87 111.76 3.52 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.572 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.63 -13.23 2.8 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.858 1.705 . . . . 0.0 114.096 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.8 mt -90.6 145.57 24.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.177 0.513 . . . . 0.0 111.953 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.8 p -69.71 -37.43 76.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.555 174.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.76 128.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.75 -33.99 75.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.068 -169.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.25 174.82 11.26 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.503 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.76 162.04 34.29 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 m -106.76 139.72 40.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.9 pt -108.16 135.77 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -146.19 141.03 27.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.375 0.607 . . . . 0.0 112.181 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.0 m -103.52 118.5 36.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.055 170.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.8 mt -81.78 153.62 70.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.064 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.42 -17.85 7.15 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.25 1.3 . . . . 0.0 113.25 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 m -79.74 3.18 20.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 63.91 48.42 3.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.122 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -130.88 133.45 45.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.271 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.86 120.48 37.28 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.678 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.06 155.81 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.554 0.692 . . . . 0.0 111.783 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -114.18 130.24 56.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.81 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.6 t -109.51 131.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.47 155.35 36.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.851 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.68 -27.33 10.73 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.605 1.537 . . . . 0.0 113.09 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -64.04 -12.03 34.78 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 10.24 66.49 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 122.153 -0.342 . . . . 0.0 112.896 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 57.4 m -99.43 139.11 35.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.48 130.49 49.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 109.993 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.62 150.88 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.141 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.34 124.9 33.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 mt -79.85 -47.13 15.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 109.793 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -114.89 166.27 11.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.358 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -52.9 -34.53 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.735 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -61.01 -49.05 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.747 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.12 76.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -61.66 -42.31 98.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.998 0.427 . . . . 0.0 110.089 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -58.23 -33.17 69.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.358 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.16 9.77 2.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.51 63.42 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.18 -0.325 . . . . 0.0 113.38 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -97.55 111.96 60.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.339 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -54.46 150.94 32.29 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.116 1.21 . . . . 0.0 111.654 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.81 158.9 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.325 1.35 . . . . 0.0 112.477 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 112' ' ' ILE . 75.3 mt -61.9 -10.62 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 t -44.41 -38.83 5.89 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -58.79 -32.49 97.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 CA-C-N 122.472 1.919 . . . . 0.0 112.462 -175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.0 pt -98.83 7.55 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -76.45 137.34 39.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.495 0.588 . . . . 0.0 110.478 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.75 153.24 22.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.636 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -84.23 148.32 26.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.833 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.98 26.17 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.621 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.1 m -57.67 -37.88 74.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.683 0.277 . . . . 0.0 111.077 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.97 177.62 20.77 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.98 12.41 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.17 -119.93 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -104.94 161.96 13.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 111.075 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.53 133.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.469 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -63.1 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.842 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.52 9.27 35.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.098 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.8 31.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.838 -0.539 . . . . 0.0 112.852 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.323 0.562 . . . . 0.0 110.752 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.8 tp -59.1 -42.35 90.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.17 -43.24 95.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.473 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.7 m -59.24 -43.64 92.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.628 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.75 -47.63 85.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.538 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.5 m -63.22 -39.69 95.33 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.088 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.11 -39.49 86.36 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.724 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -58.75 -43.09 90.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.04 -38.62 89.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.8 m -59.89 -25.33 65.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.997 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.47 22.99 57.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.648 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.39 143.46 29.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.496 0.648 . . . . 0.0 110.444 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 CA-C-O 117.955 -1.469 . . . . 0.0 111.009 -179.831 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -124.45 136.06 53.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -127.24 145.8 50.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.598 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -112.82 141.57 46.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -110.01 135.76 50.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.458 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -130.91 152.39 50.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.522 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m -119.41 147.79 43.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.348 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -120.06 147.03 45.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.546 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -175.36 47.65 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -99.5 128.71 45.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.748 0.309 . . . . 0.0 110.388 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.26 142.87 90.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.22 143.24 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.657 1.571 . . . . 0.0 112.184 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -61.4 143.8 55.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.4 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.16 -171.58 42.52 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.2 p -117.31 154.54 31.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.16 -178.49 52.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.3 mtp -129.26 161.82 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -88.19 143.98 26.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -112.97 160.83 17.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.59 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -71.46 137.57 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.46 143.58 55.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.723 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.8 151.92 45.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.53 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 146.71 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.26 142.07 29.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.744 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.14 157.65 29.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.295 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -90.63 136.02 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.475 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -126.08 153.04 45.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -69.16 147.73 50.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.504 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -111.49 142.04 44.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 mtt -117.03 163.35 16.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.504 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -64.14 144.54 57.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.65 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.4 m -120.31 165.64 17.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.406 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.92 109.98 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.287 1.325 . . . . 0.0 111.876 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.44 144.43 54.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 tt -97.96 129.18 44.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.0 102.12 0.11 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 m -126.56 145.53 50.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.777 0.323 . . . . 0.0 110.312 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.41 115.61 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -150.07 166.71 28.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.59 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.96 156.04 7.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.53 121.32 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -134.54 -176.57 4.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.841 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -71.51 163.39 27.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.365 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.91 179.68 52.51 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.24 -175.11 49.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.59 42.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -55.55 153.71 7.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.68 146.95 15.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.98 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.11 153.74 72.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.873 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.83 -169.93 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.612 1.541 . . . . 0.0 112.146 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.53 155.05 4.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -62.23 153.09 31.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -120.95 170.53 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.29 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -54.04 160.86 2.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.32 128.14 16.86 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.314 1.342 . . . . 0.0 112.351 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.29 143.11 29.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.525 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.23 160.93 2.92 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.151 1.234 . . . . 0.0 111.362 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.8 mt -63.98 154.5 81.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.686 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.62 147.74 32.08 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.311 1.341 . . . . 0.0 111.444 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 p -55.91 125.91 64.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.005 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.19 119.99 4.0 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.22 1.28 . . . . 0.0 113.289 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.7 p -76.35 158.72 31.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.1 m -56.41 125.46 22.09 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.992 -172.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 63.68 22.94 13.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.616 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -157.4 139.73 14.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -147.01 146.82 30.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.835 169.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -93.75 125.71 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 tp -126.2 144.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.514 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.3 p -150.42 158.9 44.67 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.566 0.698 . . . . 0.0 112.388 -173.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -55.54 -34.6 64.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.438 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.74 89.41 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.09 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -70.39 -46.64 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.259 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.68 -26.27 62.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 69.66 -147.17 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.85 -22.03 22.95 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.38 0.991 . . . . 0.0 112.286 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.53 -20.53 63.34 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -55.82 118.45 20.15 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.247 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -89.69 -13.3 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.807 1.671 . . . . 0.0 114.157 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.62 145.21 27.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.34 0.59 . . . . 0.0 112.101 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.2 p -67.31 -37.8 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.464 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.77 128.6 26.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.11 -33.91 75.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -147.99 173.87 12.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.778 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.01 34.23 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 m -108.92 139.09 44.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.611 -0.347 . . . . 0.0 110.105 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.51 134.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.11 144.56 38.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.233 0.54 . . . . 0.0 111.995 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.21 118.6 37.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.396 172.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.85 155.8 67.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.07 -20.6 10.88 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.323 1.349 . . . . 0.0 113.221 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -80.84 2.97 24.2 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t0 69.26 35.12 2.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -112.53 128.88 56.47 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 122.29 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.1 158.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.353 0.596 . . . . 0.0 111.557 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -114.1 126.85 55.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.039 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.47 129.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.5 155.45 36.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.647 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.49 -26.59 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.589 1.526 . . . . 0.0 113.115 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -63.95 -12.77 40.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.88 67.09 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 122.09 -0.381 . . . . 0.0 112.924 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 m -99.34 139.38 35.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 m -104.87 130.18 53.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 109.972 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -114.9 148.65 38.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.9 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.4 127.74 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.694 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -86.82 -50.53 6.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.285 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -103.43 167.12 10.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.627 0.727 . . . . 0.0 111.956 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.37 -39.88 73.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.999 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.18 -41.89 99.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.271 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.19 79.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.899 0.381 . . . . 0.0 110.968 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.97 -40.55 98.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.43 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -58.63 -34.04 70.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.721 0.296 . . . . 0.0 111.329 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.21 0.96 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.49 63.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.969 -0.35 . . . . 0.0 113.191 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -83.21 143.15 44.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.03 152.66 68.01 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.262 1.308 . . . . 0.0 111.752 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.1 153.54 28.55 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.454 1.436 . . . . 0.0 112.725 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.02 -18.98 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.779 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 t -46.6 -36.82 7.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.57 -29.01 83.58 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 CA-C-N 122.997 2.106 . . . . 0.0 112.103 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.6 pt -98.89 2.17 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 143.3 45.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.103 0.865 . . . . 0.0 110.204 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.12 152.51 18.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.776 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -85.13 140.95 30.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.305 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.66 175.66 26.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.9 m -58.27 -38.73 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.784 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.9 31.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.2 36.04 56.45 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.37 -123.04 19.63 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -109.04 161.88 14.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.051 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.7 mt -75.04 133.32 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.425 -173.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -72.25 141.37 48.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.694 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -91.68 8.5 36.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.163 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.54 -43.15 36.09 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.749 -0.595 . . . . 0.0 112.327 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.72 88.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.788 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.01 -41.68 88.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.035 0.445 . . . . 0.0 110.463 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.64 -45.2 92.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.474 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.3 p -59.73 -41.05 90.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.69 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.62 -47.76 83.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.707 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.0 m -62.67 -40.35 96.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.839 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -60.18 -39.87 88.0 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.751 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -59.44 -42.05 91.04 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.424 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.05 -38.72 89.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.107 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -59.97 -25.28 65.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.867 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.46 22.89 38.69 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.703 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.26 145.63 29.95 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.483 0.641 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.789 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.975 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.15 140.37 49.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -118.03 140.23 50.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.45 139.2 50.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.375 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -129.58 156.7 43.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.613 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -114.44 140.31 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.35 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.9 t -112.83 142.42 45.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.674 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -120.76 146.14 46.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.43 142.78 39.5 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -93.62 143.16 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.823 0.344 . . . . 0.0 110.624 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.2 153.3 86.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.1 114.34 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.386 1.391 . . . . 0.0 112.223 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -123.34 146.49 47.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.39 133.29 23.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -139.71 144.93 37.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.16 132.29 28.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.8 mtt -133.0 158.25 43.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.835 0.35 . . . . 0.0 110.552 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 146.77 23.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -101.6 149.65 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.595 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -124.09 163.28 21.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.04 45.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.48 144.13 56.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.489 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.23 145.64 29.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.558 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -91.44 145.77 24.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.522 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -106.02 134.92 48.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -103.08 142.26 34.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -66.69 140.4 57.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.485 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -101.94 131.7 48.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -116.09 138.68 51.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.352 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.5 mtm -112.25 145.07 40.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.82 143.7 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.575 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.3 m -64.07 153.53 84.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.58 109.95 2.88 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.285 1.323 . . . . 0.0 112.086 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -149.96 170.26 19.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.1 140.44 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.36 133.79 26.17 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -126.74 163.01 24.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.362 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.17 114.29 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -149.93 175.19 11.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -63.95 149.87 46.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.501 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.38 142.53 56.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -92.32 153.27 19.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.701 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 p -118.59 162.79 17.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.224 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.4 -178.05 51.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.82 -171.59 48.35 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.48 -176.92 49.6 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -121.43 151.9 39.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 0.0 110.437 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.41 152.75 20.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.477 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.02 153.95 16.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.63 169.56 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.27 1.313 . . . . 0.0 111.975 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.01 158.33 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -83.53 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.443 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.07 164.2 33.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.074 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -63.27 160.51 40.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.769 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.33 128.27 17.12 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.343 1.362 . . . . 0.0 112.159 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.28 139.66 27.0 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.11 150.44 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.095 1.197 . . . . 0.0 111.609 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.06 153.92 83.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.21 151.44 54.88 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.236 1.29 . . . . 0.0 111.496 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -55.95 136.49 73.15 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.037 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.04 119.87 4.03 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.225 1.283 . . . . 0.0 113.225 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.7 p -80.43 157.79 26.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -57.37 125.39 22.62 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.79 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 63.58 19.22 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.84 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -159.61 144.53 15.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.543 0.611 . . . . 0.0 112.384 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -142.34 153.21 43.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.763 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.88 126.0 39.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 173.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tp -124.79 141.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.5 p -143.46 163.37 33.29 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.594 0.711 . . . . 0.0 111.755 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.54 -35.53 65.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.216 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.19 85.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.729 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.44 -46.65 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.826 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.5 mt -87.02 -8.69 56.91 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 61.66 -145.37 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.0 -28.44 37.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.29 0.95 . . . . 0.0 111.92 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.33 -25.58 35.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -55.92 107.17 0.8 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.372 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.02 -13.17 3.89 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.833 1.689 . . . . 0.0 114.129 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -89.67 145.89 24.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.315 0.579 . . . . 0.0 111.821 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.1 p -69.63 -37.1 76.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.723 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.77 129.64 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -64.31 -30.14 71.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -150.26 174.62 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.662 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.5 m -107.89 140.94 40.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.629 -0.336 . . . . 0.0 110.102 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 pt -108.87 136.08 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -143.55 143.88 31.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 111.824 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.2 m -107.4 122.23 46.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.701 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.1 mt -82.7 158.83 64.87 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.03 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.0 -22.07 13.71 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.401 1.401 . . . . 0.0 113.191 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -79.54 3.05 19.97 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.2 40.09 7.03 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.196 0.522 . . . . 0.0 110.638 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -113.24 129.11 56.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.01 121.93 37.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.202 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.06 156.73 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.599 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -114.06 126.95 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.236 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.06 130.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.4 156.22 35.49 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.658 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.2 -26.73 8.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.509 1.473 . . . . 0.0 113.105 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 p30 -65.11 -11.46 40.13 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 8.51 67.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.85 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -99.47 138.48 36.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.1 m -103.7 131.0 51.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 109.865 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -115.97 149.76 38.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.979 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.38 127.23 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.674 0.273 . . . . 0.0 110.752 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -86.68 -51.02 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.941 0.4 . . . . 0.0 110.181 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -103.25 167.61 9.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.644 0.735 . . . . 0.0 111.944 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.79 -39.04 76.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.944 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -62.76 -41.27 99.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.151 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.87 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.072 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.2 -40.55 97.81 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.389 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -58.86 -34.01 71.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.689 0.281 . . . . 0.0 111.241 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.21 -1.79 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.54 63.41 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.07 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -82.09 143.19 48.8 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 109.516 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 153.47 73.84 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.366 1.378 . . . . 0.0 111.811 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.12 151.89 27.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.538 1.492 . . . . 0.0 112.66 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 90.2 mt -64.28 -18.62 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 119.015 -0.517 . . . . 0.0 111.672 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.3 t -45.12 -37.34 4.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -171.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.01 -32.11 96.95 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 CA-C-N 122.529 1.939 . . . . 0.0 112.102 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.8 pt -97.06 3.68 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.38 139.37 39.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.439 0.563 . . . . 0.0 110.331 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -83.0 142.3 31.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.38 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -90.75 139.85 30.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.684 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.19 168.32 19.94 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.551 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -57.81 -39.22 77.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 110.673 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.04 26.82 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.12 30.21 57.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.048 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.72 -120.26 19.61 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.31 158.13 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.936 0.398 . . . . 0.0 111.134 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.3 mt -79.0 130.64 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.533 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -63.29 140.8 58.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.236 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.5 mt -94.41 9.87 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.059 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.02 -45.26 32.94 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.845 -0.534 . . . . 0.0 112.735 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.3 85.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.175 0.488 . . . . 0.0 110.759 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.8 tp -59.47 -41.95 90.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.602 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.0 tp -59.64 -44.61 93.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -59.07 -43.37 91.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.66 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.59 -47.28 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 110.626 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.9 m -62.7 -41.53 99.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.794 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.16 -37.43 82.88 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.69 -43.86 90.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 110.197 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -36.24 82.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.84 -25.16 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 97.88 23.04 14.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.86 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -48.78 147.07 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.493 0.646 . . . . 0.0 112.137 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.908 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.7 tttm . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 112.327 0.491 . . . . 2.6000000000000001 112.327 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -148.61 152.91 37.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.823 -0.626 . . . . 0.28000000000000003 110.903 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' OD1' HG23 ' A' ' 79' ' ' THR . 76.1 m-20 -97.56 129.07 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.468 -0.567 . . . . 0.16 109.468 173.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.708 HD11 HD11 ' A' ' 67' ' ' LEU . 12.1 tt -129.34 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.892 0.377 . . . . 0.40999999999999998 110.938 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -150.48 167.87 25.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.59 0.709 . . . . 0.20000000000000001 111.654 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.5 -34.62 64.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.724 . . . . 1.1000000000000001 111.118 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.02 86.53 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 121.021 -0.272 . . . . 0.28999999999999998 110.727 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -66.36 -46.61 76.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.32000000000000001 111.282 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD11 HD11 ' A' ' 62' ' ' ILE . 10.8 mp -88.07 -8.79 55.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.671 0.989 . . . . 1.05 113.671 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.69 -153.79 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.419 -0.586 . . . . 0.32000000000000001 109.419 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -56.77 -21.42 28.32 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.571 0.623 . . . . 3.9399999999999999 112.4 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -59.2 -20.09 50.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.498 0.555 . . . . 1.6699999999999999 112.498 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.509 ' CE3' HD22 ' A' ' 67' ' ' LEU . 55.7 t-105 -55.81 111.94 3.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 119.121 -0.466 . . . . 0.19 110.205 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -89.55 -13.25 2.84 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.904 1.736 . . . . 0.23999999999999999 114.164 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -87.8 143.62 27.04 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.228 0.537 . . . . 0.11 111.627 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.4 p -67.99 -36.76 80.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.345 -0.843 . . . . 0.17000000000000001 110.817 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.67 129.39 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.272 -1.01 . . . . 0.17000000000000001 108.272 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.92 -32.94 72.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.023 0.379 . . . . 1.8 112.023 -169.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -147.02 174.37 11.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.406 -0.518 . . . . 0.46999999999999997 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.05 34.31 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.832 -1.307 . . . . 0.10000000000000001 109.832 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.556 HG23 ' OD1' ' A' ' 61' ' ' ASP . 6.3 m -109.93 141.58 42.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.598 -0.354 . . . . 0.12 110.349 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.64 137.23 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.988 -0.375 . . . . 0.14000000000000001 109.988 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -148.01 143.79 27.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.432 0.634 . . . . 2.1800000000000002 112.127 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.011 -0.995 . . . . 0.22 109.492 172.545 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.546 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.11 -0.33 . . . . 0.25 110.11 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.32 157.14 43.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.448 0.642 . . . . 0.12 111.396 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' HD21 ' A' ' 130' ' ' LEU . 89.1 t80 -114.03 127.75 56.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.799 -1.091 . . . . 0.11 109.932 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -108.51 130.48 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.325 -0.62 . . . . 0.13 109.325 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.41 154.8 37.0 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.655 -0.418 . . . . 0.13 110.625 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.66 -26.49 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.509 1.473 . . . . 0.17999999999999999 113.225 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.6 p30 -63.96 -12.79 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.816 0.673 . . . . 0.17999999999999999 112.816 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.52 10.43 65.48 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 122.151 -0.343 . . . . 0.16 112.92 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.7 m -99.37 139.36 35.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.233 -0.655 . . . . 0.14000000000000001 109.233 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.8 m -105.02 130.91 53.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.297 0.57 . . . . 0.14000000000000001 110.056 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -116.68 147.54 41.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.14000000000000001 108.992 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.41 126.08 34.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.13 110.771 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.04 -50.93 6.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.347 -0.388 . . . . 0.17999999999999999 110.637 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -103.11 166.58 10.35 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.643 0.735 . . . . 0.33000000000000002 112.019 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.6 -41.16 69.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.39 -0.823 . . . . 2.2000000000000002 112.209 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -63.94 -42.8 97.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.689 -0.404 . . . . 2.2200000000000002 111.398 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.584 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.62 -37.28 78.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.862 0.363 . . . . 0.22 110.907 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.56 -40.92 98.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 2.0699999999999998 110.394 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.85 -33.93 71.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 2.7200000000000002 111.288 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.66 0.44 8.72 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.083 0.771 . . . . 0.46000000000000002 113.083 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.12 23.43 63.53 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.826 -0.43 . . . . 0.46000000000000002 113.203 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 49.9 m-70 -84.89 142.64 39.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 108.938 -0.764 . . . . 0.46999999999999997 108.938 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.09 148.83 51.25 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.182 1.255 . . . . 0.72999999999999998 111.281 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 158.91 30.44 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.376 1.384 . . . . 0.45000000000000001 112.301 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 115' ' ' ILE . 92.4 mt -60.96 -11.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 119.033 -0.508 . . . . 0.20000000000000001 112.345 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.444 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.1 t -43.83 -39.65 6.06 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 115.559 1.689 . . . . 0.40000000000000002 115.559 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.2 Cg_exo -58.98 -31.95 96.62 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 CA-C-N 122.31 1.861 . . . . 0.28000000000000003 112.395 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 112' ' ' ILE . 25.1 pt -98.9 1.49 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 113.008 0.744 . . . . 0.20999999999999999 113.008 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -79.59 136.77 36.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.34 0.518 . . . . 3.3199999999999998 110.545 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.495 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.26000000000000001 111.356 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 117' ' ' ALA . 33.2 mt . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 121.05 0.452 . . . . 0.39000000000000001 109.915 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -61.83 138.81 58.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.28999999999999998 112.092 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -95.99 11.55 33.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.173 -0.921 . . . . 0.23000000000000001 112.103 171.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -42.41 30.65 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.876 -0.515 . . . . 0.19 112.632 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.5 81.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.996 0.427 . . . . 0.20000000000000001 110.78 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.55 -41.94 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.17000000000000001 110.47 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.97 -44.04 94.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.19 110.464 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.05 -43.73 91.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.924 -0.311 . . . . 1.1799999999999999 110.562 -176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 39.0 m -60.9 -47.52 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.586 -0.446 . . . . 0.19 110.597 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.546 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 27.3 m -62.84 -40.12 96.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.58 -0.448 . . . . 0.17999999999999999 110.921 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.83 -39.63 89.74 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.969 -0.292 . . . . 0.22 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -58.77 -42.58 89.26 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.777 -0.369 . . . . 1.8999999999999999 110.241 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.97 -39.55 95.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.20000000000000001 111.03 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.1 m -59.99 -25.31 65.16 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.238 -0.437 . . . . 0.29999999999999999 112.144 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.139 0 C-N-CA 121.116 -0.564 . . . . 0.60999999999999999 112.614 -179.756 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 pttt . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -143.8 153.12 42.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.581 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' HG23 ' A' ' 79' ' ' THR . 75.7 m-20 -97.3 123.95 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.827 HD11 HD11 ' A' ' 67' ' ' LEU . 6.8 tt -130.18 151.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.092 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.0 p -147.79 165.81 29.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.871 0.843 . . . . 0.0 112.061 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -55.62 -34.28 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.38 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.15 90.42 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.785 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -66.38 -46.59 76.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.904 0.383 . . . . 0.0 111.241 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.827 HD11 HD11 ' A' ' 62' ' ' ILE . 10.3 mp -81.88 -16.64 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.06 -148.3 0.3 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -56.03 -21.25 20.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.196 0.907 . . . . 0.0 112.368 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.0 tp -56.54 -27.83 58.52 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.589 ' CE3' HD22 ' A' ' 67' ' ' LEU . 43.1 t-105 -55.73 111.89 3.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.42 -175.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HB3' HG22 ' A' ' 125' ' ' ILE . 66.8 Cg_endo -89.53 -13.15 2.87 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.766 1.644 . . . . 0.0 114.167 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.31 145.33 25.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.284 0.564 . . . . 0.0 111.813 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.8 p -69.37 -37.16 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.647 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.42 129.65 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.12 -32.77 73.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -168.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -148.55 175.1 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.09 34.38 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.515 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.0 m -107.88 141.1 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.81 137.71 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.45 143.73 30.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 112.06 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.684 173.008 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.575 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.233 0.222 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.7 157.79 42.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.437 0.637 . . . . 0.0 111.452 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.4 t80 -114.05 127.47 55.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.025 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.17 130.91 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.37 155.25 36.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.735 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.39 -26.74 9.01 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.595 1.53 . . . . 0.0 113.127 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.7 p30 -64.5 -11.82 37.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.55 9.28 66.85 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.543 -0.361 . . . . 0.0 112.911 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.1 m -99.45 140.83 33.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -105.04 131.08 53.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.235 0.54 . . . . 0.0 110.118 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -116.22 148.09 40.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.997 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.679 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.35 127.93 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -86.79 -51.8 5.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -103.2 167.49 9.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 112.059 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.106 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -63.23 -41.91 99.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.207 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.34 -37.04 79.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 110.92 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.679 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 76.8 mm-40 -62.77 -41.27 99.16 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.282 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -58.77 -33.99 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.409 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.44 7.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.05 23.46 63.61 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.964 -0.353 . . . . 0.0 113.265 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 52.3 m-70 -84.9 143.16 39.79 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.469 0.635 . . . . 0.0 109.303 172.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.84 149.07 47.18 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.246 1.297 . . . . 0.0 111.458 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.05 154.88 29.57 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.403 1.402 . . . . 0.0 112.702 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 115' ' ' ILE . 91.6 mt -61.67 -14.95 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.132 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.2 t -44.12 -39.05 5.64 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.8 Cg_exo -59.31 -31.38 94.95 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.306 1.859 . . . . 0.0 112.373 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 112' ' ' ILE . 14.4 pt -98.76 7.03 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -78.09 142.03 38.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.447 0.567 . . . . 0.0 110.546 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 72' ' ' PRO . 59.3 mt . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.3 m -64.54 141.01 58.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.003 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.8 9.71 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.095 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.04 -44.06 32.34 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.87 -0.519 . . . . 0.0 112.64 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 -47.57 85.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.795 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.9 tp -59.43 -42.11 91.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 tp -60.09 -43.89 95.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -58.97 -43.27 91.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.595 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 m -60.87 -47.92 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.588 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.575 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 26.1 m -62.9 -39.84 95.76 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.923 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.81 -39.1 87.69 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.909 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.85 -42.65 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.247 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.88 -39.45 94.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.916 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.7 m -60.05 -25.24 65.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.83 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.6 -179.031 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -148.83 152.72 36.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.4 m-20 -92.22 126.74 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 6.7 tp -126.86 145.73 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.589 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -150.41 161.71 41.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.687 0.756 . . . . 0.0 112.484 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -55.57 -34.97 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.542 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.24 88.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.039 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -71.69 -46.65 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.054 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 8.0 mp -72.45 -25.76 61.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.13 -147.71 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -55.99 -21.59 22.0 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.367 0.985 . . . . 0.0 112.352 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.93 -25.32 63.37 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.495 ' HE3' HD22 ' A' ' 67' ' ' LEU . 47.0 t-105 -55.8 110.45 2.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.409 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 125' ' ' ILE . 67.0 Cg_endo -89.5 -13.27 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 114.158 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.7 145.76 24.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.304 0.573 . . . . 0.0 111.927 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 p -69.39 -36.86 77.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.67 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.12 129.48 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -61.58 -33.24 73.53 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.98 175.01 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.01 34.26 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.524 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.0 m -106.94 137.56 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.48 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -147.97 144.05 27.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.397 0.617 . . . . 0.0 112.299 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.644 169.904 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.692 0.282 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -133.16 158.64 43.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.619 0.724 . . . . 0.0 111.886 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CD1' HD21 ' A' ' 130' ' ' LEU . 89.0 t80 -114.08 128.65 56.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.848 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.84 131.37 58.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.14 155.53 36.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.781 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.71 -27.06 10.34 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.533 1.489 . . . . 0.0 113.079 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 29.6 p30 -63.99 -12.41 37.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.47 9.69 66.52 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.912 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.8 m -99.37 139.94 34.29 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m -103.54 129.55 50.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -114.69 150.56 35.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.073 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.44 126.06 34.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.311 . . . . 0.0 110.377 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.4 mt -82.99 -51.93 7.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.466 . . . . 0.0 110.187 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -109.18 166.84 10.55 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 111.761 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -52.41 -33.66 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.866 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -61.83 -48.65 79.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 110.775 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.65 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.45 -35.1 75.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.243 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.44 -41.2 98.56 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.243 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.04 -33.96 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.47 0.31 8.65 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.14 23.41 63.54 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.963 -0.354 . . . . 0.0 113.244 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -89.0 143.13 30.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 117.465 0.633 . . . . 0.0 109.421 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.14 148.39 44.31 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.256 1.304 . . . . 0.0 111.249 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.4 157.07 32.93 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.387 1.391 . . . . 0.0 112.625 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 115' ' ' ILE . 87.2 mt -60.61 -13.46 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 119.135 -0.46 . . . . 0.0 112.228 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.433 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.5 t -44.0 -39.44 6.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.5 Cg_exo -59.37 -31.29 94.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 CA-C-N 122.336 1.87 . . . . 0.0 112.387 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 112' ' ' ILE . 14.7 pt -98.83 7.83 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -77.34 140.67 40.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.341 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 117' ' ' ALA . 61.3 mt . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.984 0.421 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -64.93 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.848 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.55 8.24 39.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.193 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.91 -44.45 31.69 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.85 -0.531 . . . . 0.0 112.922 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.68 76.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.268 0.534 . . . . 0.0 110.778 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 90' ' ' PHE . 31.3 tp -59.24 -42.29 90.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.474 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.39 -42.99 97.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.53 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.9 t -59.55 -44.9 93.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.49 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.34 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.552 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.7 m -63.22 -40.04 96.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.31 -39.55 87.4 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.785 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -58.62 -42.77 88.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.09 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.4 m -60.49 -25.16 65.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.993 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.66 -179.298 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -144.55 153.14 41.51 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.271 172.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.409 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -93.19 126.57 38.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.8 tp -126.71 142.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.0 p -145.86 164.54 31.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.594 0.711 . . . . 0.0 111.929 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -55.57 -35.52 65.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.154 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.19 85.76 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.603 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -66.33 -46.63 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.577 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.672 HD12 ' CE3' ' A' ' 71' ' ' TRP . 48.3 mt -91.08 -8.13 49.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 60.93 -146.44 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -57.15 -24.04 51.5 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.306 0.957 . . . . 0.0 112.476 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD12 ' H ' ' A' ' 70' ' ' LEU . 6.5 mp -59.16 -22.37 60.84 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.672 ' CE3' HD12 ' A' ' 67' ' ' LEU . 55.9 t-105 -55.85 107.41 0.88 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.228 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.48 -13.27 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.812 1.674 . . . . 0.0 114.174 -174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.72 145.04 26.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.19 0.519 . . . . 0.0 111.66 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 p -69.04 -36.88 78.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.725 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.72 130.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.92 -32.69 73.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -169.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.78 174.43 11.83 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.734 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.409 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.6 m -107.82 139.97 41.62 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.612 -0.346 . . . . 0.0 110.071 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.49 134.84 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -145.95 142.64 28.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.425 0.631 . . . . 0.0 111.991 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.891 170.438 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.581 0.229 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.8 158.71 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.555 0.693 . . . . 0.0 111.931 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.2 t80 -114.05 129.04 56.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.898 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.9 131.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.61 155.13 36.72 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.749 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.37 -27.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.625 1.55 . . . . 0.0 113.152 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.8 p30 -64.36 -11.65 34.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.68 10.46 67.3 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.84 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.8 m -99.34 139.32 35.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.0 m -103.04 129.96 49.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.346 0.593 . . . . 0.0 110.023 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.47 150.89 37.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.188 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.39 128.88 35.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.697 0.284 . . . . 0.0 110.725 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 131' ' ' LEU . 21.6 mt -87.98 -57.12 3.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.094 0.473 . . . . 0.0 110.434 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.513 ' HB3' HD11 ' A' ' 131' ' ' LEU . 49.6 p30 -105.1 159.14 16.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -47.44 -35.26 8.28 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.095 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -61.64 -44.45 96.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.578 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.08 -37.36 74.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.392 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 31.2 mp0 -63.94 -39.22 93.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.026 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.5 -34.02 70.47 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.041 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 0.79 10.04 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.4 63.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.877 -0.402 . . . . 0.0 113.319 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -90.48 143.2 28.91 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.576 0.688 . . . . 0.0 109.668 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.11 148.1 39.14 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.267 1.311 . . . . 0.0 111.271 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.98 158.84 34.37 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.366 1.377 . . . . 0.0 112.939 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 115' ' ' ILE . 88.9 mt -61.13 -11.54 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.353 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.435 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.8 t -43.83 -39.82 6.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 113' ' ' THR . 24.7 Cg_exo -59.39 -32.11 96.01 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 CA-C-N 122.364 1.88 . . . . 0.0 112.433 -174.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 112' ' ' ILE . 23.1 pt -98.74 5.18 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -79.41 135.66 36.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.477 0.581 . . . . 0.0 110.772 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.077 0.465 . . . . 0.0 111.668 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 117' ' ' ALA . 79.9 mt . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 121.141 0.496 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 139.83 58.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.068 -174.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.99 9.43 37.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.053 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.16 31.73 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.827 -0.546 . . . . 0.0 112.913 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.1 75.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.313 0.557 . . . . 0.0 110.78 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.06 -41.58 88.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 101' ' ' ASN . 21.8 tp -60.36 -43.76 96.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -60.04 -44.15 94.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.601 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.0 m -60.56 -47.03 87.98 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.504 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.8 m -63.31 -40.4 97.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.68 -38.34 84.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.954 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.5 -42.58 87.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.55 -38.54 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.5 m -59.95 -25.23 65.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.91 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.168 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.676 179.403 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -149.03 150.71 33.26 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.792 168.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.5 m-20 -92.59 124.82 36.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 67' ' ' LEU . 5.9 tp -125.83 145.17 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -150.38 162.43 40.56 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.795 0.807 . . . . 0.0 112.419 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.95 -35.18 66.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.537 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.5 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.056 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.93 -46.65 51.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.078 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 HD11 ' A' ' 62' ' ' ILE . 8.2 mp -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.17 -147.03 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.8 -22.0 22.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.38 0.991 . . . . 0.0 112.468 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.41 -24.91 63.87 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.506 ' HE3' HD22 ' A' ' 67' ' ' LEU . 45.9 t-105 -55.89 110.98 2.64 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.357 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 125' ' ' ILE . 72.8 Cg_endo -89.55 -13.13 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.731 1.621 . . . . 0.0 114.108 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.42 145.47 24.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.191 0.52 . . . . 0.0 111.921 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.2 p -69.58 -37.03 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.663 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.11 129.34 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.97 -33.47 74.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -169.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -147.5 174.36 11.79 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.712 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.02 34.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.7 m -108.08 139.95 41.98 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.7 pt -109.36 139.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -148.01 145.44 28.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 112.303 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.3 m . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.695 173.29 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.173 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.24 157.27 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 111.458 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.3 t80 -114.17 128.07 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.98 130.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.22 155.59 36.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.802 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.47 -26.88 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.473 1.449 . . . . 0.0 113.097 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.8 p30 -64.31 -12.24 39.94 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.43 9.49 66.85 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.927 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.9 m -99.39 140.01 34.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 m -104.36 130.8 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.322 0.582 . . . . 0.0 110.087 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -116.18 148.24 40.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.082 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.686 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.4 128.3 35.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.692 0.282 . . . . 0.0 110.722 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.8 mt -87.58 -51.14 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -103.04 166.41 10.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.665 0.745 . . . . 0.0 112.037 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -55.33 -40.16 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.129 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -63.76 -42.06 97.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.334 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.597 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.61 -36.32 78.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 176.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.686 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.0 mm-40 -63.29 -41.44 98.98 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.306 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -59.2 -33.86 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.317 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.1 -1.54 10.28 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.45 63.67 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.897 -0.391 . . . . 0.0 113.238 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 14.5 m-70 -84.99 134.36 41.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.133 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.33 148.1 91.46 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.062 1.174 . . . . 0.0 111.235 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 157.97 30.36 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.315 1.343 . . . . 0.0 112.302 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 115' ' ' ILE . 91.0 mt -62.07 -11.75 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.256 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.0 t -43.79 -40.05 6.61 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -171.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD3' HG22 ' A' ' 113' ' ' THR . 25.7 Cg_exo -59.29 -32.28 96.55 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 CA-C-N 122.25 1.839 . . . . 0.0 112.417 -175.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 112' ' ' ILE . 17.7 pt -98.84 7.66 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.03 140.22 40.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.527 0.603 . . . . 0.0 110.399 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 111.82 -176.238 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.41 HG22 ' HB3' ' A' ' 72' ' ' PRO . 84.2 mt . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 121.08 0.466 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.4 m -65.01 140.81 58.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.951 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.95 9.27 36.28 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.139 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.01 -45.18 32.86 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.837 -0.54 . . . . 0.0 112.766 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.04 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.162 0.481 . . . . 0.0 110.707 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.1 tp -59.35 -42.35 91.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -43.31 94.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -58.81 -44.46 90.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.45 -47.34 86.53 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.568 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.611 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 24.3 m -62.51 -40.49 96.89 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.842 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.68 -39.41 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.858 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -58.8 -42.83 90.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 110.277 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.57 -38.21 90.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.191 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.8 m -60.08 -25.14 65.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.957 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.61 179.761 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -143.59 153.08 42.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.412 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.28 123.63 36.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.569 HD11 HD11 ' A' ' 67' ' ' LEU . 5.4 tp -125.45 145.77 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.484 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.0 p -148.48 162.94 38.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.776 0.798 . . . . 0.0 112.262 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -56.54 -34.76 67.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.478 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.55 91.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.067 -176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -69.24 -46.72 66.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 0.0 111.032 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.569 HD11 HD11 ' A' ' 62' ' ' ILE . 8.7 mp -72.7 -25.12 61.12 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.39 -148.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -55.37 -20.6 12.37 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.352 0.978 . . . . 0.0 112.417 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.75 -23.41 63.2 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.519 ' HE3' HD22 ' A' ' 67' ' ' LEU . 39.2 t-105 -55.9 112.89 4.84 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.326 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG22 ' A' ' 125' ' ' ILE . 66.0 Cg_endo -89.53 -13.24 2.85 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.863 1.709 . . . . 0.0 114.157 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -93.27 145.81 24.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.184 0.516 . . . . 0.0 111.722 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.96 -36.72 75.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.648 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.77 130.35 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -64.41 -30.59 71.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -150.64 176.86 10.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.725 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.66 162.07 34.41 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -107.47 139.84 41.35 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.7 pt -109.22 137.48 41.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -144.91 144.09 30.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.279 0.561 . . . . 0.0 112.008 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.712 173.459 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.615 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.24 157.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.344 0.592 . . . . 0.0 111.372 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.523 ' CD1' HD21 ' A' ' 130' ' ' LEU . 94.4 t80 -114.05 127.06 55.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.129 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.7 130.69 58.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.91 155.75 36.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.729 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.51 -26.68 9.25 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.44 1.427 . . . . 0.0 113.126 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 32.4 p30 -64.18 -12.56 41.46 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.96 9.17 66.17 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.911 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.4 m -99.41 139.35 35.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.412 0.606 . . . . 0.0 109.396 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.8 m -103.46 131.91 50.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.058 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -89.36 129.24 35.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.695 0.283 . . . . 0.0 110.796 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 mt -88.3 -51.88 5.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -103.6 167.6 9.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.615 0.721 . . . . 0.0 111.959 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -55.47 -40.32 71.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.975 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -63.3 -41.56 98.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.326 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.606 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.75 -37.71 79.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.832 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.04 -40.89 99.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.859 0.361 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.51 -34.07 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.714 0.292 . . . . 0.0 111.303 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.01 1.97 7.87 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.51 63.61 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.27 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -84.75 143.18 40.25 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.45 150.99 47.22 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.278 1.319 . . . . 0.0 111.931 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.89 151.97 36.2 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.299 1.332 . . . . 0.0 112.925 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 115' ' ' ILE . 91.4 mt -61.99 -13.31 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.2 t -46.76 -35.27 4.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.09 -33.78 97.73 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 CA-C-N 123.038 2.121 . . . . 0.0 112.039 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 112' ' ' ILE . 18.6 pt -98.94 7.77 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -77.26 142.3 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.684 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.152 0.501 . . . . 0.0 111.435 -178.124 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 72' ' ' PRO . 68.6 mt . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -62.1 140.51 58.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.179 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.48 6.98 47.13 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.241 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.21 -44.84 34.56 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.84 -0.538 . . . . 0.0 112.629 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.67 84.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.153 0.477 . . . . 0.0 110.74 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.9 tp -59.59 -42.23 92.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.456 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.11 -43.81 95.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.453 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -59.21 -43.35 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.641 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.54 -47.95 83.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.563 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.615 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 19.8 m -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.772 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.75 -39.0 87.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.8 -42.94 90.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.301 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.159 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.02 -25.3 65.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.772 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.224 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.911 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -145.62 153.12 40.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.589 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -90.87 123.71 34.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 67' ' ' LEU . 8.9 tp -124.55 146.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -148.99 161.62 41.55 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.804 0.811 . . . . 0.0 112.437 -173.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -56.45 -34.78 67.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.34 91.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.106 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.25 -46.72 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.04 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 62' ' ' ILE . 8.4 mp -72.5 -28.99 63.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.82 -141.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -54.0 -28.33 37.36 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.797 1.181 . . . . 0.0 112.058 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.96 -26.92 50.2 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.517 ' HE3' HD22 ' A' ' 67' ' ' LEU . 34.2 t-105 -55.82 109.97 1.98 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.709 -176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG22 ' A' ' 125' ' ' ILE . 64.4 Cg_endo -89.56 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.828 1.685 . . . . 0.0 114.108 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.2 mt -91.24 145.88 24.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 111.819 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -69.82 -37.11 76.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.623 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.49 129.95 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -64.38 -31.0 72.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -168.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -149.53 176.73 10.36 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.615 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.01 34.28 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -106.99 140.39 39.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 pt -109.51 138.66 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -144.96 144.15 30.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.568 . . . . 0.0 111.946 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.7 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.815 173.69 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.711 0.291 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.34 155.78 41.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.308 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 130' ' ' LEU . 93.8 t80 -114.16 127.52 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.139 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.5 131.12 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 36.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.852 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.2 -26.99 8.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.537 1.491 . . . . 0.0 113.106 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -64.8 -11.19 34.15 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 9.47 66.9 Favored Glycine 0 CA--C 1.537 1.422 0 O-C-N 122.104 -0.372 . . . . 0.0 112.921 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.0 m -99.44 138.95 35.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.86 130.96 50.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.209 0.528 . . . . 0.0 110.003 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.96 148.06 41.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.235 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.33 127.05 35.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.691 0.282 . . . . 0.0 110.714 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -85.22 -50.91 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.976 0.417 . . . . 0.0 110.332 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.92 167.65 9.57 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.67 0.748 . . . . 0.0 111.921 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -58.22 -37.54 75.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.076 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.77 -41.18 98.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.199 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.629 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.39 -36.94 79.27 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 175.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.33 -40.11 96.42 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.458 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -58.57 -33.94 70.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.157 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.24 1.59 7.41 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.51 63.58 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.946 -0.364 . . . . 0.0 113.253 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -86.59 143.19 35.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 117.498 0.649 . . . . 0.0 109.386 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.18 152.24 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.297 1.331 . . . . 0.0 111.349 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.04 157.84 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.297 1.331 . . . . 0.0 112.431 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.478 HG23 HD11 ' A' ' 115' ' ' ILE . 81.4 mt -62.91 -10.12 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.7 t -43.84 -39.6 6.0 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -172.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 28.0 Cg_exo -58.8 -33.72 98.62 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 CA-C-N 122.385 1.887 . . . . 0.0 112.232 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 112' ' ' ILE . 23.8 pt -98.9 7.44 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -77.61 139.3 39.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.336 0.516 . . . . 0.0 110.474 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 111.398 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 117' ' ' ALA . 60.5 mt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -59.53 139.2 57.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.403 HD23 ' CG ' ' A' ' 72' ' ' PRO . 69.9 mt -94.92 6.28 49.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.314 172.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -44.2 37.86 Favored Glycine 0 CA--C 1.526 0.758 0 O-C-N 121.873 -0.517 . . . . 0.0 112.741 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 -47.84 83.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.243 0.521 . . . . 0.0 110.76 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.2 tp -59.89 -42.43 93.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.57 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.0 tp -60.41 -43.03 97.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.523 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.2 t -58.91 -43.97 91.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.764 0.316 . . . . 0.0 110.531 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.13 -47.78 84.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.583 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.602 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.7 m -62.65 -40.56 97.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.802 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.019 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.31 -43.65 88.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.247 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.13 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.085 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.12 -25.14 65.23 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.09 0 C-N-CA 121.351 -0.452 . . . . 0.0 112.665 -179.672 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 mttt . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -148.83 150.81 33.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -94.15 126.09 39.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 4.9 tp -125.57 144.42 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.465 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 160.47 43.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.724 0.774 . . . . 0.0 112.356 -173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.66 -34.74 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.525 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.76 90.71 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.116 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -70.59 -46.54 63.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.171 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 7.7 mp -72.36 -25.05 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.87 -148.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -55.7 -20.48 14.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.271 0.941 . . . . 0.0 112.367 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.75 -24.3 63.94 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.498 ' HE3' HD22 ' A' ' 67' ' ' LEU . 46.6 t-105 -55.85 112.89 4.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.264 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB3' HG22 ' A' ' 125' ' ' ILE . 65.2 Cg_endo -89.54 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.812 1.675 . . . . 0.0 114.144 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.82 144.87 25.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 111.656 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.7 p -69.09 -37.41 78.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.585 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -64.27 129.77 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.08 -33.6 74.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -147.58 174.61 11.59 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.879 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 161.98 34.23 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.5 m -107.45 139.98 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 pt -109.58 138.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.79 145.9 31.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.24 0.543 . . . . 0.0 111.918 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.768 173.863 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.156 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 155.6 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.389 0.614 . . . . 0.0 111.405 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.512 ' CD1' HD21 ' A' ' 130' ' ' LEU . 93.8 t80 -114.1 127.54 55.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.134 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.15 130.9 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.472 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.35 155.91 35.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.838 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.61 -25.82 8.37 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.453 1.435 . . . . 0.0 113.139 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 32.4 p30 -65.23 -11.8 44.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.76 67.73 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 122.055 -0.403 . . . . 0.0 112.964 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.6 m -99.52 139.37 35.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.5 m -104.09 132.93 49.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 109.889 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -118.26 151.27 37.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.54 125.02 34.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.691 0.281 . . . . 0.0 110.646 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.9 mt -83.45 -50.33 8.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 109.918 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -103.27 167.56 9.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.574 0.702 . . . . 0.0 111.502 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.3 -38.8 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.954 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.93 -43.02 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.441 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.85 -37.68 79.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 110.723 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -63.33 -41.42 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.278 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -58.6 -32.79 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.514 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 2.38 6.27 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.09 23.48 63.51 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.176 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.76 142.4 45.39 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 153.83 76.58 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 121.316 1.344 . . . . 0.0 111.737 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 113' ' ' THR . 55.7 Cg_endo -78.06 151.58 27.29 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.375 1.383 . . . . 0.0 112.509 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 115' ' ' ILE . 92.9 mt -64.02 -16.57 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.223 -0.418 . . . . 0.0 111.878 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 111' ' ' PRO . 3.2 t -46.73 -35.26 4.84 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.38 -32.63 96.6 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 CA-C-N 123.155 2.163 . . . . 0.0 111.935 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 112' ' ' ILE . 24.0 pt -98.75 6.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -78.28 138.79 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.305 0.502 . . . . 0.0 110.74 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 121.162 0.506 . . . . 0.0 111.718 -177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 117' ' ' ALA . 55.6 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.1 0.476 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m -60.34 138.47 57.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.993 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -95.24 7.33 46.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.27 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -43.11 36.88 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.755 -0.591 . . . . 0.0 112.63 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.62 80.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.061 0.43 . . . . 0.0 110.781 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.4 tp -59.86 -42.51 93.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.23 -43.17 96.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.475 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 t -59.24 -43.95 92.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.547 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.0 m -59.93 -47.58 85.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.576 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.608 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.3 m -62.67 -40.95 98.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.04 -38.35 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.628 0.252 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.47 -43.7 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 110.2 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.88 -39.28 93.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.902 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.9 m -60.05 -25.16 65.13 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.841 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.189 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.842 -179.113 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mttp . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -152.1 151.45 31.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.505 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.0 m-20 -93.37 127.33 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.688 HD11 HD11 ' A' ' 67' ' ' LEU . 5.2 tp -127.73 145.46 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.509 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -150.48 160.89 43.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.734 0.778 . . . . 0.0 112.387 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -55.54 -34.94 65.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.12 89.99 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.031 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.16 -46.67 60.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.063 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -72.45 -26.78 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.79 -145.39 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -55.56 -23.27 25.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.486 1.039 . . . . 0.0 112.285 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.0 -23.57 63.76 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.497 ' HE3' HD22 ' A' ' 67' ' ' LEU . 44.5 t-105 -55.86 111.13 2.8 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.37 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -89.53 -13.18 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.845 1.697 . . . . 0.0 114.056 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.06 145.36 25.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 111.964 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.5 p -70.03 -37.29 75.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.535 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.65 129.59 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.84 -33.97 75.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.042 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -148.42 175.03 11.46 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.601 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.79 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.505 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.9 m -108.15 138.68 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 pt -106.81 134.37 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.32 145.18 30.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.417 0.627 . . . . 0.0 111.994 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.006 170.014 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 104' ' ' ALA . 35.3 m -132.22 156.35 42.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.464 0.649 . . . . 0.0 111.814 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.509 ' CD1' HD21 ' A' ' 130' ' ' LEU . 85.3 t80 -114.04 128.0 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.795 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.51 131.77 56.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.16 155.4 36.46 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.834 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.73 -27.1 10.46 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.62 1.546 . . . . 0.0 113.092 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 28.5 p30 -64.49 -11.69 36.43 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.55 66.63 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.936 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -99.42 140.29 33.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.7 m -103.75 129.23 51.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 110.093 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -114.79 151.88 33.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.04 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.3 124.93 33.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 110.43 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.2 -47.42 14.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.152 0.501 . . . . 0.0 109.809 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -115.36 167.62 10.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -53.84 -33.81 57.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.716 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -61.18 -49.01 78.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.323 0.582 . . . . 0.0 110.637 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.86 -37.39 76.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.09 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -61.42 -42.16 98.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.014 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -57.74 -33.96 69.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.8 9.18 3.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.5 63.6 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 122.177 -0.327 . . . . 0.0 113.358 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -97.01 112.08 59.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.366 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -54.78 150.4 36.85 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.472 1.204 . . . . 0.0 111.592 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.45 158.88 55.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.266 1.311 . . . . 0.0 112.391 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 115' ' ' ILE . 76.6 mt -61.59 -10.81 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.421 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.6 t -44.21 -38.92 5.64 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -172.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.421 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.2 Cg_exo -58.92 -33.59 98.74 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.612 1.968 . . . . 0.0 112.21 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 112' ' ' ILE . 17.9 pt -98.81 6.75 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -77.45 141.59 39.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.497 0.589 . . . . 0.0 110.796 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.508 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.416 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 117' ' ' ALA . 65.5 mt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 121.156 0.503 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -62.79 138.79 58.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.168 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -96.2 11.18 35.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.953 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -44.59 31.1 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.825 -0.547 . . . . 0.0 112.851 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.58 77.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.313 0.557 . . . . 0.0 110.797 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 90' ' ' PHE . 33.6 tp -59.15 -42.05 89.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -60.38 -43.69 96.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.656 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.9 p -60.61 -42.56 97.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.721 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.09 -47.18 87.52 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.642 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.1 m -63.09 -40.54 97.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.08 -39.46 86.15 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.799 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -58.76 -42.88 89.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.297 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.96 -39.28 91.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.055 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.6 m -59.93 -25.29 65.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.013 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.622 179.88 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.7 mttp . . . . . 0 N--CA 1.464 0.263 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -149.61 151.1 33.23 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.866 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.532 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.1 m-20 -93.76 126.99 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 67' ' ' LEU . 7.3 tp -128.25 145.95 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.144 -0.223 . . . . 0.0 110.597 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.39 161.23 42.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.695 0.76 . . . . 0.0 112.502 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -55.99 -34.82 66.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.535 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.54 86.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.07 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.33 -46.64 54.69 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.012 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -72.71 -26.19 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.56 -146.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -54.1 -28.1 37.2 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.412 1.006 . . . . 0.0 111.952 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.2 tp -53.97 -26.54 26.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.5 ' HE3' HD22 ' A' ' 67' ' ' LEU . 52.1 t-105 -55.69 111.09 2.72 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.318 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HB3' HG22 ' A' ' 125' ' ' ILE . 68.0 Cg_endo -89.69 -13.1 2.81 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.771 1.647 . . . . 0.0 114.197 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.82 145.36 25.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.204 0.526 . . . . 0.0 111.84 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.8 p -69.22 -37.12 77.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.62 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.36 129.23 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.66 -34.04 75.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.8 174.84 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.471 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.03 34.29 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.532 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.4 m -108.09 137.81 45.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 pt -106.82 133.15 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -146.81 147.17 30.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.469 0.652 . . . . 0.0 111.93 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.742 167.79 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.66 158.62 42.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.57 0.7 . . . . 0.0 111.938 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.522 ' CD1' HD21 ' A' ' 130' ' ' LEU . 86.3 t80 -114.09 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.767 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.55 131.45 57.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.14 155.21 36.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.823 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.69 -27.05 10.25 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.599 1.533 . . . . 0.0 113.103 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.1 p30 -64.11 -12.17 36.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.19 10.05 66.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.889 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 m -99.4 139.9 34.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.24 129.53 50.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.302 0.572 . . . . 0.0 110.124 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -114.58 149.41 36.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.038 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.32 126.17 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.821 0.343 . . . . 0.0 110.439 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' A' ' 131' ' ' LEU . 19.5 mt -83.71 -51.75 6.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.442 ' HB3' HD11 ' A' ' 131' ' ' LEU . 51.0 p30 -111.93 167.63 10.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.7 0.762 . . . . 0.0 111.924 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.92 -34.22 54.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -60.77 -47.07 88.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.325 0.584 . . . . 0.0 110.459 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.602 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.406 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.607 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.1 mm-40 -62.25 -41.25 98.27 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.236 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -59.49 -34.0 72.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.259 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.34 -2.88 12.0 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.53 63.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 122.128 -0.358 . . . . 0.0 113.166 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -88.93 143.2 31.08 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 117.454 0.627 . . . . 0.0 109.566 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.42 148.11 37.64 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.203 1.269 . . . . 0.0 111.324 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -76.09 158.78 37.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.368 1.378 . . . . 0.0 112.684 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 115' ' ' ILE . 82.8 mt -60.77 -12.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 119.013 -0.518 . . . . 0.0 112.28 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.435 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.8 t -43.76 -39.64 5.88 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 113' ' ' THR . 25.1 Cg_exo -59.44 -31.91 95.56 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 CA-C-N 122.35 1.875 . . . . 0.0 112.432 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 112' ' ' ILE . 20.0 pt -98.84 6.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -77.57 137.54 38.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.54 0.609 . . . . 0.0 110.453 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 111.778 -176.148 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 72' ' ' PRO . 83.9 mt . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 121.099 0.476 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.0 m -65.03 140.88 58.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.055 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.43 8.63 39.82 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.14 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.1 -43.67 32.56 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.897 -0.502 . . . . 0.0 112.745 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.45 -49.48 77.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.161 0.48 . . . . 0.0 110.84 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 90' ' ' PHE . 29.9 tp -58.82 -42.0 88.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.476 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 101' ' ' ASN . 24.0 tp -59.82 -44.22 94.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.484 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -59.96 -43.9 94.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.666 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.1 m -60.5 -46.75 88.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.449 . . . . 0.0 110.58 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.5 m -63.14 -41.35 99.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.01 -39.4 85.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.746 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.33 -42.39 91.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.56 -39.69 94.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -63.12 -25.18 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.144 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.144 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.636 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -139.01 152.81 47.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.656 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -93.87 126.21 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.681 HD11 HD11 ' A' ' 67' ' ' LEU . 6.4 tp -124.91 144.85 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.9 p -150.38 160.82 43.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.673 0.749 . . . . 0.0 112.447 -173.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -55.64 -34.68 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.567 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.64 -42.17 87.69 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.104 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -73.64 -46.61 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.375 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.681 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -71.36 -27.78 63.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.4 -142.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -54.11 -28.88 42.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.683 1.129 . . . . 0.0 111.883 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 70' ' ' LEU . 7.4 mp -56.98 -24.77 55.78 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.48 ' HE3' HD22 ' A' ' 67' ' ' LEU . 48.0 t-105 -55.91 107.49 0.9 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.368 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HB3' HG22 ' A' ' 125' ' ' ILE . 67.6 Cg_endo -87.2 -13.24 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.703 1.602 . . . . 0.0 114.136 -175.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.0 mt -89.59 145.56 25.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.559 . . . . 0.0 111.94 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.3 p -69.85 -37.28 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.719 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.15 130.13 30.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.02 -33.4 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.043 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -147.01 174.55 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.667 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.72 162.09 34.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -107.92 140.58 40.83 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.539 -0.389 . . . . 0.0 110.112 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.96 135.36 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.36 143.57 31.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.295 0.569 . . . . 0.0 112.151 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.672 173.765 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.583 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.489 HG12 ' HB1' ' A' ' 104' ' ' ALA . 31.8 m -131.86 155.23 41.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 111.225 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.51 ' CD1' HD21 ' A' ' 130' ' ' LEU . 90.0 t80 -114.1 128.04 56.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.031 178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.97 131.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.52 155.32 36.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.75 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.42 -26.54 8.83 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.565 1.51 . . . . 0.0 113.111 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.1 p30 -64.43 -12.17 40.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.36 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.92 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.9 m -99.41 140.01 34.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.6 m -104.73 130.92 52.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 110.095 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -116.32 148.41 40.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.0 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 124.94 33.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.767 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 mt -82.18 -48.5 11.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 0.0 109.982 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.5 p30 -108.39 167.63 9.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.47 0.653 . . . . 0.0 111.606 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -55.03 -40.99 70.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.979 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -63.42 -42.47 98.72 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.37 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.649 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.3 -39.27 78.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.077 0.465 . . . . 0.0 110.616 176.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -62.32 -41.7 98.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.944 0.402 . . . . 0.0 110.213 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -57.69 -33.07 67.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.495 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.79 9.92 3.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.47 63.67 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.359 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -94.64 112.03 56.33 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.097 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.39 153.41 40.97 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.183 1.255 . . . . 0.0 111.569 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.35 158.84 56.0 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.263 1.309 . . . . 0.0 112.283 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 115' ' ' ILE . 74.7 mt -62.75 -9.92 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.413 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.8 t -44.43 -38.69 5.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -172.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.6 Cg_exo -58.93 -33.14 98.55 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 CA-C-N 122.474 1.919 . . . . 0.0 112.329 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 112' ' ' ILE . 15.8 pt -98.91 6.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -77.53 140.84 39.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.479 0.581 . . . . 0.0 110.522 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 -178.286 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 72' ' ' PRO . 88.9 mt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.156 0.503 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -65.08 140.89 58.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.89 9.55 38.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.13 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -45.86 32.97 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.841 -0.537 . . . . 0.0 112.838 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.79 87.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.237 0.518 . . . . 0.0 110.822 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 90' ' ' PHE . 39.7 tp -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.492 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.465 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -58.65 -43.13 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.662 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.91 -47.74 85.03 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.584 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.583 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 25.4 m -62.62 -40.11 95.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.856 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.97 -39.93 87.33 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.788 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.82 -43.64 90.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.292 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.58 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.334 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.92 -25.23 64.98 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.117 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.709 178.084 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.9 mttm . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -151.18 152.57 33.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.533 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.2 m-20 -95.91 128.57 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 5.3 tp -128.0 145.0 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -150.12 161.63 42.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.706 0.765 . . . . 0.0 112.466 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.69 -34.42 65.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.547 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.39 90.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.104 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -69.89 -46.76 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.953 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 7.9 mp -72.91 -25.67 61.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.9 -147.61 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -55.92 -21.16 19.02 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.34 0.973 . . . . 0.0 112.292 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.87 -23.43 63.43 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.495 ' HE3' HD22 ' A' ' 67' ' ' LEU . 47.6 t-105 -55.75 113.08 5.06 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.3 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 125' ' ' ILE . 63.6 Cg_endo -89.67 -13.25 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.752 1.635 . . . . 0.0 114.306 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -94.15 147.31 23.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.173 0.511 . . . . 0.0 111.915 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.0 p -69.58 -36.4 76.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.728 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.69 128.22 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.88 -33.93 75.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -148.61 174.94 11.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.557 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 162.07 34.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.2 m -108.58 140.47 41.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.611 -0.346 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 pt -108.47 136.77 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.35 143.56 31.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.391 0.615 . . . . 0.0 111.941 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.744 173.033 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.576 0.227 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.54 154.64 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.498 0.666 . . . . 0.0 111.491 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.7 t80 -114.04 127.91 56.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.801 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.31 131.86 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.48 155.17 36.68 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.821 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.7 -26.87 10.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.629 1.553 . . . . 0.0 113.018 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 29.8 p30 -64.22 -12.16 38.13 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.72 10.37 67.31 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 121.491 -0.385 . . . . 0.0 112.832 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 m -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.6 m -101.52 130.43 47.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.261 0.553 . . . . 0.0 109.943 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.65 147.23 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.813 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.31 124.99 33.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 110.794 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.93 -48.27 11.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -112.55 167.58 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.614 0.721 . . . . 0.0 112.004 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -53.79 -40.76 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.151 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -63.36 -41.11 98.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.252 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.47 -38.61 77.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.695 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.16 -40.71 98.33 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.412 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -58.01 -33.88 69.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.314 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.89 7.53 4.7 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.48 63.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.227 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -94.49 111.99 55.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.361 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.72 151.51 31.75 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.189 1.259 . . . . 0.0 111.358 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.1 158.98 45.04 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.476 1.451 . . . . 0.0 112.705 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.512 HG23 HD11 ' A' ' 115' ' ' ILE . 80.1 mt -59.64 -12.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.344 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.1 t -43.36 -40.71 6.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -171.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.9 Cg_exo -58.05 -30.04 88.9 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 122.507 1.931 . . . . 0.0 112.703 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.512 HD11 HG23 ' A' ' 112' ' ' ILE . 13.8 pt -98.9 7.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -68.58 149.18 49.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.742 0.701 . . . . 0.0 110.801 -176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 111.626 -178.104 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 72' ' ' PRO . 74.6 mt . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 121.046 0.45 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -69.27 141.46 54.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.997 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.4 mt -91.87 5.83 48.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.318 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.89 -43.74 39.82 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.792 -0.567 . . . . 0.0 112.543 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.94 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 110.78 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.0 tp -59.62 -42.77 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.18 -42.89 95.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.435 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 m -59.54 -43.69 93.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.687 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.4 m -61.37 -47.82 84.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.605 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.6 m -63.56 -39.62 94.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.939 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.19 -38.74 87.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.936 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.36 -43.2 88.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.894 0.378 . . . . 0.0 110.222 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.76 -39.68 94.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.893 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.2 m -60.07 -25.2 65.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.631 -179.36 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE3' HG21 ' A' ' 79' ' ' THR . 49.2 tttp . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -145.61 153.15 40.74 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.056 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' HG23 ' A' ' 79' ' ' THR . 78.8 m-20 -95.02 128.25 41.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 67' ' ' LEU . 4.7 tp -126.57 141.49 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.0 p -144.23 164.66 30.08 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.595 0.712 . . . . 0.0 111.865 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -55.69 -36.15 66.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.322 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.04 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.765 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -70.63 -46.58 63.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.936 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.649 HD12 ' CE3' ' A' ' 71' ' ' TRP . 46.0 mt -85.03 -9.45 58.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.7 -151.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -56.03 -20.08 15.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.914 0.779 . . . . 0.0 112.366 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -57.54 -25.79 60.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.649 ' CE3' HD12 ' A' ' 67' ' ' LEU . 53.1 t-105 -55.79 107.18 0.81 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.27 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.21 -13.17 4.51 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.832 1.688 . . . . 0.0 114.068 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -88.21 145.69 25.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.36 0.6 . . . . 0.0 112.062 -174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.3 p -69.83 -36.89 75.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.72 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.22 129.01 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.67 -32.43 72.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -146.78 174.35 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.652 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.6 m -107.81 140.32 41.07 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.625 -0.338 . . . . 0.0 110.1 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 pt -109.34 137.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -148.04 146.45 28.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.384 0.611 . . . . 0.0 112.067 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.8 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.722 173.451 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.52 156.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.328 0.585 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.3 t80 -114.08 128.35 56.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.18 130.76 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.32 155.32 36.53 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.762 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.49 -26.8 9.35 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.495 1.463 . . . . 0.0 113.064 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.8 p30 -63.88 -12.71 39.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.84 9.68 65.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 122.071 -0.393 . . . . 0.0 112.91 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m -99.43 139.72 34.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -104.47 131.62 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 0.0 110.09 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.81 149.31 41.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.18 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.663 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.36 128.22 35.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.704 0.288 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.87 -52.66 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.478 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -103.12 167.61 9.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.598 0.714 . . . . 0.0 112.117 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.86 -40.46 69.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.148 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -63.88 -42.03 97.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.301 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.17 -37.11 79.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.663 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.0 mm-40 -63.12 -41.02 99.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.288 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.13 -33.94 71.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.638 0.256 . . . . 0.0 111.317 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.66 -1.7 12.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.44 63.72 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.907 -0.385 . . . . 0.0 113.16 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 44.2 m-70 -83.2 135.86 44.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.207 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.07 147.85 94.32 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.053 1.168 . . . . 0.0 111.27 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.07 158.87 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.445 1.43 . . . . 0.0 112.481 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 115' ' ' ILE . 86.9 mt -62.31 -10.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.438 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.2 t -43.64 -40.03 6.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.0 Cg_exo -59.14 -32.19 96.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.293 1.855 . . . . 0.0 112.605 -174.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 112' ' ' ILE . 14.9 pt -98.96 7.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 149.81 42.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.718 0.69 . . . . 0.0 110.882 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.647 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 172.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.647 HD12 ' HB3' ' A' ' 117' ' ' ALA . 88.6 mt . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.043 0.449 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -59.79 137.09 58.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.275 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.5 mt -99.16 6.81 46.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.304 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.65 -43.55 37.42 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.822 -0.549 . . . . 0.0 112.771 -173.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.93 75.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.248 0.524 . . . . 0.0 110.814 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.55 -42.15 91.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.7 tp -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.494 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.55 -43.31 93.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.595 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.6 m -60.99 -48.0 83.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.594 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.609 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 25.1 m -63.11 -40.48 97.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.805 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.09 -38.96 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.958 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -58.51 -43.76 89.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.368 . . . . 0.0 110.2 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.01 -39.55 95.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.988 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.94 -25.33 65.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.032 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.192 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.554 -179.686 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -150.6 147.51 27.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.79 167.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 79' ' ' THR . 72.7 m-20 -98.96 126.35 44.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.765 HD11 HD11 ' A' ' 67' ' ' LEU . 8.3 tt -132.04 152.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.276 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.8 p -150.44 166.41 30.19 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.683 0.754 . . . . 0.0 111.82 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -55.61 -34.6 65.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.238 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.68 88.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.743 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -66.23 -46.49 76.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.368 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.765 HD11 HD11 ' A' ' 62' ' ' ILE . 10.5 mp -84.73 -14.74 47.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.47 -148.99 0.28 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.26 -20.85 20.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.105 0.866 . . . . 0.0 112.343 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.47 -23.28 57.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.562 ' CE3' HD22 ' A' ' 67' ' ' LEU . 37.3 t-105 -55.83 113.46 5.75 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.427 -176.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -89.61 -13.2 2.82 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.786 1.658 . . . . 0.0 114.086 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.07 144.9 24.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.243 0.544 . . . . 0.0 111.875 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.1 p -68.65 -37.15 79.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.627 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.32 130.36 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -63.9 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -168.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -152.98 177.26 10.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.662 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.08 34.33 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.549 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.5 m -108.17 141.49 39.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 pt -108.95 136.77 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -139.78 140.31 36.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.444 0.64 . . . . 0.0 111.949 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.108 170.72 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.552 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 159.0 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.459 0.647 . . . . 0.0 111.402 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 130' ' ' LEU . 91.0 t80 -114.09 126.54 55.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.78 129.68 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.479 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.89 155.79 36.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.676 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.85 -26.84 10.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.541 1.494 . . . . 0.0 113.109 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.5 p30 -63.88 -12.86 40.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.83 66.43 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.886 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -99.34 139.74 34.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -104.84 129.07 53.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.013 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -114.07 149.64 35.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.008 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.654 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.45 128.98 35.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.723 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.4 mt -88.54 -52.16 5.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.445 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p30 -103.22 167.41 9.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 112.192 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -55.43 -40.4 71.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.063 -173.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -62.85 -41.7 99.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.588 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -61.06 -36.67 80.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 0.0 110.958 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.654 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.1 mm-40 -62.81 -41.35 99.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.312 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.37 -33.97 71.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.71 0.291 . . . . 0.0 111.346 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.99 -1.07 10.82 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.49 63.64 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.093 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -83.2 143.15 44.78 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.528 0.664 . . . . 0.0 109.251 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.02 147.77 55.47 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.235 1.29 . . . . 0.0 111.379 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.14 154.77 29.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.332 1.354 . . . . 0.0 112.772 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 115' ' ' ILE . 92.6 mt -62.64 -16.63 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.021 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.422 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.4 t -44.46 -38.53 5.58 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HD3' HG22 ' A' ' 113' ' ' THR . 32.5 Cg_exo -58.99 -31.89 96.54 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.383 1.887 . . . . 0.0 112.193 -176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 112' ' ' ILE . 17.4 pt -98.05 3.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -78.18 135.66 37.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.47 0.577 . . . . 0.0 110.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.454 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.189 0.519 . . . . 0.0 111.862 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' A' ' 117' ' ' ALA . 75.5 mt . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.975 0.416 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 140.39 58.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.126 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.5 mt -95.3 9.72 38.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.1 171.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.13 -44.05 33.12 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.845 -0.534 . . . . 0.0 112.648 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.78 84.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.121 0.46 . . . . 0.0 110.666 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.6 tp -59.32 -42.06 90.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 110.51 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -60.01 -44.4 94.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.496 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 m -59.2 -42.69 91.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.63 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.61 -47.97 83.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.641 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.552 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 20.8 m -62.86 -40.15 96.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.729 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.72 -39.0 86.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -58.66 -42.65 88.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.29 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.13 -39.12 93.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.96 -25.19 65.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.869 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.252 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.475 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.6 tttm . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -150.2 147.95 28.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.952 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' OD1' HG23 ' A' ' 79' ' ' THR . 77.8 m-20 -96.79 127.37 42.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.449 HD11 HD21 ' A' ' 67' ' ' LEU . 8.4 tp -128.0 143.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.984 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.5 p -143.88 164.82 29.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.516 0.674 . . . . 0.0 111.552 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -55.55 -36.22 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.163 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.52 84.29 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.766 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -70.44 -45.06 66.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.671 HD12 ' CE3' ' A' ' 71' ' ' TRP . 48.3 mt -87.23 -8.68 56.56 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.78 -149.57 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -55.76 -21.74 20.55 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.036 0.834 . . . . 0.0 112.336 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -56.42 -28.07 58.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.671 ' CE3' HD12 ' A' ' 67' ' ' LEU . 54.4 t-105 -55.69 107.25 0.82 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.397 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.34 -13.18 4.4 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.755 1.637 . . . . 0.0 114.15 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.73 145.05 26.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.82 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -69.55 -37.5 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.509 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.7 m -63.68 129.72 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.22 -33.44 75.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.16 173.14 12.79 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.709 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 161.99 34.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.537 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.6 m -108.13 139.58 42.58 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.575 -0.368 . . . . 0.0 110.082 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 pt -107.58 136.18 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.34 143.69 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.462 0.649 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.143 171.017 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.638 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.03 157.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.413 0.625 . . . . 0.0 111.412 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 130' ' ' LEU . 91.1 t80 -114.07 127.02 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.933 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.02 131.03 58.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.419 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -101.18 155.96 35.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.812 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.51 -26.67 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.503 1.469 . . . . 0.0 113.19 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 35.0 p30 -64.96 -11.58 40.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.94 9.62 67.7 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.944 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.5 m -99.43 139.9 34.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -104.58 130.57 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.1 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.54 148.02 40.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.005 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.36 127.53 35.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.762 0.315 . . . . 0.0 110.835 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.16 -50.46 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.344 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -105.66 167.6 9.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.637 0.732 . . . . 0.0 111.95 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.33 -40.74 71.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.159 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -64.09 -40.94 97.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.288 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.98 -37.66 77.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.57 -40.36 96.77 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.342 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -58.26 -34.02 70.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.211 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.62 1.82 7.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.92 23.55 63.77 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.986 -0.341 . . . . 0.0 113.227 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -88.24 125.99 62.12 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.219 172.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.68 152.48 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 CA-C-N 120.614 1.255 . . . . 0.0 111.372 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.07 158.01 30.45 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.357 1.371 . . . . 0.0 112.344 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 115' ' ' ILE . 85.3 mt -62.04 -11.18 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.993 -0.527 . . . . 0.0 112.291 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.436 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.7 t -44.09 -39.64 6.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.436 ' HD3' HG22 ' A' ' 113' ' ' THR . 24.5 Cg_exo -59.68 -32.45 95.8 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-N 122.296 1.856 . . . . 0.0 112.401 -175.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.437 HD11 HG23 ' A' ' 112' ' ' ILE . 17.8 pt -98.82 7.69 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -77.8 139.95 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.458 0.572 . . . . 0.0 110.398 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -177.905 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.1 mt . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 121.056 0.455 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -64.63 140.99 58.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.109 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -93.9 8.53 40.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.16 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.88 -44.16 31.27 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 121.808 -0.557 . . . . 0.0 112.764 -173.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.18 82.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.136 0.468 . . . . 0.0 110.759 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 90' ' ' PHE . 32.8 tp -59.5 -41.99 91.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.464 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.7 m -59.18 -43.52 92.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.597 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.2 m -61.02 -47.5 86.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.651 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.638 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 18.9 m -62.99 -40.08 96.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.815 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.65 -39.67 89.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -58.65 -42.41 88.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.342 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.97 -39.2 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.025 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.9 m -60.01 -25.22 65.12 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.938 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.16 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.644 -179.774 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.4 tttp . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -146.46 153.04 39.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.917 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' HG23 ' A' ' 79' ' ' THR . 80.0 m-20 -91.98 125.6 36.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 67' ' ' LEU . 5.2 tp -123.26 144.31 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -175.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.3 p -150.06 160.51 43.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.614 0.721 . . . . 0.0 112.299 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.57 -34.28 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.545 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.25 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.059 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -70.74 -46.66 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 62' ' ' ILE . 7.6 mp -73.57 -23.24 59.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.25 -150.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.08 -26.59 27.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.112 0.869 . . . . 0.0 111.797 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -53.06 -28.28 24.02 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.436 ' HE3' HD22 ' A' ' 67' ' ' LEU . 59.4 t-105 -55.77 107.13 0.79 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.189 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.22 -13.29 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.757 1.638 . . . . 0.0 114.113 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.31 144.43 28.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.202 0.525 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -68.17 -37.13 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.777 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.16 129.76 31.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -61.76 -32.95 73.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -147.1 174.55 11.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.07 34.34 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.474 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.2 m -107.51 138.46 43.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.659 -0.318 . . . . 0.0 110.145 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -108.98 132.83 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -148.07 144.91 28.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.38 0.61 . . . . 0.0 112.27 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.4 m . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.465 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.672 0.273 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.72 158.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.614 0.721 . . . . 0.0 111.921 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.504 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.1 t80 -114.15 129.18 56.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.879 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.88 131.73 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.66 155.15 36.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.666 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -48.85 -25.75 8.88 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.487 1.458 . . . . 0.0 113.104 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.1 p30 -65.27 -11.74 44.44 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.38 67.6 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.847 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.9 m -99.4 138.63 36.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 m -103.18 129.37 50.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.231 0.538 . . . . 0.0 110.067 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -114.14 148.83 36.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.024 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 125.93 34.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.325 . . . . 0.0 110.409 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.05 -51.38 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HB3' HD11 ' A' ' 131' ' ' LEU . 51.7 p30 -112.38 167.59 10.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.658 0.742 . . . . 0.0 112.012 -175.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -52.32 -34.02 45.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.777 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -61.71 -47.43 85.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.619 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.9 -34.29 74.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.424 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.594 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 76.9 mm-40 -62.31 -41.14 98.28 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.131 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -59.08 -34.01 71.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.064 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.09 -3.35 12.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.46 63.71 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.65 -0.309 . . . . 0.0 113.242 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -89.75 143.2 29.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.393 0.597 . . . . 0.0 109.593 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 150.17 47.42 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.242 1.295 . . . . 0.0 111.265 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.97 158.94 30.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.373 1.382 . . . . 0.0 112.783 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 115' ' ' ILE . 92.5 mt -60.02 -14.0 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.159 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.438 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.5 t -42.97 -41.33 6.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD3' HG22 ' A' ' 113' ' ' THR . 19.1 Cg_exo -61.76 -27.41 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 CA-C-N 122.039 1.764 . . . . 0.0 112.656 -173.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 112' ' ' ILE . 9.5 pt -98.8 6.64 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HD3' HD11 ' A' ' 127' ' ' LEU . 78.6 mtm180 -75.87 143.38 41.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.884 0.766 . . . . 0.0 110.828 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.812 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 117' ' ' ALA . 87.3 mt . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 121.15 0.5 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -64.08 140.88 58.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.238 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.403 HD11 ' HD3' ' A' ' 116' ' ' ARG . 67.3 mt -95.11 10.86 34.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.053 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.7 -45.44 30.76 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.8 -0.563 . . . . 0.0 112.877 -173.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.85 -48.48 81.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.263 0.531 . . . . 0.0 110.835 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 90' ' ' PHE . 31.2 tp -59.31 -42.1 90.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 101' ' ' ASN . 27.8 tp -59.59 -44.17 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -59.82 -44.2 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.599 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.9 m -60.27 -46.29 90.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.565 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.6 m -62.35 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.976 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.0 -39.61 86.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.677 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.51 -41.97 91.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.05 -39.72 93.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.97 -25.21 65.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.794 177.322 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 tttt . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -143.95 150.01 37.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.0 m-20 -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.69 HD11 HD11 ' A' ' 67' ' ' LEU . 9.2 tp -126.87 146.69 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.713 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.7 p -150.52 160.55 43.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.691 0.758 . . . . 0.0 112.305 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -55.48 -34.84 64.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.477 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.14 90.54 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.183 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -70.08 -46.58 64.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.287 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 62' ' ' ILE . 7.9 mp -72.12 -25.7 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.23 -148.64 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.25 -20.06 16.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.3 0.954 . . . . 0.0 112.429 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.5 -24.17 63.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.503 ' HE3' HD22 ' A' ' 67' ' ' LEU . 45.4 t-105 -55.88 112.59 4.49 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.32 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 125' ' ' ILE . 64.1 Cg_endo -89.52 -13.24 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.754 1.636 . . . . 0.0 114.166 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.3 mt -90.9 145.21 24.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.532 . . . . 0.0 111.883 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.03 -37.5 78.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.58 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.88 129.94 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -62.34 -33.59 75.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.95 174.49 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.765 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.06 34.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.4 m -108.09 140.07 41.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.16 136.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.74 144.12 39.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.583 . . . . 0.0 111.988 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.695 172.975 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.685 0.279 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.36 156.77 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.367 0.603 . . . . 0.0 111.306 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.6 t80 -114.08 126.47 55.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.048 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.27 130.49 57.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.448 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.28 155.83 35.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.819 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.52 -26.68 9.28 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.588 1.525 . . . . 0.0 113.105 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.448 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 33.3 p30 -64.74 -11.91 41.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.23 67.12 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 122.123 -0.361 . . . . 0.0 112.913 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.6 m -99.39 140.14 34.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.85 130.46 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.17 0.509 . . . . 0.0 110.102 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.69 149.06 38.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.106 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 126.93 35.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.696 0.284 . . . . 0.0 110.805 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.36 -50.52 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.965 0.412 . . . . 0.0 110.226 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.34 167.6 9.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 111.687 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -56.75 -38.37 72.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.062 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -64.79 -41.79 95.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.548 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.613 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.86 -37.88 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.811 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.05 -52.09 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.338 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.67 -20.27 66.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.06 9.85 3.37 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.55 63.32 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 122.28 -0.262 . . . . 0.0 113.456 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -96.98 112.97 62.18 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -54.27 152.72 24.43 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 CA-C-N 120.577 1.242 . . . . 0.0 111.7 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.02 158.98 30.7 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.457 1.438 . . . . 0.0 112.75 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 115' ' ' ILE . 93.9 mt -61.29 -10.68 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.302 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.3 t -42.19 -41.81 5.47 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -172.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD3' HG22 ' A' ' 113' ' ' THR . 19.0 Cg_exo -62.14 -30.19 81.91 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 122.004 1.752 . . . . 0.0 112.612 -173.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 112' ' ' ILE . 15.7 pt -98.87 5.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.485 ' HD2' HD11 ' A' ' 127' ' ' LEU . 83.0 mtp180 -75.63 143.03 42.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.835 0.743 . . . . 0.0 110.555 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.897 0.379 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 117' ' ' ALA . 45.4 mt . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.968 0.413 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -63.49 140.63 58.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.015 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.485 HD11 ' HD2' ' A' ' 116' ' ' ARG . 70.6 mt -93.16 9.81 34.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.121 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.78 -44.14 30.51 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.858 -0.526 . . . . 0.0 112.757 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.17 82.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.161 0.481 . . . . 0.0 110.707 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.5 tp -59.21 -41.89 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 110.458 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.48 -44.47 95.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.7 p -59.76 -40.86 89.58 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.649 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.9 m -61.66 -48.57 80.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.601 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.516 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.9 m -62.6 -40.28 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.727 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.44 -39.49 87.69 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -58.58 -43.0 89.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.315 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.07 -39.47 92.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.91 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -60.1 -25.23 65.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.794 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.643 -179.058 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -148.05 153.21 38.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.576 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.498 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.2 m-20 -90.53 125.21 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 67' ' ' LEU . 9.4 tp -126.05 147.12 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.23 162.1 41.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.783 0.801 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.62 -35.05 65.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.414 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.05 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.134 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.0 -46.64 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.257 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 HD11 ' A' ' 62' ' ' ILE . 8.3 mp -73.56 -26.61 60.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -175.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.46 -146.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -56.18 -20.12 16.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.495 1.043 . . . . 0.0 112.463 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.27 -25.13 63.83 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.49 ' HE3' HD22 ' A' ' 67' ' ' LEU . 36.1 t-105 -55.87 111.76 3.52 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.572 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.63 -13.23 2.8 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.858 1.705 . . . . 0.0 114.096 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.8 mt -90.6 145.57 24.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.177 0.513 . . . . 0.0 111.953 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.8 p -69.71 -37.43 76.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.555 174.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.76 128.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.75 -33.99 75.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.068 -169.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.25 174.82 11.26 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.503 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.76 162.04 34.29 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.1 m -106.76 139.72 40.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.9 pt -108.16 135.77 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -146.19 141.03 27.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.375 0.607 . . . . 0.0 112.181 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.055 170.814 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.323 0 CA-C-O 120.754 0.312 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.567 HG12 ' HB1' ' A' ' 104' ' ' ALA . 35.5 m -132.06 155.81 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.554 0.692 . . . . 0.0 111.783 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.3 t80 -114.18 130.24 56.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.81 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.6 t -109.51 131.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.47 155.35 36.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.851 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.68 -27.33 10.73 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.605 1.537 . . . . 0.0 113.09 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.6 p30 -64.04 -12.03 34.78 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 10.24 66.49 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 122.153 -0.342 . . . . 0.0 112.896 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 57.4 m -99.43 139.11 35.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.48 130.49 49.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 109.993 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.62 150.88 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.141 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.34 124.9 33.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 mt -79.85 -47.13 15.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 109.793 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -114.89 166.27 11.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.358 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -52.9 -34.53 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.735 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -61.01 -49.05 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.747 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.6 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.21 -37.12 76.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -61.66 -42.31 98.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.998 0.427 . . . . 0.0 110.089 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -58.23 -33.17 69.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.358 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.16 9.77 2.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.51 63.42 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.18 -0.325 . . . . 0.0 113.38 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -97.55 111.96 60.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.339 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -54.46 150.94 32.29 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.116 1.21 . . . . 0.0 111.654 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.81 158.9 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.325 1.35 . . . . 0.0 112.477 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.5 HG23 HD11 ' A' ' 115' ' ' ILE . 75.3 mt -61.9 -10.62 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.6 t -44.41 -38.83 5.89 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.424 ' HD3' HG22 ' A' ' 113' ' ' THR . 30.1 Cg_exo -58.79 -32.49 97.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 CA-C-N 122.472 1.919 . . . . 0.0 112.462 -175.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 112' ' ' ILE . 19.0 pt -98.83 7.55 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -76.45 137.34 39.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.495 0.588 . . . . 0.0 110.478 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.636 -175.9 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 121.086 0.469 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -63.1 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.842 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.52 9.27 35.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.098 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.8 31.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.838 -0.539 . . . . 0.0 112.852 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.323 0.562 . . . . 0.0 110.752 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.8 tp -59.1 -42.35 90.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.17 -43.24 95.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.473 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.7 m -59.24 -43.64 92.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.628 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.75 -47.63 85.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.538 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.5 m -63.22 -39.69 95.33 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.088 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.11 -39.49 86.36 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.724 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -58.75 -43.09 90.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.04 -38.62 89.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.8 m -59.89 -25.33 65.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.997 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.648 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 tttt . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -147.01 146.82 30.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.835 169.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.4 m-20 -93.75 125.71 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 67' ' ' LEU . 4.6 tp -126.2 144.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.514 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.3 p -150.42 158.9 44.67 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.566 0.698 . . . . 0.0 112.388 -173.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -55.54 -34.6 64.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.438 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.74 89.41 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.09 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -70.39 -46.64 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.259 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.528 HD11 HD11 ' A' ' 62' ' ' ILE . 6.9 mp -71.68 -26.27 62.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.66 -147.17 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.85 -22.03 22.95 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.38 0.991 . . . . 0.0 112.286 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 70' ' ' LEU . 7.2 mp -61.53 -20.53 63.34 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.469 ' HE3' HD22 ' A' ' 67' ' ' LEU . 51.6 t-105 -55.82 118.45 20.15 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.247 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HB3' HG22 ' A' ' 125' ' ' ILE . 58.8 Cg_endo -89.69 -13.3 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.807 1.671 . . . . 0.0 114.157 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.62 145.21 27.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.34 0.59 . . . . 0.0 112.101 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.2 p -67.31 -37.8 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.464 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.77 128.6 26.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.11 -33.91 75.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -147.99 173.87 12.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.778 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.01 34.23 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.481 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.1 m -108.92 139.09 44.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.611 -0.347 . . . . 0.0 110.105 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.51 134.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.11 144.56 38.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.233 0.54 . . . . 0.0 111.995 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.396 172.047 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.603 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.1 158.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.353 0.596 . . . . 0.0 111.557 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.2 t80 -114.1 126.85 55.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.039 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.47 129.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.5 155.45 36.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.647 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.49 -26.59 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.589 1.526 . . . . 0.0 113.115 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 33.4 p30 -63.95 -12.77 40.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.88 67.09 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 122.09 -0.381 . . . . 0.0 112.924 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 m -99.34 139.38 35.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 m -104.87 130.18 53.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 109.972 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -114.9 148.65 38.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.9 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.4 127.74 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.694 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -86.82 -50.53 6.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.285 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.402 ' HB3' HD11 ' A' ' 131' ' ' LEU . 44.9 p-10 -103.43 167.12 10.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.627 0.727 . . . . 0.0 111.956 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.37 -39.88 73.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.999 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.18 -41.89 99.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.271 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.29 -37.19 79.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.899 0.381 . . . . 0.0 110.968 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.97 -40.55 98.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.43 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -58.63 -34.04 70.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.721 0.296 . . . . 0.0 111.329 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.21 0.96 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.49 63.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.969 -0.35 . . . . 0.0 113.191 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -83.21 143.15 44.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.03 152.66 68.01 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.262 1.308 . . . . 0.0 111.752 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.1 153.54 28.55 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.454 1.436 . . . . 0.0 112.725 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 115' ' ' ILE . 90.1 mt -64.02 -18.98 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.779 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 t -46.6 -36.82 7.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.57 -29.01 83.58 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 CA-C-N 122.997 2.106 . . . . 0.0 112.103 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 112' ' ' ILE . 17.6 pt -98.89 2.17 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 143.3 45.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.103 0.865 . . . . 0.0 110.204 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.776 -175.382 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' A' ' 72' ' ' PRO . 46.7 mt . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.042 0.448 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -72.25 141.37 48.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.694 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -91.68 8.5 36.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.163 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.54 -43.15 36.09 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.749 -0.595 . . . . 0.0 112.327 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.72 88.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.788 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.4 tp -59.01 -41.68 88.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.035 0.445 . . . . 0.0 110.463 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 101' ' ' ASN . 33.8 tp -59.64 -45.2 92.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.474 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.3 p -59.73 -41.05 90.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.69 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.62 -47.76 83.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.707 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.603 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 24.0 m -62.67 -40.35 96.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.839 -177.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -60.18 -39.87 88.0 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.751 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -59.44 -42.05 91.04 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.424 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.05 -38.72 89.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.107 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -59.97 -25.28 65.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.867 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.703 179.195 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -142.34 153.21 43.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.763 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -94.88 126.0 39.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 173.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 67' ' ' LEU . 4.7 tp -124.79 141.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.5 p -143.46 163.37 33.29 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.594 0.711 . . . . 0.0 111.755 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.54 -35.53 65.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.216 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.19 85.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.729 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.44 -46.65 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.826 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.627 HD12 ' CE3' ' A' ' 71' ' ' TRP . 36.5 mt -87.02 -8.69 56.91 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 61.66 -145.37 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.0 -28.44 37.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.29 0.95 . . . . 0.0 111.92 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.33 -25.58 35.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.627 ' CE3' HD12 ' A' ' 67' ' ' LEU . 49.2 t-105 -55.92 107.17 0.8 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.372 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.02 -13.17 3.89 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.833 1.689 . . . . 0.0 114.129 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -89.67 145.89 24.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.315 0.579 . . . . 0.0 111.821 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.1 p -69.63 -37.1 76.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.723 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.77 129.64 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -64.31 -30.14 71.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -150.26 174.62 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.662 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.456 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.5 m -107.89 140.94 40.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.629 -0.336 . . . . 0.0 110.102 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 pt -108.87 136.08 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -143.55 143.88 31.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 111.824 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.701 174.157 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.06 156.73 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.599 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.4 t80 -114.06 126.95 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.06 130.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.4 156.22 35.49 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.658 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.2 -26.73 8.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.509 1.473 . . . . 0.0 113.105 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.0 p30 -65.11 -11.46 40.13 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 8.51 67.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.85 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -99.47 138.48 36.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.1 m -103.7 131.0 51.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 109.865 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -115.97 149.76 38.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.979 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.38 127.23 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.674 0.273 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -86.68 -51.02 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.941 0.4 . . . . 0.0 110.181 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.404 ' HB3' HD11 ' A' ' 131' ' ' LEU . 43.2 p-10 -103.25 167.61 9.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.644 0.735 . . . . 0.0 111.944 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.79 -39.04 76.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.944 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -62.76 -41.27 99.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.151 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.7 -35.87 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.072 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.2 -40.55 97.81 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.389 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -58.86 -34.01 71.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.689 0.281 . . . . 0.0 111.241 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.21 -1.79 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.54 63.41 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.07 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 5.1 m-70 -82.09 143.19 48.8 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 109.516 173.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 153.47 73.84 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.366 1.378 . . . . 0.0 111.811 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.12 151.89 27.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.538 1.492 . . . . 0.0 112.66 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 115' ' ' ILE . 90.2 mt -64.28 -18.62 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 119.015 -0.517 . . . . 0.0 111.672 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.422 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.3 t -45.12 -37.34 4.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HD3' HG22 ' A' ' 113' ' ' THR . 39.3 Cg_exo -59.01 -32.11 96.95 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 CA-C-N 122.529 1.939 . . . . 0.0 112.102 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 112' ' ' ILE . 15.8 pt -97.06 3.68 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.38 139.37 39.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.439 0.563 . . . . 0.0 110.331 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.38 -177.915 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.054 0.454 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -63.29 140.8 58.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.236 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.5 mt -94.41 9.87 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.059 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.02 -45.26 32.94 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.845 -0.534 . . . . 0.0 112.735 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.3 85.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.175 0.488 . . . . 0.0 110.759 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.8 tp -59.47 -41.95 90.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.602 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 101' ' ' ASN . 30.0 tp -59.64 -44.61 93.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -59.07 -43.37 91.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.66 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.59 -47.28 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 110.626 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.622 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 19.9 m -62.7 -41.53 99.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.794 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.16 -37.43 82.88 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.69 -43.86 90.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 110.197 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -36.24 82.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.84 -25.16 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.069 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.86 178.645 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 78.5 m80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.515 -0.55 . . . . 43.920000000000002 109.515 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -123.66 132.2 53.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 43.210000000000001 110.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -127.1 149.05 50.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 42.18 110.525 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -111.73 136.8 50.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 41.899999999999999 110.318 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -117.62 132.48 56.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.27 -0.423 . . . . 41.189999999999998 110.549 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -60.68 -39.76 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 40.770000000000003 110.86 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.2 m -59.52 156.26 13.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 40.93 110.872 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -63.18 161.83 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 40.539999999999999 110.768 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.26 -165.94 21.28 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.961 -0.856 . . . . 40.469999999999999 110.961 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.6 mt -76.69 145.78 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 40.109999999999999 110.584 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.98 165.46 27.16 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 40.039999999999999 110.424 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.96 -20.8 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.361 1.374 . . . . 40.359999999999999 113.098 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -55.26 -36.12 65.75 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.128 -0.229 . . . . 39.030000000000001 111.187 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.67 178.07 42.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 38.020000000000003 110.938 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -58.74 -40.29 83.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 36.799999999999997 110.799 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.27 -173.42 55.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.778 -0.929 . . . . 35.439999999999998 110.778 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.1 mtm -136.44 153.6 51.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 33.659999999999997 110.551 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -99.69 150.45 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 32.780000000000001 110.196 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -56.38 -38.59 71.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 31.449999999999999 110.961 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.7 m -129.22 136.98 50.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.525 -0.307 . . . . 30.27 110.516 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.5 51.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 29.399999999999999 110.337 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.02 129.23 38.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 28.469999999999999 110.49 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.52 81.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 28.48 111.421 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -125.76 137.48 53.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.352 . . . . 27.199999999999999 110.68 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -133.93 162.68 31.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 26.289999999999999 110.359 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.56 139.35 32.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 27.039999999999999 110.829 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -70.19 142.37 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 25.809999999999999 110.538 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -122.56 140.53 52.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 25.800000000000001 110.281 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -136.58 153.8 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.366 . . . . 25.27 110.625 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 93.0 mmm -123.33 145.41 48.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 25.539999999999999 109.951 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.53 114.03 25.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 25.859999999999999 110.849 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -125.29 99.82 33.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.091 -0.504 . . . . 25.780000000000001 110.05 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -88.37 123.9 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.549 1.499 . . . . 26.289999999999999 112.42 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -61.27 -34.68 75.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 27.32 111.452 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 29' ' ' LEU . 9.0 tt -90.85 128.06 36.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 27.800000000000001 110.637 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.9 166.26 35.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.802 -0.919 . . . . 28.449999999999999 110.802 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -129.65 162.03 29.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 29.91 110.62 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -132.24 -35.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 30.91 111.128 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.44 -35.58 68.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.641 -0.254 . . . . 29.460000000000001 111.278 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -55.57 149.26 14.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.403 . . . . 31.09 110.879 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.01 -36.2 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 30.129999999999999 111.435 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -78.83 149.15 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 28.109999999999999 110.641 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -109.52 148.16 31.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 26.989999999999998 110.196 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.86 -37.9 94.89 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.392 -0.683 . . . . 25.41 111.392 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.29 171.09 51.49 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.763 -0.935 . . . . 23.079999999999998 110.763 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.31 176.23 38.46 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.118 -0.793 . . . . 20.710000000000001 111.118 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -59.62 -34.53 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.518 0.199 . . . . 18.25 111.434 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.7 144.23 27.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 15.66 110.901 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -69.85 143.35 91.98 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 13.279999999999999 110.1 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.8 -169.98 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.228 1.285 . . . . 10.84 111.714 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.42 131.83 52.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.952 0.406 . . . . 7.7300000000000004 110.556 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.39 -37.18 79.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.539 . . . . 6.6100000000000003 111.299 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -99.59 136.6 39.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 5.5199999999999996 110.655 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -74.78 -49.2 4.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.992 -0.528 . . . . 1.48 112.228 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.19 128.14 16.51 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.203 1.268 . . . . 1.0 112.112 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -90.29 133.85 32.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.548 -0.739 . . . . 0.71999999999999997 109.386 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.22 155.42 9.26 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.034 1.156 . . . . 0.87 111.482 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.1 151.64 89.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.393 -0.367 . . . . 0.55000000000000004 110.224 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.63 157.76 48.12 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.191 1.261 . . . . 0.58999999999999997 111.532 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -55.82 120.1 30.55 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.897 -0.573 . . . . 1.26 109.956 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.04 119.89 4.03 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.134 1.223 . . . . 0.78000000000000003 113.441 -169.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -77.75 158.11 29.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.686 -1.227 . . . . 0.79000000000000004 107.686 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -56.57 125.55 22.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.16 -0.616 . . . . 1.73 110.971 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 63.58 24.03 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.45 -0.796 . . . . 2.2799999999999998 112.705 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -159.14 141.82 14.14 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.319 -0.553 . . . . 2.6000000000000001 112.327 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -148.61 152.91 37.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.823 -0.626 . . . . 0.28000000000000003 110.903 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' OD1' HG23 ' A' ' 79' ' ' THR . 76.1 m-20 -97.56 129.07 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.468 -0.567 . . . . 0.16 109.468 173.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.708 HD11 HD11 ' A' ' 67' ' ' LEU . 12.1 tt -129.34 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.892 0.377 . . . . 0.40999999999999998 110.938 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -150.48 167.87 25.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.59 0.709 . . . . 0.20000000000000001 111.654 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.5 -34.62 64.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.724 . . . . 1.1000000000000001 111.118 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.02 86.53 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 121.021 -0.272 . . . . 0.28999999999999998 110.727 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -66.36 -46.61 76.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.32000000000000001 111.282 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD11 HD11 ' A' ' 62' ' ' ILE . 10.8 mp -88.07 -8.79 55.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.671 0.989 . . . . 1.05 113.671 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.69 -153.79 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.419 -0.586 . . . . 0.32000000000000001 109.419 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -56.77 -21.42 28.32 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.571 0.623 . . . . 3.9399999999999999 112.4 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -59.2 -20.09 50.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.498 0.555 . . . . 1.6699999999999999 112.498 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.509 ' CE3' HD22 ' A' ' 67' ' ' LEU . 55.7 t-105 -55.81 111.94 3.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 119.121 -0.466 . . . . 0.19 110.205 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -89.55 -13.25 2.84 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.904 1.736 . . . . 0.23999999999999999 114.164 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -87.8 143.62 27.04 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.228 0.537 . . . . 0.11 111.627 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.4 p -67.99 -36.76 80.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.345 -0.843 . . . . 0.17000000000000001 110.817 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.67 129.39 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.272 -1.01 . . . . 0.17000000000000001 108.272 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.92 -32.94 72.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.023 0.379 . . . . 1.8 112.023 -169.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -147.02 174.37 11.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.406 -0.518 . . . . 0.46999999999999997 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.05 34.31 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.832 -1.307 . . . . 0.10000000000000001 109.832 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.556 HG23 ' OD1' ' A' ' 61' ' ' ASP . 6.3 m -109.93 141.58 42.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.598 -0.354 . . . . 0.12 110.349 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.64 137.23 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.988 -0.375 . . . . 0.14000000000000001 109.988 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -148.01 143.79 27.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.432 0.634 . . . . 2.1800000000000002 112.127 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.9 m -105.81 119.74 39.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.011 -0.995 . . . . 0.22 109.492 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.91 156.63 69.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.539 -0.3 . . . . 0.75 111.061 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.07 -19.84 4.58 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.446 1.431 . . . . 0.91000000000000003 113.223 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.4 m -79.65 3.06 20.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.358 0.873 . . . . 1.6499999999999999 113.358 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 62.98 39.5 10.17 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.1 0.476 . . . . 2.0499999999999998 110.852 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.27 127.11 55.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.215 -0.661 . . . . 1.9399999999999999 109.215 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.546 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.05 121.07 36.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.11 -0.33 . . . . 0.25 110.11 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.32 157.14 43.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.448 0.642 . . . . 0.12 111.396 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' HD21 ' A' ' 130' ' ' LEU . 89.1 t80 -114.03 127.75 56.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.799 -1.091 . . . . 0.11 109.932 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -108.51 130.48 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.325 -0.62 . . . . 0.13 109.325 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.41 154.8 37.0 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.655 -0.418 . . . . 0.13 110.625 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.66 -26.49 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.509 1.473 . . . . 0.17999999999999999 113.225 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.6 p30 -63.96 -12.79 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.816 0.673 . . . . 0.17999999999999999 112.816 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.52 10.43 65.48 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 122.151 -0.343 . . . . 0.16 112.92 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.7 m -99.37 139.36 35.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.233 -0.655 . . . . 0.14000000000000001 109.233 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.8 m -105.02 130.91 53.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.297 0.57 . . . . 0.14000000000000001 110.056 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -116.68 147.54 41.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.14000000000000001 108.992 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.41 126.08 34.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.13 110.771 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.04 -50.93 6.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.347 -0.388 . . . . 0.17999999999999999 110.637 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -103.11 166.58 10.35 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.643 0.735 . . . . 0.33000000000000002 112.019 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.6 -41.16 69.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.39 -0.823 . . . . 2.2000000000000002 112.209 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -63.94 -42.8 97.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.689 -0.404 . . . . 2.2200000000000002 111.398 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.584 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.62 -37.28 78.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.862 0.363 . . . . 0.22 110.907 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.56 -40.92 98.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 2.0699999999999998 110.394 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.85 -33.93 71.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 2.7200000000000002 111.288 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.66 0.44 8.72 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.083 0.771 . . . . 0.46000000000000002 113.083 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.12 23.43 63.53 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.826 -0.43 . . . . 0.46000000000000002 113.203 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 49.9 m-70 -84.89 142.64 39.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 108.938 -0.764 . . . . 0.46999999999999997 108.938 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.09 148.83 51.25 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.182 1.255 . . . . 0.72999999999999998 111.281 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 158.91 30.44 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.376 1.384 . . . . 0.45000000000000001 112.301 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 115' ' ' ILE . 92.4 mt -60.96 -11.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 119.033 -0.508 . . . . 0.20000000000000001 112.345 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.444 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.1 t -43.83 -39.65 6.06 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 115.559 1.689 . . . . 0.40000000000000002 115.559 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.2 Cg_exo -58.98 -31.95 96.62 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 CA-C-N 122.31 1.861 . . . . 0.28000000000000003 112.395 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 112' ' ' ILE . 25.1 pt -98.9 1.49 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 113.008 0.744 . . . . 0.20999999999999999 113.008 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -79.59 136.77 36.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.34 0.518 . . . . 3.3199999999999998 110.545 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -77.76 136.29 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.26000000000000001 111.356 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -95.12 139.91 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.869 -0.605 . . . . 2.6299999999999999 109.858 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.34 166.01 19.63 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.473 -0.651 . . . . 1.03 111.473 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 m -57.85 -38.53 75.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.967 -0.293 . . . . 2.3900000000000001 110.767 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.19 166.11 26.12 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.602 -0.999 . . . . 1.8200000000000001 110.602 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.9 58.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.042 -0.599 . . . . 2.2400000000000002 111.987 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.57 -123.91 30.1 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.568 -0.613 . . . . 0.95999999999999996 111.568 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -108.96 158.99 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 1.26 110.867 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 117' ' ' ALA . 33.2 mt -73.5 128.7 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.712 -0.676 . . . . 0.39000000000000001 109.915 -177.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -61.83 138.81 58.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.28999999999999998 112.092 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -95.99 11.55 33.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.173 -0.921 . . . . 0.23000000000000001 112.103 171.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -42.41 30.65 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.876 -0.515 . . . . 0.19 112.632 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.5 81.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.996 0.427 . . . . 0.20000000000000001 110.78 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.55 -41.94 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.17000000000000001 110.47 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.97 -44.04 94.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.19 110.464 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.05 -43.73 91.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.924 -0.311 . . . . 1.1799999999999999 110.562 -176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 39.0 m -60.9 -47.52 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.586 -0.446 . . . . 0.19 110.597 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.546 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 27.3 m -62.84 -40.12 96.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.58 -0.448 . . . . 0.17999999999999999 110.921 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.83 -39.63 89.74 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.969 -0.292 . . . . 0.22 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -58.77 -42.58 89.26 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.777 -0.369 . . . . 1.8999999999999999 110.241 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.97 -39.55 95.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.20000000000000001 111.03 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.1 m -59.99 -25.31 65.16 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.238 -0.437 . . . . 0.29999999999999999 112.144 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.25 22.99 61.84 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.116 -0.564 . . . . 0.60999999999999999 112.614 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -71.4 134.27 46.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 117.462 0.631 . . . . 4.0099999999999998 110.532 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.924 -1.486 . . . . 2.6299999999999999 110.913 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -125.36 135.77 52.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.44 134.66 53.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -124.23 135.4 53.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.515 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -123.97 135.21 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -121.91 129.81 52.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.521 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m -65.05 156.29 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m -61.99 153.14 30.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.36 -177.19 49.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.46 143.27 26.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.338 . . . . 0.0 110.408 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.44 151.94 90.21 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.561 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -88.33 168.23 6.31 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.728 1.619 . . . . 0.0 112.313 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -124.55 151.66 44.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.305 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.43 138.94 47.35 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -134.84 147.86 50.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.0 110.521 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.6 -177.87 52.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -97.29 131.45 43.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.704 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -131.09 147.37 52.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -99.58 133.34 44.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.492 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -127.95 162.3 27.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 147.2 53.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.424 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 142.82 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.554 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.11 43.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -87.54 141.01 28.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.31 151.65 38.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.54 141.79 35.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.432 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -67.76 140.42 56.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.524 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -114.78 151.6 33.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.584 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -124.32 136.06 53.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -124.67 155.17 39.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.523 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.24 119.18 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.555 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.7 p -64.26 152.9 87.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.549 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -82.4 -176.08 2.79 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.483 1.455 . . . . 0.0 112.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -98.2 167.19 11.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.779 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.7 mt -94.5 142.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.06 51.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.8 t -72.55 144.11 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -137.34 162.24 34.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -80.75 169.5 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.43 139.71 49.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.54 162.7 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -132.11 135.35 46.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -139.9 160.22 40.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.09 -177.12 51.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.04 176.49 53.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.37 -173.84 37.84 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -76.67 141.41 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 110.224 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.41 29.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.275 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.29 147.31 76.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.351 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -91.54 176.95 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.759 1.639 . . . . 0.0 112.344 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.58 152.74 44.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.223 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -100.68 135.35 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.648 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -124.78 157.35 35.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.518 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -56.16 159.63 5.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.17 128.32 16.79 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.417 1.411 . . . . 0.0 112.278 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.32 140.23 27.04 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.383 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -52.17 150.72 18.64 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.111 1.207 . . . . 0.0 111.53 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.12 153.89 83.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.484 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.25 149.96 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.233 1.289 . . . . 0.0 111.46 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.2 p -55.93 139.45 70.64 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.091 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.16 119.86 3.98 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.173 1.249 . . . . 0.0 113.112 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -80.36 162.1 24.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.2 p -54.13 125.65 19.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 111.711 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 63.77 12.65 6.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 171.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -159.77 162.33 34.84 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -143.8 153.12 42.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.581 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' HG23 ' A' ' 79' ' ' THR . 75.7 m-20 -97.3 123.95 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.827 HD11 HD11 ' A' ' 67' ' ' LEU . 6.8 tt -130.18 151.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.092 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.0 p -147.79 165.81 29.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.871 0.843 . . . . 0.0 112.061 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -55.62 -34.28 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.38 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.15 90.42 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.785 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -66.38 -46.59 76.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.904 0.383 . . . . 0.0 111.241 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.827 HD11 HD11 ' A' ' 62' ' ' ILE . 10.3 mp -81.88 -16.64 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.06 -148.3 0.3 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -56.03 -21.25 20.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.196 0.907 . . . . 0.0 112.368 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.0 tp -56.54 -27.83 58.52 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.589 ' CE3' HD22 ' A' ' 67' ' ' LEU . 43.1 t-105 -55.73 111.89 3.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.42 -175.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HB3' HG22 ' A' ' 125' ' ' ILE . 66.8 Cg_endo -89.53 -13.15 2.87 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.766 1.644 . . . . 0.0 114.167 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.31 145.33 25.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.284 0.564 . . . . 0.0 111.813 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.8 p -69.37 -37.16 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.647 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.42 129.65 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.12 -32.77 73.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -168.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -148.55 175.1 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.09 34.38 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.515 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.0 m -107.88 141.1 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.81 137.71 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.45 143.73 30.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 112.06 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 m -108.25 121.21 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.684 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -81.98 155.89 69.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.906 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.46 -19.99 7.91 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.366 1.377 . . . . 0.0 113.286 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -81.04 3.0 24.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 69.25 35.79 2.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 111.023 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -113.37 127.42 56.12 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.575 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.75 124.08 39.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.288 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.7 157.79 42.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.437 0.637 . . . . 0.0 111.452 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.4 t80 -114.05 127.47 55.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.025 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.17 130.91 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.37 155.25 36.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.735 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.39 -26.74 9.01 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.595 1.53 . . . . 0.0 113.127 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.7 p30 -64.5 -11.82 37.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.55 9.28 66.85 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.543 -0.361 . . . . 0.0 112.911 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.1 m -99.45 140.83 33.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -105.04 131.08 53.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.235 0.54 . . . . 0.0 110.118 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -116.22 148.09 40.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.997 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.679 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.35 127.93 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -86.79 -51.8 5.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -103.2 167.49 9.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 112.059 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.106 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -63.23 -41.91 99.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.207 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.34 -37.04 79.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 110.92 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.679 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 76.8 mm-40 -62.77 -41.27 99.16 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.282 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -58.77 -33.99 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.409 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.44 7.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.05 23.46 63.61 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.964 -0.353 . . . . 0.0 113.265 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 52.3 m-70 -84.9 143.16 39.79 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.469 0.635 . . . . 0.0 109.303 172.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.84 149.07 47.18 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.246 1.297 . . . . 0.0 111.458 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.05 154.88 29.57 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.403 1.402 . . . . 0.0 112.702 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 115' ' ' ILE . 91.6 mt -61.67 -14.95 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.132 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.2 t -44.12 -39.05 5.64 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.8 Cg_exo -59.31 -31.38 94.95 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.306 1.859 . . . . 0.0 112.373 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 112' ' ' ILE . 14.4 pt -98.76 7.03 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -78.09 142.03 38.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.447 0.567 . . . . 0.0 110.546 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.68 137.33 32.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -97.24 139.97 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.045 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.87 167.38 19.69 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.494 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -57.97 -39.0 77.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.619 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.44 165.22 25.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.05 27.44 60.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.27 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.6 -123.8 31.54 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -106.55 154.61 20.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 110.926 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 72' ' ' PRO . 59.3 mt -76.75 130.28 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.025 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.3 m -64.54 141.01 58.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.003 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.8 9.71 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.095 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.04 -44.06 32.34 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.87 -0.519 . . . . 0.0 112.64 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 -47.57 85.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.795 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.9 tp -59.43 -42.11 91.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 tp -60.09 -43.89 95.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -58.97 -43.27 91.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.595 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 m -60.87 -47.92 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.588 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.575 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 26.1 m -62.9 -39.84 95.76 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.923 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.81 -39.1 87.69 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.909 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.85 -42.65 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.247 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.88 -39.45 94.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.916 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.7 m -60.05 -25.24 65.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.83 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.78 22.85 48.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.6 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -88.37 133.06 34.19 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.437 0.618 . . . . 0.0 110.451 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 CA-C-O 117.945 -1.475 . . . . 0.0 110.964 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -121.02 143.09 49.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -121.23 137.52 54.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.431 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -123.51 143.23 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -109.15 137.99 46.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.515 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -129.52 150.49 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m -117.05 146.85 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.2 p -142.62 163.38 32.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.472 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.68 -178.93 52.58 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.4 mt -96.12 141.14 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.65 159.0 74.28 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.466 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -86.24 109.99 0.99 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.591 1.527 . . . . 0.0 112.266 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -125.88 147.32 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.51 117.35 0.68 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.1 p -142.85 159.88 41.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 0.0 110.498 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.36 140.43 30.78 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.8 mtt -130.05 153.74 48.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.518 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -98.85 146.02 26.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -103.17 148.9 25.2 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.5 p -123.31 162.79 22.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.441 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 145.43 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.599 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.91 154.56 43.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 143.5 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -82.77 132.98 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.4 141.5 44.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.22 143.46 44.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.647 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -128.57 143.56 50.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -75.9 145.37 40.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.725 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -123.57 145.15 49.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.4 mtp -119.83 150.31 40.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.56 144.11 54.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.671 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 p -107.13 159.62 29.37 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.408 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.56 -178.9 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.486 1.457 . . . . 0.0 112.312 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -67.38 145.4 55.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.686 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.5 tp -96.8 133.2 41.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.415 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.63 -177.03 51.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.3 m -93.56 144.52 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.589 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.2 119.28 21.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -66.71 148.31 52.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.748 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -69.15 -174.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -59.96 132.51 54.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.634 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.52 152.49 20.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 p -77.95 168.72 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.27 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.93 142.38 44.96 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -140.01 2.84 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.18 -166.95 23.42 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -53.04 155.63 2.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 111.491 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.01 152.78 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.816 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -55.77 159.68 5.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -59.99 172.09 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.402 1.402 . . . . 0.0 112.175 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.06 152.59 43.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.775 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -120.89 153.78 36.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.38 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -56.76 145.77 28.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 m -72.22 159.57 85.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.29 138.32 23.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.35 1.366 . . . . 0.0 112.265 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.26 142.82 28.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.379 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.23 154.01 11.83 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.069 1.179 . . . . 0.0 111.316 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.99 151.31 89.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.505 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -60.58 148.13 92.26 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.119 1.212 . . . . 0.0 111.236 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.5 p -55.92 131.98 73.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.09 119.88 4.01 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.171 1.247 . . . . 0.0 113.489 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.7 p -82.61 157.09 23.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 167.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 p -57.49 125.49 23.12 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.828 -172.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 m120 63.57 21.61 12.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.786 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.7 144.21 14.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.404 0.547 . . . . 0.0 112.251 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -148.83 152.72 36.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.4 m-20 -92.22 126.74 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 6.7 tp -126.86 145.73 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.589 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -150.41 161.71 41.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.687 0.756 . . . . 0.0 112.484 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -55.57 -34.97 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.542 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.24 88.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.039 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -71.69 -46.65 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.054 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 8.0 mp -72.45 -25.76 61.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.13 -147.71 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -55.99 -21.59 22.0 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.367 0.985 . . . . 0.0 112.352 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.93 -25.32 63.37 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.495 ' HE3' HD22 ' A' ' 67' ' ' LEU . 47.0 t-105 -55.8 110.45 2.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.409 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 125' ' ' ILE . 67.0 Cg_endo -89.5 -13.27 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 114.158 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.7 145.76 24.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.304 0.573 . . . . 0.0 111.927 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 p -69.39 -36.86 77.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.67 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.12 129.48 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -61.58 -33.24 73.53 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.98 175.01 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.01 34.26 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.524 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.0 m -106.94 137.56 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.48 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -147.97 144.05 27.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.397 0.617 . . . . 0.0 112.299 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m -102.51 118.52 37.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.644 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.7 mt -87.66 159.03 50.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.489 -172.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.18 -14.46 8.85 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.359 1.373 . . . . 0.0 113.133 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.0 m -78.62 2.98 17.55 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 63.05 44.49 5.84 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.137 0.494 . . . . 0.0 110.349 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -135.17 142.95 46.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.511 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.45 121.28 41.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.692 0.282 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -133.16 158.64 43.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.619 0.724 . . . . 0.0 111.886 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CD1' HD21 ' A' ' 130' ' ' LEU . 89.0 t80 -114.08 128.65 56.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.848 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.84 131.37 58.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.14 155.53 36.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.781 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.71 -27.06 10.34 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.533 1.489 . . . . 0.0 113.079 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 29.6 p30 -63.99 -12.41 37.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.47 9.69 66.52 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.912 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.8 m -99.37 139.94 34.29 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m -103.54 129.55 50.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -114.69 150.56 35.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.073 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.44 126.06 34.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.311 . . . . 0.0 110.377 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.4 mt -82.99 -51.93 7.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.466 . . . . 0.0 110.187 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -109.18 166.84 10.55 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 111.761 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -52.41 -33.66 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.866 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -61.83 -48.65 79.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 110.775 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.65 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.45 -35.1 75.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.243 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.44 -41.2 98.56 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.243 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.04 -33.96 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.47 0.31 8.65 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.14 23.41 63.54 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.963 -0.354 . . . . 0.0 113.244 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -89.0 143.13 30.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 117.465 0.633 . . . . 0.0 109.421 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.14 148.39 44.31 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.256 1.304 . . . . 0.0 111.249 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.4 157.07 32.93 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.387 1.391 . . . . 0.0 112.625 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 115' ' ' ILE . 87.2 mt -60.61 -13.46 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 119.135 -0.46 . . . . 0.0 112.228 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.433 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.5 t -44.0 -39.44 6.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.5 Cg_exo -59.37 -31.29 94.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 CA-C-N 122.336 1.87 . . . . 0.0 112.387 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 112' ' ' ILE . 14.7 pt -98.83 7.83 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -77.34 140.67 40.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -84.66 139.84 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.341 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HZ2' ' HE1' ' A' ' 124' ' ' TYR . 40.9 tttp -93.35 139.88 30.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.824 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.22 167.3 17.98 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -58.38 -39.07 78.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.646 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.04 164.91 26.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.92 29.18 59.43 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.171 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.51 -120.45 21.74 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.404 ' HE1' ' HZ2' ' A' ' 118' ' ' LYS . 4.5 m-85 -105.51 157.68 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.001 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 117' ' ' ALA . 61.3 mt -78.27 132.78 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.127 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -64.93 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.848 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.55 8.24 39.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.193 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.91 -44.45 31.69 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.85 -0.531 . . . . 0.0 112.922 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.68 76.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.268 0.534 . . . . 0.0 110.778 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 90' ' ' PHE . 31.3 tp -59.24 -42.29 90.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.474 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.39 -42.99 97.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.53 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.9 t -59.55 -44.9 93.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.49 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.34 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.552 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.7 m -63.22 -40.04 96.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.31 -39.55 87.4 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.785 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -58.62 -42.77 88.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.09 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.4 m -60.49 -25.16 65.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.993 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 22.88 50.62 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.66 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -85.99 134.89 33.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.412 0.606 . . . . 0.0 110.503 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.734 0 CA-C-O 118.057 -1.413 . . . . 0.0 110.96 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.1 141.03 49.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.518 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.96 137.01 54.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.454 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.46 144.33 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -118.78 139.0 52.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -112.02 140.05 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.456 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t -116.14 142.39 46.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.6 p -140.43 161.55 37.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.0 -178.25 38.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.5 tp -102.32 129.16 48.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.314 . . . . 0.0 110.502 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.87 158.22 68.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.586 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.67 130.65 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.622 1.548 . . . . 0.0 112.118 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -124.05 146.51 48.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.51 -176.85 48.24 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -138.88 156.3 47.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.281 . . . . 0.0 110.568 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.19 -176.65 35.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -129.32 152.43 48.89 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -95.75 135.38 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -124.25 158.65 31.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.399 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.4 m -72.25 134.88 45.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.308 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.56 159.42 43.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.652 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.18 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.523 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 146.62 26.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.737 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -128.26 138.63 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.493 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -57.54 152.84 14.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -72.47 143.13 48.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.643 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -105.98 160.05 15.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.27 165.25 26.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -125.87 171.94 10.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.509 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 mtt -106.2 158.81 16.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.692 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.78 145.32 56.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.772 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -67.62 153.98 94.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.722 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.66 -174.94 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.593 1.528 . . . . 0.0 112.341 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.44 124.96 30.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.5 150.48 28.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.6 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.71 156.83 7.22 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -122.88 170.06 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.341 . . . . 0.0 110.472 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -57.47 149.74 20.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.517 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -71.04 171.49 10.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.162 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.02 149.48 47.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.881 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -62.89 152.95 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.484 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -73.08 148.25 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.688 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -122.3 169.43 10.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.526 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.21 -170.42 27.14 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.44 121.57 20.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.88 -170.67 44.34 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -56.84 154.01 9.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.748 0.309 . . . . 0.0 110.592 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.26 147.91 15.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.851 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.57 133.58 85.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.25 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.51 -169.96 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.206 1.271 . . . . 0.0 111.626 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.25 159.13 4.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.369 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -60.71 150.15 33.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.027 0.441 . . . . 0.0 110.689 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -129.95 150.25 51.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.232 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.73 167.67 0.37 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.503 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -50.45 128.0 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.093 1.195 . . . . 0.0 112.001 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.47 120.92 68.93 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.382 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 153.27 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 120.884 1.352 . . . . 0.0 111.128 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.05 151.35 90.11 Favored Pre-proline 0 C--N 1.33 -0.283 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.427 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -81.45 163.91 19.15 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.358 1.372 . . . . 0.0 111.51 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -55.98 139.89 70.29 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.063 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.09 119.91 4.02 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.075 1.184 . . . . 0.0 113.033 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -75.69 160.06 30.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.8 m -54.0 125.62 19.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.76 10.84 5.42 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 171.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -159.7 159.53 33.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -144.55 153.14 41.51 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.271 172.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.409 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -93.19 126.57 38.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.8 tp -126.71 142.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.0 p -145.86 164.54 31.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.594 0.711 . . . . 0.0 111.929 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -55.57 -35.52 65.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.154 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.19 85.76 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.603 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -66.33 -46.63 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.577 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.672 HD12 ' CE3' ' A' ' 71' ' ' TRP . 48.3 mt -91.08 -8.13 49.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 60.93 -146.44 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -57.15 -24.04 51.5 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.306 0.957 . . . . 0.0 112.476 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD12 ' H ' ' A' ' 70' ' ' LEU . 6.5 mp -59.16 -22.37 60.84 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.672 ' CE3' HD12 ' A' ' 67' ' ' LEU . 55.9 t-105 -55.85 107.41 0.88 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.228 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.48 -13.27 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.812 1.674 . . . . 0.0 114.174 -174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.72 145.04 26.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.19 0.519 . . . . 0.0 111.66 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 p -69.04 -36.88 78.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.725 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.72 130.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.92 -32.69 73.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -169.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.78 174.43 11.83 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.734 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.409 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.6 m -107.82 139.97 41.62 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.612 -0.346 . . . . 0.0 110.071 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.49 134.84 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -145.95 142.64 28.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.425 0.631 . . . . 0.0 111.991 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.62 119.48 38.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.891 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.5 mt -87.55 156.49 53.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.189 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.01 -18.01 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.307 1.338 . . . . 0.0 113.28 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -76.93 0.0 22.63 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 67.36 44.21 1.84 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.072 0.463 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -135.12 145.25 47.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.457 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.58 123.25 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.655 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.8 158.71 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.555 0.693 . . . . 0.0 111.931 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.2 t80 -114.05 129.04 56.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.898 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.9 131.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.61 155.13 36.72 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.749 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.37 -27.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.625 1.55 . . . . 0.0 113.152 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.8 p30 -64.36 -11.65 34.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.68 10.46 67.3 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.84 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.8 m -99.34 139.32 35.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.0 m -103.04 129.96 49.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.346 0.593 . . . . 0.0 110.023 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.47 150.89 37.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.188 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.39 128.88 35.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.697 0.284 . . . . 0.0 110.725 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 131' ' ' LEU . 21.6 mt -87.98 -57.12 3.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.094 0.473 . . . . 0.0 110.434 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.513 ' HB3' HD11 ' A' ' 131' ' ' LEU . 49.6 p30 -105.1 159.14 16.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -47.44 -35.26 8.28 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.095 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -61.64 -44.45 96.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.578 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.08 -37.36 74.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.392 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 31.2 mp0 -63.94 -39.22 93.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.026 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.5 -34.02 70.47 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.041 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 0.79 10.04 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.4 63.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.877 -0.402 . . . . 0.0 113.319 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -90.48 143.2 28.91 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.576 0.688 . . . . 0.0 109.668 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.11 148.1 39.14 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.267 1.311 . . . . 0.0 111.271 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.98 158.84 34.37 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.366 1.377 . . . . 0.0 112.939 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 115' ' ' ILE . 88.9 mt -61.13 -11.54 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.353 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.435 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.8 t -43.83 -39.82 6.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 113' ' ' THR . 24.7 Cg_exo -59.39 -32.11 96.01 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 CA-C-N 122.364 1.88 . . . . 0.0 112.433 -174.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 112' ' ' ILE . 23.1 pt -98.74 5.18 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -79.41 135.66 36.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.477 0.581 . . . . 0.0 110.772 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -78.41 149.61 33.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.077 0.465 . . . . 0.0 111.668 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -85.88 142.3 28.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.467 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.08 159.41 18.84 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 m -57.33 -39.16 75.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.742 0.306 . . . . 0.0 110.686 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.44 163.98 28.1 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.52 34.15 50.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.012 -0.614 . . . . 0.0 111.73 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.38 -119.96 9.82 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.676 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -104.39 159.95 15.3 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.528 -0.396 . . . . 0.0 110.383 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 117' ' ' ALA . 79.9 mt -76.45 129.94 36.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.141 0.496 . . . . 0.0 110.357 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 139.83 58.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.068 -174.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.99 9.43 37.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.053 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.16 31.73 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.827 -0.546 . . . . 0.0 112.913 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.1 75.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.313 0.557 . . . . 0.0 110.78 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.06 -41.58 88.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 101' ' ' ASN . 21.8 tp -60.36 -43.76 96.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -60.04 -44.15 94.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.601 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.0 m -60.56 -47.03 87.98 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.504 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.8 m -63.31 -40.4 97.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.68 -38.34 84.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.954 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.5 -42.58 87.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.55 -38.54 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.5 m -59.95 -25.23 65.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.91 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.73 22.86 22.59 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.676 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.1 133.68 40.22 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.433 0.617 . . . . 0.0 110.495 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.91 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -124.65 136.12 53.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.379 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -121.69 144.48 48.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.622 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -113.68 140.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.425 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -119.49 133.51 55.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.48 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -124.3 137.1 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.507 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -116.22 143.57 45.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -61.6 154.98 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.614 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.19 -174.36 38.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.68 129.98 45.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.9 142.65 97.54 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.17 130.14 2.45 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.656 1.571 . . . . 0.0 112.203 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -60.66 144.51 51.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.653 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.2 -175.27 48.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.0 m -62.1 157.12 19.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.58 144.09 38.01 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.1 161.59 28.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -88.5 149.08 23.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.25 142.83 41.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -124.25 163.14 22.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.75 145.01 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.534 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.07 144.79 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.591 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.5 154.24 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 134.17 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.629 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -105.66 133.1 50.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.97 139.6 39.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -62.27 149.33 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -98.53 145.76 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.57 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -131.06 172.02 12.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.11 145.78 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.72 140.87 58.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.655 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -132.57 162.85 54.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.407 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -82.98 110.0 1.77 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.496 1.464 . . . . 0.0 112.205 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -150.03 165.36 32.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.5 tp -104.1 126.87 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.419 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -178.33 46.14 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.3 p -124.76 158.85 32.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.809 0.338 . . . . 0.0 110.32 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -75.69 136.85 40.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.0 137.53 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.57 133.17 42.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.627 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -149.98 167.54 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -136.21 127.25 27.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.983 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -129.99 160.54 33.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.05 165.99 36.59 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 -178.26 40.88 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.68 -172.23 47.46 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -57.81 146.95 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.718 0.294 . . . . 0.0 110.461 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.07 157.5 44.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.716 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.74 155.78 59.16 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 131.39 39.01 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.36 1.373 . . . . 0.0 111.74 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.67 164.25 32.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.64 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -90.8 159.91 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.382 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -140.59 159.24 42.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.912 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -66.83 153.84 93.2 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.17 150.41 7.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.25 1.3 . . . . 0.0 112.172 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.33 143.59 29.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.382 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.23 160.89 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.068 1.179 . . . . 0.0 111.303 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.94 153.86 83.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.579 -176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.95 151.2 44.8 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.298 1.332 . . . . 0.0 111.59 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -56.04 129.7 73.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.992 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.22 119.95 3.98 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.21 1.273 . . . . 0.0 113.252 -170.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.7 p -74.74 160.65 30.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 166.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -55.06 125.43 20.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.083 -172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p30 63.22 13.4 6.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.219 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -146.28 154.58 41.86 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.29 0.495 . . . . 0.0 111.834 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -149.03 150.71 33.26 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.792 168.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.5 m-20 -92.59 124.82 36.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 67' ' ' LEU . 5.9 tp -125.83 145.17 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -150.38 162.43 40.56 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.795 0.807 . . . . 0.0 112.419 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.95 -35.18 66.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.537 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.5 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.056 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.93 -46.65 51.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.078 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 HD11 ' A' ' 62' ' ' ILE . 8.2 mp -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.17 -147.03 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.8 -22.0 22.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.38 0.991 . . . . 0.0 112.468 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.41 -24.91 63.87 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.506 ' HE3' HD22 ' A' ' 67' ' ' LEU . 45.9 t-105 -55.89 110.98 2.64 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.357 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 125' ' ' ILE . 72.8 Cg_endo -89.55 -13.13 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.731 1.621 . . . . 0.0 114.108 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.42 145.47 24.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.191 0.52 . . . . 0.0 111.921 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.2 p -69.58 -37.03 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.663 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.11 129.34 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.97 -33.47 74.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -169.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -147.5 174.36 11.79 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.712 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.02 34.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.7 m -108.08 139.95 41.98 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.7 pt -109.36 139.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -148.01 145.44 28.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 112.303 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.3 m -108.6 124.02 49.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.695 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -85.92 156.38 58.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.005 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.12 -20.4 7.51 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.405 1.403 . . . . 0.0 113.177 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.9 p -79.23 3.01 19.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 63.74 39.67 8.34 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 121.085 0.469 . . . . 0.0 110.83 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -114.85 128.62 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -96.51 123.73 40.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.163 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.24 157.27 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 111.458 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.3 t80 -114.17 128.07 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.98 130.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.22 155.59 36.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.802 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.47 -26.88 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.473 1.449 . . . . 0.0 113.097 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.8 p30 -64.31 -12.24 39.94 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.43 9.49 66.85 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.927 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.9 m -99.39 140.01 34.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 m -104.36 130.8 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.322 0.582 . . . . 0.0 110.087 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -116.18 148.24 40.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.082 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.686 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.4 128.3 35.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.692 0.282 . . . . 0.0 110.722 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.8 mt -87.58 -51.14 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -103.04 166.41 10.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.665 0.745 . . . . 0.0 112.037 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -55.33 -40.16 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.129 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -63.76 -42.06 97.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.334 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.597 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.61 -36.32 78.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 176.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.686 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.0 mm-40 -63.29 -41.44 98.98 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.306 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -59.2 -33.86 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.317 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.1 -1.54 10.28 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.45 63.67 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.897 -0.391 . . . . 0.0 113.238 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 14.5 m-70 -84.99 134.36 41.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.133 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.33 148.1 91.46 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.062 1.174 . . . . 0.0 111.235 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 157.97 30.36 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.315 1.343 . . . . 0.0 112.302 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 115' ' ' ILE . 91.0 mt -62.07 -11.75 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.256 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.0 t -43.79 -40.05 6.61 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -171.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD3' HG22 ' A' ' 113' ' ' THR . 25.7 Cg_exo -59.29 -32.28 96.55 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 CA-C-N 122.25 1.839 . . . . 0.0 112.417 -175.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 112' ' ' ILE . 17.7 pt -98.84 7.66 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.03 140.22 40.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.527 0.603 . . . . 0.0 110.399 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.42 26.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 111.82 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.46 139.94 36.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.58 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.61 166.5 18.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 m -57.64 -39.15 76.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.592 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.99 166.82 28.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.14 55.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.11 -119.98 12.81 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.43 159.29 15.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.061 0.458 . . . . 0.0 111.059 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.41 HG22 ' HB3' ' A' ' 72' ' ' PRO . 84.2 mt -78.85 133.44 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.269 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.4 m -65.01 140.81 58.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.951 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.95 9.27 36.28 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.139 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.01 -45.18 32.86 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.837 -0.54 . . . . 0.0 112.766 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.04 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.162 0.481 . . . . 0.0 110.707 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.1 tp -59.35 -42.35 91.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -43.31 94.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -58.81 -44.46 90.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.45 -47.34 86.53 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.568 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.611 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 24.3 m -62.51 -40.49 96.89 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.842 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.68 -39.41 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.858 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -58.8 -42.83 90.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 110.277 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.57 -38.21 90.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.191 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.8 m -60.08 -25.14 65.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.957 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.72 23.01 60.74 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.61 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -85.0 133.56 34.25 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.427 0.613 . . . . 0.0 110.501 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 118.032 -1.426 . . . . 0.0 110.961 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -116.87 137.56 52.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.437 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -124.23 142.9 50.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.469 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.99 137.77 52.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.419 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -128.9 137.26 51.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.462 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -116.3 137.86 51.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.1 m -63.78 154.28 33.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -123.06 141.66 51.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.89 -176.7 50.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.6 tp -99.34 128.4 45.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.22 153.19 90.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.626 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -86.24 -177.57 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.566 1.511 . . . . 0.0 112.071 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -63.75 143.42 57.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.402 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.06 -175.11 44.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.0 m -63.95 156.46 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 0.0 110.525 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.69 -176.1 36.1 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -127.4 158.16 38.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.779 0.323 . . . . 0.0 110.494 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -73.2 138.52 45.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.503 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -93.82 138.98 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.486 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m -121.94 143.27 49.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.53 147.97 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.575 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.29 158.67 43.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 147.62 25.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -84.15 153.71 23.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -131.7 164.74 25.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.543 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.18 144.16 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -123.87 141.29 52.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -104.36 147.61 27.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.623 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -122.02 144.31 48.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -115.56 146.22 41.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.258 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.31 120.64 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.538 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 m -61.76 152.78 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.581 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.28 -175.03 2.02 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.624 1.549 . . . . 0.0 112.235 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -67.34 148.02 52.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.61 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -85.59 143.79 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.426 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.43 -139.96 3.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -76.31 166.02 24.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.813 0.34 . . . . 0.0 110.508 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -60.92 142.44 56.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -150.03 -173.26 4.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.05 153.57 11.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -55.85 154.88 6.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.015 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.53 175.79 9.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.724 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.6 p -74.78 165.57 25.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.499 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.28 -174.23 43.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.9 -174.31 48.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.69 49.71 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -58.48 149.68 24.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.747 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.22 10.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -55.0 163.08 1.61 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 140.95 95.21 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.312 1.342 . . . . 0.0 112.112 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -173.67 2.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.615 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -79.7 157.87 27.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -63.88 139.21 58.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.798 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.92 167.5 19.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.674 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' CG ' ' HB2' ' A' ' 68' ' ' ALA . 78.3 Cg_exo -48.28 147.18 8.87 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.327 1.352 . . . . 0.0 112.017 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.22 142.2 28.32 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.786 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.22 160.98 2.87 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.167 1.245 . . . . 0.0 111.289 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.93 152.97 85.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.453 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.86 155.29 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.274 1.316 . . . . 0.0 111.576 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -55.88 142.15 64.95 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.19 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.07 119.93 4.03 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.168 1.245 . . . . 0.0 113.049 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -79.96 161.57 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -53.84 125.64 19.29 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.826 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 63.83 9.63 4.61 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -159.77 163.87 34.26 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -143.59 153.08 42.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.412 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.28 123.63 36.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.569 HD11 HD11 ' A' ' 67' ' ' LEU . 5.4 tp -125.45 145.77 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.484 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.0 p -148.48 162.94 38.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.776 0.798 . . . . 0.0 112.262 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -56.54 -34.76 67.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.478 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.55 91.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.067 -176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -69.24 -46.72 66.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 0.0 111.032 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.569 HD11 HD11 ' A' ' 62' ' ' ILE . 8.7 mp -72.7 -25.12 61.12 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB2' ' CG ' ' A' ' 49' ' ' PRO . . . 70.39 -148.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -55.37 -20.6 12.37 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.352 0.978 . . . . 0.0 112.417 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.75 -23.41 63.2 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.519 ' HE3' HD22 ' A' ' 67' ' ' LEU . 39.2 t-105 -55.9 112.89 4.84 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.326 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG22 ' A' ' 125' ' ' ILE . 66.0 Cg_endo -89.53 -13.24 2.85 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.863 1.709 . . . . 0.0 114.157 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -93.27 145.81 24.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.184 0.516 . . . . 0.0 111.722 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.96 -36.72 75.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.648 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.77 130.35 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -64.41 -30.59 71.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -150.64 176.86 10.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.725 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.66 162.07 34.41 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -107.47 139.84 41.35 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.7 pt -109.22 137.48 41.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -144.91 144.09 30.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.279 0.561 . . . . 0.0 112.008 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.6 m -108.65 122.74 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.712 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -83.13 158.82 63.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.001 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.57 -21.51 10.91 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.401 1.4 . . . . 0.0 113.159 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.0 p -79.51 3.0 20.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 63.71 40.51 7.74 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.233 0.539 . . . . 0.0 110.62 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -114.41 128.6 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.615 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.01 124.11 38.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.362 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.24 157.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.344 0.592 . . . . 0.0 111.372 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.523 ' CD1' HD21 ' A' ' 130' ' ' LEU . 94.4 t80 -114.05 127.06 55.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.129 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.7 130.69 58.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.91 155.75 36.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.729 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.51 -26.68 9.25 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.44 1.427 . . . . 0.0 113.126 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 32.4 p30 -64.18 -12.56 41.46 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.96 9.17 66.17 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.911 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.4 m -99.41 139.35 35.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.412 0.606 . . . . 0.0 109.396 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.8 m -103.46 131.91 50.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.058 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -89.36 129.24 35.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.695 0.283 . . . . 0.0 110.796 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 mt -88.3 -51.88 5.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -103.6 167.6 9.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.615 0.721 . . . . 0.0 111.959 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -55.47 -40.32 71.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.975 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -63.3 -41.56 98.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.326 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.606 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.75 -37.71 79.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.832 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.04 -40.89 99.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.859 0.361 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.51 -34.07 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.714 0.292 . . . . 0.0 111.303 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.01 1.97 7.87 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.51 63.61 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.27 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -84.75 143.18 40.25 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.45 150.99 47.22 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.278 1.319 . . . . 0.0 111.931 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.89 151.97 36.2 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.299 1.332 . . . . 0.0 112.925 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 115' ' ' ILE . 91.4 mt -61.99 -13.31 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.2 t -46.76 -35.27 4.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.09 -33.78 97.73 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 CA-C-N 123.038 2.121 . . . . 0.0 112.039 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 112' ' ' ILE . 18.6 pt -98.94 7.77 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -77.26 142.3 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.684 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.44 139.51 30.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.152 0.501 . . . . 0.0 111.435 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -104.05 142.44 34.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.168 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.37 151.35 19.36 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.81 -40.88 81.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.58 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.68 171.76 19.5 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.57 -120.53 23.23 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.45 -120.02 1.73 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.44 152.94 21.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 72' ' ' PRO . 68.6 mt -79.01 128.03 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -62.1 140.51 58.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.179 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.48 6.98 47.13 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.241 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.21 -44.84 34.56 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.84 -0.538 . . . . 0.0 112.629 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.67 84.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.153 0.477 . . . . 0.0 110.74 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.9 tp -59.59 -42.23 92.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.456 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.11 -43.81 95.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.453 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -59.21 -43.35 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.641 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.54 -47.95 83.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.563 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.615 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 19.8 m -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.772 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.75 -39.0 87.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.8 -42.94 90.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.301 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.159 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.02 -25.3 65.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.772 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.19 -18.14 54.73 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.911 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.19 145.51 25.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.672 0.736 . . . . 0.0 110.633 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.82 0 CA-C-O 118.065 -1.408 . . . . 0.0 110.965 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.88 140.64 49.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -123.33 135.85 54.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.69 147.17 47.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -112.32 139.26 48.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.54 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.52 140.49 49.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.394 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -117.93 143.64 46.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.502 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -68.92 161.94 27.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.13 -171.81 40.28 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.11 143.67 27.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.331 . . . . 0.0 110.333 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.28 151.03 91.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.559 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -89.49 -178.48 1.73 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.697 1.598 . . . . 0.0 112.343 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.63 145.55 49.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.106 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.43 -172.26 44.65 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 142.65 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.429 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.6 -176.23 50.93 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -126.42 164.42 21.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 110.321 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -83.39 140.17 32.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.551 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -115.02 157.9 22.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.598 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -133.58 158.91 41.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 141.46 56.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.613 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.43 144.59 53.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.23 144.81 56.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.402 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -88.3 133.9 33.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -122.28 157.58 31.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.393 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -70.63 140.34 51.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.393 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 -123.06 152.42 41.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.741 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -106.91 155.11 20.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -103.59 131.53 50.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.69 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.98 165.95 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.382 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -62.17 147.12 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.3 m -58.17 151.93 44.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.52 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.37 174.86 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.7 1.6 . . . . 0.0 112.378 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -67.27 151.93 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.556 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 31' ' ' THR . 77.3 mt -78.99 144.92 34.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.398 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.76 126.72 41.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 29' ' ' LEU . 72.8 p -127.47 164.6 21.55 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -80.63 109.15 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 0.0 110.276 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -150.1 -176.12 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.697 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.75 156.83 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.364 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.76 121.99 19.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.567 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -133.74 -176.25 4.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -72.37 165.89 23.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.57 -175.7 43.88 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.89 -173.49 49.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.14 -170.67 45.19 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -57.43 149.83 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.533 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.69 149.5 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.768 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.51 155.12 30.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.679 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.93 -169.99 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.325 1.35 . . . . 0.0 112.044 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.97 167.88 19.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -57.27 164.18 1.89 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -55.89 143.83 30.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.035 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -139.74 167.06 19.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.626 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.33 148.21 7.85 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.396 1.397 . . . . 0.0 111.994 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.73 142.05 28.91 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.701 -0.666 . . . . 0.0 109.592 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.29 160.96 2.96 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.125 1.217 . . . . 0.0 111.427 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.05 152.39 87.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.375 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.1 150.83 34.07 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.304 1.336 . . . . 0.0 111.499 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.7 m -55.99 136.93 73.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.079 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.1 119.9 4.01 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.124 1.216 . . . . 0.0 113.262 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 p -78.68 162.64 26.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -53.82 125.52 18.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 111.751 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.8 12.88 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 171.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -159.82 165.73 31.74 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -145.62 153.12 40.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.589 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -90.87 123.71 34.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 67' ' ' LEU . 8.9 tp -124.55 146.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -148.99 161.62 41.55 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.804 0.811 . . . . 0.0 112.437 -173.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -56.45 -34.78 67.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.34 91.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.106 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.25 -46.72 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.04 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 62' ' ' ILE . 8.4 mp -72.5 -28.99 63.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.82 -141.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -54.0 -28.33 37.36 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.797 1.181 . . . . 0.0 112.058 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.96 -26.92 50.2 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.517 ' HE3' HD22 ' A' ' 67' ' ' LEU . 34.2 t-105 -55.82 109.97 1.98 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.709 -176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG22 ' A' ' 125' ' ' ILE . 64.4 Cg_endo -89.56 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.828 1.685 . . . . 0.0 114.108 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.2 mt -91.24 145.88 24.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 111.819 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -69.82 -37.11 76.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.623 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.49 129.95 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -64.38 -31.0 72.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -168.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -149.53 176.73 10.36 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.615 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.01 34.28 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -106.99 140.39 39.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 pt -109.51 138.66 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -144.96 144.15 30.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.568 . . . . 0.0 111.946 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.7 m -109.52 122.8 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.815 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -82.51 158.21 66.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.856 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.53 -21.53 19.06 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.451 1.434 . . . . 0.0 112.913 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 t -78.2 3.12 16.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 63.57 40.91 7.69 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 121.297 0.57 . . . . 0.0 110.668 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.65 128.3 56.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.03 125.68 39.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.343 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.34 155.78 41.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.308 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 130' ' ' LEU . 93.8 t80 -114.16 127.52 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.139 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.5 131.12 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 36.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.852 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.2 -26.99 8.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.537 1.491 . . . . 0.0 113.106 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -64.8 -11.19 34.15 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 9.47 66.9 Favored Glycine 0 CA--C 1.537 1.422 0 O-C-N 122.104 -0.372 . . . . 0.0 112.921 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.0 m -99.44 138.95 35.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.86 130.96 50.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.209 0.528 . . . . 0.0 110.003 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.96 148.06 41.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.235 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.33 127.05 35.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.691 0.282 . . . . 0.0 110.714 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -85.22 -50.91 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.976 0.417 . . . . 0.0 110.332 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.92 167.65 9.57 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.67 0.748 . . . . 0.0 111.921 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -58.22 -37.54 75.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.076 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.77 -41.18 98.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.199 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.629 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.39 -36.94 79.27 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 175.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.33 -40.11 96.42 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.458 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -58.57 -33.94 70.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.157 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.24 1.59 7.41 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.51 63.58 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.946 -0.364 . . . . 0.0 113.253 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -86.59 143.19 35.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 117.498 0.649 . . . . 0.0 109.386 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.18 152.24 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.297 1.331 . . . . 0.0 111.349 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.04 157.84 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.297 1.331 . . . . 0.0 112.431 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.478 HG23 HD11 ' A' ' 115' ' ' ILE . 81.4 mt -62.91 -10.12 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.7 t -43.84 -39.6 6.0 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -172.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 28.0 Cg_exo -58.8 -33.72 98.62 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 CA-C-N 122.385 1.887 . . . . 0.0 112.232 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 112' ' ' ILE . 23.8 pt -98.9 7.44 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -77.61 139.3 39.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.336 0.516 . . . . 0.0 110.474 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -87.28 136.49 32.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 111.398 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -99.38 140.37 33.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.107 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.29 167.21 20.21 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.533 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 m -58.13 -38.51 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.29 . . . . 0.0 110.713 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.52 165.78 26.01 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.95 59.29 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.181 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.07 -123.59 30.37 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -107.83 159.7 16.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 117' ' ' ALA . 60.5 mt -79.21 129.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.213 -175.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -59.53 139.2 57.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.403 HD23 ' CG ' ' A' ' 72' ' ' PRO . 69.9 mt -94.92 6.28 49.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.314 172.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -44.2 37.86 Favored Glycine 0 CA--C 1.526 0.758 0 O-C-N 121.873 -0.517 . . . . 0.0 112.741 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 -47.84 83.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.243 0.521 . . . . 0.0 110.76 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.2 tp -59.89 -42.43 93.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.57 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.0 tp -60.41 -43.03 97.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.523 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.2 t -58.91 -43.97 91.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.764 0.316 . . . . 0.0 110.531 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.13 -47.78 84.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.583 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.602 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.7 m -62.65 -40.56 97.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.802 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.019 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.31 -43.65 88.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.247 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.13 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.085 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.12 -25.14 65.23 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.92 23.01 39.98 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.351 -0.452 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -103.19 145.62 29.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.43 0.615 . . . . 0.0 110.322 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 CA-C-O 118.059 -1.412 . . . . 0.0 110.924 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -128.85 146.64 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -113.06 141.68 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -110.84 138.71 46.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.492 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -130.36 166.03 21.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.434 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -111.29 137.44 49.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.411 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.2 m -63.59 154.47 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.679 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -121.13 148.94 43.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.02 138.99 49.16 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.3 mt -98.29 140.8 32.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 110.7 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.53 154.79 94.0 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.509 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.21 112.75 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.282 1.321 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -123.76 153.35 41.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.457 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.66 -176.78 51.33 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -117.75 143.13 46.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.551 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 178.23 24.57 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt -123.45 148.54 46.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.81 0.338 . . . . 0.0 110.557 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -135.99 159.91 40.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -106.87 146.26 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -139.59 159.55 41.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.95 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.14 139.56 50.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.685 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 145.0 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.575 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -77.18 131.91 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.366 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.88 146.11 42.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.633 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.27 154.74 29.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -148.77 159.7 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.716 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.59 131.85 51.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -118.35 139.91 50.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.405 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.27 158.32 37.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.486 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -77.65 173.11 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.653 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 m -67.55 150.7 97.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.366 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -89.92 174.56 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.701 1.6 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.18 147.22 52.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.309 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.92 126.65 39.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.55 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.36 -172.58 44.5 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 m -73.02 141.6 47.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.753 0.311 . . . . 0.0 110.36 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -58.57 133.77 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -69.83 150.35 46.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.732 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.44 157.72 10.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.373 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.5 117.44 15.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.619 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -100.88 171.19 7.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.703 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.2 m -62.31 144.35 55.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.363 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.41 34.24 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 -170.68 46.82 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.15 -164.42 24.48 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -57.14 140.4 49.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.55 150.17 23.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -57.02 155.76 15.13 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.6 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.5 -170.0 0.61 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 112.32 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 151.04 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -126.14 168.74 13.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.425 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -65.53 142.6 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.605 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -66.64 153.55 93.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.608 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.58 146.28 54.35 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.324 1.349 . . . . 0.0 111.896 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.31 141.58 27.67 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.48 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 160.88 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.103 1.202 . . . . 0.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.04 153.79 83.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.457 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.42 148.63 43.37 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.215 1.276 . . . . 0.0 111.475 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.9 p -56.01 129.88 73.06 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.042 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.11 119.88 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.139 1.226 . . . . 0.0 113.455 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.6 p -76.37 159.7 30.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -56.07 125.56 22.13 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.109 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.66 14.32 8.06 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -150.92 149.86 30.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.612 0.642 . . . . 0.0 112.252 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -148.83 150.81 33.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -94.15 126.09 39.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 4.9 tp -125.57 144.42 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.465 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 160.47 43.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.724 0.774 . . . . 0.0 112.356 -173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.66 -34.74 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.525 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.76 90.71 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.116 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -70.59 -46.54 63.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.171 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 7.7 mp -72.36 -25.05 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.87 -148.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -55.7 -20.48 14.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.271 0.941 . . . . 0.0 112.367 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.75 -24.3 63.94 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.498 ' HE3' HD22 ' A' ' 67' ' ' LEU . 46.6 t-105 -55.85 112.89 4.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.264 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB3' HG22 ' A' ' 125' ' ' ILE . 65.2 Cg_endo -89.54 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.812 1.675 . . . . 0.0 114.144 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.82 144.87 25.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 111.656 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.7 p -69.09 -37.41 78.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.585 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -64.27 129.77 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.08 -33.6 74.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -147.58 174.61 11.59 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.879 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 161.98 34.23 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.5 m -107.45 139.98 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 pt -109.58 138.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.79 145.9 31.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.24 0.543 . . . . 0.0 111.918 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.7 m -108.68 120.11 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.768 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.8 mt -81.44 155.63 71.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.89 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.7 -20.15 8.9 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.372 1.381 . . . . 0.0 113.278 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.4 m -80.98 3.02 24.4 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.2 t0 69.01 37.2 2.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.87 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -114.34 127.95 56.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.3 122.14 37.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.204 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 155.6 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.389 0.614 . . . . 0.0 111.405 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.512 ' CD1' HD21 ' A' ' 130' ' ' LEU . 93.8 t80 -114.1 127.54 55.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.134 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.15 130.9 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.472 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.35 155.91 35.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.838 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.61 -25.82 8.37 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.453 1.435 . . . . 0.0 113.139 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 32.4 p30 -65.23 -11.8 44.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.76 67.73 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 122.055 -0.403 . . . . 0.0 112.964 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.6 m -99.52 139.37 35.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.5 m -104.09 132.93 49.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 109.889 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -118.26 151.27 37.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.54 125.02 34.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.691 0.281 . . . . 0.0 110.646 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.9 mt -83.45 -50.33 8.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 109.918 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -103.27 167.56 9.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.574 0.702 . . . . 0.0 111.502 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.3 -38.8 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.954 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.93 -43.02 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.441 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.85 -37.68 79.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 110.723 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -63.33 -41.42 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.278 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -58.6 -32.79 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.514 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 2.38 6.27 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.09 23.48 63.51 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.176 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.76 142.4 45.39 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 153.83 76.58 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 121.316 1.344 . . . . 0.0 111.737 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 113' ' ' THR . 55.7 Cg_endo -78.06 151.58 27.29 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.375 1.383 . . . . 0.0 112.509 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 115' ' ' ILE . 92.9 mt -64.02 -16.57 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.223 -0.418 . . . . 0.0 111.878 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 111' ' ' PRO . 3.2 t -46.73 -35.26 4.84 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.38 -32.63 96.6 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 CA-C-N 123.155 2.163 . . . . 0.0 111.935 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 112' ' ' ILE . 24.0 pt -98.75 6.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -78.28 138.79 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.305 0.502 . . . . 0.0 110.74 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -83.93 138.11 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.162 0.506 . . . . 0.0 111.718 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -98.23 139.98 33.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.13 144.54 16.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -57.17 -40.0 76.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.8 169.45 19.14 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.18 -119.95 20.66 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.67 -119.95 1.71 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.58 150.6 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.272 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 117' ' ' ALA . 55.6 mt -75.61 126.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.192 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m -60.34 138.47 57.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.993 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -95.24 7.33 46.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.27 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -43.11 36.88 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.755 -0.591 . . . . 0.0 112.63 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.62 80.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.061 0.43 . . . . 0.0 110.781 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.4 tp -59.86 -42.51 93.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.23 -43.17 96.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.475 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 t -59.24 -43.95 92.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.547 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.0 m -59.93 -47.58 85.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.576 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.608 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.3 m -62.67 -40.95 98.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.04 -38.35 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.628 0.252 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.47 -43.7 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 110.2 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.88 -39.28 93.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.902 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.9 m -60.05 -25.16 65.13 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.841 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.35 44.62 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.842 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.68 145.37 24.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.722 0.761 . . . . 0.0 110.598 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.732 0 CA-C-O 118.035 -1.425 . . . . 0.0 110.987 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.28 139.68 50.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.465 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -119.99 141.52 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -115.23 138.84 50.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.509 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -123.85 145.8 48.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.54 140.0 48.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.4 m -61.27 153.88 25.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t -123.31 145.2 48.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.25 -176.99 51.64 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.67 139.6 30.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.601 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.47 155.07 93.1 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.601 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.92 119.93 6.78 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.37 1.38 . . . . 0.0 111.939 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -150.0 166.01 30.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -175.46 50.49 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -113.94 143.34 44.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.553 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.85 -175.54 37.72 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtt -110.59 144.39 39.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.388 . . . . 0.0 110.528 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -116.81 148.8 40.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.497 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -56.98 146.05 28.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.9 p -122.03 162.12 21.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.514 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.71 49.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 148.23 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.621 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.66 145.7 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.532 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.24 151.79 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.9 134.81 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.416 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -106.85 156.83 18.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.592 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -147.32 162.61 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.43 151.53 27.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.634 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -129.62 159.76 35.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.395 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.5 mtp -99.25 141.04 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.636 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -87.37 172.26 9.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -65.17 153.22 89.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.528 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.2 155.9 14.71 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.544 1.496 . . . . 0.0 112.328 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -68.05 149.01 50.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.572 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.35 144.29 28.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.456 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.08 -140.0 2.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -72.44 169.56 16.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.317 . . . . 0.0 110.436 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -55.23 145.37 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -150.1 167.5 26.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.473 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.16 153.39 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.57 122.77 21.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.691 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -128.64 144.07 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.339 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 p -71.47 162.38 29.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.332 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.33 178.73 53.76 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.48 -171.91 47.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.26 -156.37 6.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -55.47 148.86 14.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.73 145.28 29.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.2 157.54 89.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.686 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.49 -169.97 0.74 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.396 1.397 . . . . 0.0 112.216 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -172.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -56.08 169.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.776 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -116.78 147.17 42.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.793 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -70.95 163.91 60.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 68' ' ' ALA . 75.0 Cg_exo -48.23 162.11 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.416 1.411 . . . . 0.0 112.131 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.27 142.42 28.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.391 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.23 160.8 3.04 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.15 1.233 . . . . 0.0 111.41 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.98 154.25 82.3 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.717 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.96 151.62 67.99 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.246 1.297 . . . . 0.0 111.425 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -55.83 135.65 72.6 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -80.21 119.96 3.99 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.289 1.326 . . . . 0.0 113.311 -170.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -82.89 158.02 22.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -56.79 125.46 22.49 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.856 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 63.55 14.96 8.48 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -152.08 151.21 30.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.65 0.659 . . . . 0.0 112.205 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -152.1 151.45 31.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.505 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.0 m-20 -93.37 127.33 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.688 HD11 HD11 ' A' ' 67' ' ' LEU . 5.2 tp -127.73 145.46 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.509 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -150.48 160.89 43.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.734 0.778 . . . . 0.0 112.387 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -55.54 -34.94 65.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.12 89.99 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.031 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.16 -46.67 60.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.063 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -72.45 -26.78 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . 69.79 -145.39 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -55.56 -23.27 25.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.486 1.039 . . . . 0.0 112.285 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.0 -23.57 63.76 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.497 ' HE3' HD22 ' A' ' 67' ' ' LEU . 44.5 t-105 -55.86 111.13 2.8 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.37 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -89.53 -13.18 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.845 1.697 . . . . 0.0 114.056 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.06 145.36 25.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 111.964 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.5 p -70.03 -37.29 75.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.535 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.65 129.59 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.84 -33.97 75.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.042 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -148.42 175.03 11.46 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.601 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.79 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.505 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.9 m -108.15 138.68 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 pt -106.81 134.37 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.32 145.18 30.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.417 0.627 . . . . 0.0 111.994 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.6 m -102.47 118.55 37.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.006 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt -81.92 156.37 69.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.267 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.9 -16.78 12.42 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.398 1.399 . . . . 0.0 113.016 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -79.93 3.08 21.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 63.88 47.4 3.52 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -131.4 136.33 47.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.463 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.25 120.43 35.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.624 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 104' ' ' ALA . 35.3 m -132.22 156.35 42.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.464 0.649 . . . . 0.0 111.814 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.509 ' CD1' HD21 ' A' ' 130' ' ' LEU . 85.3 t80 -114.04 128.0 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.795 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.51 131.77 56.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.16 155.4 36.46 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.834 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.73 -27.1 10.46 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.62 1.546 . . . . 0.0 113.092 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 28.5 p30 -64.49 -11.69 36.43 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.55 66.63 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.936 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -99.42 140.29 33.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.7 m -103.75 129.23 51.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 110.093 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -114.79 151.88 33.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.04 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.3 124.93 33.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 110.43 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.2 -47.42 14.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.152 0.501 . . . . 0.0 109.809 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -115.36 167.62 10.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -53.84 -33.81 57.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.716 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -61.18 -49.01 78.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.323 0.582 . . . . 0.0 110.637 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.86 -37.39 76.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.09 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -61.42 -42.16 98.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.014 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -57.74 -33.96 69.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.8 9.18 3.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.5 63.6 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 122.177 -0.327 . . . . 0.0 113.358 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -97.01 112.08 59.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.366 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -54.78 150.4 36.85 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.472 1.204 . . . . 0.0 111.592 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.45 158.88 55.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.266 1.311 . . . . 0.0 112.391 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 115' ' ' ILE . 76.6 mt -61.59 -10.81 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.421 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.6 t -44.21 -38.92 5.64 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -172.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.421 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.2 Cg_exo -58.92 -33.59 98.74 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.612 1.968 . . . . 0.0 112.21 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 112' ' ' ILE . 17.9 pt -98.81 6.75 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -77.45 141.59 39.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.497 0.589 . . . . 0.0 110.796 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.508 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -77.67 146.49 36.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.416 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -86.82 155.12 20.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.967 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.97 -167.6 36.09 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.894 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 m -57.7 -48.86 78.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.09 114.94 0.63 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.271 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.43 34.13 88.41 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.084 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.39 154.85 26.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.18 142.87 39.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 117' ' ' ALA . 65.5 mt -78.62 128.43 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.156 0.503 . . . . 0.0 110.116 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -62.79 138.79 58.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.168 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -96.2 11.18 35.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.953 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -44.59 31.1 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.825 -0.547 . . . . 0.0 112.851 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.58 77.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.313 0.557 . . . . 0.0 110.797 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 90' ' ' PHE . 33.6 tp -59.15 -42.05 89.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -60.38 -43.69 96.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.656 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.9 p -60.61 -42.56 97.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.721 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.09 -47.18 87.52 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.642 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.1 m -63.09 -40.54 97.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.08 -39.46 86.15 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.799 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -58.76 -42.88 89.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.297 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.96 -39.28 91.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.055 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.6 m -59.93 -25.29 65.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.013 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.83 60.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.622 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.95 133.59 36.88 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.451 0.626 . . . . 0.0 110.551 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.808 0 CA-C-O 118.045 -1.419 . . . . 0.0 110.988 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.83 135.21 52.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.491 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -129.14 148.92 51.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -111.93 140.72 46.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.527 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -112.61 139.81 47.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -120.96 132.75 55.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.506 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 m -63.44 156.07 27.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.9 p -68.69 162.55 25.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.556 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.35 -177.86 51.94 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -100.14 131.15 46.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.445 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.1 163.69 36.28 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.5 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.01 158.97 27.36 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.366 1.378 . . . . 0.0 111.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.58 146.84 47.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.542 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 -177.48 40.41 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 143.12 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.13 -176.59 50.76 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.5 mtp -108.35 144.15 36.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 110.52 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -79.4 135.06 36.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -57.7 144.72 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -134.38 158.8 42.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 148.71 42.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.624 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.17 147.47 30.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.4 146.76 25.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -86.88 155.49 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.431 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -95.01 131.5 40.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -63.66 145.26 56.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -140.18 165.04 28.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.993 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -109.45 146.2 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.401 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.54 133.35 35.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.403 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.8 149.6 47.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -57.17 154.79 19.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.46 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.96 129.53 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.299 1.333 . . . . 0.0 111.993 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -67.2 149.51 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.773 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.87 148.45 27.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.14 -177.93 51.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -123.08 167.78 13.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 110.474 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -66.31 179.93 0.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -71.44 170.17 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -82.62 174.65 10.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -73.95 -174.1 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.832 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.84 151.86 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -71.19 136.2 47.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.74 -150.05 9.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.82 -173.65 47.48 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.86 179.36 53.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -126.5 157.16 39.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 110.432 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.75 149.63 21.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.246 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.56 134.48 82.22 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.278 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.7 -169.97 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.821 1.681 . . . . 0.0 112.274 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.4 -173.97 2.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.262 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -107.5 139.41 42.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.499 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -103.5 142.79 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.635 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 p -70.43 154.11 94.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.09 139.8 33.81 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.379 1.386 . . . . 0.0 112.094 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.29 143.01 28.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.316 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.2 158.83 4.76 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.14 1.227 . . . . 0.0 111.294 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 mt -64.0 149.85 92.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.531 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -63.63 146.16 92.22 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.171 1.247 . . . . 0.0 111.135 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.7 p -55.94 137.6 72.49 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.111 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.2 119.94 3.99 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.172 1.248 . . . . 0.0 113.385 -170.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.8 p -81.59 158.73 24.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 167.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -56.87 125.44 22.51 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.967 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 m120 63.64 14.07 7.84 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -151.72 150.77 30.58 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.59 0.632 . . . . 0.0 112.208 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -149.61 151.1 33.23 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.866 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.532 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.1 m-20 -93.76 126.99 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 67' ' ' LEU . 7.3 tp -128.25 145.95 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.144 -0.223 . . . . 0.0 110.597 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.39 161.23 42.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.695 0.76 . . . . 0.0 112.502 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -55.99 -34.82 66.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.535 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.54 86.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.07 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.33 -46.64 54.69 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.012 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -72.71 -26.19 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.56 -146.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -54.1 -28.1 37.2 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.412 1.006 . . . . 0.0 111.952 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.2 tp -53.97 -26.54 26.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.5 ' HE3' HD22 ' A' ' 67' ' ' LEU . 52.1 t-105 -55.69 111.09 2.72 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.318 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HB3' HG22 ' A' ' 125' ' ' ILE . 68.0 Cg_endo -89.69 -13.1 2.81 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.771 1.647 . . . . 0.0 114.197 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.82 145.36 25.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.204 0.526 . . . . 0.0 111.84 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.8 p -69.22 -37.12 77.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.62 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.36 129.23 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.66 -34.04 75.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.8 174.84 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.471 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.03 34.29 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.532 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.4 m -108.09 137.81 45.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 pt -106.82 133.15 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -146.81 147.17 30.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.469 0.652 . . . . 0.0 111.93 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.2 m -102.48 120.49 40.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.742 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.499 HD11 HG21 ' A' ' 89' ' ' VAL . 60.6 mt -87.67 156.97 52.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.353 -173.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.73 -16.27 5.48 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.511 1.474 . . . . 0.0 113.183 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.6 m -77.54 3.0 14.67 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 62.99 43.62 6.51 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -135.13 145.79 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.618 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.55 42.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 110.774 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 83' ' ' LEU . 35.2 m -133.66 158.62 42.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.57 0.7 . . . . 0.0 111.938 -176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.522 ' CD1' HD21 ' A' ' 130' ' ' LEU . 86.3 t80 -114.09 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.767 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.55 131.45 57.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.14 155.21 36.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.823 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.69 -27.05 10.25 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.599 1.533 . . . . 0.0 113.103 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.1 p30 -64.11 -12.17 36.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.19 10.05 66.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.889 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 m -99.4 139.9 34.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.24 129.53 50.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.302 0.572 . . . . 0.0 110.124 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -114.58 149.41 36.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.038 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.32 126.17 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.821 0.343 . . . . 0.0 110.439 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' A' ' 131' ' ' LEU . 19.5 mt -83.71 -51.75 6.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.442 ' HB3' HD11 ' A' ' 131' ' ' LEU . 51.0 p30 -111.93 167.63 10.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.7 0.762 . . . . 0.0 111.924 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.92 -34.22 54.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -60.77 -47.07 88.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.325 0.584 . . . . 0.0 110.459 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.602 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.406 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.607 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.1 mm-40 -62.25 -41.25 98.27 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.236 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -59.49 -34.0 72.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.259 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.34 -2.88 12.0 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.53 63.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 122.128 -0.358 . . . . 0.0 113.166 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -88.93 143.2 31.08 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 117.454 0.627 . . . . 0.0 109.566 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.42 148.11 37.64 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.203 1.269 . . . . 0.0 111.324 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -76.09 158.78 37.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.368 1.378 . . . . 0.0 112.684 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 115' ' ' ILE . 82.8 mt -60.77 -12.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 119.013 -0.518 . . . . 0.0 112.28 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.435 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.8 t -43.76 -39.64 5.88 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 113' ' ' THR . 25.1 Cg_exo -59.44 -31.91 95.56 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 CA-C-N 122.35 1.875 . . . . 0.0 112.432 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 112' ' ' ILE . 20.0 pt -98.84 6.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -77.57 137.54 38.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.54 0.609 . . . . 0.0 110.453 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.95 142.88 31.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.58 140.0 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.846 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.35 150.34 18.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -57.5 -41.15 80.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.35 171.83 23.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.26 -120.05 20.09 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.95 -119.89 1.55 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.66 150.5 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 72' ' ' PRO . 83.9 mt -79.58 129.16 37.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.468 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.0 m -65.03 140.88 58.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.055 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.43 8.63 39.82 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.14 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.1 -43.67 32.56 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.897 -0.502 . . . . 0.0 112.745 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.45 -49.48 77.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.161 0.48 . . . . 0.0 110.84 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 90' ' ' PHE . 29.9 tp -58.82 -42.0 88.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.476 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 101' ' ' ASN . 24.0 tp -59.82 -44.22 94.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.484 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -59.96 -43.9 94.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.666 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.1 m -60.5 -46.75 88.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.449 . . . . 0.0 110.58 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.5 m -63.14 -41.35 99.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.01 -39.4 85.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.746 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.33 -42.39 91.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.56 -39.69 94.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -63.12 -25.18 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.144 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.86 22.95 40.41 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.636 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.65 144.92 25.67 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.43 0.615 . . . . 0.0 110.503 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.998 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -117.69 139.47 50.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.52 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -120.99 142.79 49.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.12 138.72 50.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.424 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -122.15 144.41 48.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.491 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.79 139.49 49.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.415 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.2 p -134.99 160.03 39.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.621 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.9 p -67.93 163.77 21.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.79 -176.92 51.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.78 142.94 26.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.81 154.69 85.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.66 133.83 41.3 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.8 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -123.08 152.46 41.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.439 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.82 -176.67 51.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p -69.17 159.91 32.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.597 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.82 -175.09 45.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.4 135.78 40.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -134.18 134.76 42.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.603 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.51 144.16 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -122.16 160.15 25.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.12 157.12 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.62 141.61 56.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.03 158.41 44.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.561 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -66.66 139.81 57.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -102.2 133.91 46.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.726 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -102.38 146.09 28.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.392 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -54.42 147.45 13.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.258 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -68.11 147.91 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -119.6 145.41 46.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.9 mtp -117.62 166.14 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -61.32 145.03 52.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.8 p -62.15 152.45 78.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -86.47 -174.97 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.679 1.586 . . . . 0.0 112.297 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.59 123.83 27.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.5 mt -81.77 144.11 31.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.553 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.78 -139.95 2.77 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.7 t -59.0 167.04 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -61.55 144.04 55.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.39 -179.96 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.737 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -63.03 150.8 41.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.655 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -59.06 151.04 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.85 136.96 58.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.559 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 p -82.63 166.8 18.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.641 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.5 -167.3 28.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.36 -177.0 36.72 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.09 -177.51 51.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 168.69 23.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.3 . . . . 0.0 110.713 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 144.68 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.639 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 156.74 64.83 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.23 173.98 7.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.233 1.289 . . . . 0.0 111.944 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 142.7 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.686 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.38 164.82 26.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.447 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -147.01 157.02 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.9 m -80.98 153.15 72.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.339 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.33 162.19 10.27 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.204 1.269 . . . . 0.0 111.63 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.35 141.0 27.13 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.42 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.32 153.48 13.15 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.102 1.201 . . . . 0.0 111.336 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.11 153.77 84.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.325 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.63 145.85 53.26 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.157 1.238 . . . . 0.0 111.133 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.5 m -55.89 139.38 70.41 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.146 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.07 119.81 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.109 1.206 . . . . 0.0 113.1 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.9 p -84.04 159.69 21.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 p -55.54 125.59 21.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.026 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 63.43 14.12 7.69 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.265 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -157.08 144.18 18.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -139.01 152.81 47.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.656 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -93.87 126.21 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.681 HD11 HD11 ' A' ' 67' ' ' LEU . 6.4 tp -124.91 144.85 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.9 p -150.38 160.82 43.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.673 0.749 . . . . 0.0 112.447 -173.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -55.64 -34.68 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.567 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.64 -42.17 87.69 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.104 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -73.64 -46.61 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.375 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.681 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -71.36 -27.78 63.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.4 -142.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -54.11 -28.88 42.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.683 1.129 . . . . 0.0 111.883 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 70' ' ' LEU . 7.4 mp -56.98 -24.77 55.78 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.48 ' HE3' HD22 ' A' ' 67' ' ' LEU . 48.0 t-105 -55.91 107.49 0.9 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.368 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HB3' HG22 ' A' ' 125' ' ' ILE . 67.6 Cg_endo -87.2 -13.24 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.703 1.602 . . . . 0.0 114.136 -175.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.0 mt -89.59 145.56 25.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.559 . . . . 0.0 111.94 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.3 p -69.85 -37.28 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.719 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.15 130.13 30.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.02 -33.4 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.043 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -147.01 174.55 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.667 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.72 162.09 34.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -107.92 140.58 40.83 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.539 -0.389 . . . . 0.0 110.112 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.96 135.36 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.36 143.57 31.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.295 0.569 . . . . 0.0 112.151 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.7 m -108.59 121.8 45.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -83.28 158.97 63.0 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.955 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.35 -18.46 18.98 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.386 1.391 . . . . 0.0 113.099 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.8 m -80.32 3.07 22.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 63.9 41.48 6.64 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 0.0 110.545 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -116.4 128.46 55.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.259 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.583 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.03 123.74 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.387 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.489 HG12 ' HB1' ' A' ' 104' ' ' ALA . 31.8 m -131.86 155.23 41.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 111.225 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.51 ' CD1' HD21 ' A' ' 130' ' ' LEU . 90.0 t80 -114.1 128.04 56.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.031 178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.97 131.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.52 155.32 36.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.75 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.42 -26.54 8.83 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.565 1.51 . . . . 0.0 113.111 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.1 p30 -64.43 -12.17 40.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.36 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.92 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.9 m -99.41 140.01 34.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.6 m -104.73 130.92 52.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 110.095 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -116.32 148.41 40.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.0 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 124.94 33.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.767 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 mt -82.18 -48.5 11.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 0.0 109.982 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.5 p30 -108.39 167.63 9.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.47 0.653 . . . . 0.0 111.606 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -55.03 -40.99 70.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.979 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -63.42 -42.47 98.72 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.37 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.649 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.3 -39.27 78.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.077 0.465 . . . . 0.0 110.616 176.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -62.32 -41.7 98.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.944 0.402 . . . . 0.0 110.213 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -57.69 -33.07 67.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.495 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.79 9.92 3.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.47 63.67 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.359 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -94.64 112.03 56.33 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.097 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.39 153.41 40.97 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.183 1.255 . . . . 0.0 111.569 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.35 158.84 56.0 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.263 1.309 . . . . 0.0 112.283 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 115' ' ' ILE . 74.7 mt -62.75 -9.92 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.413 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.8 t -44.43 -38.69 5.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -172.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.6 Cg_exo -58.93 -33.14 98.55 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 CA-C-N 122.474 1.919 . . . . 0.0 112.329 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 112' ' ' ILE . 15.8 pt -98.91 6.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -77.53 140.84 39.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.479 0.581 . . . . 0.0 110.522 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.09 141.89 29.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -97.86 139.88 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.777 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.09 169.68 20.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 86.3 p -60.83 -35.13 75.73 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.087 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.17 164.24 26.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.61 27.51 63.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.05 -122.05 27.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -104.29 156.71 17.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.023 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 72' ' ' PRO . 88.9 mt -78.74 133.12 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.53 -175.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -65.08 140.89 58.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.89 9.55 38.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.13 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -45.86 32.97 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.841 -0.537 . . . . 0.0 112.838 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.79 87.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.237 0.518 . . . . 0.0 110.822 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 90' ' ' PHE . 39.7 tp -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.492 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.465 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -58.65 -43.13 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.662 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.91 -47.74 85.03 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.584 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.583 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 25.4 m -62.62 -40.11 95.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.856 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.97 -39.93 87.33 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.788 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.82 -43.64 90.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.292 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.58 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.334 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.92 -25.23 64.98 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.95 23.01 62.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.709 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.43 142.81 47.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.497 0.648 . . . . 0.0 110.988 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.801 0 CA-C-O 118.107 -1.385 . . . . 0.0 110.975 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.43 140.0 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.452 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.42 139.04 51.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.453 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -121.03 141.7 50.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.51 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -123.31 133.78 54.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.487 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -125.52 136.37 53.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.45 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m -119.72 147.55 44.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -121.87 144.36 48.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.58 -177.74 33.95 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.3 tp -100.78 131.7 46.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 0.0 110.529 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.53 159.72 40.89 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.52 151.7 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.492 1.461 . . . . 0.0 112.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -150.02 163.04 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.635 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.97 -177.43 51.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 m -62.99 154.5 30.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 110.561 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.8 43.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.9 153.44 35.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 110.402 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -93.44 142.5 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.697 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.84 156.64 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.371 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -78.29 159.57 28.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.02 156.98 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 146.0 27.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.479 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.34 144.81 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.632 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -122.87 148.09 45.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.343 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -106.12 133.89 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.465 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -110.94 152.35 26.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -79.63 147.53 32.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -138.11 165.1 27.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.148 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.82 141.74 40.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.434 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.5 mtm -94.4 144.2 25.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.559 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -147.7 173.66 12.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 m -62.72 152.93 80.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.54 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.25 156.55 14.73 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.536 1.49 . . . . 0.0 112.246 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.12 145.62 54.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -88.51 144.62 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.469 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.24 146.35 43.38 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 t -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.745 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -69.38 -178.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -65.35 127.62 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.657 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -150.01 -179.66 7.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.806 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.06 150.81 32.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.47 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -71.6 145.41 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.552 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -122.55 166.09 15.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.88 -169.94 39.8 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.31 -176.34 44.36 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.92 -168.7 19.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.0 146.22 27.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.15 146.56 50.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.92 153.8 83.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.522 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.85 166.91 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.343 1.362 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.07 55.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -125.95 146.92 49.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.65 147.06 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -104.72 99.94 20.98 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.427 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.22 162.1 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.427 1.418 . . . . 0.0 112.125 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.57 142.5 31.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.311 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.32 155.29 9.69 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.025 1.15 . . . . 0.0 111.257 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 mt -64.04 150.36 92.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.292 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 146.23 96.49 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.125 1.217 . . . . 0.0 111.158 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 p -55.94 138.87 71.48 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.08 119.83 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.195 1.263 . . . . 0.0 113.212 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.8 p -87.01 158.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 167.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -57.22 125.54 23.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.85 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.7 m120 63.56 15.05 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -150.03 148.27 28.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.585 0.63 . . . . 0.0 112.28 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -151.18 152.57 33.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.533 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.2 m-20 -95.91 128.57 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 5.3 tp -128.0 145.0 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -150.12 161.63 42.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.706 0.765 . . . . 0.0 112.466 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.69 -34.42 65.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.547 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.39 90.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.104 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -69.89 -46.76 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.953 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 7.9 mp -72.91 -25.67 61.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.9 -147.61 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -55.92 -21.16 19.02 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.34 0.973 . . . . 0.0 112.292 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.87 -23.43 63.43 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.495 ' HE3' HD22 ' A' ' 67' ' ' LEU . 47.6 t-105 -55.75 113.08 5.06 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.3 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 125' ' ' ILE . 63.6 Cg_endo -89.67 -13.25 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.752 1.635 . . . . 0.0 114.306 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -94.15 147.31 23.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.173 0.511 . . . . 0.0 111.915 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.0 p -69.58 -36.4 76.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.728 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.69 128.22 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.88 -33.93 75.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -148.61 174.94 11.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.557 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 162.07 34.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.2 m -108.58 140.47 41.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.611 -0.346 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 pt -108.47 136.77 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.35 143.56 31.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.391 0.615 . . . . 0.0 111.941 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 m -110.19 122.61 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.744 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.0 mt -83.02 157.78 65.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.34 -22.29 15.56 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.433 1.422 . . . . 0.0 113.012 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -79.37 3.02 19.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 63.82 39.98 7.93 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.254 0.55 . . . . 0.0 110.811 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -110.53 128.01 55.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.76 122.56 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.508 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.54 154.64 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.498 0.666 . . . . 0.0 111.491 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.7 t80 -114.04 127.91 56.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.801 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.31 131.86 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.48 155.17 36.68 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.821 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.7 -26.87 10.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.629 1.553 . . . . 0.0 113.018 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 29.8 p30 -64.22 -12.16 38.13 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.72 10.37 67.31 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 121.491 -0.385 . . . . 0.0 112.832 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 m -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.6 m -101.52 130.43 47.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.261 0.553 . . . . 0.0 109.943 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.65 147.23 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.813 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.31 124.99 33.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 110.794 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.93 -48.27 11.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -112.55 167.58 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.614 0.721 . . . . 0.0 112.004 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -53.79 -40.76 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.151 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -63.36 -41.11 98.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.252 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.47 -38.61 77.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.695 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.16 -40.71 98.33 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.412 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -58.01 -33.88 69.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.314 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.89 7.53 4.7 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.48 63.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.227 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -94.49 111.99 55.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.361 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.72 151.51 31.75 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.189 1.259 . . . . 0.0 111.358 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.1 158.98 45.04 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.476 1.451 . . . . 0.0 112.705 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.512 HG23 HD11 ' A' ' 115' ' ' ILE . 80.1 mt -59.64 -12.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.344 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.1 t -43.36 -40.71 6.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -171.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.9 Cg_exo -58.05 -30.04 88.9 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 122.507 1.931 . . . . 0.0 112.703 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.512 HD11 HG23 ' A' ' 112' ' ' ILE . 13.8 pt -98.9 7.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -68.58 149.18 49.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.742 0.701 . . . . 0.0 110.801 -176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.53 143.15 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 111.626 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -96.74 139.96 32.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.696 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.8 155.39 17.75 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.2 p -58.87 -34.58 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.022 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.11 158.09 24.13 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.23 25.74 61.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.437 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.02 18.68 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 117.359 0.58 . . . . 0.0 111.68 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.47 156.33 18.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 0.0 110.685 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 72' ' ' PRO . 74.6 mt -86.13 132.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.046 0.45 . . . . 0.0 110.254 -176.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -69.27 141.46 54.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.997 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.4 mt -91.87 5.83 48.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.318 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.89 -43.74 39.82 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.792 -0.567 . . . . 0.0 112.543 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.94 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 110.78 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.0 tp -59.62 -42.77 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.18 -42.89 95.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.435 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 m -59.54 -43.69 93.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.687 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.4 m -61.37 -47.82 84.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.605 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.6 m -63.56 -39.62 94.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.939 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.19 -38.74 87.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.936 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.36 -43.2 88.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.894 0.378 . . . . 0.0 110.222 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.76 -39.68 94.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.893 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.2 m -60.07 -25.2 65.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 22.95 54.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.631 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -84.05 133.75 34.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.465 0.633 . . . . 0.0 110.641 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 117.937 -1.48 . . . . 0.0 111.021 179.855 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -120.74 142.65 49.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.526 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.76 137.84 51.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.399 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -120.29 140.46 51.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -120.38 141.02 50.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.435 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -122.9 132.91 54.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t -121.4 142.68 49.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m -63.45 155.73 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.76 -176.17 38.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 tp -100.09 128.54 46.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.04 163.81 45.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.567 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.92 159.59 24.82 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.343 1.362 . . . . 0.0 111.803 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.55 141.88 58.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.658 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.61 -174.87 47.32 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.5 p -131.34 156.28 45.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.733 0.301 . . . . 0.0 110.485 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.49 179.23 50.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.2 mtp -133.52 159.22 41.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.514 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.78 140.61 48.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.91 151.38 36.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.761 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -124.65 141.38 52.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.195 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.16 107.73 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.629 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.07 157.13 42.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.457 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.8 105.0 11.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.294 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -137.14 144.09 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -121.45 154.64 36.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.035 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -142.52 169.07 18.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -148.23 164.11 34.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.428 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.13 141.08 40.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.742 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -131.94 156.86 45.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.394 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.0 mtt -102.1 141.58 34.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -88.51 118.28 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -137.85 160.13 65.93 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.11 -174.94 2.02 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.509 1.473 . . . . 0.0 112.115 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.63 128.39 34.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.567 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.9 tp -100.48 130.22 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.626 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.1 -173.93 50.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 m -72.05 135.94 46.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.719 0.295 . . . . 0.0 110.464 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.44 157.41 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.738 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.0 150.16 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.98 145.75 45.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.477 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -72.55 172.17 11.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.915 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -135.16 171.47 14.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.97 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 m -71.22 140.16 50.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.419 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.49 -177.32 50.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.27 -140.02 3.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.62 -174.35 49.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -57.96 148.78 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.719 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 151.8 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.553 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.96 159.06 6.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.758 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.91 -179.0 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.298 1.332 . . . . 0.0 111.998 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.61 158.77 43.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.74 140.83 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.434 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -64.7 141.26 58.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.576 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -127.55 162.41 49.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HG3' ' HB2' ' A' ' 68' ' ' ALA . 50.3 Cg_exo -50.67 128.16 23.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.24 1.293 . . . . 0.0 111.642 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.41 139.45 26.77 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.573 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -52.24 155.5 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.053 1.169 . . . . 0.0 111.262 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.01 152.73 86.82 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.24 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.56 154.6 71.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.111 1.207 . . . . 0.0 111.122 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.6 m -55.96 130.76 73.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.231 -0.414 . . . . 0.0 109.974 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.07 119.87 4.02 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.111 1.207 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -83.99 159.0 21.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.9 m -55.07 125.51 20.79 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.025 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.2 p30 63.35 16.46 9.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.224 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE3' HG21 ' A' ' 79' ' ' THR . 49.2 tttp -154.99 141.56 18.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.293 0.497 . . . . 0.0 112.254 -175.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -145.61 153.15 40.74 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.056 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' HG23 ' A' ' 79' ' ' THR . 78.8 m-20 -95.02 128.25 41.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 67' ' ' LEU . 4.7 tp -126.57 141.49 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.0 p -144.23 164.66 30.08 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.595 0.712 . . . . 0.0 111.865 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -55.69 -36.15 66.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.322 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.04 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.765 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -70.63 -46.58 63.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.936 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.649 HD12 ' CE3' ' A' ' 71' ' ' TRP . 46.0 mt -85.03 -9.45 58.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.485 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . 65.7 -151.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -56.03 -20.08 15.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.914 0.779 . . . . 0.0 112.366 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -57.54 -25.79 60.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.649 ' CE3' HD12 ' A' ' 67' ' ' LEU . 53.1 t-105 -55.79 107.18 0.81 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.27 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.21 -13.17 4.51 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.832 1.688 . . . . 0.0 114.068 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -88.21 145.69 25.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.36 0.6 . . . . 0.0 112.062 -174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.3 p -69.83 -36.89 75.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.72 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.22 129.01 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.67 -32.43 72.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -146.78 174.35 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.652 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.6 m -107.81 140.32 41.07 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.625 -0.338 . . . . 0.0 110.1 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 pt -109.34 137.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -148.04 146.45 28.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.384 0.611 . . . . 0.0 112.067 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.8 m -109.47 125.58 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.722 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.93 160.41 55.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.058 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.15 -20.93 8.44 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.453 1.436 . . . . 0.0 113.177 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -80.08 3.07 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 62.87 40.12 9.95 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.143 0.497 . . . . 0.0 110.692 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -112.61 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -94.97 121.97 37.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.322 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.52 156.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.328 0.585 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.3 t80 -114.08 128.35 56.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.18 130.76 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.32 155.32 36.53 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.762 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.49 -26.8 9.35 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.495 1.463 . . . . 0.0 113.064 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.8 p30 -63.88 -12.71 39.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.84 9.68 65.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 122.071 -0.393 . . . . 0.0 112.91 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m -99.43 139.72 34.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -104.47 131.62 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 0.0 110.09 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.81 149.31 41.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.18 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.663 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.36 128.22 35.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.704 0.288 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.87 -52.66 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.478 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -103.12 167.61 9.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.598 0.714 . . . . 0.0 112.117 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.86 -40.46 69.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.148 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -63.88 -42.03 97.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.301 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.17 -37.11 79.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.663 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.0 mm-40 -63.12 -41.02 99.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.288 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.13 -33.94 71.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.638 0.256 . . . . 0.0 111.317 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.66 -1.7 12.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.44 63.72 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.907 -0.385 . . . . 0.0 113.16 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 44.2 m-70 -83.2 135.86 44.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.207 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.07 147.85 94.32 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.053 1.168 . . . . 0.0 111.27 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.07 158.87 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.445 1.43 . . . . 0.0 112.481 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 115' ' ' ILE . 86.9 mt -62.31 -10.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.438 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.2 t -43.64 -40.03 6.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.0 Cg_exo -59.14 -32.19 96.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.293 1.855 . . . . 0.0 112.605 -174.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 112' ' ' ILE . 14.9 pt -98.96 7.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 149.81 42.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.718 0.69 . . . . 0.0 110.882 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.647 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -85.19 138.43 32.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.22 139.87 32.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.01 16.15 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.0 p -61.75 -34.77 76.43 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.194 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.46 135.89 11.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.31 -36.67 3.56 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.03 -59.96 0.35 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 141.06 42.36 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.8 -0.235 . . . . 0.0 110.785 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.647 HD12 ' HB3' ' A' ' 117' ' ' ALA . 88.6 mt -81.3 133.86 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.043 0.449 . . . . 0.0 109.798 175.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -59.79 137.09 58.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.275 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.5 mt -99.16 6.81 46.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.304 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.65 -43.55 37.42 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.822 -0.549 . . . . 0.0 112.771 -173.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.93 75.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.248 0.524 . . . . 0.0 110.814 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.55 -42.15 91.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.7 tp -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.494 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.55 -43.31 93.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.595 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.6 m -60.99 -48.0 83.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.594 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.609 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 25.1 m -63.11 -40.48 97.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.805 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.09 -38.96 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.958 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -58.51 -43.76 89.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.368 . . . . 0.0 110.2 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.01 -39.55 95.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.988 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.94 -25.33 65.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.032 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.6 22.97 61.09 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.554 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -75.8 134.53 40.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.454 0.627 . . . . 0.0 110.525 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.886 -1.508 . . . . 0.0 111.036 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.97 139.99 50.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -124.57 135.56 53.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -128.69 148.42 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.346 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -110.4 138.92 46.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.628 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -118.48 143.09 46.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.365 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m -117.56 147.3 42.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.562 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.7 p -140.92 162.53 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.61 -177.98 52.17 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.6 mp -94.93 141.49 28.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.557 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.64 163.65 43.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.465 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.97 175.76 0.89 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.327 1.351 . . . . 0.0 111.969 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -61.52 147.63 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.374 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.63 -176.78 28.17 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -117.76 144.08 45.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 0.0 110.463 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.02 -175.51 35.82 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 44.4 ttm -98.36 135.67 39.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.34 . . . . 0.0 110.599 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -89.87 146.48 24.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -99.14 139.35 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.536 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -122.85 163.26 20.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.7 147.29 42.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.25 146.58 38.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.566 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 147.36 38.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.554 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -66.73 147.84 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.068 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.69 164.59 27.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.484 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -95.36 149.69 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.617 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -127.09 140.99 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -108.05 147.72 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.494 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.97 147.58 49.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -117.69 151.72 36.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.463 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.56 143.59 56.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.0 m -113.09 159.98 32.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.99 -178.82 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.349 1.366 . . . . 0.0 111.973 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -67.28 147.12 53.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 29' ' ' LEU . 8.7 tt -94.5 127.75 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.29 -175.19 38.36 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 m -79.34 137.22 37.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.786 0.326 . . . . 0.0 110.609 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.69 144.42 55.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.543 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -147.83 170.43 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.82 144.57 56.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.628 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -65.91 144.85 56.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.619 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -133.31 167.23 20.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -79.05 163.2 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.483 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.9 144.75 48.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 -173.91 37.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.98 -178.49 51.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.45 142.64 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 110.405 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.33 144.77 45.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.241 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.44 148.83 97.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.247 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.95 -171.0 0.45 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.779 1.653 . . . . 0.0 112.077 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.96 145.36 55.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.145 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -115.8 120.34 38.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.667 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -131.46 146.99 52.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.228 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 m -64.92 151.29 93.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.078 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.83 128.13 23.42 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.084 1.189 . . . . 0.0 111.704 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.38 139.62 26.85 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.51 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.33 140.74 52.13 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.061 1.174 . . . . 0.0 111.25 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.12 153.67 84.61 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 143.26 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.048 1.166 . . . . 0.0 110.85 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -55.82 144.65 55.91 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.197 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.68 119.78 6.46 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 120.864 1.043 . . . . 0.0 112.825 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -98.34 156.86 16.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -56.31 125.5 22.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.192 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.7 m120 63.63 10.93 5.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -149.09 148.06 29.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.834 0.743 . . . . 0.0 112.845 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -150.6 147.51 27.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.79 167.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 79' ' ' THR . 72.7 m-20 -98.96 126.35 44.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.765 HD11 HD11 ' A' ' 67' ' ' LEU . 8.3 tt -132.04 152.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.276 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.8 p -150.44 166.41 30.19 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.683 0.754 . . . . 0.0 111.82 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -55.61 -34.6 65.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.238 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.68 88.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.743 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -66.23 -46.49 76.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.368 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.765 HD11 HD11 ' A' ' 62' ' ' ILE . 10.5 mp -84.73 -14.74 47.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.47 -148.99 0.28 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.26 -20.85 20.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.105 0.866 . . . . 0.0 112.343 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.47 -23.28 57.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.562 ' CE3' HD22 ' A' ' 67' ' ' LEU . 37.3 t-105 -55.83 113.46 5.75 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.427 -176.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -89.61 -13.2 2.82 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.786 1.658 . . . . 0.0 114.086 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.07 144.9 24.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.243 0.544 . . . . 0.0 111.875 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.1 p -68.65 -37.15 79.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.627 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.32 130.36 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -63.9 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -168.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -152.98 177.26 10.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.662 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.08 34.33 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.549 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.5 m -108.17 141.49 39.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 pt -108.95 136.77 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -139.78 140.31 36.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.444 0.64 . . . . 0.0 111.949 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.7 m -108.48 118.51 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.108 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.6 157.63 52.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.402 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -49.32 -20.74 3.94 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.344 1.363 . . . . 0.0 113.0 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -75.93 3.39 10.27 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 p30 54.04 34.59 20.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.009 0.923 . . . . 0.0 111.773 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -109.12 133.28 53.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.552 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -97.07 123.94 40.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.093 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 159.0 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.459 0.647 . . . . 0.0 111.402 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 130' ' ' LEU . 91.0 t80 -114.09 126.54 55.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.78 129.68 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.479 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.89 155.79 36.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.676 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.85 -26.84 10.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.541 1.494 . . . . 0.0 113.109 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.5 p30 -63.88 -12.86 40.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.83 66.43 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.886 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -99.34 139.74 34.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -104.84 129.07 53.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.013 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -114.07 149.64 35.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.008 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.654 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.45 128.98 35.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.723 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.4 mt -88.54 -52.16 5.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.445 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p30 -103.22 167.41 9.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 112.192 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -55.43 -40.4 71.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.063 -173.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -62.85 -41.7 99.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.588 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -61.06 -36.67 80.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 0.0 110.958 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.654 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.1 mm-40 -62.81 -41.35 99.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.312 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.37 -33.97 71.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.71 0.291 . . . . 0.0 111.346 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.99 -1.07 10.82 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.49 63.64 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.093 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -83.2 143.15 44.78 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.528 0.664 . . . . 0.0 109.251 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.02 147.77 55.47 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.235 1.29 . . . . 0.0 111.379 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.14 154.77 29.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.332 1.354 . . . . 0.0 112.772 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 115' ' ' ILE . 92.6 mt -62.64 -16.63 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.021 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.422 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.4 t -44.46 -38.53 5.58 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HD3' HG22 ' A' ' 113' ' ' THR . 32.5 Cg_exo -58.99 -31.89 96.54 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.383 1.887 . . . . 0.0 112.193 -176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 112' ' ' ILE . 17.4 pt -98.05 3.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -78.18 135.66 37.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.47 0.577 . . . . 0.0 110.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.454 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -77.81 146.57 35.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.189 0.519 . . . . 0.0 111.862 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -92.14 140.5 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.685 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.84 157.23 18.68 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.1 p -59.13 -35.27 73.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.936 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.42 160.37 26.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.68 30.27 56.48 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.184 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.96 -119.92 14.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.41 157.58 17.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.298 . . . . 0.0 110.405 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' A' ' 117' ' ' ALA . 75.5 mt -79.79 130.06 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.416 . . . . 0.0 110.348 -175.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 140.39 58.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.126 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.5 mt -95.3 9.72 38.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.1 171.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.13 -44.05 33.12 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.845 -0.534 . . . . 0.0 112.648 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.78 84.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.121 0.46 . . . . 0.0 110.666 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.6 tp -59.32 -42.06 90.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 110.51 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -60.01 -44.4 94.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.496 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 m -59.2 -42.69 91.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.63 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.61 -47.97 83.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.641 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.552 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 20.8 m -62.86 -40.15 96.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.729 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.72 -39.0 86.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -58.66 -42.65 88.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.29 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.13 -39.12 93.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.96 -25.19 65.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.869 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.94 4.6 55.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -101.4 145.03 29.48 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.078 0.939 . . . . 0.0 110.551 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.957 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.44 140.09 50.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -117.03 138.99 51.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.0 143.56 49.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -118.99 131.54 56.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -126.93 149.02 50.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.43 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.9 m -61.0 154.46 22.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.421 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -119.78 148.27 43.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.511 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.35 -173.97 50.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.1 tp -95.45 131.12 41.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.67 142.65 98.02 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -88.83 -174.94 1.11 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.636 1.557 . . . . 0.0 112.127 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -55.7 150.9 11.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.034 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.32 32.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -114.34 141.6 47.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 110.62 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 -174.03 49.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.7 mtm -107.17 153.84 22.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.481 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -69.84 132.9 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.672 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.29 143.95 47.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -121.63 138.75 54.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.99 145.63 56.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.617 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.97 145.48 52.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.408 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.71 154.85 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -92.35 155.32 17.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -94.17 130.42 40.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -114.34 160.09 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -117.23 153.42 32.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.247 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -55.86 141.37 39.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -132.44 167.67 19.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.493 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -97.73 144.65 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -68.98 139.75 55.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -133.09 162.55 56.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.86 -174.99 2.35 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.454 1.436 . . . . 0.0 112.093 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -73.55 176.26 6.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.766 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.64 128.73 44.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.4 -173.74 48.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -79.58 165.56 22.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.691 0.282 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -61.13 135.35 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.79 140.12 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.4 123.62 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.433 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.72 134.96 56.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 0.0 110.54 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -100.74 151.17 21.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.2 p -80.55 166.47 21.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.327 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.35 178.45 51.62 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.0 -165.52 27.5 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -167.89 28.59 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -56.06 144.71 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 110.859 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.27 151.6 24.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.67 155.0 23.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.93 171.21 3.07 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.243 1.295 . . . . 0.0 111.903 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.42 160.83 39.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.714 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -105.25 145.13 31.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.296 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -104.11 142.89 33.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.263 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 m -81.81 160.41 63.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.598 ' HG3' ' HB2' ' A' ' 68' ' ' ALA . 57.0 Cg_exo -48.5 128.84 18.68 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.448 1.432 . . . . 0.0 112.082 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.34 139.63 26.91 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.544 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -52.33 159.96 3.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.182 1.255 . . . . 0.0 111.796 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -64.05 159.84 52.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.5 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.9 148.21 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.098 1.199 . . . . 0.0 110.833 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -55.86 143.72 59.88 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.453 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.42 119.86 7.39 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.139 1.226 . . . . 0.0 112.509 -172.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -124.37 143.73 50.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -55.82 125.59 21.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.25 -170.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.4 p30 63.35 12.45 6.25 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.537 168.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -150.41 138.13 19.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.666 0.666 . . . . 0.0 112.669 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -150.2 147.95 28.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.952 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' OD1' HG23 ' A' ' 79' ' ' THR . 77.8 m-20 -96.79 127.37 42.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.449 HD11 HD21 ' A' ' 67' ' ' LEU . 8.4 tp -128.0 143.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.984 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.5 p -143.88 164.82 29.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.516 0.674 . . . . 0.0 111.552 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -55.55 -36.22 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.163 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.52 84.29 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.766 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -70.44 -45.06 66.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.671 HD12 ' CE3' ' A' ' 71' ' ' TRP . 48.3 mt -87.23 -8.68 56.56 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.598 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . 63.78 -149.57 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -55.76 -21.74 20.55 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.036 0.834 . . . . 0.0 112.336 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -56.42 -28.07 58.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.671 ' CE3' HD12 ' A' ' 67' ' ' LEU . 54.4 t-105 -55.69 107.25 0.82 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.397 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.34 -13.18 4.4 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.755 1.637 . . . . 0.0 114.15 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.73 145.05 26.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.82 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -69.55 -37.5 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.509 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.7 m -63.68 129.72 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.22 -33.44 75.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.16 173.14 12.79 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.709 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 161.99 34.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.537 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.6 m -108.13 139.58 42.58 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.575 -0.368 . . . . 0.0 110.082 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 pt -107.58 136.18 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.34 143.69 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.462 0.649 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 m -106.62 118.61 37.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.143 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.75 160.03 47.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.148 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.42 -17.92 7.27 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.452 1.434 . . . . 0.0 113.52 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.4 p -80.08 2.89 22.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 t0 67.66 33.51 4.94 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.904 0.32 . . . . 0.0 111.486 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -121.5 138.89 54.1 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.638 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -97.57 128.28 44.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.237 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.03 157.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.413 0.625 . . . . 0.0 111.412 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 130' ' ' LEU . 91.1 t80 -114.07 127.02 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.933 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.02 131.03 58.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.419 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -101.18 155.96 35.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.812 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.51 -26.67 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.503 1.469 . . . . 0.0 113.19 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 35.0 p30 -64.96 -11.58 40.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.94 9.62 67.7 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.944 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.5 m -99.43 139.9 34.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -104.58 130.57 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.1 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.54 148.02 40.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.005 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.36 127.53 35.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.762 0.315 . . . . 0.0 110.835 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.16 -50.46 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.344 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -105.66 167.6 9.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.637 0.732 . . . . 0.0 111.95 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.33 -40.74 71.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.159 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -64.09 -40.94 97.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.288 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.98 -37.66 77.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.57 -40.36 96.77 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.342 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -58.26 -34.02 70.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.211 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.62 1.82 7.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.92 23.55 63.77 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.986 -0.341 . . . . 0.0 113.227 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -88.24 125.99 62.12 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.219 172.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.68 152.48 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 CA-C-N 120.614 1.255 . . . . 0.0 111.372 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.07 158.01 30.45 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.357 1.371 . . . . 0.0 112.344 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 115' ' ' ILE . 85.3 mt -62.04 -11.18 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.993 -0.527 . . . . 0.0 112.291 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.436 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.7 t -44.09 -39.64 6.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.436 ' HD3' HG22 ' A' ' 113' ' ' THR . 24.5 Cg_exo -59.68 -32.45 95.8 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-N 122.296 1.856 . . . . 0.0 112.401 -175.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.437 HD11 HG23 ' A' ' 112' ' ' ILE . 17.8 pt -98.82 7.69 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -77.8 139.95 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.458 0.572 . . . . 0.0 110.398 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.93 143.11 29.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -91.66 139.97 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.849 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.5 168.83 19.95 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 m -58.39 -38.79 78.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.733 0.301 . . . . 0.0 110.709 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.49 166.43 26.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.61 29.67 59.28 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.127 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.27 -120.04 19.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -104.21 157.77 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 0.0 111.031 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.1 mt -79.05 132.81 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.514 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -64.63 140.99 58.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.109 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -93.9 8.53 40.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.16 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.88 -44.16 31.27 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 121.808 -0.557 . . . . 0.0 112.764 -173.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.18 82.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.136 0.468 . . . . 0.0 110.759 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 90' ' ' PHE . 32.8 tp -59.5 -41.99 91.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.464 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.7 m -59.18 -43.52 92.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.597 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.2 m -61.02 -47.5 86.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.651 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.638 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 18.9 m -62.99 -40.08 96.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.815 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.65 -39.67 89.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -58.65 -42.41 88.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.342 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.97 -39.2 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.025 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.9 m -60.01 -25.22 65.12 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.938 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.77 23.0 43.95 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.644 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -77.27 134.26 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.455 0.627 . . . . 0.0 110.359 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.818 0 CA-C-O 117.968 -1.462 . . . . 0.0 111.024 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.98 133.7 53.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -128.01 141.85 51.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.406 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -123.22 140.49 52.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.505 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -111.38 138.59 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.99 132.52 53.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.4 t -120.34 142.61 48.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.499 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 t -120.27 141.31 50.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.0 -176.39 50.0 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.6 mp -92.37 140.86 29.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.754 0.312 . . . . 0.0 110.425 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.02 142.83 97.56 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.47 -174.95 0.81 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.741 1.628 . . . . 0.0 112.14 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -58.91 148.76 29.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.315 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.66 124.22 32.93 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -147.84 163.53 36.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 110.427 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 115.68 8.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -133.97 162.14 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -78.6 165.67 23.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.948 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -61.53 143.1 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.314 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -122.34 164.8 17.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.493 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.47 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.617 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.24 147.85 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.537 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.13 146.86 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.92 150.61 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.66 142.64 38.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.68 154.21 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.62 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -70.21 146.14 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -86.5 138.31 31.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -117.13 142.27 47.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.462 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.42 146.0 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.641 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -144.68 160.69 40.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.555 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -56.73 154.28 18.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.51 136.48 31.11 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.359 1.373 . . . . 0.0 112.083 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -137.41 169.23 18.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.82 145.03 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.19 -174.37 50.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -134.24 165.64 24.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 110.618 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -63.2 168.79 3.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.603 ' CG ' ' HH ' ' A' ' 69' ' ' TYR . 80.2 m-20 -70.22 138.42 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -150.0 155.14 39.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.335 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -73.19 169.95 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.439 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -94.95 113.06 24.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.845 0.355 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -131.74 162.68 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.51 137.57 30.99 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.0 -169.63 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.94 -149.92 0.46 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.42 150.46 11.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.27 162.3 6.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -54.12 163.85 1.13 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.05 168.81 5.48 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.403 1.402 . . . . 0.0 112.243 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.95 156.28 28.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.796 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -113.84 174.62 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -56.84 145.43 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.724 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -65.04 112.69 8.73 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.52 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.12 159.77 45.16 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.266 1.311 . . . . 0.0 111.636 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -90.31 140.96 27.18 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.359 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.36 134.96 53.2 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.083 1.188 . . . . 0.0 111.561 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.0 152.4 87.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.99 142.93 99.02 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.248 1.299 . . . . 0.0 111.201 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.0 p -55.88 137.05 72.57 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.098 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.21 119.91 3.97 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.123 1.216 . . . . 0.0 113.334 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -85.19 157.04 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -57.32 125.54 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.794 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.58 21.12 12.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.82 173.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -159.69 142.71 14.02 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.336 0.516 . . . . 0.0 112.274 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -146.46 153.04 39.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.917 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' HG23 ' A' ' 79' ' ' THR . 80.0 m-20 -91.98 125.6 36.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 67' ' ' LEU . 5.2 tp -123.26 144.31 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -175.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.3 p -150.06 160.51 43.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.614 0.721 . . . . 0.0 112.299 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.57 -34.28 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.545 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.25 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.059 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -70.74 -46.66 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 62' ' ' ILE . 7.6 mp -73.57 -23.24 59.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.25 -150.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.603 ' HH ' ' CG ' ' A' ' 33' ' ' ASP . 58.2 t80 -54.08 -26.59 27.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.112 0.869 . . . . 0.0 111.797 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -53.06 -28.28 24.02 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.436 ' HE3' HD22 ' A' ' 67' ' ' LEU . 59.4 t-105 -55.77 107.13 0.79 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.189 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.22 -13.29 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.757 1.638 . . . . 0.0 114.113 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.31 144.43 28.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.202 0.525 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -68.17 -37.13 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.777 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.16 129.76 31.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -61.76 -32.95 73.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -147.1 174.55 11.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.07 34.34 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.474 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.2 m -107.51 138.46 43.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.659 -0.318 . . . . 0.0 110.145 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -108.98 132.83 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -148.07 144.91 28.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.38 0.61 . . . . 0.0 112.27 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.4 m -102.45 118.73 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.65 158.06 51.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.545 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.37 -18.26 5.19 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.417 1.411 . . . . 0.0 113.327 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.6 p -77.5 3.03 14.48 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 63.18 45.53 5.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.073 0.463 . . . . 0.0 110.638 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -135.2 144.66 47.07 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.571 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.84 120.46 40.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.72 158.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.614 0.721 . . . . 0.0 111.921 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.504 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.1 t80 -114.15 129.18 56.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.879 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.88 131.73 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.66 155.15 36.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.666 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -48.85 -25.75 8.88 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.487 1.458 . . . . 0.0 113.104 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.1 p30 -65.27 -11.74 44.44 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.38 67.6 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.847 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.9 m -99.4 138.63 36.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 m -103.18 129.37 50.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.231 0.538 . . . . 0.0 110.067 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -114.14 148.83 36.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.024 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 125.93 34.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.325 . . . . 0.0 110.409 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.05 -51.38 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HB3' HD11 ' A' ' 131' ' ' LEU . 51.7 p30 -112.38 167.59 10.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.658 0.742 . . . . 0.0 112.012 -175.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -52.32 -34.02 45.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.777 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -61.71 -47.43 85.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.619 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.9 -34.29 74.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.424 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.594 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 76.9 mm-40 -62.31 -41.14 98.28 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.131 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -59.08 -34.01 71.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.064 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.09 -3.35 12.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.46 63.71 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.65 -0.309 . . . . 0.0 113.242 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -89.75 143.2 29.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.393 0.597 . . . . 0.0 109.593 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 150.17 47.42 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.242 1.295 . . . . 0.0 111.265 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.97 158.94 30.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.373 1.382 . . . . 0.0 112.783 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 115' ' ' ILE . 92.5 mt -60.02 -14.0 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.159 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.438 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.5 t -42.97 -41.33 6.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD3' HG22 ' A' ' 113' ' ' THR . 19.1 Cg_exo -61.76 -27.41 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 CA-C-N 122.039 1.764 . . . . 0.0 112.656 -173.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 112' ' ' ILE . 9.5 pt -98.8 6.64 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HD3' HD11 ' A' ' 127' ' ' LEU . 78.6 mtm180 -75.87 143.38 41.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.884 0.766 . . . . 0.0 110.828 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -79.73 150.99 30.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.812 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -81.28 139.79 35.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.066 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.98 172.58 34.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 m -62.83 -35.9 81.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.643 0.259 . . . . 0.0 111.535 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.76 110.06 3.24 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.864 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 49.98 26.9 9.15 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.617 -0.325 . . . . 0.0 112.639 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.6 -60.07 4.73 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.14 145.87 35.02 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.639 -0.33 . . . . 0.0 110.361 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 117' ' ' ALA . 87.3 mt -73.07 133.47 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.15 0.5 . . . . 0.0 110.476 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -64.08 140.88 58.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.238 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.403 HD11 ' HD3' ' A' ' 116' ' ' ARG . 67.3 mt -95.11 10.86 34.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.053 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.7 -45.44 30.76 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.8 -0.563 . . . . 0.0 112.877 -173.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.85 -48.48 81.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.263 0.531 . . . . 0.0 110.835 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 90' ' ' PHE . 31.2 tp -59.31 -42.1 90.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 101' ' ' ASN . 27.8 tp -59.59 -44.17 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -59.82 -44.2 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.599 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.9 m -60.27 -46.29 90.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.565 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.6 m -62.35 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.976 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.0 -39.61 86.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.677 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.51 -41.97 91.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.05 -39.72 93.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.97 -25.21 65.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.0 60.0 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.794 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -53.65 141.74 25.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.487 0.643 . . . . 0.0 111.416 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.985 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -122.5 129.18 51.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.423 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -135.14 157.71 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.541 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -111.88 138.89 47.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.41 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -115.72 138.91 50.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -126.01 134.95 51.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.325 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.7 t -118.52 141.78 48.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.603 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 t -126.22 144.15 50.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.369 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 179.76 52.73 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.3 mt -98.6 139.28 34.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.53 142.98 84.59 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -89.16 132.16 2.23 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.573 1.515 . . . . 0.0 112.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -150.01 162.48 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.51 -166.44 41.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.8 p -132.0 156.77 45.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.496 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.67 -174.89 50.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.6 mtt -107.69 160.09 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.383 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -68.33 125.21 25.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.423 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -126.68 143.61 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.512 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 t -75.23 152.86 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.302 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.09 56.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.596 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.08 155.25 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.4 144.75 56.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.436 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -80.13 138.1 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.634 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.88 154.89 36.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.517 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.02 146.0 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -143.62 160.17 41.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.007 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -116.72 157.26 25.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.556 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -106.13 134.21 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -99.18 146.77 25.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -74.8 179.58 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.726 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.9 p -61.05 157.49 41.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.473 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.96 159.84 24.08 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.289 1.326 . . . . 0.0 112.041 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -76.06 -174.57 2.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 30' ' ' GLY . 6.0 tt -91.66 130.03 37.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.911 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -53.46 138.45 36.68 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -176.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -136.49 161.14 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.618 0.247 . . . . 0.0 110.658 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -81.63 108.52 15.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.654 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -145.1 176.31 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.444 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.14 147.21 48.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.339 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -57.67 136.47 56.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 110.638 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -140.64 -173.28 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.584 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -56.58 177.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.494 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.44 179.98 32.12 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.37 -155.83 7.5 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.16 -174.95 44.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.96 142.47 55.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.85 151.23 42.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.648 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.85 161.94 4.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.91 145.5 98.14 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.322 1.348 . . . . 0.0 112.003 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.06 40.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.505 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.43 133.21 36.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -126.08 152.41 45.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.9 m -61.44 157.71 43.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.38 137.01 25.36 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.306 1.338 . . . . 0.0 112.238 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -90.34 142.64 28.51 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.717 -0.658 . . . . 0.0 109.646 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.33 160.92 3.03 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.221 1.281 . . . . 0.0 111.377 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.3 mt -63.9 153.3 84.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.74 150.5 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.42 1.414 . . . . 0.0 111.172 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.3 p -55.99 134.85 73.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.066 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.05 119.8 4.01 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.236 1.291 . . . . 0.0 113.059 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -75.97 157.59 32.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 168.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.1 m -54.74 125.58 20.56 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.239 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 58' ' ' ASN . 0.1 OUTLIER 63.31 16.28 9.34 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.295 171.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -153.83 140.65 19.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -143.95 150.01 37.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.0 m-20 -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.69 HD11 HD11 ' A' ' 67' ' ' LEU . 9.2 tp -126.87 146.69 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.713 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.7 p -150.52 160.55 43.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.691 0.758 . . . . 0.0 112.305 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -55.48 -34.84 64.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.477 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.14 90.54 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.183 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -70.08 -46.58 64.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.287 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 62' ' ' ILE . 7.9 mp -72.12 -25.7 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.23 -148.64 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.25 -20.06 16.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.3 0.954 . . . . 0.0 112.429 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.5 -24.17 63.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.503 ' HE3' HD22 ' A' ' 67' ' ' LEU . 45.4 t-105 -55.88 112.59 4.49 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.32 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 125' ' ' ILE . 64.1 Cg_endo -89.52 -13.24 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.754 1.636 . . . . 0.0 114.166 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.3 mt -90.9 145.21 24.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.532 . . . . 0.0 111.883 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.03 -37.5 78.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.58 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.88 129.94 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -62.34 -33.59 75.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.95 174.49 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.765 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.06 34.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.4 m -108.09 140.07 41.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.16 136.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.74 144.12 39.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.583 . . . . 0.0 111.988 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.18 118.53 36.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.695 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -83.12 156.77 66.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.061 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.01 -18.29 16.59 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.403 1.402 . . . . 0.0 113.055 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -80.11 3.1 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 64.1 40.78 6.75 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.178 0.514 . . . . 0.0 110.559 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -115.68 128.11 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -96.78 124.22 40.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.262 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.36 156.77 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.367 0.603 . . . . 0.0 111.306 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.6 t80 -114.08 126.47 55.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.048 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.27 130.49 57.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.448 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.28 155.83 35.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.819 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.52 -26.68 9.28 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.588 1.525 . . . . 0.0 113.105 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.448 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 33.3 p30 -64.74 -11.91 41.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.23 67.12 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 122.123 -0.361 . . . . 0.0 112.913 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.6 m -99.39 140.14 34.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.85 130.46 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.17 0.509 . . . . 0.0 110.102 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.69 149.06 38.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.106 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 126.93 35.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.696 0.284 . . . . 0.0 110.805 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.36 -50.52 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.965 0.412 . . . . 0.0 110.226 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.34 167.6 9.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 111.687 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -56.75 -38.37 72.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.062 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -64.79 -41.79 95.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.548 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.613 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.86 -37.88 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.811 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.05 -52.09 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.338 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.67 -20.27 66.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.06 9.85 3.37 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.55 63.32 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 122.28 -0.262 . . . . 0.0 113.456 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -96.98 112.97 62.18 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -54.27 152.72 24.43 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 CA-C-N 120.577 1.242 . . . . 0.0 111.7 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.02 158.98 30.7 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.457 1.438 . . . . 0.0 112.75 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 115' ' ' ILE . 93.9 mt -61.29 -10.68 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.302 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.3 t -42.19 -41.81 5.47 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -172.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD3' HG22 ' A' ' 113' ' ' THR . 19.0 Cg_exo -62.14 -30.19 81.91 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 122.004 1.752 . . . . 0.0 112.612 -173.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 112' ' ' ILE . 15.7 pt -98.87 5.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.485 ' HD2' HD11 ' A' ' 127' ' ' LEU . 83.0 mtp180 -75.63 143.03 42.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.835 0.743 . . . . 0.0 110.555 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -86.91 138.53 31.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.897 0.379 . . . . 0.0 111.105 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -92.56 139.89 30.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.53 169.52 19.47 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -58.33 -39.07 78.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.706 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.35 165.65 26.3 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.32 28.68 59.51 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.204 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.53 -121.44 25.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.67 155.11 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.991 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 117' ' ' ALA . 45.4 mt -74.58 129.94 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.019 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -63.49 140.63 58.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.015 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.485 HD11 ' HD2' ' A' ' 116' ' ' ARG . 70.6 mt -93.16 9.81 34.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.121 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.78 -44.14 30.51 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.858 -0.526 . . . . 0.0 112.757 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.17 82.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.161 0.481 . . . . 0.0 110.707 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.5 tp -59.21 -41.89 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 110.458 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.48 -44.47 95.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.7 p -59.76 -40.86 89.58 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.649 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.9 m -61.66 -48.57 80.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.601 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.516 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.9 m -62.6 -40.28 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.727 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.44 -39.49 87.69 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -58.58 -43.0 89.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.315 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.07 -39.47 92.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.91 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -60.1 -25.23 65.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.794 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.94 22.95 24.22 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.643 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -88.71 145.9 25.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.474 0.637 . . . . 0.0 110.311 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.911 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.42 139.71 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.466 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -120.67 141.83 50.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -114.67 137.67 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.453 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -128.17 137.05 51.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.467 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -119.68 141.44 49.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.419 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.1 m -119.19 149.3 41.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.561 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 t -70.71 149.54 46.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.67 141.46 43.99 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.67 135.07 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.352 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 142.5 83.59 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -90.97 111.29 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.744 1.629 . . . . 0.0 112.494 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.94 132.75 43.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.312 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 -173.06 35.96 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -119.92 147.82 44.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.692 0.282 . . . . 0.0 110.459 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.78 -178.1 51.13 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.65 155.38 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.81 0.338 . . . . 0.0 110.484 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -80.23 133.47 36.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.507 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -68.22 142.94 55.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.51 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -136.14 157.06 47.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.836 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.83 146.66 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.645 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.93 146.78 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.57 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 144.18 54.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -98.1 152.68 19.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -132.94 164.03 27.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.404 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.57 143.24 36.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -63.74 145.7 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -99.55 125.62 45.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -127.93 138.79 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.5 mtp -126.39 162.62 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.599 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -72.33 -175.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.611 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -57.15 153.11 26.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 176.05 9.33 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.459 1.439 . . . . 0.0 112.271 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.87 123.97 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 29' ' ' LEU . 5.7 mp -76.8 152.92 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.415 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.24 150.95 14.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.7 p -121.07 170.13 9.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.744 0.307 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.82 127.64 33.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.471 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.0 145.17 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -137.86 175.31 9.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -59.7 150.42 27.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.461 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.16 141.48 49.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.547 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -124.81 168.35 13.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.538 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.73 -165.99 19.2 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 147.93 19.13 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.33 -158.29 9.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.74 146.35 31.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.423 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 147.4 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.02 153.61 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.491 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.28 174.24 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.349 1.366 . . . . 0.0 112.194 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.58 150.24 24.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -109.06 138.66 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.591 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -63.35 147.79 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 m -116.82 156.09 48.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.375 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.23 135.46 59.93 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.227 1.285 . . . . 0.0 111.858 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.34 141.39 32.54 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.246 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.33 149.97 21.4 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.15 1.233 . . . . 0.0 111.636 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.97 154.58 81.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.01 146.82 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.196 1.264 . . . . 0.0 111.174 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.5 m -55.82 139.81 69.18 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.241 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.17 119.92 3.99 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.142 1.228 . . . . 0.0 113.131 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -88.42 159.85 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 168.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 p -54.71 125.61 20.62 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.702 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 63.72 15.66 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 170.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -159.8 158.81 31.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -148.05 153.21 38.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.576 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.498 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.2 m-20 -90.53 125.21 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 67' ' ' LEU . 9.4 tp -126.05 147.12 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.23 162.1 41.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.783 0.801 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.62 -35.05 65.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.414 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.05 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.134 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.0 -46.64 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.257 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 HD11 ' A' ' 62' ' ' ILE . 8.3 mp -73.56 -26.61 60.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -175.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.46 -146.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -56.18 -20.12 16.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.495 1.043 . . . . 0.0 112.463 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.27 -25.13 63.83 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.49 ' HE3' HD22 ' A' ' 67' ' ' LEU . 36.1 t-105 -55.87 111.76 3.52 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.572 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.63 -13.23 2.8 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.858 1.705 . . . . 0.0 114.096 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.8 mt -90.6 145.57 24.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.177 0.513 . . . . 0.0 111.953 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.8 p -69.71 -37.43 76.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.555 174.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.76 128.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.75 -33.99 75.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.068 -169.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.25 174.82 11.26 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.503 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.76 162.04 34.29 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.1 m -106.76 139.72 40.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.9 pt -108.16 135.77 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -146.19 141.03 27.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.375 0.607 . . . . 0.0 112.181 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.0 m -103.52 118.5 36.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.055 170.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.8 mt -81.78 153.62 70.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.064 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.42 -17.85 7.15 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.25 1.3 . . . . 0.0 113.25 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 m -79.74 3.18 20.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 63.91 48.42 3.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.122 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -130.88 133.45 45.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.271 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.86 120.48 37.28 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.678 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.567 HG12 ' HB1' ' A' ' 104' ' ' ALA . 35.5 m -132.06 155.81 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.554 0.692 . . . . 0.0 111.783 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.3 t80 -114.18 130.24 56.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.81 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.6 t -109.51 131.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.47 155.35 36.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.851 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.68 -27.33 10.73 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.605 1.537 . . . . 0.0 113.09 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.6 p30 -64.04 -12.03 34.78 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 10.24 66.49 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 122.153 -0.342 . . . . 0.0 112.896 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 57.4 m -99.43 139.11 35.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.48 130.49 49.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 109.993 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.62 150.88 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.141 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.34 124.9 33.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 mt -79.85 -47.13 15.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 109.793 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -114.89 166.27 11.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.358 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -52.9 -34.53 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.735 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -61.01 -49.05 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.747 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.6 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.21 -37.12 76.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -61.66 -42.31 98.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.998 0.427 . . . . 0.0 110.089 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -58.23 -33.17 69.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.358 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.16 9.77 2.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.51 63.42 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.18 -0.325 . . . . 0.0 113.38 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -97.55 111.96 60.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.339 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -54.46 150.94 32.29 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.116 1.21 . . . . 0.0 111.654 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.81 158.9 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.325 1.35 . . . . 0.0 112.477 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.5 HG23 HD11 ' A' ' 115' ' ' ILE . 75.3 mt -61.9 -10.62 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.6 t -44.41 -38.83 5.89 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.424 ' HD3' HG22 ' A' ' 113' ' ' THR . 30.1 Cg_exo -58.79 -32.49 97.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 CA-C-N 122.472 1.919 . . . . 0.0 112.462 -175.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 112' ' ' ILE . 19.0 pt -98.83 7.55 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -76.45 137.34 39.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.495 0.588 . . . . 0.0 110.478 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.75 153.24 22.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.636 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -84.23 148.32 26.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.833 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.98 26.17 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.621 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.1 m -57.67 -37.88 74.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.683 0.277 . . . . 0.0 111.077 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.97 177.62 20.77 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.98 12.41 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.17 -119.93 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -104.94 161.96 13.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 111.075 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.53 133.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.469 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -63.1 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.842 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.52 9.27 35.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.098 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.8 31.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.838 -0.539 . . . . 0.0 112.852 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.323 0.562 . . . . 0.0 110.752 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.8 tp -59.1 -42.35 90.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.17 -43.24 95.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.473 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.7 m -59.24 -43.64 92.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.628 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.75 -47.63 85.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.538 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.5 m -63.22 -39.69 95.33 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.088 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.11 -39.49 86.36 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.724 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -58.75 -43.09 90.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.04 -38.62 89.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.8 m -59.89 -25.33 65.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.997 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.47 22.99 57.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.648 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.39 143.46 29.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.496 0.648 . . . . 0.0 110.444 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 CA-C-O 117.955 -1.469 . . . . 0.0 111.009 -179.831 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -124.45 136.06 53.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -127.24 145.8 50.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.598 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -112.82 141.57 46.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -110.01 135.76 50.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.458 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -130.91 152.39 50.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.522 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m -119.41 147.79 43.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.348 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -120.06 147.03 45.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.546 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -175.36 47.65 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -99.5 128.71 45.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.748 0.309 . . . . 0.0 110.388 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.26 142.87 90.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.22 143.24 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.657 1.571 . . . . 0.0 112.184 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -61.4 143.8 55.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.4 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.16 -171.58 42.52 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.2 p -117.31 154.54 31.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.16 -178.49 52.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.3 mtp -129.26 161.82 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -88.19 143.98 26.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -112.97 160.83 17.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.59 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -71.46 137.57 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.46 143.58 55.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.723 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.8 151.92 45.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.53 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 146.71 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.26 142.07 29.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.744 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.14 157.65 29.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.295 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -90.63 136.02 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.475 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -126.08 153.04 45.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -69.16 147.73 50.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.504 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -111.49 142.04 44.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 mtt -117.03 163.35 16.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.504 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -64.14 144.54 57.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.65 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.4 m -120.31 165.64 17.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.406 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.92 109.98 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.287 1.325 . . . . 0.0 111.876 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.44 144.43 54.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 29' ' ' LEU . 9.2 tt -97.96 129.18 44.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.0 102.12 0.11 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 m -126.56 145.53 50.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.777 0.323 . . . . 0.0 110.312 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.41 115.61 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -150.07 166.71 28.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.59 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.96 156.04 7.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.53 121.32 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -134.54 -176.57 4.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.841 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -71.51 163.39 27.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.365 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.91 179.68 52.51 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.24 -175.11 49.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.59 42.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -55.55 153.71 7.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.68 146.95 15.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.98 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.11 153.74 72.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.873 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.83 -169.93 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.612 1.541 . . . . 0.0 112.146 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.53 155.05 4.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -62.23 153.09 31.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -120.95 170.53 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.29 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -54.04 160.86 2.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 68' ' ' ALA . 65.8 Cg_exo -48.32 128.14 16.86 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.314 1.342 . . . . 0.0 112.351 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.29 143.11 29.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.525 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.23 160.93 2.92 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.151 1.234 . . . . 0.0 111.362 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.8 mt -63.98 154.5 81.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.686 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.62 147.74 32.08 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.311 1.341 . . . . 0.0 111.444 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 p -55.91 125.91 64.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.005 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.19 119.99 4.0 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.22 1.28 . . . . 0.0 113.289 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.7 p -76.35 158.72 31.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.1 m -56.41 125.46 22.09 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.992 -172.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 m120 63.68 22.94 13.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.616 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -157.4 139.73 14.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -147.01 146.82 30.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.835 169.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.4 m-20 -93.75 125.71 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 67' ' ' LEU . 4.6 tp -126.2 144.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.514 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.3 p -150.42 158.9 44.67 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.566 0.698 . . . . 0.0 112.388 -173.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -55.54 -34.6 64.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.438 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.74 89.41 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.09 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -70.39 -46.64 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.259 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.528 HD11 HD11 ' A' ' 62' ' ' ILE . 6.9 mp -71.68 -26.27 62.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . 69.66 -147.17 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.85 -22.03 22.95 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.38 0.991 . . . . 0.0 112.286 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 70' ' ' LEU . 7.2 mp -61.53 -20.53 63.34 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.469 ' HE3' HD22 ' A' ' 67' ' ' LEU . 51.6 t-105 -55.82 118.45 20.15 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.247 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HB3' HG22 ' A' ' 125' ' ' ILE . 58.8 Cg_endo -89.69 -13.3 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.807 1.671 . . . . 0.0 114.157 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.62 145.21 27.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.34 0.59 . . . . 0.0 112.101 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.2 p -67.31 -37.8 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.464 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.77 128.6 26.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.11 -33.91 75.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -147.99 173.87 12.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.778 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.01 34.23 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.481 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.1 m -108.92 139.09 44.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.611 -0.347 . . . . 0.0 110.105 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.51 134.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.11 144.56 38.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.233 0.54 . . . . 0.0 111.995 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.21 118.6 37.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.396 172.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.85 155.8 67.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.07 -20.6 10.88 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.323 1.349 . . . . 0.0 113.221 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -80.84 2.97 24.2 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t0 69.26 35.12 2.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -112.53 128.88 56.47 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.603 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -96.52 122.29 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.1 158.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.353 0.596 . . . . 0.0 111.557 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.2 t80 -114.1 126.85 55.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.039 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.47 129.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.5 155.45 36.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.647 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.49 -26.59 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.589 1.526 . . . . 0.0 113.115 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 33.4 p30 -63.95 -12.77 40.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.88 67.09 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 122.09 -0.381 . . . . 0.0 112.924 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 m -99.34 139.38 35.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 m -104.87 130.18 53.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 109.972 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -114.9 148.65 38.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.9 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.4 127.74 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.694 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -86.82 -50.53 6.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.285 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.402 ' HB3' HD11 ' A' ' 131' ' ' LEU . 44.9 p-10 -103.43 167.12 10.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.627 0.727 . . . . 0.0 111.956 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.37 -39.88 73.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.999 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.18 -41.89 99.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.271 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.29 -37.19 79.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.899 0.381 . . . . 0.0 110.968 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.97 -40.55 98.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.43 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -58.63 -34.04 70.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.721 0.296 . . . . 0.0 111.329 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.21 0.96 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.49 63.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.969 -0.35 . . . . 0.0 113.191 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -83.21 143.15 44.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.03 152.66 68.01 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.262 1.308 . . . . 0.0 111.752 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.1 153.54 28.55 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.454 1.436 . . . . 0.0 112.725 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 115' ' ' ILE . 90.1 mt -64.02 -18.98 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.779 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 t -46.6 -36.82 7.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.57 -29.01 83.58 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 CA-C-N 122.997 2.106 . . . . 0.0 112.103 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 112' ' ' ILE . 17.6 pt -98.89 2.17 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 143.3 45.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.103 0.865 . . . . 0.0 110.204 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.12 152.51 18.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.776 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -85.13 140.95 30.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.305 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.66 175.66 26.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.9 m -58.27 -38.73 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.784 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.9 31.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.2 36.04 56.45 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.37 -123.04 19.63 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -109.04 161.88 14.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.051 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' A' ' 72' ' ' PRO . 46.7 mt -75.04 133.32 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.425 -173.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -72.25 141.37 48.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.694 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -91.68 8.5 36.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.163 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.54 -43.15 36.09 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.749 -0.595 . . . . 0.0 112.327 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.72 88.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.788 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.4 tp -59.01 -41.68 88.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.035 0.445 . . . . 0.0 110.463 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 101' ' ' ASN . 33.8 tp -59.64 -45.2 92.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.474 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.3 p -59.73 -41.05 90.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.69 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.62 -47.76 83.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.707 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.603 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 24.0 m -62.67 -40.35 96.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.839 -177.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -60.18 -39.87 88.0 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.751 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -59.44 -42.05 91.04 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.424 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.05 -38.72 89.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.107 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -59.97 -25.28 65.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.867 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.46 22.89 38.69 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.703 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.26 145.63 29.95 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.483 0.641 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.789 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.975 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.15 140.37 49.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -118.03 140.23 50.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.45 139.2 50.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.375 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -129.58 156.7 43.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.613 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -114.44 140.31 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.35 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.9 t -112.83 142.42 45.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.674 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -120.76 146.14 46.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.43 142.78 39.5 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -93.62 143.16 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.823 0.344 . . . . 0.0 110.624 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.2 153.3 86.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.1 114.34 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.386 1.391 . . . . 0.0 112.223 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -123.34 146.49 47.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.39 133.29 23.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -139.71 144.93 37.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.16 132.29 28.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.8 mtt -133.0 158.25 43.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.835 0.35 . . . . 0.0 110.552 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 146.77 23.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -101.6 149.65 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.595 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -124.09 163.28 21.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.04 45.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.48 144.13 56.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.489 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.23 145.64 29.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.558 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -91.44 145.77 24.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.522 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -106.02 134.92 48.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -103.08 142.26 34.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -66.69 140.4 57.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.485 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -101.94 131.7 48.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -116.09 138.68 51.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.352 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.5 mtm -112.25 145.07 40.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.82 143.7 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.575 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.3 m -64.07 153.53 84.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.58 109.95 2.88 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.285 1.323 . . . . 0.0 112.086 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -149.96 170.26 19.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.1 140.44 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.36 133.79 26.17 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -126.74 163.01 24.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.362 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.17 114.29 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -149.93 175.19 11.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -63.95 149.87 46.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.501 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.38 142.53 56.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -92.32 153.27 19.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.701 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 p -118.59 162.79 17.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.224 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.4 -178.05 51.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.82 -171.59 48.35 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.48 -176.92 49.6 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -121.43 151.9 39.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 0.0 110.437 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.41 152.75 20.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.477 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.02 153.95 16.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.63 169.56 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.27 1.313 . . . . 0.0 111.975 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.01 158.33 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -83.53 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.443 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.07 164.2 33.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.074 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -63.27 160.51 40.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.769 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.33 128.27 17.12 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.343 1.362 . . . . 0.0 112.159 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.28 139.66 27.0 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.11 150.44 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.095 1.197 . . . . 0.0 111.609 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.06 153.92 83.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.21 151.44 54.88 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.236 1.29 . . . . 0.0 111.496 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -55.95 136.49 73.15 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.037 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.04 119.87 4.03 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.225 1.283 . . . . 0.0 113.225 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.7 p -80.43 157.79 26.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -57.37 125.39 22.62 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.79 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 63.58 19.22 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.84 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -159.61 144.53 15.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.543 0.611 . . . . 0.0 112.384 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -142.34 153.21 43.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.763 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -94.88 126.0 39.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 173.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 67' ' ' LEU . 4.7 tp -124.79 141.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.5 p -143.46 163.37 33.29 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.594 0.711 . . . . 0.0 111.755 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.54 -35.53 65.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.216 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.19 85.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.729 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.44 -46.65 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.826 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.627 HD12 ' CE3' ' A' ' 71' ' ' TRP . 36.5 mt -87.02 -8.69 56.91 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 61.66 -145.37 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.0 -28.44 37.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.29 0.95 . . . . 0.0 111.92 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.33 -25.58 35.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.627 ' CE3' HD12 ' A' ' 67' ' ' LEU . 49.2 t-105 -55.92 107.17 0.8 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.372 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.02 -13.17 3.89 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.833 1.689 . . . . 0.0 114.129 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -89.67 145.89 24.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.315 0.579 . . . . 0.0 111.821 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.1 p -69.63 -37.1 76.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.723 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.77 129.64 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -64.31 -30.14 71.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -150.26 174.62 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.662 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.456 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.5 m -107.89 140.94 40.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.629 -0.336 . . . . 0.0 110.102 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 pt -108.87 136.08 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -143.55 143.88 31.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 111.824 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.2 m -107.4 122.23 46.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.701 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.1 mt -82.7 158.83 64.87 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.03 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.0 -22.07 13.71 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.401 1.401 . . . . 0.0 113.191 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -79.54 3.05 19.97 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.2 40.09 7.03 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.196 0.522 . . . . 0.0 110.638 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -113.24 129.11 56.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.01 121.93 37.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.202 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.06 156.73 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.599 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.4 t80 -114.06 126.95 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.06 130.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.4 156.22 35.49 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.658 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.2 -26.73 8.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.509 1.473 . . . . 0.0 113.105 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.0 p30 -65.11 -11.46 40.13 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 8.51 67.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.85 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -99.47 138.48 36.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.1 m -103.7 131.0 51.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 109.865 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -115.97 149.76 38.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.979 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.38 127.23 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.674 0.273 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -86.68 -51.02 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.941 0.4 . . . . 0.0 110.181 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.404 ' HB3' HD11 ' A' ' 131' ' ' LEU . 43.2 p-10 -103.25 167.61 9.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.644 0.735 . . . . 0.0 111.944 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.79 -39.04 76.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.944 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -62.76 -41.27 99.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.151 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.7 -35.87 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.072 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.2 -40.55 97.81 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.389 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -58.86 -34.01 71.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.689 0.281 . . . . 0.0 111.241 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.21 -1.79 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.54 63.41 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.07 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 5.1 m-70 -82.09 143.19 48.8 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 109.516 173.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 153.47 73.84 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.366 1.378 . . . . 0.0 111.811 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.12 151.89 27.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.538 1.492 . . . . 0.0 112.66 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 115' ' ' ILE . 90.2 mt -64.28 -18.62 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 119.015 -0.517 . . . . 0.0 111.672 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.422 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.3 t -45.12 -37.34 4.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HD3' HG22 ' A' ' 113' ' ' THR . 39.3 Cg_exo -59.01 -32.11 96.95 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 CA-C-N 122.529 1.939 . . . . 0.0 112.102 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 112' ' ' ILE . 15.8 pt -97.06 3.68 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.38 139.37 39.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.439 0.563 . . . . 0.0 110.331 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -83.0 142.3 31.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.38 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -90.75 139.85 30.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.684 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.19 168.32 19.94 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.551 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -57.81 -39.22 77.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 110.673 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.04 26.82 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.12 30.21 57.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.048 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.72 -120.26 19.61 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.31 158.13 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.936 0.398 . . . . 0.0 111.134 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.3 mt -79.0 130.64 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.533 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -63.29 140.8 58.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.236 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.5 mt -94.41 9.87 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.059 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.02 -45.26 32.94 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.845 -0.534 . . . . 0.0 112.735 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.3 85.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.175 0.488 . . . . 0.0 110.759 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.8 tp -59.47 -41.95 90.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.602 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 101' ' ' ASN . 30.0 tp -59.64 -44.61 93.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -59.07 -43.37 91.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.66 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.59 -47.28 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 110.626 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.622 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 19.9 m -62.7 -41.53 99.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.794 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.16 -37.43 82.88 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.69 -43.86 90.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 110.197 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -36.24 82.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.84 -25.16 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 97.88 23.04 14.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.86 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -48.78 147.07 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.493 0.646 . . . . 0.0 112.137 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.908 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.7 tttm . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 112.327 0.491 . . . . 2.6000000000000001 112.327 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -148.61 152.91 37.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.823 -0.626 . . . . 0.28000000000000003 110.903 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' OD1' HG23 ' A' ' 79' ' ' THR . 76.1 m-20 -97.56 129.07 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.468 -0.567 . . . . 0.16 109.468 173.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.708 HD11 HD11 ' A' ' 67' ' ' LEU . 12.1 tt -129.34 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.892 0.377 . . . . 0.40999999999999998 110.938 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -150.48 167.87 25.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.59 0.709 . . . . 0.20000000000000001 111.654 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.5 -34.62 64.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.724 . . . . 1.1000000000000001 111.118 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.02 86.53 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 121.021 -0.272 . . . . 0.28999999999999998 110.727 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -66.36 -46.61 76.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.32000000000000001 111.282 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD11 HD11 ' A' ' 62' ' ' ILE . 10.8 mp -88.07 -8.79 55.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.671 0.989 . . . . 1.05 113.671 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.69 -153.79 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.419 -0.586 . . . . 0.32000000000000001 109.419 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -56.77 -21.42 28.32 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.571 0.623 . . . . 3.9399999999999999 112.4 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -59.2 -20.09 50.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.498 0.555 . . . . 1.6699999999999999 112.498 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.509 ' CE3' HD22 ' A' ' 67' ' ' LEU . 55.7 t-105 -55.81 111.94 3.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 119.121 -0.466 . . . . 0.19 110.205 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -89.55 -13.25 2.84 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.904 1.736 . . . . 0.23999999999999999 114.164 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -87.8 143.62 27.04 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.228 0.537 . . . . 0.11 111.627 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.4 p -67.99 -36.76 80.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.345 -0.843 . . . . 0.17000000000000001 110.817 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.67 129.39 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.272 -1.01 . . . . 0.17000000000000001 108.272 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.92 -32.94 72.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.023 0.379 . . . . 1.8 112.023 -169.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -147.02 174.37 11.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.406 -0.518 . . . . 0.46999999999999997 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.05 34.31 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.832 -1.307 . . . . 0.10000000000000001 109.832 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.556 HG23 ' OD1' ' A' ' 61' ' ' ASP . 6.3 m -109.93 141.58 42.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.598 -0.354 . . . . 0.12 110.349 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.64 137.23 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.988 -0.375 . . . . 0.14000000000000001 109.988 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -148.01 143.79 27.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.432 0.634 . . . . 2.1800000000000002 112.127 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.011 -0.995 . . . . 0.22 109.492 172.545 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.546 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.11 -0.33 . . . . 0.25 110.11 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.32 157.14 43.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.448 0.642 . . . . 0.12 111.396 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' HD21 ' A' ' 130' ' ' LEU . 89.1 t80 -114.03 127.75 56.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.799 -1.091 . . . . 0.11 109.932 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -108.51 130.48 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.325 -0.62 . . . . 0.13 109.325 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.41 154.8 37.0 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.655 -0.418 . . . . 0.13 110.625 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.66 -26.49 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.509 1.473 . . . . 0.17999999999999999 113.225 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.6 p30 -63.96 -12.79 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.816 0.673 . . . . 0.17999999999999999 112.816 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.52 10.43 65.48 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 122.151 -0.343 . . . . 0.16 112.92 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.7 m -99.37 139.36 35.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.233 -0.655 . . . . 0.14000000000000001 109.233 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.8 m -105.02 130.91 53.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.297 0.57 . . . . 0.14000000000000001 110.056 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -116.68 147.54 41.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.14000000000000001 108.992 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.41 126.08 34.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.13 110.771 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.04 -50.93 6.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.347 -0.388 . . . . 0.17999999999999999 110.637 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -103.11 166.58 10.35 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.643 0.735 . . . . 0.33000000000000002 112.019 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.6 -41.16 69.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.39 -0.823 . . . . 2.2000000000000002 112.209 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -63.94 -42.8 97.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.689 -0.404 . . . . 2.2200000000000002 111.398 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.584 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.62 -37.28 78.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.862 0.363 . . . . 0.22 110.907 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.56 -40.92 98.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 2.0699999999999998 110.394 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.85 -33.93 71.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 2.7200000000000002 111.288 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.66 0.44 8.72 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.083 0.771 . . . . 0.46000000000000002 113.083 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.12 23.43 63.53 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.826 -0.43 . . . . 0.46000000000000002 113.203 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 49.9 m-70 -84.89 142.64 39.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 108.938 -0.764 . . . . 0.46999999999999997 108.938 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.09 148.83 51.25 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.182 1.255 . . . . 0.72999999999999998 111.281 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 158.91 30.44 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.376 1.384 . . . . 0.45000000000000001 112.301 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 115' ' ' ILE . 92.4 mt -60.96 -11.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 119.033 -0.508 . . . . 0.20000000000000001 112.345 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.444 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.1 t -43.83 -39.65 6.06 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 115.559 1.689 . . . . 0.40000000000000002 115.559 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.2 Cg_exo -58.98 -31.95 96.62 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 CA-C-N 122.31 1.861 . . . . 0.28000000000000003 112.395 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 112' ' ' ILE . 25.1 pt -98.9 1.49 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 113.008 0.744 . . . . 0.20999999999999999 113.008 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -79.59 136.77 36.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.34 0.518 . . . . 3.3199999999999998 110.545 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.495 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.26000000000000001 111.356 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 117' ' ' ALA . 33.2 mt . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 121.05 0.452 . . . . 0.39000000000000001 109.915 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -61.83 138.81 58.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.28999999999999998 112.092 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -95.99 11.55 33.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.173 -0.921 . . . . 0.23000000000000001 112.103 171.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -42.41 30.65 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.876 -0.515 . . . . 0.19 112.632 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.5 81.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.996 0.427 . . . . 0.20000000000000001 110.78 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.55 -41.94 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.17000000000000001 110.47 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.97 -44.04 94.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.19 110.464 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.05 -43.73 91.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.924 -0.311 . . . . 1.1799999999999999 110.562 -176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 39.0 m -60.9 -47.52 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.586 -0.446 . . . . 0.19 110.597 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.546 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 27.3 m -62.84 -40.12 96.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.58 -0.448 . . . . 0.17999999999999999 110.921 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.83 -39.63 89.74 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.969 -0.292 . . . . 0.22 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -58.77 -42.58 89.26 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.777 -0.369 . . . . 1.8999999999999999 110.241 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.97 -39.55 95.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.20000000000000001 111.03 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.1 m -59.99 -25.31 65.16 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.238 -0.437 . . . . 0.29999999999999999 112.144 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.139 0 C-N-CA 121.116 -0.564 . . . . 0.60999999999999999 112.614 -179.756 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 pttt . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -143.8 153.12 42.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.581 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' HG23 ' A' ' 79' ' ' THR . 75.7 m-20 -97.3 123.95 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.827 HD11 HD11 ' A' ' 67' ' ' LEU . 6.8 tt -130.18 151.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.092 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.0 p -147.79 165.81 29.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.871 0.843 . . . . 0.0 112.061 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -55.62 -34.28 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.38 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.15 90.42 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.785 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -66.38 -46.59 76.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.904 0.383 . . . . 0.0 111.241 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.827 HD11 HD11 ' A' ' 62' ' ' ILE . 10.3 mp -81.88 -16.64 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.06 -148.3 0.3 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -56.03 -21.25 20.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.196 0.907 . . . . 0.0 112.368 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.0 tp -56.54 -27.83 58.52 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.589 ' CE3' HD22 ' A' ' 67' ' ' LEU . 43.1 t-105 -55.73 111.89 3.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.42 -175.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HB3' HG22 ' A' ' 125' ' ' ILE . 66.8 Cg_endo -89.53 -13.15 2.87 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.766 1.644 . . . . 0.0 114.167 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.31 145.33 25.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.284 0.564 . . . . 0.0 111.813 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.8 p -69.37 -37.16 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.647 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.42 129.65 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.12 -32.77 73.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -168.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -148.55 175.1 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.09 34.38 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.515 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.0 m -107.88 141.1 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.81 137.71 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.45 143.73 30.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 112.06 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.684 173.008 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.575 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.233 0.222 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.7 157.79 42.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.437 0.637 . . . . 0.0 111.452 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.4 t80 -114.05 127.47 55.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.025 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.17 130.91 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.37 155.25 36.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.735 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.39 -26.74 9.01 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.595 1.53 . . . . 0.0 113.127 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.7 p30 -64.5 -11.82 37.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.55 9.28 66.85 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.543 -0.361 . . . . 0.0 112.911 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.1 m -99.45 140.83 33.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -105.04 131.08 53.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.235 0.54 . . . . 0.0 110.118 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -116.22 148.09 40.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.997 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.679 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.35 127.93 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -86.79 -51.8 5.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -103.2 167.49 9.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 112.059 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.106 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -63.23 -41.91 99.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.207 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.34 -37.04 79.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 110.92 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.679 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 76.8 mm-40 -62.77 -41.27 99.16 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.282 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -58.77 -33.99 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.409 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.44 7.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.05 23.46 63.61 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.964 -0.353 . . . . 0.0 113.265 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 52.3 m-70 -84.9 143.16 39.79 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.469 0.635 . . . . 0.0 109.303 172.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.84 149.07 47.18 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.246 1.297 . . . . 0.0 111.458 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.05 154.88 29.57 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.403 1.402 . . . . 0.0 112.702 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 115' ' ' ILE . 91.6 mt -61.67 -14.95 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.132 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.2 t -44.12 -39.05 5.64 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.8 Cg_exo -59.31 -31.38 94.95 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.306 1.859 . . . . 0.0 112.373 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 112' ' ' ILE . 14.4 pt -98.76 7.03 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -78.09 142.03 38.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.447 0.567 . . . . 0.0 110.546 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 72' ' ' PRO . 59.3 mt . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.3 m -64.54 141.01 58.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.003 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.8 9.71 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.095 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.04 -44.06 32.34 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.87 -0.519 . . . . 0.0 112.64 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 -47.57 85.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.795 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.9 tp -59.43 -42.11 91.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 tp -60.09 -43.89 95.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -58.97 -43.27 91.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.595 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 m -60.87 -47.92 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.588 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.575 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 26.1 m -62.9 -39.84 95.76 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.923 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.81 -39.1 87.69 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.909 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.85 -42.65 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.247 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.88 -39.45 94.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.916 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.7 m -60.05 -25.24 65.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.83 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.6 -179.031 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -148.83 152.72 36.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.4 m-20 -92.22 126.74 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 6.7 tp -126.86 145.73 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.589 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -150.41 161.71 41.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.687 0.756 . . . . 0.0 112.484 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -55.57 -34.97 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.542 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.24 88.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.039 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -71.69 -46.65 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.054 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 8.0 mp -72.45 -25.76 61.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.13 -147.71 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -55.99 -21.59 22.0 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.367 0.985 . . . . 0.0 112.352 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.93 -25.32 63.37 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.495 ' HE3' HD22 ' A' ' 67' ' ' LEU . 47.0 t-105 -55.8 110.45 2.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.409 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 125' ' ' ILE . 67.0 Cg_endo -89.5 -13.27 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 114.158 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.7 145.76 24.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.304 0.573 . . . . 0.0 111.927 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 p -69.39 -36.86 77.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.67 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.12 129.48 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -61.58 -33.24 73.53 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.98 175.01 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.01 34.26 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.524 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.0 m -106.94 137.56 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.48 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -147.97 144.05 27.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.397 0.617 . . . . 0.0 112.299 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.644 169.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.692 0.282 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -133.16 158.64 43.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.619 0.724 . . . . 0.0 111.886 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CD1' HD21 ' A' ' 130' ' ' LEU . 89.0 t80 -114.08 128.65 56.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.848 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.84 131.37 58.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.14 155.53 36.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.781 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.71 -27.06 10.34 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.533 1.489 . . . . 0.0 113.079 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 29.6 p30 -63.99 -12.41 37.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.47 9.69 66.52 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.912 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.8 m -99.37 139.94 34.29 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m -103.54 129.55 50.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -114.69 150.56 35.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.073 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.44 126.06 34.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.311 . . . . 0.0 110.377 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.4 mt -82.99 -51.93 7.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.466 . . . . 0.0 110.187 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -109.18 166.84 10.55 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 111.761 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -52.41 -33.66 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.866 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -61.83 -48.65 79.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 110.775 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.65 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.45 -35.1 75.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.243 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.44 -41.2 98.56 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.243 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.04 -33.96 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.47 0.31 8.65 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.14 23.41 63.54 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.963 -0.354 . . . . 0.0 113.244 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -89.0 143.13 30.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 117.465 0.633 . . . . 0.0 109.421 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.14 148.39 44.31 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.256 1.304 . . . . 0.0 111.249 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.4 157.07 32.93 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.387 1.391 . . . . 0.0 112.625 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 115' ' ' ILE . 87.2 mt -60.61 -13.46 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 119.135 -0.46 . . . . 0.0 112.228 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.433 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.5 t -44.0 -39.44 6.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.5 Cg_exo -59.37 -31.29 94.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 CA-C-N 122.336 1.87 . . . . 0.0 112.387 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 112' ' ' ILE . 14.7 pt -98.83 7.83 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -77.34 140.67 40.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.341 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 117' ' ' ALA . 61.3 mt . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.984 0.421 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -64.93 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.848 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.55 8.24 39.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.193 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.91 -44.45 31.69 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.85 -0.531 . . . . 0.0 112.922 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.68 76.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.268 0.534 . . . . 0.0 110.778 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 90' ' ' PHE . 31.3 tp -59.24 -42.29 90.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.474 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.39 -42.99 97.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.53 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.9 t -59.55 -44.9 93.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.49 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.34 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.552 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.7 m -63.22 -40.04 96.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.31 -39.55 87.4 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.785 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -58.62 -42.77 88.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.09 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.4 m -60.49 -25.16 65.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.993 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.66 -179.298 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -144.55 153.14 41.51 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.271 172.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.409 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -93.19 126.57 38.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.8 tp -126.71 142.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.0 p -145.86 164.54 31.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.594 0.711 . . . . 0.0 111.929 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -55.57 -35.52 65.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.154 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.19 85.76 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.603 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -66.33 -46.63 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.577 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.672 HD12 ' CE3' ' A' ' 71' ' ' TRP . 48.3 mt -91.08 -8.13 49.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 60.93 -146.44 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -57.15 -24.04 51.5 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.306 0.957 . . . . 0.0 112.476 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD12 ' H ' ' A' ' 70' ' ' LEU . 6.5 mp -59.16 -22.37 60.84 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.672 ' CE3' HD12 ' A' ' 67' ' ' LEU . 55.9 t-105 -55.85 107.41 0.88 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.228 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.48 -13.27 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.812 1.674 . . . . 0.0 114.174 -174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.72 145.04 26.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.19 0.519 . . . . 0.0 111.66 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 p -69.04 -36.88 78.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.725 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.72 130.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.92 -32.69 73.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -169.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.78 174.43 11.83 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.734 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.409 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.6 m -107.82 139.97 41.62 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.612 -0.346 . . . . 0.0 110.071 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.49 134.84 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -145.95 142.64 28.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.425 0.631 . . . . 0.0 111.991 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.891 170.438 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.581 0.229 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.8 158.71 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.555 0.693 . . . . 0.0 111.931 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.2 t80 -114.05 129.04 56.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.898 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.9 131.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.61 155.13 36.72 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.749 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.37 -27.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.625 1.55 . . . . 0.0 113.152 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.8 p30 -64.36 -11.65 34.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.68 10.46 67.3 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.84 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.8 m -99.34 139.32 35.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.0 m -103.04 129.96 49.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.346 0.593 . . . . 0.0 110.023 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.47 150.89 37.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.188 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.39 128.88 35.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.697 0.284 . . . . 0.0 110.725 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 131' ' ' LEU . 21.6 mt -87.98 -57.12 3.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.094 0.473 . . . . 0.0 110.434 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.513 ' HB3' HD11 ' A' ' 131' ' ' LEU . 49.6 p30 -105.1 159.14 16.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -47.44 -35.26 8.28 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.095 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -61.64 -44.45 96.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.578 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.08 -37.36 74.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.392 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 31.2 mp0 -63.94 -39.22 93.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.026 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.5 -34.02 70.47 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.041 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 0.79 10.04 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.4 63.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.877 -0.402 . . . . 0.0 113.319 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -90.48 143.2 28.91 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.576 0.688 . . . . 0.0 109.668 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.11 148.1 39.14 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.267 1.311 . . . . 0.0 111.271 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.98 158.84 34.37 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.366 1.377 . . . . 0.0 112.939 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 115' ' ' ILE . 88.9 mt -61.13 -11.54 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.353 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.435 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.8 t -43.83 -39.82 6.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 113' ' ' THR . 24.7 Cg_exo -59.39 -32.11 96.01 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 CA-C-N 122.364 1.88 . . . . 0.0 112.433 -174.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 112' ' ' ILE . 23.1 pt -98.74 5.18 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -79.41 135.66 36.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.477 0.581 . . . . 0.0 110.772 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.077 0.465 . . . . 0.0 111.668 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 117' ' ' ALA . 79.9 mt . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 121.141 0.496 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 139.83 58.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.068 -174.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.99 9.43 37.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.053 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.16 31.73 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.827 -0.546 . . . . 0.0 112.913 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.1 75.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.313 0.557 . . . . 0.0 110.78 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.06 -41.58 88.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 101' ' ' ASN . 21.8 tp -60.36 -43.76 96.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -60.04 -44.15 94.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.601 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.0 m -60.56 -47.03 87.98 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.504 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.8 m -63.31 -40.4 97.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.68 -38.34 84.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.954 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.5 -42.58 87.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.55 -38.54 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.5 m -59.95 -25.23 65.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.91 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.168 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.676 179.403 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -149.03 150.71 33.26 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.792 168.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.5 m-20 -92.59 124.82 36.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 67' ' ' LEU . 5.9 tp -125.83 145.17 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -150.38 162.43 40.56 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.795 0.807 . . . . 0.0 112.419 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.95 -35.18 66.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.537 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.5 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.056 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.93 -46.65 51.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.078 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 HD11 ' A' ' 62' ' ' ILE . 8.2 mp -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.17 -147.03 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.8 -22.0 22.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.38 0.991 . . . . 0.0 112.468 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.41 -24.91 63.87 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.506 ' HE3' HD22 ' A' ' 67' ' ' LEU . 45.9 t-105 -55.89 110.98 2.64 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.357 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 125' ' ' ILE . 72.8 Cg_endo -89.55 -13.13 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.731 1.621 . . . . 0.0 114.108 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.42 145.47 24.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.191 0.52 . . . . 0.0 111.921 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.2 p -69.58 -37.03 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.663 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.11 129.34 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.97 -33.47 74.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -169.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -147.5 174.36 11.79 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.712 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.02 34.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.7 m -108.08 139.95 41.98 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.7 pt -109.36 139.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -148.01 145.44 28.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 112.303 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.3 m . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.695 173.29 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.173 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.24 157.27 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 111.458 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.3 t80 -114.17 128.07 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.98 130.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.22 155.59 36.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.802 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.47 -26.88 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.473 1.449 . . . . 0.0 113.097 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.8 p30 -64.31 -12.24 39.94 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.43 9.49 66.85 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.927 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.9 m -99.39 140.01 34.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 m -104.36 130.8 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.322 0.582 . . . . 0.0 110.087 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -116.18 148.24 40.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.082 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.686 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.4 128.3 35.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.692 0.282 . . . . 0.0 110.722 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.8 mt -87.58 -51.14 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -103.04 166.41 10.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.665 0.745 . . . . 0.0 112.037 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -55.33 -40.16 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.129 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -63.76 -42.06 97.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.334 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.597 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.61 -36.32 78.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 176.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.686 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.0 mm-40 -63.29 -41.44 98.98 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.306 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -59.2 -33.86 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.317 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.1 -1.54 10.28 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.45 63.67 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.897 -0.391 . . . . 0.0 113.238 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 14.5 m-70 -84.99 134.36 41.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.133 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.33 148.1 91.46 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.062 1.174 . . . . 0.0 111.235 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 157.97 30.36 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.315 1.343 . . . . 0.0 112.302 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 115' ' ' ILE . 91.0 mt -62.07 -11.75 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.256 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.0 t -43.79 -40.05 6.61 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -171.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD3' HG22 ' A' ' 113' ' ' THR . 25.7 Cg_exo -59.29 -32.28 96.55 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 CA-C-N 122.25 1.839 . . . . 0.0 112.417 -175.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 112' ' ' ILE . 17.7 pt -98.84 7.66 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.03 140.22 40.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.527 0.603 . . . . 0.0 110.399 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 111.82 -176.238 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.41 HG22 ' HB3' ' A' ' 72' ' ' PRO . 84.2 mt . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 121.08 0.466 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.4 m -65.01 140.81 58.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.951 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.95 9.27 36.28 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.139 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.01 -45.18 32.86 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.837 -0.54 . . . . 0.0 112.766 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.04 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.162 0.481 . . . . 0.0 110.707 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.1 tp -59.35 -42.35 91.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -43.31 94.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -58.81 -44.46 90.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.45 -47.34 86.53 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.568 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.611 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 24.3 m -62.51 -40.49 96.89 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.842 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.68 -39.41 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.858 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -58.8 -42.83 90.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 110.277 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.57 -38.21 90.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.191 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.8 m -60.08 -25.14 65.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.957 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.61 179.761 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -143.59 153.08 42.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.412 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.28 123.63 36.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.569 HD11 HD11 ' A' ' 67' ' ' LEU . 5.4 tp -125.45 145.77 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.484 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.0 p -148.48 162.94 38.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.776 0.798 . . . . 0.0 112.262 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -56.54 -34.76 67.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.478 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.55 91.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.067 -176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -69.24 -46.72 66.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 0.0 111.032 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.569 HD11 HD11 ' A' ' 62' ' ' ILE . 8.7 mp -72.7 -25.12 61.12 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.39 -148.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -55.37 -20.6 12.37 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.352 0.978 . . . . 0.0 112.417 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.75 -23.41 63.2 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.519 ' HE3' HD22 ' A' ' 67' ' ' LEU . 39.2 t-105 -55.9 112.89 4.84 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.326 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG22 ' A' ' 125' ' ' ILE . 66.0 Cg_endo -89.53 -13.24 2.85 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.863 1.709 . . . . 0.0 114.157 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -93.27 145.81 24.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.184 0.516 . . . . 0.0 111.722 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.96 -36.72 75.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.648 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.77 130.35 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -64.41 -30.59 71.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -150.64 176.86 10.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.725 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.66 162.07 34.41 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -107.47 139.84 41.35 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.7 pt -109.22 137.48 41.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -144.91 144.09 30.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.279 0.561 . . . . 0.0 112.008 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.712 173.459 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.615 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.24 157.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.344 0.592 . . . . 0.0 111.372 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.523 ' CD1' HD21 ' A' ' 130' ' ' LEU . 94.4 t80 -114.05 127.06 55.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.129 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.7 130.69 58.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.91 155.75 36.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.729 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.51 -26.68 9.25 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.44 1.427 . . . . 0.0 113.126 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 32.4 p30 -64.18 -12.56 41.46 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.96 9.17 66.17 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.911 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.4 m -99.41 139.35 35.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.412 0.606 . . . . 0.0 109.396 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.8 m -103.46 131.91 50.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.058 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -89.36 129.24 35.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.695 0.283 . . . . 0.0 110.796 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 mt -88.3 -51.88 5.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -103.6 167.6 9.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.615 0.721 . . . . 0.0 111.959 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -55.47 -40.32 71.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.975 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -63.3 -41.56 98.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.326 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.606 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.75 -37.71 79.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.832 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.04 -40.89 99.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.859 0.361 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.51 -34.07 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.714 0.292 . . . . 0.0 111.303 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.01 1.97 7.87 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.51 63.61 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.27 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -84.75 143.18 40.25 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.45 150.99 47.22 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.278 1.319 . . . . 0.0 111.931 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.89 151.97 36.2 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.299 1.332 . . . . 0.0 112.925 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 115' ' ' ILE . 91.4 mt -61.99 -13.31 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.2 t -46.76 -35.27 4.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.09 -33.78 97.73 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 CA-C-N 123.038 2.121 . . . . 0.0 112.039 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 112' ' ' ILE . 18.6 pt -98.94 7.77 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -77.26 142.3 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.684 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.152 0.501 . . . . 0.0 111.435 -178.124 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 72' ' ' PRO . 68.6 mt . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -62.1 140.51 58.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.179 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.48 6.98 47.13 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.241 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.21 -44.84 34.56 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.84 -0.538 . . . . 0.0 112.629 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.67 84.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.153 0.477 . . . . 0.0 110.74 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.9 tp -59.59 -42.23 92.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.456 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.11 -43.81 95.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.453 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -59.21 -43.35 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.641 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.54 -47.95 83.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.563 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.615 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 19.8 m -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.772 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.75 -39.0 87.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.8 -42.94 90.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.301 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.159 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.02 -25.3 65.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.772 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.224 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.911 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -145.62 153.12 40.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.589 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -90.87 123.71 34.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 67' ' ' LEU . 8.9 tp -124.55 146.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -148.99 161.62 41.55 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.804 0.811 . . . . 0.0 112.437 -173.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -56.45 -34.78 67.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.34 91.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.106 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.25 -46.72 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.04 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 62' ' ' ILE . 8.4 mp -72.5 -28.99 63.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.82 -141.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -54.0 -28.33 37.36 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.797 1.181 . . . . 0.0 112.058 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.96 -26.92 50.2 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.517 ' HE3' HD22 ' A' ' 67' ' ' LEU . 34.2 t-105 -55.82 109.97 1.98 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.709 -176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG22 ' A' ' 125' ' ' ILE . 64.4 Cg_endo -89.56 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.828 1.685 . . . . 0.0 114.108 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.2 mt -91.24 145.88 24.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 111.819 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -69.82 -37.11 76.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.623 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.49 129.95 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -64.38 -31.0 72.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -168.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -149.53 176.73 10.36 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.615 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.01 34.28 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -106.99 140.39 39.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 pt -109.51 138.66 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -144.96 144.15 30.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.568 . . . . 0.0 111.946 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.7 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.815 173.69 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.711 0.291 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.34 155.78 41.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.308 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 130' ' ' LEU . 93.8 t80 -114.16 127.52 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.139 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.5 131.12 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 36.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.852 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.2 -26.99 8.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.537 1.491 . . . . 0.0 113.106 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -64.8 -11.19 34.15 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 9.47 66.9 Favored Glycine 0 CA--C 1.537 1.422 0 O-C-N 122.104 -0.372 . . . . 0.0 112.921 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.0 m -99.44 138.95 35.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.86 130.96 50.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.209 0.528 . . . . 0.0 110.003 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.96 148.06 41.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.235 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.33 127.05 35.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.691 0.282 . . . . 0.0 110.714 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -85.22 -50.91 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.976 0.417 . . . . 0.0 110.332 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.92 167.65 9.57 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.67 0.748 . . . . 0.0 111.921 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -58.22 -37.54 75.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.076 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.77 -41.18 98.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.199 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.629 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.39 -36.94 79.27 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 175.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.33 -40.11 96.42 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.458 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -58.57 -33.94 70.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.157 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.24 1.59 7.41 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.51 63.58 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.946 -0.364 . . . . 0.0 113.253 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -86.59 143.19 35.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 117.498 0.649 . . . . 0.0 109.386 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.18 152.24 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.297 1.331 . . . . 0.0 111.349 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.04 157.84 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.297 1.331 . . . . 0.0 112.431 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.478 HG23 HD11 ' A' ' 115' ' ' ILE . 81.4 mt -62.91 -10.12 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.7 t -43.84 -39.6 6.0 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -172.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 28.0 Cg_exo -58.8 -33.72 98.62 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 CA-C-N 122.385 1.887 . . . . 0.0 112.232 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 112' ' ' ILE . 23.8 pt -98.9 7.44 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -77.61 139.3 39.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.336 0.516 . . . . 0.0 110.474 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 111.398 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 117' ' ' ALA . 60.5 mt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -59.53 139.2 57.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.403 HD23 ' CG ' ' A' ' 72' ' ' PRO . 69.9 mt -94.92 6.28 49.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.314 172.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -44.2 37.86 Favored Glycine 0 CA--C 1.526 0.758 0 O-C-N 121.873 -0.517 . . . . 0.0 112.741 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 -47.84 83.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.243 0.521 . . . . 0.0 110.76 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.2 tp -59.89 -42.43 93.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.57 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.0 tp -60.41 -43.03 97.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.523 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.2 t -58.91 -43.97 91.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.764 0.316 . . . . 0.0 110.531 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.13 -47.78 84.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.583 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.602 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.7 m -62.65 -40.56 97.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.802 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.019 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.31 -43.65 88.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.247 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.13 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.085 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.12 -25.14 65.23 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.09 0 C-N-CA 121.351 -0.452 . . . . 0.0 112.665 -179.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 mttt . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -148.83 150.81 33.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -94.15 126.09 39.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 4.9 tp -125.57 144.42 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.465 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 160.47 43.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.724 0.774 . . . . 0.0 112.356 -173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.66 -34.74 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.525 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.76 90.71 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.116 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -70.59 -46.54 63.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.171 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 7.7 mp -72.36 -25.05 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.87 -148.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -55.7 -20.48 14.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.271 0.941 . . . . 0.0 112.367 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.75 -24.3 63.94 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.498 ' HE3' HD22 ' A' ' 67' ' ' LEU . 46.6 t-105 -55.85 112.89 4.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.264 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB3' HG22 ' A' ' 125' ' ' ILE . 65.2 Cg_endo -89.54 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.812 1.675 . . . . 0.0 114.144 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.82 144.87 25.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 111.656 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.7 p -69.09 -37.41 78.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.585 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -64.27 129.77 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.08 -33.6 74.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -147.58 174.61 11.59 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.879 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 161.98 34.23 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.5 m -107.45 139.98 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 pt -109.58 138.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.79 145.9 31.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.24 0.543 . . . . 0.0 111.918 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.768 173.863 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.156 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 155.6 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.389 0.614 . . . . 0.0 111.405 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.512 ' CD1' HD21 ' A' ' 130' ' ' LEU . 93.8 t80 -114.1 127.54 55.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.134 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.15 130.9 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.472 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.35 155.91 35.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.838 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.61 -25.82 8.37 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.453 1.435 . . . . 0.0 113.139 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 32.4 p30 -65.23 -11.8 44.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.76 67.73 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 122.055 -0.403 . . . . 0.0 112.964 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.6 m -99.52 139.37 35.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.5 m -104.09 132.93 49.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 109.889 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -118.26 151.27 37.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.54 125.02 34.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.691 0.281 . . . . 0.0 110.646 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.9 mt -83.45 -50.33 8.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 109.918 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -103.27 167.56 9.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.574 0.702 . . . . 0.0 111.502 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.3 -38.8 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.954 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.93 -43.02 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.441 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.85 -37.68 79.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 110.723 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -63.33 -41.42 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.278 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -58.6 -32.79 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.514 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 2.38 6.27 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.09 23.48 63.51 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.176 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.76 142.4 45.39 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 153.83 76.58 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 121.316 1.344 . . . . 0.0 111.737 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 113' ' ' THR . 55.7 Cg_endo -78.06 151.58 27.29 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.375 1.383 . . . . 0.0 112.509 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 115' ' ' ILE . 92.9 mt -64.02 -16.57 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.223 -0.418 . . . . 0.0 111.878 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 111' ' ' PRO . 3.2 t -46.73 -35.26 4.84 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.38 -32.63 96.6 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 CA-C-N 123.155 2.163 . . . . 0.0 111.935 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 112' ' ' ILE . 24.0 pt -98.75 6.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -78.28 138.79 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.305 0.502 . . . . 0.0 110.74 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 121.162 0.506 . . . . 0.0 111.718 -177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 117' ' ' ALA . 55.6 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.1 0.476 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m -60.34 138.47 57.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.993 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -95.24 7.33 46.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.27 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -43.11 36.88 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.755 -0.591 . . . . 0.0 112.63 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.62 80.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.061 0.43 . . . . 0.0 110.781 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.4 tp -59.86 -42.51 93.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.23 -43.17 96.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.475 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 t -59.24 -43.95 92.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.547 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.0 m -59.93 -47.58 85.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.576 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.608 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.3 m -62.67 -40.95 98.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.04 -38.35 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.628 0.252 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.47 -43.7 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 110.2 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.88 -39.28 93.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.902 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.9 m -60.05 -25.16 65.13 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.841 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.189 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.842 -179.113 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mttp . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -152.1 151.45 31.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.505 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.0 m-20 -93.37 127.33 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.688 HD11 HD11 ' A' ' 67' ' ' LEU . 5.2 tp -127.73 145.46 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.509 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -150.48 160.89 43.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.734 0.778 . . . . 0.0 112.387 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -55.54 -34.94 65.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.12 89.99 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.031 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.16 -46.67 60.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.063 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -72.45 -26.78 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.79 -145.39 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -55.56 -23.27 25.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.486 1.039 . . . . 0.0 112.285 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.0 -23.57 63.76 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.497 ' HE3' HD22 ' A' ' 67' ' ' LEU . 44.5 t-105 -55.86 111.13 2.8 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.37 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -89.53 -13.18 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.845 1.697 . . . . 0.0 114.056 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.06 145.36 25.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 111.964 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.5 p -70.03 -37.29 75.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.535 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.65 129.59 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.84 -33.97 75.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.042 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -148.42 175.03 11.46 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.601 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.79 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.505 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.9 m -108.15 138.68 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 pt -106.81 134.37 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.32 145.18 30.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.417 0.627 . . . . 0.0 111.994 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.006 170.014 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 104' ' ' ALA . 35.3 m -132.22 156.35 42.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.464 0.649 . . . . 0.0 111.814 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.509 ' CD1' HD21 ' A' ' 130' ' ' LEU . 85.3 t80 -114.04 128.0 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.795 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.51 131.77 56.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.16 155.4 36.46 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.834 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.73 -27.1 10.46 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.62 1.546 . . . . 0.0 113.092 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 28.5 p30 -64.49 -11.69 36.43 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.55 66.63 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.936 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -99.42 140.29 33.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.7 m -103.75 129.23 51.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 110.093 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -114.79 151.88 33.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.04 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.3 124.93 33.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 110.43 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.2 -47.42 14.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.152 0.501 . . . . 0.0 109.809 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -115.36 167.62 10.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -53.84 -33.81 57.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.716 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -61.18 -49.01 78.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.323 0.582 . . . . 0.0 110.637 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.86 -37.39 76.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.09 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -61.42 -42.16 98.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.014 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -57.74 -33.96 69.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.8 9.18 3.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.5 63.6 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 122.177 -0.327 . . . . 0.0 113.358 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -97.01 112.08 59.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.366 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -54.78 150.4 36.85 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.472 1.204 . . . . 0.0 111.592 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.45 158.88 55.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.266 1.311 . . . . 0.0 112.391 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 115' ' ' ILE . 76.6 mt -61.59 -10.81 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.421 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.6 t -44.21 -38.92 5.64 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -172.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.421 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.2 Cg_exo -58.92 -33.59 98.74 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.612 1.968 . . . . 0.0 112.21 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 112' ' ' ILE . 17.9 pt -98.81 6.75 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -77.45 141.59 39.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.497 0.589 . . . . 0.0 110.796 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.508 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.416 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 117' ' ' ALA . 65.5 mt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 121.156 0.503 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -62.79 138.79 58.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.168 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -96.2 11.18 35.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.953 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -44.59 31.1 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.825 -0.547 . . . . 0.0 112.851 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.58 77.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.313 0.557 . . . . 0.0 110.797 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 90' ' ' PHE . 33.6 tp -59.15 -42.05 89.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -60.38 -43.69 96.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.656 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.9 p -60.61 -42.56 97.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.721 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.09 -47.18 87.52 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.642 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.1 m -63.09 -40.54 97.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.08 -39.46 86.15 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.799 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -58.76 -42.88 89.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.297 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.96 -39.28 91.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.055 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.6 m -59.93 -25.29 65.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.013 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.622 179.88 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.7 mttp . . . . . 0 N--CA 1.464 0.263 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -149.61 151.1 33.23 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.866 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.532 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.1 m-20 -93.76 126.99 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 67' ' ' LEU . 7.3 tp -128.25 145.95 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.144 -0.223 . . . . 0.0 110.597 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.39 161.23 42.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.695 0.76 . . . . 0.0 112.502 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -55.99 -34.82 66.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.535 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.54 86.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.07 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.33 -46.64 54.69 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.012 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -72.71 -26.19 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.56 -146.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -54.1 -28.1 37.2 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.412 1.006 . . . . 0.0 111.952 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.2 tp -53.97 -26.54 26.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.5 ' HE3' HD22 ' A' ' 67' ' ' LEU . 52.1 t-105 -55.69 111.09 2.72 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.318 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HB3' HG22 ' A' ' 125' ' ' ILE . 68.0 Cg_endo -89.69 -13.1 2.81 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.771 1.647 . . . . 0.0 114.197 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.82 145.36 25.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.204 0.526 . . . . 0.0 111.84 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.8 p -69.22 -37.12 77.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.62 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.36 129.23 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.66 -34.04 75.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.8 174.84 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.471 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.03 34.29 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.532 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.4 m -108.09 137.81 45.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 pt -106.82 133.15 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -146.81 147.17 30.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.469 0.652 . . . . 0.0 111.93 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.2 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.742 167.79 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.663 0.268 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.66 158.62 42.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.57 0.7 . . . . 0.0 111.938 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.522 ' CD1' HD21 ' A' ' 130' ' ' LEU . 86.3 t80 -114.09 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.767 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.55 131.45 57.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.14 155.21 36.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.823 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.69 -27.05 10.25 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.599 1.533 . . . . 0.0 113.103 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.1 p30 -64.11 -12.17 36.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.19 10.05 66.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.889 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 m -99.4 139.9 34.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.24 129.53 50.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.302 0.572 . . . . 0.0 110.124 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -114.58 149.41 36.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.038 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.32 126.17 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.821 0.343 . . . . 0.0 110.439 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' A' ' 131' ' ' LEU . 19.5 mt -83.71 -51.75 6.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.442 ' HB3' HD11 ' A' ' 131' ' ' LEU . 51.0 p30 -111.93 167.63 10.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.7 0.762 . . . . 0.0 111.924 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.92 -34.22 54.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -60.77 -47.07 88.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.325 0.584 . . . . 0.0 110.459 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.602 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.406 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.607 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.1 mm-40 -62.25 -41.25 98.27 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.236 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -59.49 -34.0 72.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.259 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.34 -2.88 12.0 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.53 63.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 122.128 -0.358 . . . . 0.0 113.166 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -88.93 143.2 31.08 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 117.454 0.627 . . . . 0.0 109.566 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.42 148.11 37.64 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.203 1.269 . . . . 0.0 111.324 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -76.09 158.78 37.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.368 1.378 . . . . 0.0 112.684 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 115' ' ' ILE . 82.8 mt -60.77 -12.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 119.013 -0.518 . . . . 0.0 112.28 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.435 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.8 t -43.76 -39.64 5.88 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 113' ' ' THR . 25.1 Cg_exo -59.44 -31.91 95.56 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 CA-C-N 122.35 1.875 . . . . 0.0 112.432 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 112' ' ' ILE . 20.0 pt -98.84 6.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -77.57 137.54 38.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.54 0.609 . . . . 0.0 110.453 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 111.778 -176.148 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 72' ' ' PRO . 83.9 mt . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 121.099 0.476 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.0 m -65.03 140.88 58.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.055 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.43 8.63 39.82 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.14 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.1 -43.67 32.56 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.897 -0.502 . . . . 0.0 112.745 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.45 -49.48 77.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.161 0.48 . . . . 0.0 110.84 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 90' ' ' PHE . 29.9 tp -58.82 -42.0 88.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.476 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 101' ' ' ASN . 24.0 tp -59.82 -44.22 94.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.484 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -59.96 -43.9 94.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.666 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.1 m -60.5 -46.75 88.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.449 . . . . 0.0 110.58 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.5 m -63.14 -41.35 99.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.01 -39.4 85.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.746 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.33 -42.39 91.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.56 -39.69 94.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -63.12 -25.18 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.144 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.144 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.636 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -139.01 152.81 47.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.656 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -93.87 126.21 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.681 HD11 HD11 ' A' ' 67' ' ' LEU . 6.4 tp -124.91 144.85 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.9 p -150.38 160.82 43.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.673 0.749 . . . . 0.0 112.447 -173.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -55.64 -34.68 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.567 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.64 -42.17 87.69 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.104 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -73.64 -46.61 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.375 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.681 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -71.36 -27.78 63.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.4 -142.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -54.11 -28.88 42.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.683 1.129 . . . . 0.0 111.883 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 70' ' ' LEU . 7.4 mp -56.98 -24.77 55.78 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.48 ' HE3' HD22 ' A' ' 67' ' ' LEU . 48.0 t-105 -55.91 107.49 0.9 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.368 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HB3' HG22 ' A' ' 125' ' ' ILE . 67.6 Cg_endo -87.2 -13.24 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.703 1.602 . . . . 0.0 114.136 -175.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.0 mt -89.59 145.56 25.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.559 . . . . 0.0 111.94 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.3 p -69.85 -37.28 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.719 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.15 130.13 30.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.02 -33.4 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.043 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -147.01 174.55 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.667 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.72 162.09 34.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -107.92 140.58 40.83 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.539 -0.389 . . . . 0.0 110.112 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.96 135.36 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.36 143.57 31.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.295 0.569 . . . . 0.0 112.151 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.672 173.765 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.583 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.489 HG12 ' HB1' ' A' ' 104' ' ' ALA . 31.8 m -131.86 155.23 41.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 111.225 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.51 ' CD1' HD21 ' A' ' 130' ' ' LEU . 90.0 t80 -114.1 128.04 56.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.031 178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.97 131.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.52 155.32 36.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.75 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.42 -26.54 8.83 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.565 1.51 . . . . 0.0 113.111 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.1 p30 -64.43 -12.17 40.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.36 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.92 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.9 m -99.41 140.01 34.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.6 m -104.73 130.92 52.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 110.095 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -116.32 148.41 40.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.0 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 124.94 33.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.767 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 mt -82.18 -48.5 11.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 0.0 109.982 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.5 p30 -108.39 167.63 9.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.47 0.653 . . . . 0.0 111.606 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -55.03 -40.99 70.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.979 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -63.42 -42.47 98.72 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.37 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.649 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.3 -39.27 78.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.077 0.465 . . . . 0.0 110.616 176.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -62.32 -41.7 98.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.944 0.402 . . . . 0.0 110.213 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -57.69 -33.07 67.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.495 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.79 9.92 3.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.47 63.67 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.359 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -94.64 112.03 56.33 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.097 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.39 153.41 40.97 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.183 1.255 . . . . 0.0 111.569 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.35 158.84 56.0 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.263 1.309 . . . . 0.0 112.283 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 115' ' ' ILE . 74.7 mt -62.75 -9.92 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.413 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.8 t -44.43 -38.69 5.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -172.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.6 Cg_exo -58.93 -33.14 98.55 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 CA-C-N 122.474 1.919 . . . . 0.0 112.329 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 112' ' ' ILE . 15.8 pt -98.91 6.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -77.53 140.84 39.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.479 0.581 . . . . 0.0 110.522 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 -178.286 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 72' ' ' PRO . 88.9 mt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.156 0.503 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -65.08 140.89 58.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.89 9.55 38.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.13 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -45.86 32.97 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.841 -0.537 . . . . 0.0 112.838 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.79 87.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.237 0.518 . . . . 0.0 110.822 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 90' ' ' PHE . 39.7 tp -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.492 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.465 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -58.65 -43.13 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.662 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.91 -47.74 85.03 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.584 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.583 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 25.4 m -62.62 -40.11 95.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.856 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.97 -39.93 87.33 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.788 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.82 -43.64 90.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.292 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.58 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.334 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.92 -25.23 64.98 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.117 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.709 178.084 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.9 mttm . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -151.18 152.57 33.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.533 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.2 m-20 -95.91 128.57 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 5.3 tp -128.0 145.0 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -150.12 161.63 42.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.706 0.765 . . . . 0.0 112.466 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.69 -34.42 65.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.547 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.39 90.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.104 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -69.89 -46.76 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.953 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 7.9 mp -72.91 -25.67 61.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.9 -147.61 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -55.92 -21.16 19.02 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.34 0.973 . . . . 0.0 112.292 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.87 -23.43 63.43 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.495 ' HE3' HD22 ' A' ' 67' ' ' LEU . 47.6 t-105 -55.75 113.08 5.06 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.3 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 125' ' ' ILE . 63.6 Cg_endo -89.67 -13.25 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.752 1.635 . . . . 0.0 114.306 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -94.15 147.31 23.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.173 0.511 . . . . 0.0 111.915 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.0 p -69.58 -36.4 76.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.728 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.69 128.22 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.88 -33.93 75.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -148.61 174.94 11.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.557 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 162.07 34.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.2 m -108.58 140.47 41.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.611 -0.346 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 pt -108.47 136.77 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.35 143.56 31.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.391 0.615 . . . . 0.0 111.941 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.744 173.033 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.576 0.227 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.54 154.64 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.498 0.666 . . . . 0.0 111.491 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.7 t80 -114.04 127.91 56.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.801 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.31 131.86 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.48 155.17 36.68 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.821 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.7 -26.87 10.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.629 1.553 . . . . 0.0 113.018 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 29.8 p30 -64.22 -12.16 38.13 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.72 10.37 67.31 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 121.491 -0.385 . . . . 0.0 112.832 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 m -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.6 m -101.52 130.43 47.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.261 0.553 . . . . 0.0 109.943 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.65 147.23 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.813 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.31 124.99 33.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 110.794 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.93 -48.27 11.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -112.55 167.58 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.614 0.721 . . . . 0.0 112.004 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -53.79 -40.76 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.151 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -63.36 -41.11 98.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.252 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.47 -38.61 77.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.695 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.16 -40.71 98.33 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.412 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -58.01 -33.88 69.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.314 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.89 7.53 4.7 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.48 63.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.227 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -94.49 111.99 55.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.361 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.72 151.51 31.75 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.189 1.259 . . . . 0.0 111.358 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.1 158.98 45.04 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.476 1.451 . . . . 0.0 112.705 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.512 HG23 HD11 ' A' ' 115' ' ' ILE . 80.1 mt -59.64 -12.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.344 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.1 t -43.36 -40.71 6.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -171.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.9 Cg_exo -58.05 -30.04 88.9 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 122.507 1.931 . . . . 0.0 112.703 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.512 HD11 HG23 ' A' ' 112' ' ' ILE . 13.8 pt -98.9 7.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -68.58 149.18 49.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.742 0.701 . . . . 0.0 110.801 -176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 111.626 -178.104 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 72' ' ' PRO . 74.6 mt . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 121.046 0.45 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -69.27 141.46 54.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.997 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.4 mt -91.87 5.83 48.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.318 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.89 -43.74 39.82 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.792 -0.567 . . . . 0.0 112.543 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.94 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 110.78 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.0 tp -59.62 -42.77 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.18 -42.89 95.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.435 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 m -59.54 -43.69 93.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.687 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.4 m -61.37 -47.82 84.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.605 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.6 m -63.56 -39.62 94.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.939 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.19 -38.74 87.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.936 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.36 -43.2 88.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.894 0.378 . . . . 0.0 110.222 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.76 -39.68 94.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.893 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.2 m -60.07 -25.2 65.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.631 -179.36 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE3' HG21 ' A' ' 79' ' ' THR . 49.2 tttp . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -145.61 153.15 40.74 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.056 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' HG23 ' A' ' 79' ' ' THR . 78.8 m-20 -95.02 128.25 41.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 67' ' ' LEU . 4.7 tp -126.57 141.49 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.0 p -144.23 164.66 30.08 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.595 0.712 . . . . 0.0 111.865 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -55.69 -36.15 66.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.322 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.04 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.765 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -70.63 -46.58 63.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.936 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.649 HD12 ' CE3' ' A' ' 71' ' ' TRP . 46.0 mt -85.03 -9.45 58.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.7 -151.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -56.03 -20.08 15.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.914 0.779 . . . . 0.0 112.366 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -57.54 -25.79 60.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.649 ' CE3' HD12 ' A' ' 67' ' ' LEU . 53.1 t-105 -55.79 107.18 0.81 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.27 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.21 -13.17 4.51 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.832 1.688 . . . . 0.0 114.068 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -88.21 145.69 25.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.36 0.6 . . . . 0.0 112.062 -174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.3 p -69.83 -36.89 75.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.72 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.22 129.01 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.67 -32.43 72.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -146.78 174.35 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.652 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.6 m -107.81 140.32 41.07 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.625 -0.338 . . . . 0.0 110.1 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 pt -109.34 137.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -148.04 146.45 28.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.384 0.611 . . . . 0.0 112.067 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.8 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.722 173.451 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.52 156.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.328 0.585 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.3 t80 -114.08 128.35 56.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.18 130.76 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.32 155.32 36.53 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.762 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.49 -26.8 9.35 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.495 1.463 . . . . 0.0 113.064 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.8 p30 -63.88 -12.71 39.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.84 9.68 65.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 122.071 -0.393 . . . . 0.0 112.91 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m -99.43 139.72 34.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -104.47 131.62 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 0.0 110.09 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.81 149.31 41.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.18 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.663 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.36 128.22 35.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.704 0.288 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.87 -52.66 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.478 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -103.12 167.61 9.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.598 0.714 . . . . 0.0 112.117 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.86 -40.46 69.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.148 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -63.88 -42.03 97.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.301 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.17 -37.11 79.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.663 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.0 mm-40 -63.12 -41.02 99.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.288 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.13 -33.94 71.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.638 0.256 . . . . 0.0 111.317 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.66 -1.7 12.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.44 63.72 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.907 -0.385 . . . . 0.0 113.16 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 44.2 m-70 -83.2 135.86 44.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.207 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.07 147.85 94.32 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.053 1.168 . . . . 0.0 111.27 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.07 158.87 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.445 1.43 . . . . 0.0 112.481 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 115' ' ' ILE . 86.9 mt -62.31 -10.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.438 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.2 t -43.64 -40.03 6.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.0 Cg_exo -59.14 -32.19 96.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.293 1.855 . . . . 0.0 112.605 -174.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 112' ' ' ILE . 14.9 pt -98.96 7.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 149.81 42.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.718 0.69 . . . . 0.0 110.882 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.647 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 172.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.647 HD12 ' HB3' ' A' ' 117' ' ' ALA . 88.6 mt . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.043 0.449 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -59.79 137.09 58.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.275 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.5 mt -99.16 6.81 46.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.304 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.65 -43.55 37.42 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.822 -0.549 . . . . 0.0 112.771 -173.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.93 75.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.248 0.524 . . . . 0.0 110.814 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.55 -42.15 91.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.7 tp -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.494 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.55 -43.31 93.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.595 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.6 m -60.99 -48.0 83.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.594 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.609 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 25.1 m -63.11 -40.48 97.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.805 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.09 -38.96 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.958 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -58.51 -43.76 89.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.368 . . . . 0.0 110.2 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.01 -39.55 95.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.988 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.94 -25.33 65.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.032 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.192 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.554 -179.686 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -150.6 147.51 27.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.79 167.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 79' ' ' THR . 72.7 m-20 -98.96 126.35 44.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.765 HD11 HD11 ' A' ' 67' ' ' LEU . 8.3 tt -132.04 152.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.276 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.8 p -150.44 166.41 30.19 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.683 0.754 . . . . 0.0 111.82 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -55.61 -34.6 65.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.238 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.68 88.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.743 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -66.23 -46.49 76.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.368 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.765 HD11 HD11 ' A' ' 62' ' ' ILE . 10.5 mp -84.73 -14.74 47.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.47 -148.99 0.28 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.26 -20.85 20.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.105 0.866 . . . . 0.0 112.343 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.47 -23.28 57.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.562 ' CE3' HD22 ' A' ' 67' ' ' LEU . 37.3 t-105 -55.83 113.46 5.75 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.427 -176.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -89.61 -13.2 2.82 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.786 1.658 . . . . 0.0 114.086 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.07 144.9 24.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.243 0.544 . . . . 0.0 111.875 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.1 p -68.65 -37.15 79.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.627 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.32 130.36 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -63.9 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -168.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -152.98 177.26 10.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.662 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.08 34.33 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.549 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.5 m -108.17 141.49 39.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 pt -108.95 136.77 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -139.78 140.31 36.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.444 0.64 . . . . 0.0 111.949 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.108 170.72 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.552 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 159.0 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.459 0.647 . . . . 0.0 111.402 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 130' ' ' LEU . 91.0 t80 -114.09 126.54 55.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.78 129.68 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.479 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.89 155.79 36.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.676 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.85 -26.84 10.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.541 1.494 . . . . 0.0 113.109 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.5 p30 -63.88 -12.86 40.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.83 66.43 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.886 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -99.34 139.74 34.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -104.84 129.07 53.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.013 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -114.07 149.64 35.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.008 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.654 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.45 128.98 35.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.723 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.4 mt -88.54 -52.16 5.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.445 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p30 -103.22 167.41 9.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 112.192 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -55.43 -40.4 71.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.063 -173.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -62.85 -41.7 99.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.588 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -61.06 -36.67 80.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 0.0 110.958 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.654 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.1 mm-40 -62.81 -41.35 99.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.312 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.37 -33.97 71.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.71 0.291 . . . . 0.0 111.346 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.99 -1.07 10.82 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.49 63.64 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.093 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -83.2 143.15 44.78 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.528 0.664 . . . . 0.0 109.251 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.02 147.77 55.47 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.235 1.29 . . . . 0.0 111.379 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.14 154.77 29.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.332 1.354 . . . . 0.0 112.772 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 115' ' ' ILE . 92.6 mt -62.64 -16.63 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.021 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.422 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.4 t -44.46 -38.53 5.58 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HD3' HG22 ' A' ' 113' ' ' THR . 32.5 Cg_exo -58.99 -31.89 96.54 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.383 1.887 . . . . 0.0 112.193 -176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 112' ' ' ILE . 17.4 pt -98.05 3.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -78.18 135.66 37.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.47 0.577 . . . . 0.0 110.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.454 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.189 0.519 . . . . 0.0 111.862 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' A' ' 117' ' ' ALA . 75.5 mt . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.975 0.416 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 140.39 58.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.126 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.5 mt -95.3 9.72 38.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.1 171.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.13 -44.05 33.12 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.845 -0.534 . . . . 0.0 112.648 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.78 84.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.121 0.46 . . . . 0.0 110.666 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.6 tp -59.32 -42.06 90.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 110.51 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -60.01 -44.4 94.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.496 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 m -59.2 -42.69 91.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.63 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.61 -47.97 83.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.641 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.552 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 20.8 m -62.86 -40.15 96.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.729 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.72 -39.0 86.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -58.66 -42.65 88.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.29 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.13 -39.12 93.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.96 -25.19 65.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.869 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.252 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.475 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.6 tttm . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -150.2 147.95 28.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.952 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' OD1' HG23 ' A' ' 79' ' ' THR . 77.8 m-20 -96.79 127.37 42.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.449 HD11 HD21 ' A' ' 67' ' ' LEU . 8.4 tp -128.0 143.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.984 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.5 p -143.88 164.82 29.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.516 0.674 . . . . 0.0 111.552 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -55.55 -36.22 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.163 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.52 84.29 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.766 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -70.44 -45.06 66.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.671 HD12 ' CE3' ' A' ' 71' ' ' TRP . 48.3 mt -87.23 -8.68 56.56 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.78 -149.57 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -55.76 -21.74 20.55 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.036 0.834 . . . . 0.0 112.336 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -56.42 -28.07 58.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.671 ' CE3' HD12 ' A' ' 67' ' ' LEU . 54.4 t-105 -55.69 107.25 0.82 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.397 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.34 -13.18 4.4 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.755 1.637 . . . . 0.0 114.15 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.73 145.05 26.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.82 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -69.55 -37.5 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.509 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.7 m -63.68 129.72 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.22 -33.44 75.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.16 173.14 12.79 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.709 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 161.99 34.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.537 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.6 m -108.13 139.58 42.58 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.575 -0.368 . . . . 0.0 110.082 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 pt -107.58 136.18 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.34 143.69 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.462 0.649 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.143 171.017 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.638 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.03 157.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.413 0.625 . . . . 0.0 111.412 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 130' ' ' LEU . 91.1 t80 -114.07 127.02 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.933 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.02 131.03 58.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.419 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -101.18 155.96 35.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.812 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.51 -26.67 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.503 1.469 . . . . 0.0 113.19 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 35.0 p30 -64.96 -11.58 40.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.94 9.62 67.7 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.944 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.5 m -99.43 139.9 34.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -104.58 130.57 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.1 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.54 148.02 40.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.005 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.36 127.53 35.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.762 0.315 . . . . 0.0 110.835 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.16 -50.46 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.344 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -105.66 167.6 9.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.637 0.732 . . . . 0.0 111.95 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.33 -40.74 71.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.159 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -64.09 -40.94 97.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.288 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.98 -37.66 77.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.57 -40.36 96.77 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.342 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -58.26 -34.02 70.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.211 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.62 1.82 7.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.92 23.55 63.77 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.986 -0.341 . . . . 0.0 113.227 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -88.24 125.99 62.12 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.219 172.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.68 152.48 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 CA-C-N 120.614 1.255 . . . . 0.0 111.372 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.07 158.01 30.45 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.357 1.371 . . . . 0.0 112.344 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 115' ' ' ILE . 85.3 mt -62.04 -11.18 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.993 -0.527 . . . . 0.0 112.291 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.436 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.7 t -44.09 -39.64 6.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.436 ' HD3' HG22 ' A' ' 113' ' ' THR . 24.5 Cg_exo -59.68 -32.45 95.8 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-N 122.296 1.856 . . . . 0.0 112.401 -175.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.437 HD11 HG23 ' A' ' 112' ' ' ILE . 17.8 pt -98.82 7.69 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -77.8 139.95 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.458 0.572 . . . . 0.0 110.398 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -177.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.1 mt . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 121.056 0.455 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -64.63 140.99 58.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.109 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -93.9 8.53 40.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.16 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.88 -44.16 31.27 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 121.808 -0.557 . . . . 0.0 112.764 -173.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.18 82.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.136 0.468 . . . . 0.0 110.759 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 90' ' ' PHE . 32.8 tp -59.5 -41.99 91.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.464 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.7 m -59.18 -43.52 92.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.597 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.2 m -61.02 -47.5 86.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.651 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.638 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 18.9 m -62.99 -40.08 96.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.815 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.65 -39.67 89.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -58.65 -42.41 88.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.342 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.97 -39.2 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.025 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.9 m -60.01 -25.22 65.12 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.938 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.16 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.644 -179.774 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.4 tttp . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -146.46 153.04 39.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.917 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' HG23 ' A' ' 79' ' ' THR . 80.0 m-20 -91.98 125.6 36.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 67' ' ' LEU . 5.2 tp -123.26 144.31 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -175.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.3 p -150.06 160.51 43.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.614 0.721 . . . . 0.0 112.299 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.57 -34.28 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.545 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.25 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.059 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -70.74 -46.66 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 62' ' ' ILE . 7.6 mp -73.57 -23.24 59.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.25 -150.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.08 -26.59 27.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.112 0.869 . . . . 0.0 111.797 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -53.06 -28.28 24.02 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.436 ' HE3' HD22 ' A' ' 67' ' ' LEU . 59.4 t-105 -55.77 107.13 0.79 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.189 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.22 -13.29 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.757 1.638 . . . . 0.0 114.113 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.31 144.43 28.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.202 0.525 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -68.17 -37.13 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.777 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.16 129.76 31.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -61.76 -32.95 73.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -147.1 174.55 11.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.07 34.34 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.474 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.2 m -107.51 138.46 43.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.659 -0.318 . . . . 0.0 110.145 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -108.98 132.83 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -148.07 144.91 28.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.38 0.61 . . . . 0.0 112.27 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.4 m . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.465 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.672 0.273 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.72 158.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.614 0.721 . . . . 0.0 111.921 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.504 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.1 t80 -114.15 129.18 56.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.879 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.88 131.73 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.66 155.15 36.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.666 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -48.85 -25.75 8.88 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.487 1.458 . . . . 0.0 113.104 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.1 p30 -65.27 -11.74 44.44 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.38 67.6 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.847 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.9 m -99.4 138.63 36.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 m -103.18 129.37 50.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.231 0.538 . . . . 0.0 110.067 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -114.14 148.83 36.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.024 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 125.93 34.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.325 . . . . 0.0 110.409 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.05 -51.38 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HB3' HD11 ' A' ' 131' ' ' LEU . 51.7 p30 -112.38 167.59 10.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.658 0.742 . . . . 0.0 112.012 -175.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -52.32 -34.02 45.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.777 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -61.71 -47.43 85.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.619 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.9 -34.29 74.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.424 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.594 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 76.9 mm-40 -62.31 -41.14 98.28 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.131 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -59.08 -34.01 71.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.064 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.09 -3.35 12.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.46 63.71 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.65 -0.309 . . . . 0.0 113.242 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -89.75 143.2 29.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.393 0.597 . . . . 0.0 109.593 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 150.17 47.42 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.242 1.295 . . . . 0.0 111.265 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.97 158.94 30.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.373 1.382 . . . . 0.0 112.783 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 115' ' ' ILE . 92.5 mt -60.02 -14.0 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.159 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.438 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.5 t -42.97 -41.33 6.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD3' HG22 ' A' ' 113' ' ' THR . 19.1 Cg_exo -61.76 -27.41 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 CA-C-N 122.039 1.764 . . . . 0.0 112.656 -173.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 112' ' ' ILE . 9.5 pt -98.8 6.64 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HD3' HD11 ' A' ' 127' ' ' LEU . 78.6 mtm180 -75.87 143.38 41.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.884 0.766 . . . . 0.0 110.828 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.812 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 117' ' ' ALA . 87.3 mt . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 121.15 0.5 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -64.08 140.88 58.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.238 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.403 HD11 ' HD3' ' A' ' 116' ' ' ARG . 67.3 mt -95.11 10.86 34.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.053 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.7 -45.44 30.76 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.8 -0.563 . . . . 0.0 112.877 -173.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.85 -48.48 81.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.263 0.531 . . . . 0.0 110.835 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 90' ' ' PHE . 31.2 tp -59.31 -42.1 90.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 101' ' ' ASN . 27.8 tp -59.59 -44.17 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -59.82 -44.2 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.599 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.9 m -60.27 -46.29 90.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.565 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.6 m -62.35 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.976 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.0 -39.61 86.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.677 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.51 -41.97 91.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.05 -39.72 93.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.97 -25.21 65.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.794 177.322 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 tttt . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -143.95 150.01 37.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.0 m-20 -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.69 HD11 HD11 ' A' ' 67' ' ' LEU . 9.2 tp -126.87 146.69 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.713 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.7 p -150.52 160.55 43.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.691 0.758 . . . . 0.0 112.305 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -55.48 -34.84 64.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.477 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.14 90.54 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.183 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -70.08 -46.58 64.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.287 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 62' ' ' ILE . 7.9 mp -72.12 -25.7 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.23 -148.64 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.25 -20.06 16.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.3 0.954 . . . . 0.0 112.429 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.5 -24.17 63.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.503 ' HE3' HD22 ' A' ' 67' ' ' LEU . 45.4 t-105 -55.88 112.59 4.49 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.32 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 125' ' ' ILE . 64.1 Cg_endo -89.52 -13.24 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.754 1.636 . . . . 0.0 114.166 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.3 mt -90.9 145.21 24.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.532 . . . . 0.0 111.883 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.03 -37.5 78.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.58 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.88 129.94 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -62.34 -33.59 75.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.95 174.49 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.765 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.06 34.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.4 m -108.09 140.07 41.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.16 136.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.74 144.12 39.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.583 . . . . 0.0 111.988 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.695 172.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.685 0.279 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.36 156.77 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.367 0.603 . . . . 0.0 111.306 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.6 t80 -114.08 126.47 55.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.048 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.27 130.49 57.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.448 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.28 155.83 35.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.819 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.52 -26.68 9.28 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.588 1.525 . . . . 0.0 113.105 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.448 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 33.3 p30 -64.74 -11.91 41.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.23 67.12 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 122.123 -0.361 . . . . 0.0 112.913 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.6 m -99.39 140.14 34.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.85 130.46 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.17 0.509 . . . . 0.0 110.102 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.69 149.06 38.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.106 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 126.93 35.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.696 0.284 . . . . 0.0 110.805 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.36 -50.52 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.965 0.412 . . . . 0.0 110.226 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.34 167.6 9.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 111.687 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -56.75 -38.37 72.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.062 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -64.79 -41.79 95.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.548 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.613 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.86 -37.88 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.811 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.05 -52.09 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.338 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.67 -20.27 66.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.06 9.85 3.37 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.55 63.32 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 122.28 -0.262 . . . . 0.0 113.456 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -96.98 112.97 62.18 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -54.27 152.72 24.43 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 CA-C-N 120.577 1.242 . . . . 0.0 111.7 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.02 158.98 30.7 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.457 1.438 . . . . 0.0 112.75 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 115' ' ' ILE . 93.9 mt -61.29 -10.68 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.302 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.3 t -42.19 -41.81 5.47 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -172.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD3' HG22 ' A' ' 113' ' ' THR . 19.0 Cg_exo -62.14 -30.19 81.91 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 122.004 1.752 . . . . 0.0 112.612 -173.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 112' ' ' ILE . 15.7 pt -98.87 5.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.485 ' HD2' HD11 ' A' ' 127' ' ' LEU . 83.0 mtp180 -75.63 143.03 42.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.835 0.743 . . . . 0.0 110.555 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.897 0.379 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 117' ' ' ALA . 45.4 mt . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.968 0.413 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -63.49 140.63 58.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.015 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.485 HD11 ' HD2' ' A' ' 116' ' ' ARG . 70.6 mt -93.16 9.81 34.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.121 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.78 -44.14 30.51 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.858 -0.526 . . . . 0.0 112.757 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.17 82.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.161 0.481 . . . . 0.0 110.707 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.5 tp -59.21 -41.89 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 110.458 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.48 -44.47 95.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.7 p -59.76 -40.86 89.58 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.649 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.9 m -61.66 -48.57 80.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.601 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.516 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.9 m -62.6 -40.28 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.727 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.44 -39.49 87.69 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -58.58 -43.0 89.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.315 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.07 -39.47 92.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.91 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -60.1 -25.23 65.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.794 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.643 -179.058 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -148.05 153.21 38.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.576 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.498 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.2 m-20 -90.53 125.21 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 67' ' ' LEU . 9.4 tp -126.05 147.12 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.23 162.1 41.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.783 0.801 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.62 -35.05 65.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.414 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.05 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.134 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.0 -46.64 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.257 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 HD11 ' A' ' 62' ' ' ILE . 8.3 mp -73.56 -26.61 60.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -175.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.46 -146.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -56.18 -20.12 16.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.495 1.043 . . . . 0.0 112.463 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.27 -25.13 63.83 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.49 ' HE3' HD22 ' A' ' 67' ' ' LEU . 36.1 t-105 -55.87 111.76 3.52 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.572 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.63 -13.23 2.8 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.858 1.705 . . . . 0.0 114.096 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.8 mt -90.6 145.57 24.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.177 0.513 . . . . 0.0 111.953 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.8 p -69.71 -37.43 76.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.555 174.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.76 128.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.75 -33.99 75.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.068 -169.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.25 174.82 11.26 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.503 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.76 162.04 34.29 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.1 m -106.76 139.72 40.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.9 pt -108.16 135.77 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -146.19 141.03 27.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.375 0.607 . . . . 0.0 112.181 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.055 170.814 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.323 0 CA-C-O 120.754 0.312 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.567 HG12 ' HB1' ' A' ' 104' ' ' ALA . 35.5 m -132.06 155.81 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.554 0.692 . . . . 0.0 111.783 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.3 t80 -114.18 130.24 56.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.81 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.6 t -109.51 131.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.47 155.35 36.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.851 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.68 -27.33 10.73 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.605 1.537 . . . . 0.0 113.09 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.6 p30 -64.04 -12.03 34.78 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 10.24 66.49 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 122.153 -0.342 . . . . 0.0 112.896 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 57.4 m -99.43 139.11 35.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.48 130.49 49.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 109.993 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.62 150.88 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.141 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.34 124.9 33.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 mt -79.85 -47.13 15.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 109.793 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -114.89 166.27 11.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.358 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -52.9 -34.53 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.735 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -61.01 -49.05 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.747 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.6 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.21 -37.12 76.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -61.66 -42.31 98.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.998 0.427 . . . . 0.0 110.089 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -58.23 -33.17 69.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.358 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.16 9.77 2.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.51 63.42 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.18 -0.325 . . . . 0.0 113.38 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -97.55 111.96 60.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.339 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -54.46 150.94 32.29 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.116 1.21 . . . . 0.0 111.654 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.81 158.9 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.325 1.35 . . . . 0.0 112.477 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.5 HG23 HD11 ' A' ' 115' ' ' ILE . 75.3 mt -61.9 -10.62 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.6 t -44.41 -38.83 5.89 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.424 ' HD3' HG22 ' A' ' 113' ' ' THR . 30.1 Cg_exo -58.79 -32.49 97.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 CA-C-N 122.472 1.919 . . . . 0.0 112.462 -175.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 112' ' ' ILE . 19.0 pt -98.83 7.55 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -76.45 137.34 39.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.495 0.588 . . . . 0.0 110.478 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.636 -175.9 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 121.086 0.469 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -63.1 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.842 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.52 9.27 35.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.098 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.8 31.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.838 -0.539 . . . . 0.0 112.852 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.323 0.562 . . . . 0.0 110.752 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.8 tp -59.1 -42.35 90.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.17 -43.24 95.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.473 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.7 m -59.24 -43.64 92.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.628 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.75 -47.63 85.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.538 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.5 m -63.22 -39.69 95.33 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.088 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.11 -39.49 86.36 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.724 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -58.75 -43.09 90.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.04 -38.62 89.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.8 m -59.89 -25.33 65.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.997 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.648 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 tttt . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -147.01 146.82 30.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.835 169.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.4 m-20 -93.75 125.71 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 67' ' ' LEU . 4.6 tp -126.2 144.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.514 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.3 p -150.42 158.9 44.67 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.566 0.698 . . . . 0.0 112.388 -173.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -55.54 -34.6 64.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.438 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.74 89.41 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.09 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -70.39 -46.64 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.259 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.528 HD11 HD11 ' A' ' 62' ' ' ILE . 6.9 mp -71.68 -26.27 62.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.66 -147.17 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.85 -22.03 22.95 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.38 0.991 . . . . 0.0 112.286 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 70' ' ' LEU . 7.2 mp -61.53 -20.53 63.34 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.469 ' HE3' HD22 ' A' ' 67' ' ' LEU . 51.6 t-105 -55.82 118.45 20.15 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.247 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HB3' HG22 ' A' ' 125' ' ' ILE . 58.8 Cg_endo -89.69 -13.3 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.807 1.671 . . . . 0.0 114.157 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.62 145.21 27.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.34 0.59 . . . . 0.0 112.101 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.2 p -67.31 -37.8 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.464 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.77 128.6 26.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.11 -33.91 75.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -147.99 173.87 12.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.778 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.01 34.23 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.481 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.1 m -108.92 139.09 44.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.611 -0.347 . . . . 0.0 110.105 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.51 134.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.11 144.56 38.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.233 0.54 . . . . 0.0 111.995 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.396 172.047 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.603 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.1 158.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.353 0.596 . . . . 0.0 111.557 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.2 t80 -114.1 126.85 55.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.039 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.47 129.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.5 155.45 36.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.647 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.49 -26.59 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.589 1.526 . . . . 0.0 113.115 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 33.4 p30 -63.95 -12.77 40.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.88 67.09 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 122.09 -0.381 . . . . 0.0 112.924 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 m -99.34 139.38 35.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 m -104.87 130.18 53.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 109.972 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -114.9 148.65 38.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.9 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.4 127.74 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.694 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -86.82 -50.53 6.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.285 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.402 ' HB3' HD11 ' A' ' 131' ' ' LEU . 44.9 p-10 -103.43 167.12 10.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.627 0.727 . . . . 0.0 111.956 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.37 -39.88 73.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.999 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.18 -41.89 99.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.271 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.29 -37.19 79.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.899 0.381 . . . . 0.0 110.968 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.97 -40.55 98.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.43 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -58.63 -34.04 70.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.721 0.296 . . . . 0.0 111.329 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.21 0.96 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.49 63.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.969 -0.35 . . . . 0.0 113.191 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -83.21 143.15 44.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.03 152.66 68.01 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.262 1.308 . . . . 0.0 111.752 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.1 153.54 28.55 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.454 1.436 . . . . 0.0 112.725 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 115' ' ' ILE . 90.1 mt -64.02 -18.98 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.779 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 t -46.6 -36.82 7.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.57 -29.01 83.58 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 CA-C-N 122.997 2.106 . . . . 0.0 112.103 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 112' ' ' ILE . 17.6 pt -98.89 2.17 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 143.3 45.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.103 0.865 . . . . 0.0 110.204 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.776 -175.382 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' A' ' 72' ' ' PRO . 46.7 mt . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.042 0.448 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -72.25 141.37 48.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.694 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -91.68 8.5 36.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.163 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.54 -43.15 36.09 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.749 -0.595 . . . . 0.0 112.327 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.72 88.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.788 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.4 tp -59.01 -41.68 88.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.035 0.445 . . . . 0.0 110.463 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 101' ' ' ASN . 33.8 tp -59.64 -45.2 92.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.474 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.3 p -59.73 -41.05 90.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.69 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.62 -47.76 83.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.707 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.603 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 24.0 m -62.67 -40.35 96.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.839 -177.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -60.18 -39.87 88.0 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.751 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -59.44 -42.05 91.04 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.424 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.05 -38.72 89.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.107 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -59.97 -25.28 65.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.867 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.703 179.195 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -142.34 153.21 43.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.763 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -94.88 126.0 39.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 173.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 67' ' ' LEU . 4.7 tp -124.79 141.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.5 p -143.46 163.37 33.29 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.594 0.711 . . . . 0.0 111.755 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.54 -35.53 65.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.216 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.19 85.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.729 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.44 -46.65 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.826 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.627 HD12 ' CE3' ' A' ' 71' ' ' TRP . 36.5 mt -87.02 -8.69 56.91 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 61.66 -145.37 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.0 -28.44 37.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.29 0.95 . . . . 0.0 111.92 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.33 -25.58 35.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.627 ' CE3' HD12 ' A' ' 67' ' ' LEU . 49.2 t-105 -55.92 107.17 0.8 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.372 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.02 -13.17 3.89 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.833 1.689 . . . . 0.0 114.129 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -89.67 145.89 24.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.315 0.579 . . . . 0.0 111.821 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.1 p -69.63 -37.1 76.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.723 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.77 129.64 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -64.31 -30.14 71.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -150.26 174.62 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.662 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.456 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.5 m -107.89 140.94 40.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.629 -0.336 . . . . 0.0 110.102 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 pt -108.87 136.08 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -143.55 143.88 31.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 111.824 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.701 174.157 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.06 156.73 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.599 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.4 t80 -114.06 126.95 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.06 130.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.4 156.22 35.49 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.658 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.2 -26.73 8.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.509 1.473 . . . . 0.0 113.105 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.0 p30 -65.11 -11.46 40.13 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 8.51 67.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.85 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -99.47 138.48 36.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.1 m -103.7 131.0 51.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 109.865 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -115.97 149.76 38.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.979 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.38 127.23 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.674 0.273 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -86.68 -51.02 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.941 0.4 . . . . 0.0 110.181 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.404 ' HB3' HD11 ' A' ' 131' ' ' LEU . 43.2 p-10 -103.25 167.61 9.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.644 0.735 . . . . 0.0 111.944 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.79 -39.04 76.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.944 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -62.76 -41.27 99.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.151 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.7 -35.87 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.072 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.2 -40.55 97.81 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.389 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -58.86 -34.01 71.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.689 0.281 . . . . 0.0 111.241 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.21 -1.79 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.54 63.41 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.07 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 5.1 m-70 -82.09 143.19 48.8 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 109.516 173.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 153.47 73.84 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.366 1.378 . . . . 0.0 111.811 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.12 151.89 27.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.538 1.492 . . . . 0.0 112.66 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 115' ' ' ILE . 90.2 mt -64.28 -18.62 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 119.015 -0.517 . . . . 0.0 111.672 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.422 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.3 t -45.12 -37.34 4.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HD3' HG22 ' A' ' 113' ' ' THR . 39.3 Cg_exo -59.01 -32.11 96.95 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 CA-C-N 122.529 1.939 . . . . 0.0 112.102 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 112' ' ' ILE . 15.8 pt -97.06 3.68 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.38 139.37 39.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.439 0.563 . . . . 0.0 110.331 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.38 -177.915 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.3 mt . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.054 0.454 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -63.29 140.8 58.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.236 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.5 mt -94.41 9.87 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.059 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.02 -45.26 32.94 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.845 -0.534 . . . . 0.0 112.735 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.3 85.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.175 0.488 . . . . 0.0 110.759 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.8 tp -59.47 -41.95 90.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.602 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 101' ' ' ASN . 30.0 tp -59.64 -44.61 93.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -59.07 -43.37 91.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.66 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.59 -47.28 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 110.626 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.622 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 19.9 m -62.7 -41.53 99.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.794 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.16 -37.43 82.88 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.69 -43.86 90.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 110.197 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -36.24 82.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.84 -25.16 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.069 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.86 178.645 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 78.5 m80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.515 -0.55 . . . . 43.920000000000002 109.515 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -123.66 132.2 53.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 43.210000000000001 110.43 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -127.1 149.05 50.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 42.18 110.525 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -111.73 136.8 50.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 41.899999999999999 110.318 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -117.62 132.48 56.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.27 -0.423 . . . . 41.189999999999998 110.549 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -60.68 -39.76 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 40.770000000000003 110.86 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.2 m -59.52 156.26 13.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 40.93 110.872 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -63.18 161.83 12.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 40.539999999999999 110.768 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.26 -165.94 21.28 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.961 -0.856 . . . . 40.469999999999999 110.961 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.6 mt -76.69 145.78 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 40.109999999999999 110.584 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.98 165.46 27.16 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 40.039999999999999 110.424 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.96 -20.8 61.98 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.361 1.374 . . . . 40.359999999999999 113.098 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -55.26 -36.12 65.75 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.128 -0.229 . . . . 39.030000000000001 111.187 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.67 178.07 42.49 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 38.020000000000003 110.938 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -58.74 -40.29 83.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 36.799999999999997 110.799 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.27 -173.42 55.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.778 -0.929 . . . . 35.439999999999998 110.778 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.1 mtm -136.44 153.6 51.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 33.659999999999997 110.551 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -99.69 150.45 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 32.780000000000001 110.196 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -56.38 -38.59 71.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 31.449999999999999 110.961 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.7 m -129.22 136.98 50.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.525 -0.307 . . . . 30.27 110.516 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.5 51.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 29.399999999999999 110.337 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.02 129.23 38.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 28.469999999999999 110.49 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.52 81.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 28.48 111.421 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -125.76 137.48 53.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.352 . . . . 27.199999999999999 110.68 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -133.93 162.68 31.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 26.289999999999999 110.359 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.56 139.35 32.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 27.039999999999999 110.829 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -70.19 142.37 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 25.809999999999999 110.538 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -122.56 140.53 52.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 25.800000000000001 110.281 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -136.58 153.8 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.366 . . . . 25.27 110.625 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 93.0 mmm -123.33 145.41 48.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 25.539999999999999 109.951 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.53 114.03 25.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 25.859999999999999 110.849 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -125.29 99.82 33.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.091 -0.504 . . . . 25.780000000000001 110.05 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -88.37 123.9 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.549 1.499 . . . . 26.289999999999999 112.42 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -61.27 -34.68 75.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 27.32 111.452 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 29' ' ' LEU . 9.0 tt -90.85 128.06 36.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 27.800000000000001 110.637 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.9 166.26 35.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.802 -0.919 . . . . 28.449999999999999 110.802 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -129.65 162.03 29.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 29.91 110.62 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -132.24 -35.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 30.91 111.128 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.44 -35.58 68.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.641 -0.254 . . . . 29.460000000000001 111.278 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -55.57 149.26 14.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.403 . . . . 31.09 110.879 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.01 -36.2 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 30.129999999999999 111.435 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -78.83 149.15 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 28.109999999999999 110.641 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.8 m -109.52 148.16 31.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 26.989999999999998 110.196 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.86 -37.9 94.89 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.392 -0.683 . . . . 25.41 111.392 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.29 171.09 51.49 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.763 -0.935 . . . . 23.079999999999998 110.763 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.31 176.23 38.46 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.118 -0.793 . . . . 20.710000000000001 111.118 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -59.62 -34.53 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.518 0.199 . . . . 18.25 111.434 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.7 144.23 27.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.952 0.406 . . . . 15.66 110.901 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -69.85 143.35 91.98 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 13.279999999999999 110.1 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.8 -169.98 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.228 1.285 . . . . 10.84 111.714 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.42 131.83 52.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.952 0.406 . . . . 7.7300000000000004 110.556 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.39 -37.18 79.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.539 . . . . 6.6100000000000003 111.299 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -99.59 136.6 39.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.839 0.352 . . . . 5.5199999999999996 110.655 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -74.78 -49.2 4.65 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.992 -0.528 . . . . 1.48 112.228 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.19 128.14 16.51 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.203 1.268 . . . . 1.0 112.112 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -90.29 133.85 32.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.548 -0.739 . . . . 0.71999999999999997 109.386 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -52.22 155.42 9.26 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.034 1.156 . . . . 0.87 111.482 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.1 151.64 89.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.393 -0.367 . . . . 0.55000000000000004 110.224 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.63 157.76 48.12 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.191 1.261 . . . . 0.58999999999999997 111.532 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -55.82 120.1 30.55 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.897 -0.573 . . . . 1.26 109.956 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.04 119.89 4.03 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.134 1.223 . . . . 0.78000000000000003 113.441 -169.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -77.75 158.11 29.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.686 -1.227 . . . . 0.79000000000000004 107.686 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -56.57 125.55 22.64 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.16 -0.616 . . . . 1.73 110.971 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 63.58 24.03 13.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.45 -0.796 . . . . 2.2799999999999998 112.705 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -159.14 141.82 14.14 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.319 -0.553 . . . . 2.6000000000000001 112.327 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -148.61 152.91 37.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.823 -0.626 . . . . 0.28000000000000003 110.903 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' OD1' HG23 ' A' ' 79' ' ' THR . 76.1 m-20 -97.56 129.07 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.468 -0.567 . . . . 0.16 109.468 173.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.708 HD11 HD11 ' A' ' 67' ' ' LEU . 12.1 tt -129.34 151.86 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.892 0.377 . . . . 0.40999999999999998 110.938 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -150.48 167.87 25.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.59 0.709 . . . . 0.20000000000000001 111.654 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.5 -34.62 64.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.606 -0.724 . . . . 1.1000000000000001 111.118 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.02 86.53 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 121.021 -0.272 . . . . 0.28999999999999998 110.727 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -66.36 -46.61 76.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.32000000000000001 111.282 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD11 HD11 ' A' ' 62' ' ' ILE . 10.8 mp -88.07 -8.79 55.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.671 0.989 . . . . 1.05 113.671 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 63.69 -153.79 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.419 -0.586 . . . . 0.32000000000000001 109.419 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -56.77 -21.42 28.32 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.571 0.623 . . . . 3.9399999999999999 112.4 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -59.2 -20.09 50.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.498 0.555 . . . . 1.6699999999999999 112.498 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.509 ' CE3' HD22 ' A' ' 67' ' ' LEU . 55.7 t-105 -55.81 111.94 3.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 119.121 -0.466 . . . . 0.19 110.205 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -89.55 -13.25 2.84 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.904 1.736 . . . . 0.23999999999999999 114.164 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.3 mt -87.8 143.62 27.04 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.228 0.537 . . . . 0.11 111.627 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.4 p -67.99 -36.76 80.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.345 -0.843 . . . . 0.17000000000000001 110.817 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.67 129.39 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.272 -1.01 . . . . 0.17000000000000001 108.272 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -60.92 -32.94 72.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.023 0.379 . . . . 1.8 112.023 -169.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -147.02 174.37 11.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.406 -0.518 . . . . 0.46999999999999997 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.05 34.31 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.832 -1.307 . . . . 0.10000000000000001 109.832 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.556 HG23 ' OD1' ' A' ' 61' ' ' ASP . 6.3 m -109.93 141.58 42.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.598 -0.354 . . . . 0.12 110.349 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.64 137.23 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.988 -0.375 . . . . 0.14000000000000001 109.988 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -148.01 143.79 27.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.432 0.634 . . . . 2.1800000000000002 112.127 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.9 m -105.81 119.74 39.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.011 -0.995 . . . . 0.22 109.492 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.91 156.63 69.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.539 -0.3 . . . . 0.75 111.061 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.07 -19.84 4.58 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.446 1.431 . . . . 0.91000000000000003 113.223 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.4 m -79.65 3.06 20.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.358 0.873 . . . . 1.6499999999999999 113.358 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 62.98 39.5 10.17 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.1 0.476 . . . . 2.0499999999999998 110.852 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.27 127.11 55.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.215 -0.661 . . . . 1.9399999999999999 109.215 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.546 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.05 121.07 36.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.11 -0.33 . . . . 0.25 110.11 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.32 157.14 43.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.448 0.642 . . . . 0.12 111.396 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' HD21 ' A' ' 130' ' ' LEU . 89.1 t80 -114.03 127.75 56.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.799 -1.091 . . . . 0.11 109.932 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -108.51 130.48 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.325 -0.62 . . . . 0.13 109.325 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.41 154.8 37.0 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.655 -0.418 . . . . 0.13 110.625 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.66 -26.49 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.509 1.473 . . . . 0.17999999999999999 113.225 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.6 p30 -63.96 -12.79 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.816 0.673 . . . . 0.17999999999999999 112.816 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.52 10.43 65.48 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 122.151 -0.343 . . . . 0.16 112.92 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.7 m -99.37 139.36 35.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.233 -0.655 . . . . 0.14000000000000001 109.233 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.8 m -105.02 130.91 53.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.297 0.57 . . . . 0.14000000000000001 110.056 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -116.68 147.54 41.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.248 -0.887 . . . . 0.14000000000000001 108.992 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.41 126.08 34.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.13 110.771 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.04 -50.93 6.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.347 -0.388 . . . . 0.17999999999999999 110.637 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -103.11 166.58 10.35 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.643 0.735 . . . . 0.33000000000000002 112.019 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.6 -41.16 69.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.39 -0.823 . . . . 2.2000000000000002 112.209 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -63.94 -42.8 97.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.689 -0.404 . . . . 2.2200000000000002 111.398 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.584 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.62 -37.28 78.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.862 0.363 . . . . 0.22 110.907 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.56 -40.92 98.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 2.0699999999999998 110.394 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -58.85 -33.93 71.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 2.7200000000000002 111.288 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.66 0.44 8.72 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.083 0.771 . . . . 0.46000000000000002 113.083 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.12 23.43 63.53 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.826 -0.43 . . . . 0.46000000000000002 113.203 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 49.9 m-70 -84.89 142.64 39.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 108.938 -0.764 . . . . 0.46999999999999997 108.938 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.09 148.83 51.25 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.182 1.255 . . . . 0.72999999999999998 111.281 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 158.91 30.44 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.376 1.384 . . . . 0.45000000000000001 112.301 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 115' ' ' ILE . 92.4 mt -60.96 -11.79 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 119.033 -0.508 . . . . 0.20000000000000001 112.345 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.444 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.1 t -43.83 -39.65 6.06 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 115.559 1.689 . . . . 0.40000000000000002 115.559 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.2 Cg_exo -58.98 -31.95 96.62 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 CA-C-N 122.31 1.861 . . . . 0.28000000000000003 112.395 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 112' ' ' ILE . 25.1 pt -98.9 1.49 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 113.008 0.744 . . . . 0.20999999999999999 113.008 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -79.59 136.77 36.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.34 0.518 . . . . 3.3199999999999998 110.545 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -77.76 136.29 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.26000000000000001 111.356 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -95.12 139.91 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.869 -0.605 . . . . 2.6299999999999999 109.858 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.34 166.01 19.63 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.473 -0.651 . . . . 1.03 111.473 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 m -57.85 -38.53 75.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.967 -0.293 . . . . 2.3900000000000001 110.767 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.19 166.11 26.12 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.602 -0.999 . . . . 1.8200000000000001 110.602 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.9 58.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.042 -0.599 . . . . 2.2400000000000002 111.987 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.57 -123.91 30.1 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.568 -0.613 . . . . 0.95999999999999996 111.568 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -108.96 158.99 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 1.26 110.867 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 117' ' ' ALA . 33.2 mt -73.5 128.7 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.712 -0.676 . . . . 0.39000000000000001 109.915 -177.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -61.83 138.81 58.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.28999999999999998 112.092 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -95.99 11.55 33.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.173 -0.921 . . . . 0.23000000000000001 112.103 171.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -42.41 30.65 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.876 -0.515 . . . . 0.19 112.632 -174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.5 81.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.996 0.427 . . . . 0.20000000000000001 110.78 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.55 -41.94 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.17000000000000001 110.47 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.97 -44.04 94.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.19 110.464 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.05 -43.73 91.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.924 -0.311 . . . . 1.1799999999999999 110.562 -176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 39.0 m -60.9 -47.52 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.586 -0.446 . . . . 0.19 110.597 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.546 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 27.3 m -62.84 -40.12 96.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.58 -0.448 . . . . 0.17999999999999999 110.921 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.83 -39.63 89.74 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.969 -0.292 . . . . 0.22 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -58.77 -42.58 89.26 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.777 -0.369 . . . . 1.8999999999999999 110.241 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.97 -39.55 95.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.20000000000000001 111.03 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.1 m -59.99 -25.31 65.16 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.238 -0.437 . . . . 0.29999999999999999 112.144 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.25 22.99 61.84 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.116 -0.564 . . . . 0.60999999999999999 112.614 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -71.4 134.27 46.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 117.462 0.631 . . . . 4.0099999999999998 110.532 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.924 -1.486 . . . . 2.6299999999999999 110.913 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -125.36 135.77 52.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.44 134.66 53.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -124.23 135.4 53.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.515 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -123.97 135.21 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.401 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -121.91 129.81 52.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.521 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m -65.05 156.29 31.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m -61.99 153.14 30.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.36 -177.19 49.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.46 143.27 26.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.338 . . . . 0.0 110.408 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.44 151.94 90.21 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.561 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -88.33 168.23 6.31 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.728 1.619 . . . . 0.0 112.313 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -124.55 151.66 44.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.305 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.43 138.94 47.35 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -134.84 147.86 50.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.0 110.521 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.6 -177.87 52.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -97.29 131.45 43.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 110.704 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -131.09 147.37 52.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -99.58 133.34 44.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.492 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -127.95 162.3 27.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 147.2 53.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.424 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.12 142.82 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.554 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.11 43.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.572 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -87.54 141.01 28.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.31 151.65 38.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.54 141.79 35.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.432 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -67.76 140.42 56.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.524 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -114.78 151.6 33.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.584 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -124.32 136.06 53.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -124.67 155.17 39.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.523 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.24 119.18 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.555 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.7 p -64.26 152.9 87.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.549 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -82.4 -176.08 2.79 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.483 1.455 . . . . 0.0 112.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -98.2 167.19 11.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.779 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.7 mt -94.5 142.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.517 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.06 51.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.8 t -72.55 144.11 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -137.34 162.24 34.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -80.75 169.5 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.43 139.71 49.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.54 162.7 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -132.11 135.35 46.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -139.9 160.22 40.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.09 -177.12 51.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.04 176.49 53.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.37 -173.84 37.84 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -76.67 141.41 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.705 0.288 . . . . 0.0 110.224 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 147.41 29.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.275 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.29 147.31 76.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.351 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -91.54 176.95 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.759 1.639 . . . . 0.0 112.344 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.58 152.74 44.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.223 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -100.68 135.35 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.648 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -124.78 157.35 35.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.518 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -56.16 159.63 5.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.17 128.32 16.79 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.417 1.411 . . . . 0.0 112.278 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.32 140.23 27.04 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.383 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -52.17 150.72 18.64 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.111 1.207 . . . . 0.0 111.53 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.12 153.89 83.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.484 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.25 149.96 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.233 1.289 . . . . 0.0 111.46 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.2 p -55.93 139.45 70.64 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.091 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.16 119.86 3.98 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.173 1.249 . . . . 0.0 113.112 -170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -80.36 162.1 24.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.2 p -54.13 125.65 19.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 111.711 -171.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 63.77 12.65 6.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 171.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -159.77 162.33 34.84 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -143.8 153.12 42.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.581 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' HG23 ' A' ' 79' ' ' THR . 75.7 m-20 -97.3 123.95 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.827 HD11 HD11 ' A' ' 67' ' ' LEU . 6.8 tt -130.18 151.44 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.092 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.0 p -147.79 165.81 29.43 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.871 0.843 . . . . 0.0 112.061 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -55.62 -34.28 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.38 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.15 90.42 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.785 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -66.38 -46.59 76.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.904 0.383 . . . . 0.0 111.241 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.827 HD11 HD11 ' A' ' 62' ' ' ILE . 10.3 mp -81.88 -16.64 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.06 -148.3 0.3 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -56.03 -21.25 20.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.196 0.907 . . . . 0.0 112.368 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.0 tp -56.54 -27.83 58.52 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.589 ' CE3' HD22 ' A' ' 67' ' ' LEU . 43.1 t-105 -55.73 111.89 3.65 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.42 -175.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HB3' HG22 ' A' ' 125' ' ' ILE . 66.8 Cg_endo -89.53 -13.15 2.87 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.766 1.644 . . . . 0.0 114.167 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.31 145.33 25.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.284 0.564 . . . . 0.0 111.813 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.8 p -69.37 -37.16 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.647 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.42 129.65 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -62.12 -32.77 73.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -168.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -148.55 175.1 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.09 34.38 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.515 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.0 m -107.88 141.1 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.81 137.71 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -145.45 143.73 30.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.348 0.594 . . . . 0.0 112.06 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.8 m -108.25 121.21 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.684 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -81.98 155.89 69.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.906 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.46 -19.99 7.91 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.366 1.377 . . . . 0.0 113.286 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -81.04 3.0 24.66 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 69.25 35.79 2.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 111.023 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -113.37 127.42 56.12 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.575 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.75 124.08 39.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.288 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.7 157.79 42.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.437 0.637 . . . . 0.0 111.452 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.4 t80 -114.05 127.47 55.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.025 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.17 130.91 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.37 155.25 36.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.735 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.39 -26.74 9.01 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.595 1.53 . . . . 0.0 113.127 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.7 p30 -64.5 -11.82 37.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.55 9.28 66.85 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.543 -0.361 . . . . 0.0 112.911 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.1 m -99.45 140.83 33.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -105.04 131.08 53.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.235 0.54 . . . . 0.0 110.118 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -116.22 148.09 40.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.997 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.679 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.35 127.93 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -86.79 -51.8 5.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -103.2 167.49 9.79 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.617 0.722 . . . . 0.0 112.059 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.27 -40.09 73.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.106 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -63.23 -41.91 99.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.207 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.34 -37.04 79.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.751 0.31 . . . . 0.0 110.92 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.679 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 76.8 mm-40 -62.77 -41.27 99.16 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.282 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -58.77 -33.99 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.409 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.35 1.44 7.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.05 23.46 63.61 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.964 -0.353 . . . . 0.0 113.265 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 52.3 m-70 -84.9 143.16 39.79 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 117.469 0.635 . . . . 0.0 109.303 172.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.84 149.07 47.18 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.246 1.297 . . . . 0.0 111.458 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.05 154.88 29.57 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.403 1.402 . . . . 0.0 112.702 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 115' ' ' ILE . 91.6 mt -61.67 -14.95 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.132 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.2 t -44.12 -39.05 5.64 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.8 Cg_exo -59.31 -31.38 94.95 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.306 1.859 . . . . 0.0 112.373 -176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 112' ' ' ILE . 14.4 pt -98.76 7.03 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -78.09 142.03 38.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.447 0.567 . . . . 0.0 110.546 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.68 137.33 32.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -97.24 139.97 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.045 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.87 167.38 19.69 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.494 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -57.97 -39.0 77.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.619 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.44 165.22 25.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.05 27.44 60.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.27 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.6 -123.8 31.54 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -106.55 154.61 20.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 110.926 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 72' ' ' PRO . 59.3 mt -76.75 130.28 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.025 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.3 m -64.54 141.01 58.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.003 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.8 9.71 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.095 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.04 -44.06 32.34 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.87 -0.519 . . . . 0.0 112.64 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 -47.57 85.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.795 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.9 tp -59.43 -42.11 91.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 tp -60.09 -43.89 95.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -58.97 -43.27 91.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.595 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 m -60.87 -47.92 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.588 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.575 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 26.1 m -62.9 -39.84 95.76 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.923 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.81 -39.1 87.69 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.909 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -58.85 -42.65 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.247 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.88 -39.45 94.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.916 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.7 m -60.05 -25.24 65.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.83 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.78 22.85 48.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.6 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -88.37 133.06 34.19 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.437 0.618 . . . . 0.0 110.451 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 CA-C-O 117.945 -1.475 . . . . 0.0 110.964 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -121.02 143.09 49.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -121.23 137.52 54.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.431 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -123.51 143.23 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -109.15 137.99 46.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.515 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -129.52 150.49 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m -117.05 146.85 42.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.583 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.2 p -142.62 163.38 32.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.472 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.68 -178.93 52.58 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.4 mt -96.12 141.14 29.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.777 0.322 . . . . 0.0 110.598 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.65 159.0 74.28 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.466 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -86.24 109.99 0.99 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.591 1.527 . . . . 0.0 112.266 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -125.88 147.32 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.555 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.51 117.35 0.68 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.1 p -142.85 159.88 41.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 0.0 110.498 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.36 140.43 30.78 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.8 mtt -130.05 153.74 48.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.518 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -98.85 146.02 26.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -103.17 148.9 25.2 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.5 p -123.31 162.79 22.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.441 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 145.43 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.599 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.91 154.56 43.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.563 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 143.5 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -82.77 132.98 35.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.4 141.5 44.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.518 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.22 143.46 44.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.647 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -128.57 143.56 50.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.468 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -75.9 145.37 40.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.725 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -123.57 145.15 49.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.372 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.4 mtp -119.83 150.31 40.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.56 144.11 54.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.671 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 p -107.13 159.62 29.37 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.408 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.56 -178.9 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.486 1.457 . . . . 0.0 112.312 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -67.38 145.4 55.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.686 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.5 tp -96.8 133.2 41.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.415 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.63 -177.03 51.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.3 m -93.56 144.52 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.589 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.2 119.28 21.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -66.71 148.31 52.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.748 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -69.15 -174.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -59.96 132.51 54.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.634 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -101.52 152.49 20.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 p -77.95 168.72 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.27 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.93 142.38 44.96 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -140.01 2.84 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.18 -166.95 23.42 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -53.04 155.63 2.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 111.491 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.01 152.78 9.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.816 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -55.77 159.68 5.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.824 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -59.99 172.09 2.56 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.402 1.402 . . . . 0.0 112.175 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.06 152.59 43.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.775 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -120.89 153.78 36.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.38 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -56.76 145.77 28.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 m -72.22 159.57 85.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.792 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.29 138.32 23.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.35 1.366 . . . . 0.0 112.265 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -90.26 142.82 28.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.379 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.23 154.01 11.83 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.069 1.179 . . . . 0.0 111.316 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.99 151.31 89.99 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.505 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -60.58 148.13 92.26 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.119 1.212 . . . . 0.0 111.236 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.5 p -55.92 131.98 73.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.09 119.88 4.01 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.171 1.247 . . . . 0.0 113.489 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.7 p -82.61 157.09 23.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 167.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 p -57.49 125.49 23.12 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.828 -172.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 63.57 21.61 12.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.786 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.7 144.21 14.99 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.404 0.547 . . . . 0.0 112.251 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -148.83 152.72 36.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.4 m-20 -92.22 126.74 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 6.7 tp -126.86 145.73 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.589 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -150.41 161.71 41.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.687 0.756 . . . . 0.0 112.484 -174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -55.57 -34.97 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.542 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.24 88.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.039 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -71.69 -46.65 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.054 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 8.0 mp -72.45 -25.76 61.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.13 -147.71 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -55.99 -21.59 22.0 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.367 0.985 . . . . 0.0 112.352 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.93 -25.32 63.37 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.495 ' HE3' HD22 ' A' ' 67' ' ' LEU . 47.0 t-105 -55.8 110.45 2.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.409 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 125' ' ' ILE . 67.0 Cg_endo -89.5 -13.27 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 114.158 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.7 145.76 24.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.304 0.573 . . . . 0.0 111.927 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 p -69.39 -36.86 77.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.67 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.12 129.48 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -61.58 -33.24 73.53 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.98 175.01 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 162.01 34.26 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.524 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.0 m -106.94 137.56 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 pt -107.48 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -147.97 144.05 27.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.397 0.617 . . . . 0.0 112.299 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m -102.51 118.52 37.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.644 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.7 mt -87.66 159.03 50.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.489 -172.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.18 -14.46 8.85 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.359 1.373 . . . . 0.0 113.133 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.0 m -78.62 2.98 17.55 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 63.05 44.49 5.84 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.137 0.494 . . . . 0.0 110.349 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -135.17 142.95 46.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.511 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.45 121.28 41.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.692 0.282 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -133.16 158.64 43.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.619 0.724 . . . . 0.0 111.886 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CD1' HD21 ' A' ' 130' ' ' LEU . 89.0 t80 -114.08 128.65 56.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.848 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.84 131.37 58.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.14 155.53 36.31 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.781 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.71 -27.06 10.34 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.533 1.489 . . . . 0.0 113.079 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 29.6 p30 -63.99 -12.41 37.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.47 9.69 66.52 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.912 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.8 m -99.37 139.94 34.29 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m -103.54 129.55 50.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -114.69 150.56 35.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.073 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.44 126.06 34.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.311 . . . . 0.0 110.377 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.4 mt -82.99 -51.93 7.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.08 0.466 . . . . 0.0 110.187 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -109.18 166.84 10.55 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 111.761 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -52.41 -33.66 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.866 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -61.83 -48.65 79.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 110.775 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.65 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.45 -35.1 75.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.243 177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.44 -41.2 98.56 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.243 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.04 -33.96 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.47 0.31 8.65 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.14 23.41 63.54 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.963 -0.354 . . . . 0.0 113.244 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -89.0 143.13 30.85 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 117.465 0.633 . . . . 0.0 109.421 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.14 148.39 44.31 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.256 1.304 . . . . 0.0 111.249 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.4 157.07 32.93 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.387 1.391 . . . . 0.0 112.625 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 115' ' ' ILE . 87.2 mt -60.61 -13.46 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 119.135 -0.46 . . . . 0.0 112.228 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.433 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.5 t -44.0 -39.44 6.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.5 Cg_exo -59.37 -31.29 94.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 CA-C-N 122.336 1.87 . . . . 0.0 112.387 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 112' ' ' ILE . 14.7 pt -98.83 7.83 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -77.34 140.67 40.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -84.66 139.84 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.341 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HZ2' ' HE1' ' A' ' 124' ' ' TYR . 40.9 tttp -93.35 139.88 30.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.824 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.22 167.3 17.98 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -58.38 -39.07 78.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.646 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.04 164.91 26.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.92 29.18 59.43 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.171 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.51 -120.45 21.74 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.404 ' HE1' ' HZ2' ' A' ' 118' ' ' LYS . 4.5 m-85 -105.51 157.68 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.001 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 117' ' ' ALA . 61.3 mt -78.27 132.78 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.127 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -64.93 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.848 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.55 8.24 39.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.193 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.91 -44.45 31.69 Favored Glycine 0 CA--C 1.527 0.835 0 O-C-N 121.85 -0.531 . . . . 0.0 112.922 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.68 76.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.268 0.534 . . . . 0.0 110.778 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 90' ' ' PHE . 31.3 tp -59.24 -42.29 90.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.474 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.39 -42.99 97.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.53 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.9 t -59.55 -44.9 93.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.49 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.34 -47.27 86.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.552 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.7 m -63.22 -40.04 96.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.31 -39.55 87.4 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.785 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -58.62 -42.77 88.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.09 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.4 m -60.49 -25.16 65.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.993 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.19 22.88 50.62 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.66 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -85.99 134.89 33.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.412 0.606 . . . . 0.0 110.503 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.734 0 CA-C-O 118.057 -1.413 . . . . 0.0 110.96 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.1 141.03 49.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.518 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.96 137.01 54.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.454 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.46 144.33 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -118.78 139.0 52.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -112.02 140.05 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.456 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t -116.14 142.39 46.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.6 p -140.43 161.55 37.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.0 -178.25 38.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.5 tp -102.32 129.16 48.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.314 . . . . 0.0 110.502 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.87 158.22 68.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.586 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.67 130.65 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.622 1.548 . . . . 0.0 112.118 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -124.05 146.51 48.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.51 -176.85 48.24 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.9 p -138.88 156.3 47.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.691 0.281 . . . . 0.0 110.568 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.19 -176.65 35.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -129.32 152.43 48.89 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -95.75 135.38 37.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -124.25 158.65 31.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.399 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.4 m -72.25 134.88 45.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.308 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.56 159.42 43.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.652 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.18 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.523 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 146.62 26.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.737 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -128.26 138.63 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.493 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -57.54 152.84 14.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -72.47 143.13 48.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.643 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -105.98 160.05 15.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.27 165.25 26.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -125.87 171.94 10.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.509 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 mtt -106.2 158.81 16.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.692 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.78 145.32 56.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.772 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -67.62 153.98 94.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.722 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.66 -174.94 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.593 1.528 . . . . 0.0 112.341 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.44 124.96 30.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.5 150.48 28.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.6 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.71 156.83 7.22 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -122.88 170.06 10.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.341 . . . . 0.0 110.472 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -57.47 149.74 20.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.517 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -71.04 171.49 10.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.162 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -70.02 149.48 47.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.881 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -62.89 152.95 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.484 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -73.08 148.25 44.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.688 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -122.3 169.43 10.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.526 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.21 -170.42 27.14 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.44 121.57 20.79 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.88 -170.67 44.34 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -56.84 154.01 9.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.748 0.309 . . . . 0.0 110.592 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.26 147.91 15.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.851 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.57 133.58 85.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.25 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.51 -169.96 0.6 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.206 1.271 . . . . 0.0 111.626 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.25 159.13 4.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.369 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -60.71 150.15 33.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.027 0.441 . . . . 0.0 110.689 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -129.95 150.25 51.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.232 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.73 167.67 0.37 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.503 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -50.45 128.0 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.093 1.195 . . . . 0.0 112.001 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.47 120.92 68.93 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.382 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 153.27 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 120.884 1.352 . . . . 0.0 111.128 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.05 151.35 90.11 Favored Pre-proline 0 C--N 1.33 -0.283 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.427 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -81.45 163.91 19.15 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.358 1.372 . . . . 0.0 111.51 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 m -55.98 139.89 70.29 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.063 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.09 119.91 4.02 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.075 1.184 . . . . 0.0 113.033 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -75.69 160.06 30.46 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.8 m -54.0 125.62 19.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.76 10.84 5.42 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 171.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -159.7 159.53 33.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -144.55 153.14 41.51 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.271 172.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.409 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -93.19 126.57 38.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.8 tp -126.71 142.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.0 p -145.86 164.54 31.62 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.594 0.711 . . . . 0.0 111.929 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -55.57 -35.52 65.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.154 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.38 -40.19 85.76 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.603 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -66.33 -46.63 76.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.577 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.672 HD12 ' CE3' ' A' ' 71' ' ' TRP . 48.3 mt -91.08 -8.13 49.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 60.93 -146.44 0.45 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -57.15 -24.04 51.5 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.306 0.957 . . . . 0.0 112.476 -175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD12 ' H ' ' A' ' 70' ' ' LEU . 6.5 mp -59.16 -22.37 60.84 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.672 ' CE3' HD12 ' A' ' 67' ' ' LEU . 55.9 t-105 -55.85 107.41 0.88 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.228 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.48 -13.27 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.812 1.674 . . . . 0.0 114.174 -174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.72 145.04 26.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.19 0.519 . . . . 0.0 111.66 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 p -69.04 -36.88 78.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.725 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.72 130.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.92 -32.69 73.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -169.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.78 174.43 11.83 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.734 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.409 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.6 m -107.82 139.97 41.62 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.612 -0.346 . . . . 0.0 110.071 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.1 pt -107.49 134.84 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -145.95 142.64 28.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.425 0.631 . . . . 0.0 111.991 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 63.2 m -102.62 119.48 38.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.891 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.5 mt -87.55 156.49 53.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.189 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.01 -18.01 6.44 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.307 1.338 . . . . 0.0 113.28 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -76.93 0.0 22.63 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t70 67.36 44.21 1.84 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.072 0.463 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -135.12 145.25 47.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.457 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.58 123.25 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.655 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.8 158.71 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.555 0.693 . . . . 0.0 111.931 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.2 t80 -114.05 129.04 56.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.898 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.9 131.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.61 155.13 36.72 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.749 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.37 -27.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.625 1.55 . . . . 0.0 113.152 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.8 p30 -64.36 -11.65 34.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.68 10.46 67.3 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 121.47 -0.395 . . . . 0.0 112.84 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.8 m -99.34 139.32 35.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.0 m -103.04 129.96 49.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.346 0.593 . . . . 0.0 110.023 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -116.47 150.89 37.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.188 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.39 128.88 35.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.697 0.284 . . . . 0.0 110.725 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 131' ' ' LEU . 21.6 mt -87.98 -57.12 3.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.094 0.473 . . . . 0.0 110.434 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.513 ' HB3' HD11 ' A' ' 131' ' ' LEU . 49.6 p30 -105.1 159.14 16.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -47.44 -35.26 8.28 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.095 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -61.64 -44.45 96.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.151 0.5 . . . . 0.0 110.748 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.578 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.08 -37.36 74.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.392 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 31.2 mp0 -63.94 -39.22 93.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.026 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -58.5 -34.02 70.47 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.041 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 0.79 10.04 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.4 63.85 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.877 -0.402 . . . . 0.0 113.319 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -90.48 143.2 28.91 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.576 0.688 . . . . 0.0 109.668 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.11 148.1 39.14 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.267 1.311 . . . . 0.0 111.271 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.98 158.84 34.37 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.366 1.377 . . . . 0.0 112.939 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 115' ' ' ILE . 88.9 mt -61.13 -11.54 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.353 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.435 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.8 t -43.83 -39.82 6.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 113' ' ' THR . 24.7 Cg_exo -59.39 -32.11 96.01 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 CA-C-N 122.364 1.88 . . . . 0.0 112.433 -174.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 112' ' ' ILE . 23.1 pt -98.74 5.18 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -79.41 135.66 36.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.477 0.581 . . . . 0.0 110.772 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -78.41 149.61 33.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.077 0.465 . . . . 0.0 111.668 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -85.88 142.3 28.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.467 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.08 159.41 18.84 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 m -57.33 -39.16 75.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.742 0.306 . . . . 0.0 110.686 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.44 163.98 28.1 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.52 34.15 50.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.012 -0.614 . . . . 0.0 111.73 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.38 -119.96 9.82 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.676 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -104.39 159.95 15.3 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.528 -0.396 . . . . 0.0 110.383 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 117' ' ' ALA . 79.9 mt -76.45 129.94 36.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.141 0.496 . . . . 0.0 110.357 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 139.83 58.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.068 -174.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.99 9.43 37.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.053 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.85 -45.16 31.73 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.827 -0.546 . . . . 0.0 112.913 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.1 75.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.313 0.557 . . . . 0.0 110.78 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.06 -41.58 88.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 101' ' ' ASN . 21.8 tp -60.36 -43.76 96.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -60.04 -44.15 94.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.601 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.0 m -60.56 -47.03 87.98 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.504 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.8 m -63.31 -40.4 97.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.68 -38.34 84.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.954 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.5 -42.58 87.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.55 -38.54 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.5 m -59.95 -25.23 65.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.91 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.73 22.86 22.59 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.676 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.1 133.68 40.22 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.433 0.617 . . . . 0.0 110.495 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.91 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -124.65 136.12 53.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.379 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -121.69 144.48 48.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.622 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -113.68 140.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.425 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -119.49 133.51 55.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.48 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -124.3 137.1 54.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.507 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -116.22 143.57 45.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -61.6 154.98 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.614 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.19 -174.36 38.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.68 129.98 45.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.9 142.65 97.54 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.17 130.14 2.45 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.656 1.571 . . . . 0.0 112.203 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -60.66 144.51 51.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.653 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.2 -175.27 48.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.0 m -62.1 157.12 19.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.58 144.09 38.01 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.1 161.59 28.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.571 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -88.5 149.08 23.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.25 142.83 41.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -124.25 163.14 22.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.75 145.01 53.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.534 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.07 144.79 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.591 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.5 154.24 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 134.17 38.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.629 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -105.66 133.1 50.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.97 139.6 39.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.619 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -62.27 149.33 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -98.53 145.76 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.57 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -131.06 172.02 12.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.11 145.78 27.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.387 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.72 140.87 58.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.655 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -132.57 162.85 54.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.407 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -82.98 110.0 1.77 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.496 1.464 . . . . 0.0 112.205 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -150.03 165.36 32.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.5 tp -104.1 126.87 51.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.419 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -178.33 46.14 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.3 p -124.76 158.85 32.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.809 0.338 . . . . 0.0 110.32 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -75.69 136.85 40.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.0 137.53 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.57 133.17 42.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.627 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -149.98 167.54 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -136.21 127.25 27.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.958 0.409 . . . . 0.0 110.983 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -129.99 160.54 33.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.298 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.05 165.99 36.59 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 -178.26 40.88 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.68 -172.23 47.46 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -57.81 146.95 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.718 0.294 . . . . 0.0 110.461 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.07 157.5 44.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.716 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.74 155.78 59.16 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.521 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 131.39 39.01 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.36 1.373 . . . . 0.0 111.74 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.67 164.25 32.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.64 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -90.8 159.91 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.382 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -140.59 159.24 42.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.912 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -66.83 153.84 93.2 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.17 150.41 7.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.25 1.3 . . . . 0.0 112.172 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.33 143.59 29.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.382 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.23 160.89 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.068 1.179 . . . . 0.0 111.303 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.94 153.86 83.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.579 -176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.95 151.2 44.8 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.298 1.332 . . . . 0.0 111.59 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -56.04 129.7 73.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.992 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.22 119.95 3.98 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.21 1.273 . . . . 0.0 113.252 -170.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.7 p -74.74 160.65 30.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 166.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.4 m -55.06 125.43 20.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.083 -172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p30 63.22 13.4 6.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.219 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -146.28 154.58 41.86 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.29 0.495 . . . . 0.0 111.834 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -149.03 150.71 33.26 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.792 168.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.5 m-20 -92.59 124.82 36.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 67' ' ' LEU . 5.9 tp -125.83 145.17 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -176.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -150.38 162.43 40.56 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.795 0.807 . . . . 0.0 112.419 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.95 -35.18 66.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.537 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -41.5 88.63 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.056 -176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.93 -46.65 51.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.078 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 HD11 ' A' ' 62' ' ' ILE . 8.2 mp -72.49 -25.83 61.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.17 -147.03 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -55.8 -22.0 22.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.38 0.991 . . . . 0.0 112.468 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.41 -24.91 63.87 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.506 ' HE3' HD22 ' A' ' 67' ' ' LEU . 45.9 t-105 -55.89 110.98 2.64 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.357 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 125' ' ' ILE . 72.8 Cg_endo -89.55 -13.13 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.731 1.621 . . . . 0.0 114.108 -175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -90.42 145.47 24.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.191 0.52 . . . . 0.0 111.921 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.2 p -69.58 -37.03 76.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.663 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.11 129.34 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.97 -33.47 74.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -169.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -147.5 174.36 11.79 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.712 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.02 34.3 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.7 m -108.08 139.95 41.98 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.7 pt -109.36 139.36 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -148.01 145.44 28.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 112.303 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.3 m -108.6 124.02 49.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.695 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -85.92 156.38 58.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.005 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.12 -20.4 7.51 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.405 1.403 . . . . 0.0 113.177 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.9 p -79.23 3.01 19.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 63.74 39.67 8.34 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 121.085 0.469 . . . . 0.0 110.83 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -114.85 128.62 56.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -96.51 123.73 40.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.163 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.24 157.27 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.423 0.63 . . . . 0.0 111.458 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.3 t80 -114.17 128.07 56.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.98 130.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.22 155.59 36.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.802 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.47 -26.88 9.41 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.473 1.449 . . . . 0.0 113.097 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.8 p30 -64.31 -12.24 39.94 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.43 9.49 66.85 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.927 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.9 m -99.39 140.01 34.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.7 m -104.36 130.8 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.322 0.582 . . . . 0.0 110.087 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -116.18 148.24 40.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.082 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.686 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.4 128.3 35.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.692 0.282 . . . . 0.0 110.722 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.8 mt -87.58 -51.14 6.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -103.04 166.41 10.45 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.665 0.745 . . . . 0.0 112.037 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -55.33 -40.16 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.129 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -63.76 -42.06 97.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.334 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.597 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.61 -36.32 78.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.779 0.323 . . . . 0.0 110.991 176.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.686 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.0 mm-40 -63.29 -41.44 98.98 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.306 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -59.2 -33.86 71.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.317 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.1 -1.54 10.28 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.45 63.67 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.897 -0.391 . . . . 0.0 113.238 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 14.5 m-70 -84.99 134.36 41.42 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.133 172.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.33 148.1 91.46 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.062 1.174 . . . . 0.0 111.235 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 157.97 30.36 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.315 1.343 . . . . 0.0 112.302 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 115' ' ' ILE . 91.0 mt -62.07 -11.75 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.95 -0.548 . . . . 0.0 112.256 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.0 t -43.79 -40.05 6.61 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -171.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD3' HG22 ' A' ' 113' ' ' THR . 25.7 Cg_exo -59.29 -32.28 96.55 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 CA-C-N 122.25 1.839 . . . . 0.0 112.417 -175.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 112' ' ' ILE . 17.7 pt -98.84 7.66 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.03 140.22 40.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.527 0.603 . . . . 0.0 110.399 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.42 26.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 111.82 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.46 139.94 36.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.58 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.61 166.5 18.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 m -57.64 -39.15 76.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.592 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.99 166.82 28.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.09 33.14 55.25 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.867 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.11 -119.98 12.81 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.43 159.29 15.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.061 0.458 . . . . 0.0 111.059 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.41 HG22 ' HB3' ' A' ' 72' ' ' PRO . 84.2 mt -78.85 133.44 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.269 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.4 m -65.01 140.81 58.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.951 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.95 9.27 36.28 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.139 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.01 -45.18 32.86 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.837 -0.54 . . . . 0.0 112.766 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.04 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.162 0.481 . . . . 0.0 110.707 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.1 tp -59.35 -42.35 91.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -43.31 94.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.397 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -58.81 -44.46 90.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.45 -47.34 86.53 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.568 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.611 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 24.3 m -62.51 -40.49 96.89 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.842 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.68 -39.41 88.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.858 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -58.8 -42.83 90.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 110.277 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.57 -38.21 90.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.191 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.8 m -60.08 -25.14 65.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.957 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.72 23.01 60.74 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.61 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -85.0 133.56 34.25 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.427 0.613 . . . . 0.0 110.501 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 118.032 -1.426 . . . . 0.0 110.961 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -116.87 137.56 52.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.437 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -124.23 142.9 50.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.469 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.99 137.77 52.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.419 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -128.9 137.26 51.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.462 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -116.3 137.86 51.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.1 m -63.78 154.28 33.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -123.06 141.66 51.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.89 -176.7 50.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.6 tp -99.34 128.4 45.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.22 153.19 90.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.626 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -86.24 -177.57 2.48 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.566 1.511 . . . . 0.0 112.071 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -63.75 143.42 57.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.402 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.06 -175.11 44.18 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.0 m -63.95 156.46 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 0.0 110.525 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.69 -176.1 36.1 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -127.4 158.16 38.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.779 0.323 . . . . 0.0 110.494 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -73.2 138.52 45.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.503 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -93.82 138.98 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.486 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 m -121.94 143.27 49.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.53 147.97 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.575 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.29 158.67 43.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.29 147.62 25.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -84.15 153.71 23.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -131.7 164.74 25.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.543 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.18 144.16 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -123.87 141.29 52.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -104.36 147.61 27.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.623 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -122.02 144.31 48.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -115.56 146.22 41.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.258 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.31 120.64 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.538 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.8 m -61.76 152.78 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.581 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.28 -175.03 2.02 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.624 1.549 . . . . 0.0 112.235 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -67.34 148.02 52.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.61 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -85.59 143.79 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.426 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.43 -139.96 3.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -76.31 166.02 24.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.813 0.34 . . . . 0.0 110.508 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -60.92 142.44 56.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -150.03 -173.26 4.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.688 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.05 153.57 11.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -55.85 154.88 6.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.015 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -135.53 175.79 9.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.724 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.6 p -74.78 165.57 25.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.499 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.28 -174.23 43.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.9 -174.31 48.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.8 -174.69 49.71 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -58.48 149.68 24.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.923 0.392 . . . . 0.0 110.747 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.22 10.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -55.0 163.08 1.61 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 140.95 95.21 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.312 1.342 . . . . 0.0 112.112 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -173.67 2.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.615 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -79.7 157.87 27.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.483 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -63.88 139.21 58.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.798 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.92 167.5 19.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.674 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' CG ' ' HB2' ' A' ' 68' ' ' ALA . 78.3 Cg_exo -48.28 147.18 8.87 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.327 1.352 . . . . 0.0 112.017 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.22 142.2 28.32 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.786 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.22 160.98 2.87 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.167 1.245 . . . . 0.0 111.289 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.93 152.97 85.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.453 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.86 155.29 43.63 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.274 1.316 . . . . 0.0 111.576 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -55.88 142.15 64.95 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.19 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.07 119.93 4.03 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.168 1.245 . . . . 0.0 113.049 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.9 p -79.96 161.57 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.3 m -53.84 125.64 19.29 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.826 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 63.83 9.63 4.61 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -159.77 163.87 34.26 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -143.59 153.08 42.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.412 172.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.28 123.63 36.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.569 HD11 HD11 ' A' ' 67' ' ' LEU . 5.4 tp -125.45 145.77 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.484 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.0 p -148.48 162.94 38.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.776 0.798 . . . . 0.0 112.262 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -56.54 -34.76 67.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.478 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.55 91.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.067 -176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -69.24 -46.72 66.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 0.0 111.032 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.569 HD11 HD11 ' A' ' 62' ' ' ILE . 8.7 mp -72.7 -25.12 61.12 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB2' ' CG ' ' A' ' 49' ' ' PRO . . . 70.39 -148.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -55.37 -20.6 12.37 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.352 0.978 . . . . 0.0 112.417 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.75 -23.41 63.2 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.519 ' HE3' HD22 ' A' ' 67' ' ' LEU . 39.2 t-105 -55.9 112.89 4.84 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.326 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG22 ' A' ' 125' ' ' ILE . 66.0 Cg_endo -89.53 -13.24 2.85 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.863 1.709 . . . . 0.0 114.157 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.9 mt -93.27 145.81 24.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.184 0.516 . . . . 0.0 111.722 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.96 -36.72 75.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.648 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.77 130.35 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -64.41 -30.59 71.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -150.64 176.86 10.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.725 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.66 162.07 34.41 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -107.47 139.84 41.35 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.7 pt -109.22 137.48 41.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -144.91 144.09 30.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.279 0.561 . . . . 0.0 112.008 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.6 m -108.65 122.74 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.712 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -83.13 158.82 63.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.001 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.57 -21.51 10.91 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.401 1.4 . . . . 0.0 113.159 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.0 p -79.51 3.0 20.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 63.71 40.51 7.74 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.233 0.539 . . . . 0.0 110.62 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -114.41 128.6 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.615 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.01 124.11 38.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.362 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.24 157.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.344 0.592 . . . . 0.0 111.372 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.523 ' CD1' HD21 ' A' ' 130' ' ' LEU . 94.4 t80 -114.05 127.06 55.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.129 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.7 130.69 58.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.91 155.75 36.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.729 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.51 -26.68 9.25 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.44 1.427 . . . . 0.0 113.126 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 32.4 p30 -64.18 -12.56 41.46 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.96 9.17 66.17 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.911 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.4 m -99.41 139.35 35.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.412 0.606 . . . . 0.0 109.396 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.8 m -103.46 131.91 50.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.058 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.05 151.94 36.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.29 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -89.36 129.24 35.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.695 0.283 . . . . 0.0 110.796 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 mt -88.3 -51.88 5.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -103.6 167.6 9.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.615 0.721 . . . . 0.0 111.959 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -55.47 -40.32 71.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.975 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -63.3 -41.56 98.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.326 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.606 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.75 -37.71 79.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.832 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.04 -40.89 99.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.859 0.361 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.51 -34.07 70.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.714 0.292 . . . . 0.0 111.303 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.01 1.97 7.87 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.51 63.61 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.27 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -84.75 143.18 40.25 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.45 150.99 47.22 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.278 1.319 . . . . 0.0 111.931 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.89 151.97 36.2 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.299 1.332 . . . . 0.0 112.925 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 115' ' ' ILE . 91.4 mt -61.99 -13.31 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.2 t -46.76 -35.27 4.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.09 -33.78 97.73 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 CA-C-N 123.038 2.121 . . . . 0.0 112.039 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 112' ' ' ILE . 18.6 pt -98.94 7.77 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -77.26 142.3 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.684 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.44 139.51 30.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.152 0.501 . . . . 0.0 111.435 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -104.05 142.44 34.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.168 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.37 151.35 19.36 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.81 -40.88 81.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.58 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.68 171.76 19.5 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.57 -120.53 23.23 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.45 -120.02 1.73 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -103.44 152.94 21.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 72' ' ' PRO . 68.6 mt -79.01 128.03 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.205 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.9 m -62.1 140.51 58.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.179 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.48 6.98 47.13 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.241 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.21 -44.84 34.56 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.84 -0.538 . . . . 0.0 112.629 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.67 84.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.153 0.477 . . . . 0.0 110.74 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.9 tp -59.59 -42.23 92.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.456 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.11 -43.81 95.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.453 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 m -59.21 -43.35 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.641 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.54 -47.95 83.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.563 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.615 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 19.8 m -62.63 -40.28 96.5 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.772 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.75 -39.0 87.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.8 -42.94 90.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.301 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.159 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.02 -25.3 65.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.772 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.19 -18.14 54.73 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.911 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.19 145.51 25.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.672 0.736 . . . . 0.0 110.633 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.82 0 CA-C-O 118.065 -1.408 . . . . 0.0 110.965 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.88 140.64 49.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -123.33 135.85 54.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.69 147.17 47.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -112.32 139.26 48.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.54 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.52 140.49 49.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.394 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -117.93 143.64 46.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.502 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -68.92 161.94 27.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.13 -171.81 40.28 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.11 143.67 27.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.331 . . . . 0.0 110.333 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.28 151.03 91.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.559 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -89.49 -178.48 1.73 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.697 1.598 . . . . 0.0 112.343 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.63 145.55 49.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.106 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.43 -172.26 44.65 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -112.97 142.65 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.429 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.6 -176.23 50.93 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -126.42 164.42 21.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 110.321 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -83.39 140.17 32.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.551 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -115.02 157.9 22.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.598 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -133.58 158.91 41.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 141.46 56.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.613 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.43 144.59 53.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.659 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.23 144.81 56.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.402 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -88.3 133.9 33.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.104 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -122.28 157.58 31.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.393 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -70.63 140.34 51.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.393 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 -123.06 152.42 41.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.741 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -106.91 155.11 20.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -103.59 131.53 50.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.69 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.98 165.95 19.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.382 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -62.17 147.12 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.3 m -58.17 151.93 44.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.52 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.37 174.86 4.94 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.7 1.6 . . . . 0.0 112.378 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -67.27 151.93 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.556 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 31' ' ' THR . 77.3 mt -78.99 144.92 34.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.398 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.76 126.72 41.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 29' ' ' LEU . 72.8 p -127.47 164.6 21.55 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -80.63 109.15 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 0.0 110.276 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -150.1 -176.12 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.697 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.75 156.83 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.364 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.76 121.99 19.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.567 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -133.74 -176.25 4.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -72.37 165.89 23.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.57 -175.7 43.88 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.89 -173.49 49.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.14 -170.67 45.19 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -57.43 149.83 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.533 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.69 149.5 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.768 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -58.51 155.12 30.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.679 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.93 -169.99 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.325 1.35 . . . . 0.0 112.044 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -133.97 167.88 19.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -57.27 164.18 1.89 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -55.89 143.83 30.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.072 0.463 . . . . 0.0 111.035 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -139.74 167.06 19.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.626 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.33 148.21 7.85 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.396 1.397 . . . . 0.0 111.994 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.73 142.05 28.91 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.701 -0.666 . . . . 0.0 109.592 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.29 160.96 2.96 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.125 1.217 . . . . 0.0 111.427 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.05 152.39 87.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.375 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.1 150.83 34.07 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.304 1.336 . . . . 0.0 111.499 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.7 m -55.99 136.93 73.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.079 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.1 119.9 4.01 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.124 1.216 . . . . 0.0 113.262 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.5 p -78.68 162.64 26.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -53.82 125.52 18.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 111.751 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.8 12.88 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 171.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -159.82 165.73 31.74 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -145.62 153.12 40.7 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.589 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -90.87 123.71 34.6 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 67' ' ' LEU . 8.9 tp -124.55 146.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -148.99 161.62 41.55 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.804 0.811 . . . . 0.0 112.437 -173.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -56.45 -34.78 67.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.34 91.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.106 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.25 -46.72 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.04 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 62' ' ' ILE . 8.4 mp -72.5 -28.99 63.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.82 -141.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -54.0 -28.33 37.36 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.797 1.181 . . . . 0.0 112.058 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.96 -26.92 50.2 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.517 ' HE3' HD22 ' A' ' 67' ' ' LEU . 34.2 t-105 -55.82 109.97 1.98 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.709 -176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HB3' HG22 ' A' ' 125' ' ' ILE . 64.4 Cg_endo -89.56 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.828 1.685 . . . . 0.0 114.108 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.2 mt -91.24 145.88 24.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 111.819 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -69.82 -37.11 76.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.623 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.49 129.95 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -64.38 -31.0 72.03 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -168.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -149.53 176.73 10.36 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.615 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.73 162.01 34.28 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -106.99 140.39 39.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 pt -109.51 138.66 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -144.96 144.15 30.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.294 0.568 . . . . 0.0 111.946 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.7 m -109.52 122.8 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.815 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -82.51 158.21 66.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.856 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.53 -21.53 19.06 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.451 1.434 . . . . 0.0 112.913 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 t -78.2 3.12 16.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 63.57 40.91 7.69 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 121.297 0.57 . . . . 0.0 110.668 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.65 128.3 56.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.03 125.68 39.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.343 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.34 155.78 41.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.308 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 130' ' ' LEU . 93.8 t80 -114.16 127.52 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.139 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.5 131.12 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.67 155.5 36.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.852 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.2 -26.99 8.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.537 1.491 . . . . 0.0 113.106 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -64.8 -11.19 34.15 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.41 9.47 66.9 Favored Glycine 0 CA--C 1.537 1.422 0 O-C-N 122.104 -0.372 . . . . 0.0 112.921 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.0 m -99.44 138.95 35.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.86 130.96 50.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.209 0.528 . . . . 0.0 110.003 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -116.96 148.06 41.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.235 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.33 127.05 35.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.691 0.282 . . . . 0.0 110.714 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -85.22 -50.91 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.976 0.417 . . . . 0.0 110.332 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.92 167.65 9.57 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.67 0.748 . . . . 0.0 111.921 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -58.22 -37.54 75.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.076 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.77 -41.18 98.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.199 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.629 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.39 -36.94 79.27 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 175.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.33 -40.11 96.42 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.458 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -58.57 -33.94 70.51 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.157 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.24 1.59 7.41 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.51 63.58 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.946 -0.364 . . . . 0.0 113.253 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -86.59 143.19 35.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 117.498 0.649 . . . . 0.0 109.386 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.18 152.24 44.9 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.297 1.331 . . . . 0.0 111.349 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -78.04 157.84 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.297 1.331 . . . . 0.0 112.431 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.478 HG23 HD11 ' A' ' 115' ' ' ILE . 81.4 mt -62.91 -10.12 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.7 t -43.84 -39.6 6.0 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -172.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 28.0 Cg_exo -58.8 -33.72 98.62 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 CA-C-N 122.385 1.887 . . . . 0.0 112.232 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 112' ' ' ILE . 23.8 pt -98.9 7.44 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -77.61 139.3 39.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.336 0.516 . . . . 0.0 110.474 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -87.28 136.49 32.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 111.398 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -99.38 140.37 33.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.107 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.29 167.21 20.21 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.533 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 m -58.13 -38.51 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.29 . . . . 0.0 110.713 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.52 165.78 26.01 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.19 28.95 59.29 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.181 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.07 -123.59 30.37 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -107.83 159.7 16.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 117' ' ' ALA . 60.5 mt -79.21 129.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.213 -175.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -59.53 139.2 57.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.403 HD23 ' CG ' ' A' ' 72' ' ' PRO . 69.9 mt -94.92 6.28 49.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.314 172.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -44.2 37.86 Favored Glycine 0 CA--C 1.526 0.758 0 O-C-N 121.873 -0.517 . . . . 0.0 112.741 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 -47.84 83.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.243 0.521 . . . . 0.0 110.76 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.2 tp -59.89 -42.43 93.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.57 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.0 tp -60.41 -43.03 97.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.523 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.2 t -58.91 -43.97 91.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.764 0.316 . . . . 0.0 110.531 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.13 -47.78 84.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.583 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.602 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.7 m -62.65 -40.56 97.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.802 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.019 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.31 -43.65 88.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.247 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.13 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.085 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -60.12 -25.14 65.23 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.92 23.01 39.98 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.351 -0.452 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -103.19 145.62 29.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.43 0.615 . . . . 0.0 110.322 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 CA-C-O 118.059 -1.412 . . . . 0.0 110.924 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -128.85 146.64 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -113.06 141.68 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -110.84 138.71 46.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.492 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -130.36 166.03 21.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.434 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -111.29 137.44 49.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.411 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.2 m -63.59 154.47 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.679 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -121.13 148.94 43.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.02 138.99 49.16 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.3 mt -98.29 140.8 32.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 110.7 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.53 154.79 94.0 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.509 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.21 112.75 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.282 1.321 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -123.76 153.35 41.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.457 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.66 -176.78 51.33 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -117.75 143.13 46.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.551 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.79 178.23 24.57 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt -123.45 148.54 46.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.81 0.338 . . . . 0.0 110.557 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -135.99 159.91 40.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -106.87 146.26 31.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -139.59 159.55 41.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.95 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.533 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.14 139.56 50.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.685 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 145.0 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.575 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -77.18 131.91 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.366 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.88 146.11 42.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.633 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.27 154.74 29.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.421 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -148.77 159.7 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.716 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.59 131.85 51.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -118.35 139.91 50.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.405 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.27 158.32 37.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.486 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -77.65 173.11 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.653 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 m -67.55 150.7 97.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.366 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -89.92 174.56 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.701 1.6 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -68.18 147.22 52.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.309 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.92 126.65 39.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.55 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.36 -172.58 44.5 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.7 m -73.02 141.6 47.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.753 0.311 . . . . 0.0 110.36 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -58.57 133.77 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -69.83 150.35 46.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.732 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.44 157.72 10.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.373 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.5 117.44 15.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.619 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -100.88 171.19 7.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.703 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.2 m -62.31 144.35 55.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.363 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.41 34.24 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 -170.68 46.82 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.15 -164.42 24.48 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -57.14 140.4 49.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.55 150.17 23.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.804 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -57.02 155.76 15.13 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.6 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.5 -170.0 0.61 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 112.32 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.7 151.04 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -126.14 168.74 13.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.425 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -65.53 142.6 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.605 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -66.64 153.55 93.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.608 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.58 146.28 54.35 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.324 1.349 . . . . 0.0 111.896 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.31 141.58 27.67 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.48 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 160.88 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.103 1.202 . . . . 0.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.04 153.79 83.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.457 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.42 148.63 43.37 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.215 1.276 . . . . 0.0 111.475 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.9 p -56.01 129.88 73.06 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.042 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.11 119.88 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.139 1.226 . . . . 0.0 113.455 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.6 p -76.37 159.7 30.26 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -56.07 125.56 22.13 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.109 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.66 14.32 8.06 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -150.92 149.86 30.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.612 0.642 . . . . 0.0 112.252 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -148.83 150.81 33.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -94.15 126.09 39.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 4.9 tp -125.57 144.42 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.465 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.9 p -149.27 160.47 43.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.724 0.774 . . . . 0.0 112.356 -173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.66 -34.74 65.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.525 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.76 90.71 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.116 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -70.59 -46.54 63.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.171 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 7.7 mp -72.36 -25.05 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.87 -148.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -55.7 -20.48 14.51 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.271 0.941 . . . . 0.0 112.367 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.75 -24.3 63.94 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.498 ' HE3' HD22 ' A' ' 67' ' ' LEU . 46.6 t-105 -55.85 112.89 4.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.264 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB3' HG22 ' A' ' 125' ' ' ILE . 65.2 Cg_endo -89.54 -13.16 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.812 1.675 . . . . 0.0 114.144 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.82 144.87 25.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.49 . . . . 0.0 111.656 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.7 p -69.09 -37.41 78.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.585 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -64.27 129.77 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.08 -33.6 74.73 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -147.58 174.61 11.59 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.879 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 161.98 34.23 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.5 m -107.45 139.98 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 pt -109.58 138.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.79 145.9 31.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.24 0.543 . . . . 0.0 111.918 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.7 m -108.68 120.11 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.768 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.8 mt -81.44 155.63 71.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.89 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.7 -20.15 8.9 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.372 1.381 . . . . 0.0 113.278 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.4 m -80.98 3.02 24.4 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.2 t0 69.01 37.2 2.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.87 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -114.34 127.95 56.11 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.3 122.14 37.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.204 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 155.6 41.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.389 0.614 . . . . 0.0 111.405 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.512 ' CD1' HD21 ' A' ' 130' ' ' LEU . 93.8 t80 -114.1 127.54 55.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.134 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.15 130.9 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.472 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.35 155.91 35.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.838 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.61 -25.82 8.37 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.453 1.435 . . . . 0.0 113.139 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 32.4 p30 -65.23 -11.8 44.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.44 8.76 67.73 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 122.055 -0.403 . . . . 0.0 112.964 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.6 m -99.52 139.37 35.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.5 m -104.09 132.93 49.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 109.889 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -118.26 151.27 37.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.54 125.02 34.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.691 0.281 . . . . 0.0 110.646 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.9 mt -83.45 -50.33 8.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 109.918 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -103.27 167.56 9.74 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.574 0.702 . . . . 0.0 111.502 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.3 -38.8 74.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.954 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -63.93 -43.02 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.441 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.85 -37.68 79.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 110.723 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -63.33 -41.42 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.278 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -58.6 -32.79 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.514 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 2.38 6.27 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.09 23.48 63.51 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.176 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.76 142.4 45.39 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.72 153.83 76.58 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 121.316 1.344 . . . . 0.0 111.737 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 113' ' ' THR . 55.7 Cg_endo -78.06 151.58 27.29 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.375 1.383 . . . . 0.0 112.509 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 115' ' ' ILE . 92.9 mt -64.02 -16.57 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 119.223 -0.418 . . . . 0.0 111.878 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 111' ' ' PRO . 3.2 t -46.73 -35.26 4.84 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.38 -32.63 96.6 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 CA-C-N 123.155 2.163 . . . . 0.0 111.935 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 112' ' ' ILE . 24.0 pt -98.75 6.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -78.28 138.79 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.305 0.502 . . . . 0.0 110.74 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -83.93 138.11 33.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.162 0.506 . . . . 0.0 111.718 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -98.23 139.98 33.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.171 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.13 144.54 16.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -57.17 -40.0 76.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.755 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.8 169.45 19.14 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.18 -119.95 20.66 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.67 -119.95 1.71 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.58 150.6 23.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.272 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 117' ' ' ALA . 55.6 mt -75.61 126.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 110.192 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.9 m -60.34 138.47 57.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.993 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -95.24 7.33 46.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.27 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.63 -43.11 36.88 Favored Glycine 0 CA--C 1.527 0.786 0 O-C-N 121.755 -0.591 . . . . 0.0 112.63 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.62 80.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.061 0.43 . . . . 0.0 110.781 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.4 tp -59.86 -42.51 93.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.23 -43.17 96.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.475 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.2 t -59.24 -43.95 92.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.547 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.0 m -59.93 -47.58 85.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.576 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.608 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.3 m -62.67 -40.95 98.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.04 -38.35 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.628 0.252 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.47 -43.7 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 110.2 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.88 -39.28 93.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.902 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.9 m -60.05 -25.16 65.13 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.841 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.35 44.62 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.842 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -94.68 145.37 24.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.722 0.761 . . . . 0.0 110.598 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.732 0 CA-C-O 118.035 -1.425 . . . . 0.0 110.987 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.28 139.68 50.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.465 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -119.99 141.52 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -115.23 138.84 50.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.509 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -123.85 145.8 48.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.483 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.54 140.0 48.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.4 m -61.27 153.88 25.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t -123.31 145.2 48.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.25 -176.99 51.64 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.67 139.6 30.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.601 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.47 155.07 93.1 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.601 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.92 119.93 6.78 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.37 1.38 . . . . 0.0 111.939 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -150.0 166.01 30.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -175.46 50.49 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -113.94 143.34 44.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.553 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.85 -175.54 37.72 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtt -110.59 144.39 39.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.388 . . . . 0.0 110.528 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -116.81 148.8 40.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.497 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -56.98 146.05 28.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.9 p -122.03 162.12 21.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.514 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.71 49.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 148.23 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.621 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.66 145.7 38.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.532 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.24 151.79 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.686 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.9 134.81 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.416 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -106.85 156.83 18.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.592 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -147.32 162.61 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.621 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.43 151.53 27.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.634 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -129.62 159.76 35.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.395 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.5 mtp -99.25 141.04 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.636 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -87.37 172.26 9.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -65.17 153.22 89.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.528 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.2 155.9 14.71 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.544 1.496 . . . . 0.0 112.328 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -68.05 149.01 50.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.572 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.35 144.29 28.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.456 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.08 -140.0 2.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -72.44 169.56 16.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.317 . . . . 0.0 110.436 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -55.23 145.37 21.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -150.1 167.5 26.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.473 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.16 153.39 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.57 122.77 21.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.691 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -128.64 144.07 51.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.339 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 p -71.47 162.38 29.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.332 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.33 178.73 53.76 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.48 -171.91 47.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.26 -156.37 6.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -55.47 148.86 14.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.872 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.73 145.28 29.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.2 157.54 89.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.686 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.49 -169.97 0.74 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.396 1.397 . . . . 0.0 112.216 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -172.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -56.08 169.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.776 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -116.78 147.17 42.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.793 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -70.95 163.91 60.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 68' ' ' ALA . 75.0 Cg_exo -48.23 162.11 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.416 1.411 . . . . 0.0 112.131 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.27 142.42 28.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.391 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.23 160.8 3.04 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.15 1.233 . . . . 0.0 111.41 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.98 154.25 82.3 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.717 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.96 151.62 67.99 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.246 1.297 . . . . 0.0 111.425 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -55.83 135.65 72.6 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.198 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -80.21 119.96 3.99 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.289 1.326 . . . . 0.0 113.311 -170.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -82.89 158.02 22.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -56.79 125.46 22.49 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.856 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 63.55 14.96 8.48 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -152.08 151.21 30.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.65 0.659 . . . . 0.0 112.205 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -152.1 151.45 31.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.505 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.0 m-20 -93.37 127.33 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.688 HD11 HD11 ' A' ' 67' ' ' LEU . 5.2 tp -127.73 145.46 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.509 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -150.48 160.89 43.45 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.734 0.778 . . . . 0.0 112.387 -174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -55.54 -34.94 65.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.48 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.71 -43.12 89.99 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.031 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.16 -46.67 60.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.063 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -72.45 -26.78 61.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.482 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . 69.79 -145.39 0.09 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -55.56 -23.27 25.87 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.486 1.039 . . . . 0.0 112.285 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.0 -23.57 63.76 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.497 ' HE3' HD22 ' A' ' 67' ' ' LEU . 44.5 t-105 -55.86 111.13 2.8 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.37 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -89.53 -13.18 2.87 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.845 1.697 . . . . 0.0 114.056 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.06 145.36 25.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 111.964 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.5 p -70.03 -37.29 75.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.535 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.65 129.59 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.84 -33.97 75.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.042 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -148.42 175.03 11.46 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.601 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.79 162.03 34.27 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.505 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.9 m -108.15 138.68 44.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 pt -106.81 134.37 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.32 145.18 30.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.417 0.627 . . . . 0.0 111.994 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.6 m -102.47 118.55 37.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.006 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt -81.92 156.37 69.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.267 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.9 -16.78 12.42 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.398 1.399 . . . . 0.0 113.016 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -79.93 3.08 21.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 63.88 47.4 3.52 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -131.4 136.33 47.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.463 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.25 120.43 35.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.624 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 104' ' ' ALA . 35.3 m -132.22 156.35 42.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 121.464 0.649 . . . . 0.0 111.814 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.509 ' CD1' HD21 ' A' ' 130' ' ' LEU . 85.3 t80 -114.04 128.0 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.795 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.51 131.77 56.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.16 155.4 36.46 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.834 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.73 -27.1 10.46 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.62 1.546 . . . . 0.0 113.092 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 28.5 p30 -64.49 -11.69 36.43 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.55 66.63 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.936 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -99.42 140.29 33.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.7 m -103.75 129.23 51.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.238 0.542 . . . . 0.0 110.093 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -114.79 151.88 33.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.04 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.3 124.93 33.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.821 0.343 . . . . 0.0 110.43 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.2 -47.42 14.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.152 0.501 . . . . 0.0 109.809 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -115.36 167.62 10.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -53.84 -33.81 57.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.716 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -61.18 -49.01 78.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.323 0.582 . . . . 0.0 110.637 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.86 -37.39 76.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.09 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -61.42 -42.16 98.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.014 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -57.74 -33.96 69.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.8 9.18 3.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.5 63.6 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 122.177 -0.327 . . . . 0.0 113.358 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -97.01 112.08 59.62 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.366 171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -54.78 150.4 36.85 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.472 1.204 . . . . 0.0 111.592 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.45 158.88 55.79 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.266 1.311 . . . . 0.0 112.391 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 115' ' ' ILE . 76.6 mt -61.59 -10.81 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.421 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.6 t -44.21 -38.92 5.64 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -172.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.421 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.2 Cg_exo -58.92 -33.59 98.74 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.612 1.968 . . . . 0.0 112.21 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 112' ' ' ILE . 17.9 pt -98.81 6.75 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -77.45 141.59 39.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.497 0.589 . . . . 0.0 110.796 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.508 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -77.67 146.49 36.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.416 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -86.82 155.12 20.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.967 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.97 -167.6 36.09 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.894 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 m -57.7 -48.86 78.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.09 114.94 0.63 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.271 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.43 34.13 88.41 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.084 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -147.39 154.85 26.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.18 142.87 39.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 117' ' ' ALA . 65.5 mt -78.62 128.43 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.156 0.503 . . . . 0.0 110.116 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -62.79 138.79 58.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.168 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -96.2 11.18 35.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.953 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -44.59 31.1 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.825 -0.547 . . . . 0.0 112.851 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.58 77.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.313 0.557 . . . . 0.0 110.797 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 90' ' ' PHE . 33.6 tp -59.15 -42.05 89.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.449 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 26.0 tp -60.38 -43.69 96.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.656 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 85.9 p -60.61 -42.56 97.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.721 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.09 -47.18 87.52 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.642 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.1 m -63.09 -40.54 97.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.08 -39.46 86.15 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.799 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -58.76 -42.88 89.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.297 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.96 -39.28 91.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.055 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.6 m -59.93 -25.29 65.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.013 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.83 60.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.622 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -78.95 133.59 36.88 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.451 0.626 . . . . 0.0 110.551 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.808 0 CA-C-O 118.045 -1.419 . . . . 0.0 110.988 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -124.83 135.21 52.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.491 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -129.14 148.92 51.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -111.93 140.72 46.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.527 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -112.61 139.81 47.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -120.96 132.75 55.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.506 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 m -63.44 156.07 27.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.9 p -68.69 162.55 25.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.556 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.35 -177.86 51.94 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -100.14 131.15 46.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.445 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.1 163.69 36.28 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.5 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.01 158.97 27.36 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.366 1.378 . . . . 0.0 111.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -61.58 146.84 47.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.542 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 -177.48 40.41 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 143.12 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.13 -176.59 50.76 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.5 mtp -108.35 144.15 36.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 110.52 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -79.4 135.06 36.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -57.7 144.72 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -134.38 158.8 42.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.84 148.71 42.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.624 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.17 147.47 30.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.4 146.76 25.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -86.88 155.49 20.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.431 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -95.01 131.5 40.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -63.66 145.26 56.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -140.18 165.04 28.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.993 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -109.45 146.2 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.401 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 93.4 mmm -80.54 133.35 35.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.403 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.8 149.6 47.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.741 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -57.17 154.79 19.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.46 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.96 129.53 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.299 1.333 . . . . 0.0 111.993 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -67.2 149.51 50.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.773 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.87 148.45 27.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.14 -177.93 51.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -123.08 167.78 13.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 110.474 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -66.31 179.93 0.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -71.44 170.17 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -82.62 174.65 10.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -73.95 -174.1 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.832 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.84 151.86 37.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -71.19 136.2 47.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.74 -150.05 9.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.82 -173.65 47.48 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.86 179.36 53.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -126.5 157.16 39.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.747 0.308 . . . . 0.0 110.432 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.75 149.63 21.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.246 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.56 134.48 82.22 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.278 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.7 -169.97 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.821 1.681 . . . . 0.0 112.274 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.4 -173.97 2.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.262 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -107.5 139.41 42.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.499 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -103.5 142.79 33.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.635 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.7 p -70.43 154.11 94.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.09 139.8 33.81 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.379 1.386 . . . . 0.0 112.094 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.29 143.01 28.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.316 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.2 158.83 4.76 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.14 1.227 . . . . 0.0 111.294 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 mt -64.0 149.85 92.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.531 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -63.63 146.16 92.22 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.171 1.247 . . . . 0.0 111.135 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.7 p -55.94 137.6 72.49 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.111 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.2 119.94 3.99 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.172 1.248 . . . . 0.0 113.385 -170.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.8 p -81.59 158.73 24.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 167.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -56.87 125.44 22.51 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.967 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 m120 63.64 14.07 7.84 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -151.72 150.77 30.58 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.59 0.632 . . . . 0.0 112.208 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -149.61 151.1 33.23 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.866 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.532 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.1 m-20 -93.76 126.99 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 67' ' ' LEU . 7.3 tp -128.25 145.95 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.144 -0.223 . . . . 0.0 110.597 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.39 161.23 42.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.695 0.76 . . . . 0.0 112.502 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -55.99 -34.82 66.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.535 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.54 86.81 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.07 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.33 -46.64 54.69 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.012 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -72.71 -26.19 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.56 -146.49 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -54.1 -28.1 37.2 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.412 1.006 . . . . 0.0 111.952 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.2 tp -53.97 -26.54 26.3 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.5 ' HE3' HD22 ' A' ' 67' ' ' LEU . 52.1 t-105 -55.69 111.09 2.72 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.318 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HB3' HG22 ' A' ' 125' ' ' ILE . 68.0 Cg_endo -89.69 -13.1 2.81 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.771 1.647 . . . . 0.0 114.197 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.82 145.36 25.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.204 0.526 . . . . 0.0 111.84 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.8 p -69.22 -37.12 77.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.62 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.36 129.23 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.66 -34.04 75.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.8 174.84 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.471 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.03 34.29 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.532 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.4 m -108.09 137.81 45.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 pt -106.82 133.15 52.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -146.81 147.17 30.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.469 0.652 . . . . 0.0 111.93 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 48.2 m -102.48 120.49 40.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.742 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.499 HD11 HG21 ' A' ' 89' ' ' VAL . 60.6 mt -87.67 156.97 52.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.353 -173.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.73 -16.27 5.48 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.511 1.474 . . . . 0.0 113.183 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.6 m -77.54 3.0 14.67 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 62.99 43.62 6.51 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -135.13 145.79 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.618 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.43 122.55 42.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 110.774 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 83' ' ' LEU . 35.2 m -133.66 158.62 42.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.57 0.7 . . . . 0.0 111.938 -176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.522 ' CD1' HD21 ' A' ' 130' ' ' LEU . 86.3 t80 -114.09 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.767 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.55 131.45 57.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.14 155.21 36.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.823 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.69 -27.05 10.25 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.599 1.533 . . . . 0.0 113.103 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.1 p30 -64.11 -12.17 36.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.19 10.05 66.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.889 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.7 m -99.4 139.9 34.36 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.24 129.53 50.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.302 0.572 . . . . 0.0 110.124 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -114.58 149.41 36.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.038 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.32 126.17 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.821 0.343 . . . . 0.0 110.439 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' A' ' 131' ' ' LEU . 19.5 mt -83.71 -51.75 6.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.442 ' HB3' HD11 ' A' ' 131' ' ' LEU . 51.0 p30 -111.93 167.63 10.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.7 0.762 . . . . 0.0 111.924 -175.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.92 -34.22 54.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -60.77 -47.07 88.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.325 0.584 . . . . 0.0 110.459 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.602 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.406 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.607 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.1 mm-40 -62.25 -41.25 98.27 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.236 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -59.49 -34.0 72.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.259 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.34 -2.88 12.0 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.03 23.53 63.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 122.128 -0.358 . . . . 0.0 113.166 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -88.93 143.2 31.08 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 117.454 0.627 . . . . 0.0 109.566 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.42 148.11 37.64 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.203 1.269 . . . . 0.0 111.324 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -76.09 158.78 37.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.368 1.378 . . . . 0.0 112.684 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 115' ' ' ILE . 82.8 mt -60.77 -12.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 119.013 -0.518 . . . . 0.0 112.28 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.435 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.8 t -43.76 -39.64 5.88 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 113' ' ' THR . 25.1 Cg_exo -59.44 -31.91 95.56 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 CA-C-N 122.35 1.875 . . . . 0.0 112.432 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 112' ' ' ILE . 20.0 pt -98.84 6.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -77.57 137.54 38.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.54 0.609 . . . . 0.0 110.453 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.95 142.88 31.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.099 0.476 . . . . 0.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -102.58 140.0 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.846 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.35 150.34 18.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -57.5 -41.15 80.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.35 171.83 23.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.26 -120.05 20.09 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.95 -119.89 1.55 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.66 150.5 23.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 72' ' ' PRO . 83.9 mt -79.58 129.16 37.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.468 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.0 m -65.03 140.88 58.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.055 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.43 8.63 39.82 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.14 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.1 -43.67 32.56 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.897 -0.502 . . . . 0.0 112.745 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.45 -49.48 77.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.161 0.48 . . . . 0.0 110.84 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 90' ' ' PHE . 29.9 tp -58.82 -42.0 88.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.476 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 101' ' ' ASN . 24.0 tp -59.82 -44.22 94.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.484 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -59.96 -43.9 94.78 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.666 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.1 m -60.5 -46.75 88.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.449 . . . . 0.0 110.58 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.5 m -63.14 -41.35 99.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.01 -39.4 85.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.746 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -59.33 -42.39 91.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.56 -39.69 94.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -63.12 -25.18 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.144 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.86 22.95 40.41 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.636 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.65 144.92 25.67 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.43 0.615 . . . . 0.0 110.503 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.998 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -117.69 139.47 50.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.52 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -120.99 142.79 49.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.433 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.12 138.72 50.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.424 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -122.15 144.41 48.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.491 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.79 139.49 49.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.415 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.2 p -134.99 160.03 39.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.621 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.9 p -67.93 163.77 21.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.551 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.79 -176.92 51.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.78 142.94 26.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 110.635 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.81 154.69 85.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.66 133.83 41.3 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.8 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -123.08 152.46 41.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.439 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.82 -176.67 51.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p -69.17 159.91 32.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.597 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.82 -175.09 45.9 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.4 135.78 40.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 110.393 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -134.18 134.76 42.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.603 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.51 144.16 43.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.475 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -122.16 160.15 25.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.12 157.12 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.62 141.61 56.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.03 158.41 44.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.561 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -66.66 139.81 57.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.39 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -102.2 133.91 46.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.726 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -102.38 146.09 28.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.392 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -54.42 147.45 13.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.258 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -68.11 147.91 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.759 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -119.6 145.41 46.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.9 mtp -117.62 166.14 12.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -61.32 145.03 52.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.489 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.8 p -62.15 152.45 78.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -86.47 -174.97 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.679 1.586 . . . . 0.0 112.297 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.59 123.83 27.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.5 mt -81.77 144.11 31.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.553 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.78 -139.95 2.77 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.7 t -59.0 167.04 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -61.55 144.04 55.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.39 -179.96 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.737 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -63.03 150.8 41.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.655 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -59.06 151.04 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.85 136.96 58.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.559 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 p -82.63 166.8 18.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.641 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.5 -167.3 28.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.36 -177.0 36.72 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.09 -177.51 51.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.99 168.69 23.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.3 . . . . 0.0 110.713 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 144.68 33.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.639 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 156.74 64.83 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.404 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.23 173.98 7.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.233 1.289 . . . . 0.0 111.944 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 142.7 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.686 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.38 164.82 26.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.447 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -147.01 157.02 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.9 m -80.98 153.15 72.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.339 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.33 162.19 10.27 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.204 1.269 . . . . 0.0 111.63 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.35 141.0 27.13 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.42 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.32 153.48 13.15 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.102 1.201 . . . . 0.0 111.336 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.11 153.77 84.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.325 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.63 145.85 53.26 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.157 1.238 . . . . 0.0 111.133 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.5 m -55.89 139.38 70.41 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 119.339 -0.363 . . . . 0.0 110.146 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.07 119.81 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.109 1.206 . . . . 0.0 113.1 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.9 p -84.04 159.69 21.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 p -55.54 125.59 21.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.026 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 63.43 14.12 7.69 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.265 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -157.08 144.18 18.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -139.01 152.81 47.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.656 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -93.87 126.21 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.681 HD11 HD11 ' A' ' 67' ' ' LEU . 6.4 tp -124.91 144.85 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.9 p -150.38 160.82 43.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.673 0.749 . . . . 0.0 112.447 -173.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -55.64 -34.68 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.567 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.64 -42.17 87.69 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.104 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -73.64 -46.61 45.63 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.375 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.681 HD11 HD11 ' A' ' 62' ' ' ILE . 7.8 mp -71.36 -27.78 63.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.4 -142.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -54.11 -28.88 42.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.683 1.129 . . . . 0.0 111.883 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 70' ' ' LEU . 7.4 mp -56.98 -24.77 55.78 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.48 ' HE3' HD22 ' A' ' 67' ' ' LEU . 48.0 t-105 -55.91 107.49 0.9 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.368 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HB3' HG22 ' A' ' 125' ' ' ILE . 67.6 Cg_endo -87.2 -13.24 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.703 1.602 . . . . 0.0 114.136 -175.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.0 mt -89.59 145.56 25.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.559 . . . . 0.0 111.94 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.3 p -69.85 -37.28 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.719 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.15 130.13 30.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -62.02 -33.4 74.28 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.043 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -147.01 174.55 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.667 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.72 162.09 34.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -107.92 140.58 40.83 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.539 -0.389 . . . . 0.0 110.112 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.96 135.36 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.36 143.57 31.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.295 0.569 . . . . 0.0 112.151 -176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.7 m -108.59 121.8 45.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.672 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -83.28 158.97 63.0 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.955 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.35 -18.46 18.98 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.386 1.391 . . . . 0.0 113.099 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.8 m -80.32 3.07 22.24 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 63.9 41.48 6.64 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 0.0 110.545 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -116.4 128.46 55.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.259 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.583 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.03 123.74 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.387 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.489 HG12 ' HB1' ' A' ' 104' ' ' ALA . 31.8 m -131.86 155.23 41.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 111.225 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.51 ' CD1' HD21 ' A' ' 130' ' ' LEU . 90.0 t80 -114.1 128.04 56.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.031 178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.97 131.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.52 155.32 36.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.75 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.42 -26.54 8.83 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.565 1.51 . . . . 0.0 113.111 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.1 p30 -64.43 -12.17 40.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.36 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.92 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.9 m -99.41 140.01 34.22 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.6 m -104.73 130.92 52.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 110.095 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -116.32 148.41 40.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.0 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 124.94 33.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.805 0.336 . . . . 0.0 110.767 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 mt -82.18 -48.5 11.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 0.0 109.982 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.5 p30 -108.39 167.63 9.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.47 0.653 . . . . 0.0 111.606 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -55.03 -40.99 70.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.979 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -63.42 -42.47 98.72 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.37 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.649 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.3 -39.27 78.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.077 0.465 . . . . 0.0 110.616 176.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -62.32 -41.7 98.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.944 0.402 . . . . 0.0 110.213 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -57.69 -33.07 67.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.495 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.79 9.92 3.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.47 63.67 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.359 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -94.64 112.03 56.33 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.097 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.39 153.41 40.97 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.183 1.255 . . . . 0.0 111.569 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.35 158.84 56.0 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.263 1.309 . . . . 0.0 112.283 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 115' ' ' ILE . 74.7 mt -62.75 -9.92 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.413 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.8 t -44.43 -38.69 5.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -172.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 113' ' ' THR . 27.6 Cg_exo -58.93 -33.14 98.55 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 CA-C-N 122.474 1.919 . . . . 0.0 112.329 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 112' ' ' ILE . 15.8 pt -98.91 6.98 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -77.53 140.84 39.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.479 0.581 . . . . 0.0 110.522 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.09 141.89 29.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -97.86 139.88 33.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.777 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.09 169.68 20.04 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 86.3 p -60.83 -35.13 75.73 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.087 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.17 164.24 26.55 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.61 27.51 63.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.05 -122.05 27.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -104.29 156.71 17.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.023 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 72' ' ' PRO . 88.9 mt -78.74 133.12 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.53 -175.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.7 m -65.08 140.89 58.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.3 mt -94.89 9.55 38.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.13 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.03 -45.86 32.97 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.841 -0.537 . . . . 0.0 112.838 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.79 87.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.237 0.518 . . . . 0.0 110.822 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 90' ' ' PHE . 39.7 tp -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.492 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.465 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.4 m -58.65 -43.13 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.662 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.8 m -60.91 -47.74 85.03 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.584 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.583 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 25.4 m -62.62 -40.11 95.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.856 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.97 -39.93 87.33 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.788 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.82 -43.64 90.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.018 0.437 . . . . 0.0 110.292 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.58 -36.93 84.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.334 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.92 -25.23 64.98 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.95 23.01 62.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.709 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.43 142.81 47.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.497 0.648 . . . . 0.0 110.988 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.801 0 CA-C-O 118.107 -1.385 . . . . 0.0 110.975 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.43 140.0 50.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.452 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.42 139.04 51.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.453 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -121.03 141.7 50.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.51 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -123.31 133.78 54.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.487 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -125.52 136.37 53.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.45 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m -119.72 147.55 44.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.496 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -121.87 144.36 48.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.58 -177.74 33.95 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.3 tp -100.78 131.7 46.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 0.0 110.529 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.53 159.72 40.89 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.445 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.52 151.7 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.492 1.461 . . . . 0.0 112.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -150.02 163.04 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.635 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.97 -177.43 51.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 m -62.99 154.5 30.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 110.561 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.8 43.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.9 153.44 35.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 110.402 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -93.44 142.5 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.697 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.84 156.64 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.371 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -78.29 159.57 28.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.02 156.98 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 146.0 27.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.479 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.34 144.81 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.632 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -122.87 148.09 45.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.343 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -106.12 133.89 50.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.465 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -110.94 152.35 26.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.432 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -79.63 147.53 32.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -138.11 165.1 27.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.148 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.82 141.74 40.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.434 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.5 mtm -94.4 144.2 25.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.559 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -147.7 173.66 12.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 m -62.72 152.93 80.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.54 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.25 156.55 14.73 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.536 1.49 . . . . 0.0 112.246 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -68.12 145.62 54.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.2 mt -88.51 144.62 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.469 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.24 146.35 43.38 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 t -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.745 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -69.38 -178.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -65.35 127.62 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.657 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -150.01 -179.66 7.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.806 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.06 150.81 32.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.47 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -71.6 145.41 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.552 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -122.55 166.09 15.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.88 -169.94 39.8 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.31 -176.34 44.36 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.92 -168.7 19.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.0 146.22 27.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.15 146.56 50.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -63.92 153.8 83.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.522 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.85 166.91 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.343 1.362 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.07 55.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -125.95 146.92 49.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.65 147.06 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -104.72 99.94 20.98 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.427 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.22 162.1 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.427 1.418 . . . . 0.0 112.125 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.57 142.5 31.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.311 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.32 155.29 9.69 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.025 1.15 . . . . 0.0 111.257 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 mt -64.04 150.36 92.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.292 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 146.23 96.49 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.125 1.217 . . . . 0.0 111.158 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 p -55.94 138.87 71.48 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.08 119.83 4.0 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.195 1.263 . . . . 0.0 113.212 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.8 p -87.01 158.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 167.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 p -57.22 125.54 23.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.85 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.7 m120 63.56 15.05 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -150.03 148.27 28.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.585 0.63 . . . . 0.0 112.28 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -151.18 152.57 33.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.533 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.2 m-20 -95.91 128.57 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 67' ' ' LEU . 5.3 tp -128.0 145.0 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.9 p -150.12 161.63 42.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.706 0.765 . . . . 0.0 112.466 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -55.69 -34.42 65.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.547 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.39 90.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.104 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -69.89 -46.76 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.953 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 62' ' ' ILE . 7.9 mp -72.91 -25.67 61.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.9 -147.61 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -55.92 -21.16 19.02 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.34 0.973 . . . . 0.0 112.292 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.87 -23.43 63.43 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.495 ' HE3' HD22 ' A' ' 67' ' ' LEU . 47.6 t-105 -55.75 113.08 5.06 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.3 -176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 125' ' ' ILE . 63.6 Cg_endo -89.67 -13.25 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.752 1.635 . . . . 0.0 114.306 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.6 mt -94.15 147.31 23.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.173 0.511 . . . . 0.0 111.915 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.0 p -69.58 -36.4 76.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.728 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.69 128.22 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -61.88 -33.93 75.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -148.61 174.94 11.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.557 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 162.07 34.29 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.2 m -108.58 140.47 41.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.611 -0.346 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 pt -108.47 136.77 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.35 143.56 31.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.391 0.615 . . . . 0.0 111.941 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 m -110.19 122.61 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.744 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.0 mt -83.02 157.78 65.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.027 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.34 -22.29 15.56 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.433 1.422 . . . . 0.0 113.012 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -79.37 3.02 19.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 63.82 39.98 7.93 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.254 0.55 . . . . 0.0 110.811 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -110.53 128.01 55.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.76 122.56 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.508 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.54 154.64 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.498 0.666 . . . . 0.0 111.491 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.7 t80 -114.04 127.91 56.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.801 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.31 131.86 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.48 155.17 36.68 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.821 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.7 -26.87 10.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.629 1.553 . . . . 0.0 113.018 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 29.8 p30 -64.22 -12.16 38.13 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.72 10.37 67.31 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 121.491 -0.385 . . . . 0.0 112.832 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.8 m -99.36 138.48 36.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.6 m -101.52 130.43 47.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.261 0.553 . . . . 0.0 109.943 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -115.65 147.23 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.813 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.31 124.99 33.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 110.794 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.93 -48.27 11.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -112.55 167.58 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.614 0.721 . . . . 0.0 112.004 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -53.79 -40.76 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.151 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -63.36 -41.11 98.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.252 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.47 -38.61 77.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.695 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.16 -40.71 98.33 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.412 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -58.01 -33.88 69.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.314 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.89 7.53 4.7 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.0 23.48 63.7 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.227 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -94.49 111.99 55.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.361 172.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.72 151.51 31.75 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.189 1.259 . . . . 0.0 111.358 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.1 158.98 45.04 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.476 1.451 . . . . 0.0 112.705 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.512 HG23 HD11 ' A' ' 115' ' ' ILE . 80.1 mt -59.64 -12.24 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.344 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.1 t -43.36 -40.71 6.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -171.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.9 Cg_exo -58.05 -30.04 88.9 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 122.507 1.931 . . . . 0.0 112.703 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.512 HD11 HG23 ' A' ' 112' ' ' ILE . 13.8 pt -98.9 7.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -68.58 149.18 49.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.742 0.701 . . . . 0.0 110.801 -176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.53 143.15 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 111.626 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -96.74 139.96 32.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.696 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.8 155.39 17.75 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.2 p -58.87 -34.58 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.022 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.11 158.09 24.13 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.23 25.74 61.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.437 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.02 18.68 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 117.359 0.58 . . . . 0.0 111.68 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.47 156.33 18.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.738 0.304 . . . . 0.0 110.685 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 72' ' ' PRO . 74.6 mt -86.13 132.27 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.046 0.45 . . . . 0.0 110.254 -176.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -69.27 141.46 54.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.997 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.4 mt -91.87 5.83 48.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.318 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.89 -43.74 39.82 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.792 -0.567 . . . . 0.0 112.543 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.94 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 110.78 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.0 tp -59.62 -42.77 93.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.18 -42.89 95.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.435 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.3 m -59.54 -43.69 93.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.687 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.4 m -61.37 -47.82 84.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.605 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.6 m -63.56 -39.62 94.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.939 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.19 -38.74 87.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.936 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.36 -43.2 88.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.894 0.378 . . . . 0.0 110.222 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.76 -39.68 94.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.893 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.2 m -60.07 -25.2 65.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 22.95 54.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.631 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -84.05 133.75 34.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.465 0.633 . . . . 0.0 110.641 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 117.937 -1.48 . . . . 0.0 111.021 179.855 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -120.74 142.65 49.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.526 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -113.76 137.84 51.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.399 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -120.29 140.46 51.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -120.38 141.02 50.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.435 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -122.9 132.91 54.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t -121.4 142.68 49.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m -63.45 155.73 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.76 -176.17 38.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 tp -100.09 128.54 46.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.04 163.81 45.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.567 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.92 159.59 24.82 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.343 1.362 . . . . 0.0 111.803 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.55 141.88 58.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.658 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.61 -174.87 47.32 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.5 p -131.34 156.28 45.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.733 0.301 . . . . 0.0 110.485 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.49 179.23 50.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.2 mtp -133.52 159.22 41.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.514 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.78 140.61 48.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.91 151.38 36.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.761 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 m -124.65 141.38 52.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.195 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.16 107.73 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.629 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.07 157.13 42.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.457 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.8 105.0 11.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.294 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -137.14 144.09 42.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -121.45 154.64 36.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.035 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -142.52 169.07 18.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -148.23 164.11 34.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.428 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.13 141.08 40.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.742 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -131.94 156.86 45.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.394 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.0 mtt -102.1 141.58 34.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -88.51 118.28 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -137.85 160.13 65.93 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.11 -174.94 2.02 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.509 1.473 . . . . 0.0 112.115 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.63 128.39 34.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.567 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.9 tp -100.48 130.22 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.626 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.1 -173.93 50.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 m -72.05 135.94 46.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.719 0.295 . . . . 0.0 110.464 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.44 157.41 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.738 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.0 150.16 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.98 145.75 45.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.477 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -72.55 172.17 11.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.915 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -135.16 171.47 14.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.97 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.5 m -71.22 140.16 50.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.419 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.49 -177.32 50.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.27 -140.02 3.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.62 -174.35 49.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -57.96 148.78 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.719 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 151.8 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.553 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.96 159.06 6.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.758 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.91 -179.0 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.298 1.332 . . . . 0.0 111.998 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.61 158.77 43.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.614 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.74 140.83 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.434 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -64.7 141.26 58.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.576 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -127.55 162.41 49.07 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HG3' ' HB2' ' A' ' 68' ' ' ALA . 50.3 Cg_exo -50.67 128.16 23.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.24 1.293 . . . . 0.0 111.642 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -90.41 139.45 26.77 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.573 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -52.24 155.5 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.053 1.169 . . . . 0.0 111.262 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.01 152.73 86.82 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.24 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.56 154.6 71.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.111 1.207 . . . . 0.0 111.122 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.6 m -55.96 130.76 73.42 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.231 -0.414 . . . . 0.0 109.974 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.07 119.87 4.02 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.111 1.207 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -83.99 159.0 21.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.9 m -55.07 125.51 20.79 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.025 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.2 p30 63.35 16.46 9.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.224 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE3' HG21 ' A' ' 79' ' ' THR . 49.2 tttp -154.99 141.56 18.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.293 0.497 . . . . 0.0 112.254 -175.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -145.61 153.15 40.74 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.056 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' HG23 ' A' ' 79' ' ' THR . 78.8 m-20 -95.02 128.25 41.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 67' ' ' LEU . 4.7 tp -126.57 141.49 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.0 p -144.23 164.66 30.08 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.595 0.712 . . . . 0.0 111.865 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -55.69 -36.15 66.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.322 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.04 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.765 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -70.63 -46.58 63.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.936 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.649 HD12 ' CE3' ' A' ' 71' ' ' TRP . 46.0 mt -85.03 -9.45 58.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.485 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . 65.7 -151.57 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -56.03 -20.08 15.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.914 0.779 . . . . 0.0 112.366 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -57.54 -25.79 60.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.649 ' CE3' HD12 ' A' ' 67' ' ' LEU . 53.1 t-105 -55.79 107.18 0.81 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.27 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.21 -13.17 4.51 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.832 1.688 . . . . 0.0 114.068 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -88.21 145.69 25.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.36 0.6 . . . . 0.0 112.062 -174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.3 p -69.83 -36.89 75.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.72 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.22 129.01 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.67 -32.43 72.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -146.78 174.35 11.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.652 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.6 m -107.81 140.32 41.07 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.625 -0.338 . . . . 0.0 110.1 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 pt -109.34 137.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -148.04 146.45 28.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.384 0.611 . . . . 0.0 112.067 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.8 m -109.47 125.58 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.722 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.93 160.41 55.45 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.058 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.15 -20.93 8.44 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.453 1.436 . . . . 0.0 113.177 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -80.08 3.07 21.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 62.87 40.12 9.95 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.143 0.497 . . . . 0.0 110.692 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -112.61 128.4 56.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.609 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -94.97 121.97 37.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.322 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.52 156.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.328 0.585 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.3 t80 -114.08 128.35 56.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.18 130.76 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.32 155.32 36.53 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.762 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.49 -26.8 9.35 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.495 1.463 . . . . 0.0 113.064 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 34.8 p30 -63.88 -12.71 39.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.84 9.68 65.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 122.071 -0.393 . . . . 0.0 112.91 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m -99.43 139.72 34.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -104.47 131.62 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 0.0 110.09 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.81 149.31 41.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.18 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.663 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.36 128.22 35.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.704 0.288 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.87 -52.66 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 110.478 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -103.12 167.61 9.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.598 0.714 . . . . 0.0 112.117 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.86 -40.46 69.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.148 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -63.88 -42.03 97.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.301 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.17 -37.11 79.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.663 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.0 mm-40 -63.12 -41.02 99.25 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.288 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.13 -33.94 71.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.638 0.256 . . . . 0.0 111.317 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.66 -1.7 12.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.44 63.72 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.907 -0.385 . . . . 0.0 113.16 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 44.2 m-70 -83.2 135.86 44.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.207 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.07 147.85 94.32 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.053 1.168 . . . . 0.0 111.27 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.07 158.87 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.445 1.43 . . . . 0.0 112.481 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 115' ' ' ILE . 86.9 mt -62.31 -10.22 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.438 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.2 t -43.64 -40.03 6.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD3' HG22 ' A' ' 113' ' ' THR . 26.0 Cg_exo -59.14 -32.19 96.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.293 1.855 . . . . 0.0 112.605 -174.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 112' ' ' ILE . 14.9 pt -98.96 7.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 149.81 42.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.718 0.69 . . . . 0.0 110.882 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.647 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -85.19 138.43 32.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -84.22 139.87 32.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.01 16.15 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.0 p -61.75 -34.77 76.43 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.194 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.46 135.89 11.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.31 -36.67 3.56 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.03 -59.96 0.35 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 141.06 42.36 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.8 -0.235 . . . . 0.0 110.785 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.647 HD12 ' HB3' ' A' ' 117' ' ' ALA . 88.6 mt -81.3 133.86 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.043 0.449 . . . . 0.0 109.798 175.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -59.79 137.09 58.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.275 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.5 mt -99.16 6.81 46.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.304 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.65 -43.55 37.42 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.822 -0.549 . . . . 0.0 112.771 -173.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.93 75.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.248 0.524 . . . . 0.0 110.814 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 90' ' ' PHE . 34.4 tp -59.55 -42.15 91.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.7 tp -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.494 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.55 -43.31 93.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.595 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.6 m -60.99 -48.0 83.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.594 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.609 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 25.1 m -63.11 -40.48 97.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.805 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.09 -38.96 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.958 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -58.51 -43.76 89.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.368 . . . . 0.0 110.2 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.01 -39.55 95.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.988 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.94 -25.33 65.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.032 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.6 22.97 61.09 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.554 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -75.8 134.53 40.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.454 0.627 . . . . 0.0 110.525 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.886 -1.508 . . . . 0.0 111.036 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -117.97 139.99 50.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.436 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -124.57 135.56 53.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.511 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -128.69 148.42 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.346 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -110.4 138.92 46.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.628 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -118.48 143.09 46.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.365 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m -117.56 147.3 42.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.562 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.7 p -140.92 162.53 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.463 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.61 -177.98 52.17 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.6 mp -94.93 141.49 28.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.557 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.64 163.65 43.57 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.465 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.97 175.76 0.89 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.327 1.351 . . . . 0.0 111.969 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -61.52 147.63 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.374 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.63 -176.78 28.17 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -117.76 144.08 45.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.848 0.356 . . . . 0.0 110.463 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.02 -175.51 35.82 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 44.4 ttm -98.36 135.67 39.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.34 . . . . 0.0 110.599 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -89.87 146.48 24.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -99.14 139.35 34.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.536 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -122.85 163.26 20.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.461 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.7 147.29 42.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.576 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.25 146.58 38.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.566 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.91 147.36 38.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.554 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -66.73 147.84 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.068 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.69 164.59 27.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.484 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -95.36 149.69 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.617 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -127.09 140.99 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.09 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -108.05 147.72 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.494 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.97 147.58 49.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -117.69 151.72 36.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.463 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.56 143.59 56.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.0 m -113.09 159.98 32.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.99 -178.82 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.349 1.366 . . . . 0.0 111.973 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -67.28 147.12 53.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 29' ' ' LEU . 8.7 tt -94.5 127.75 40.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.29 -175.19 38.36 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.7 m -79.34 137.22 37.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.786 0.326 . . . . 0.0 110.609 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -67.69 144.42 55.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.543 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -147.83 170.43 17.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.82 144.57 56.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.628 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -65.91 144.85 56.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.619 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -133.31 167.23 20.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -79.05 163.2 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.483 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.9 144.75 48.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 -173.91 37.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.98 -178.49 51.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.45 142.64 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 110.405 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.33 144.77 45.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.241 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.44 148.83 97.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.247 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.95 -171.0 0.45 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.779 1.653 . . . . 0.0 112.077 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.96 145.36 55.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.145 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -115.8 120.34 38.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.667 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -131.46 146.99 52.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.228 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 m -64.92 151.29 93.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.078 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.83 128.13 23.42 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.084 1.189 . . . . 0.0 111.704 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.38 139.62 26.85 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.51 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.33 140.74 52.13 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.061 1.174 . . . . 0.0 111.25 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.12 153.67 84.61 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.01 143.26 99.59 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.048 1.166 . . . . 0.0 110.85 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -55.82 144.65 55.91 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.197 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.68 119.78 6.46 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 120.864 1.043 . . . . 0.0 112.825 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.6 p -98.34 156.86 16.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -56.31 125.5 22.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.192 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.7 m120 63.63 10.93 5.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -149.09 148.06 29.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.834 0.743 . . . . 0.0 112.845 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -150.6 147.51 27.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.79 167.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 79' ' ' THR . 72.7 m-20 -98.96 126.35 44.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.765 HD11 HD11 ' A' ' 67' ' ' LEU . 8.3 tt -132.04 152.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.786 0.327 . . . . 0.0 111.276 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.8 p -150.44 166.41 30.19 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.683 0.754 . . . . 0.0 111.82 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -55.61 -34.6 65.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.238 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.68 88.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.743 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -66.23 -46.49 76.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.368 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.765 HD11 HD11 ' A' ' 62' ' ' ILE . 10.5 mp -84.73 -14.74 47.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 64.47 -148.99 0.28 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.26 -20.85 20.29 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.105 0.866 . . . . 0.0 112.343 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.47 -23.28 57.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.562 ' CE3' HD22 ' A' ' 67' ' ' LEU . 37.3 t-105 -55.83 113.46 5.75 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.427 -176.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -89.61 -13.2 2.82 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.786 1.658 . . . . 0.0 114.086 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.07 144.9 24.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.243 0.544 . . . . 0.0 111.875 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.1 p -68.65 -37.15 79.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.627 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.32 130.36 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -63.9 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -168.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -152.98 177.26 10.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.662 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.78 162.08 34.33 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.549 HG23 ' OD1' ' A' ' 61' ' ' ASP . 3.5 m -108.17 141.49 39.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 pt -108.95 136.77 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -139.78 140.31 36.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.444 0.64 . . . . 0.0 111.949 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.7 m -108.48 118.51 36.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.108 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.6 157.63 52.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.402 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -49.32 -20.74 3.94 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.344 1.363 . . . . 0.0 113.0 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -75.93 3.39 10.27 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 p30 54.04 34.59 20.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.009 0.923 . . . . 0.0 111.773 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -109.12 133.28 53.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 172.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.552 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -97.07 123.94 40.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.093 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 159.0 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.459 0.647 . . . . 0.0 111.402 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CD1' HD21 ' A' ' 130' ' ' LEU . 91.0 t80 -114.09 126.54 55.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.78 129.68 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.479 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.89 155.79 36.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.676 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.85 -26.84 10.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.541 1.494 . . . . 0.0 113.109 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.5 p30 -63.88 -12.86 40.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.83 66.43 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.886 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -99.34 139.74 34.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -104.84 129.07 53.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.013 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -114.07 149.64 35.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.008 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.654 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . -87.45 128.98 35.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.723 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.4 mt -88.54 -52.16 5.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.445 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.3 p30 -103.22 167.41 9.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 112.192 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -55.43 -40.4 71.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.063 -173.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -62.85 -41.7 99.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.588 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -61.06 -36.67 80.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 0.0 110.958 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.654 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 77.1 mm-40 -62.81 -41.35 99.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.312 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.37 -33.97 71.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.71 0.291 . . . . 0.0 111.346 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.99 -1.07 10.82 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.49 63.64 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.093 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -83.2 143.15 44.78 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.528 0.664 . . . . 0.0 109.251 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.02 147.77 55.47 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.235 1.29 . . . . 0.0 111.379 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.14 154.77 29.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.332 1.354 . . . . 0.0 112.772 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 115' ' ' ILE . 92.6 mt -62.64 -16.63 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 119.035 -0.507 . . . . 0.0 112.021 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.422 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.4 t -44.46 -38.53 5.58 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HD3' HG22 ' A' ' 113' ' ' THR . 32.5 Cg_exo -58.99 -31.89 96.54 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 CA-C-N 122.383 1.887 . . . . 0.0 112.193 -176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 112' ' ' ILE . 17.4 pt -98.05 3.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -78.18 135.66 37.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.47 0.577 . . . . 0.0 110.455 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.454 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -77.81 146.57 35.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.189 0.519 . . . . 0.0 111.862 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -92.14 140.5 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.685 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.84 157.23 18.68 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.1 p -59.13 -35.27 73.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.936 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.42 160.37 26.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.68 30.27 56.48 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.184 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.96 -119.92 14.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.41 157.58 17.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.298 . . . . 0.0 110.405 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' A' ' 117' ' ' ALA . 75.5 mt -79.79 130.06 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.416 . . . . 0.0 110.348 -175.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 140.39 58.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.126 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.5 mt -95.3 9.72 38.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.1 171.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.13 -44.05 33.12 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.845 -0.534 . . . . 0.0 112.648 -174.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.17 -47.78 84.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.121 0.46 . . . . 0.0 110.666 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.511 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.6 tp -59.32 -42.06 90.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 110.51 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -60.01 -44.4 94.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.496 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 m -59.2 -42.69 91.51 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.63 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.61 -47.97 83.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.641 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.552 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 20.8 m -62.86 -40.15 96.61 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.729 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.72 -39.0 86.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -58.66 -42.65 88.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.29 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.13 -39.12 93.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.96 -25.19 65.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.869 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.94 4.6 55.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.475 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -101.4 145.03 29.48 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.078 0.939 . . . . 0.0 110.551 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.957 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -118.44 140.09 50.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -117.03 138.99 51.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.0 143.56 49.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -118.99 131.54 56.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -126.93 149.02 50.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.43 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.9 m -61.0 154.46 22.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.421 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -119.78 148.27 43.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.511 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.35 -173.97 50.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.1 tp -95.45 131.12 41.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.67 142.65 98.02 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -88.83 -174.94 1.11 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.636 1.557 . . . . 0.0 112.127 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -55.7 150.9 11.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.034 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.23 -165.32 32.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -114.34 141.6 47.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.377 . . . . 0.0 110.62 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 -174.03 49.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.7 mtm -107.17 153.84 22.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.481 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -69.84 132.9 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.672 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.29 143.95 47.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -121.63 138.75 54.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.99 145.63 56.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.617 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.97 145.48 52.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.408 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.71 154.85 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -92.35 155.32 17.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -94.17 130.42 40.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -114.34 160.09 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -117.23 153.42 32.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.247 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -55.86 141.37 39.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -132.44 167.67 19.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.493 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -97.73 144.65 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -68.98 139.75 55.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -133.09 162.55 56.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.86 -174.99 2.35 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.454 1.436 . . . . 0.0 112.093 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -73.55 176.26 6.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.766 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.64 128.73 44.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.4 -173.74 48.41 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -79.58 165.56 22.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.691 0.282 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -61.13 135.35 57.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -71.79 140.12 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.4 123.62 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.433 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.72 134.96 56.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 0.0 110.54 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -100.74 151.17 21.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.2 p -80.55 166.47 21.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.327 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.35 178.45 51.62 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.0 -165.52 27.5 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.09 -167.89 28.59 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -56.06 144.71 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 110.859 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.27 151.6 24.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.725 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.67 155.0 23.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.395 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.93 171.21 3.07 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.243 1.295 . . . . 0.0 111.903 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.42 160.83 39.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.714 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -105.25 145.13 31.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.296 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -104.11 142.89 33.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.263 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 m -81.81 160.41 63.86 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.598 ' HG3' ' HB2' ' A' ' 68' ' ' ALA . 57.0 Cg_exo -48.5 128.84 18.68 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.448 1.432 . . . . 0.0 112.082 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.34 139.63 26.91 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.544 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -52.33 159.96 3.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.182 1.255 . . . . 0.0 111.796 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -64.05 159.84 52.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.5 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -59.9 148.21 89.53 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.098 1.199 . . . . 0.0 110.833 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -55.86 143.72 59.88 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.453 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.42 119.86 7.39 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.139 1.226 . . . . 0.0 112.509 -172.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -124.37 143.73 50.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -55.82 125.59 21.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.25 -170.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.4 p30 63.35 12.45 6.25 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.537 168.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -150.41 138.13 19.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.666 0.666 . . . . 0.0 112.669 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -150.2 147.95 28.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.952 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' OD1' HG23 ' A' ' 79' ' ' THR . 77.8 m-20 -96.79 127.37 42.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.449 HD11 HD21 ' A' ' 67' ' ' LEU . 8.4 tp -128.0 143.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.984 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.5 p -143.88 164.82 29.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.516 0.674 . . . . 0.0 111.552 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -55.55 -36.22 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.163 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.52 84.29 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.766 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -70.44 -45.06 66.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.671 HD12 ' CE3' ' A' ' 71' ' ' TRP . 48.3 mt -87.23 -8.68 56.56 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.598 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . 63.78 -149.57 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -55.76 -21.74 20.55 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.036 0.834 . . . . 0.0 112.336 -177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -56.42 -28.07 58.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.671 ' CE3' HD12 ' A' ' 67' ' ' LEU . 54.4 t-105 -55.69 107.25 0.82 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.397 -176.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.34 -13.18 4.4 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.755 1.637 . . . . 0.0 114.15 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.73 145.05 26.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.82 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -69.55 -37.5 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.509 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.7 m -63.68 129.72 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.22 -33.44 75.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -147.16 173.14 12.79 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.709 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.77 161.99 34.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.537 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.6 m -108.13 139.58 42.58 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.575 -0.368 . . . . 0.0 110.082 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 pt -107.58 136.18 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.34 143.69 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.462 0.649 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 m -106.62 118.61 37.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.143 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.75 160.03 47.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.148 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.42 -17.92 7.27 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.452 1.434 . . . . 0.0 113.52 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.4 p -80.08 2.89 22.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 t0 67.66 33.51 4.94 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.904 0.32 . . . . 0.0 111.486 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -121.5 138.89 54.1 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.638 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -97.57 128.28 44.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.237 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.03 157.8 42.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.413 0.625 . . . . 0.0 111.412 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 130' ' ' LEU . 91.1 t80 -114.07 127.02 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.933 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.02 131.03 58.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.419 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -101.18 155.96 35.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.812 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.51 -26.67 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.503 1.469 . . . . 0.0 113.19 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 35.0 p30 -64.96 -11.58 40.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.94 9.62 67.7 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.944 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.5 m -99.43 139.9 34.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.1 m -104.58 130.57 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.1 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.54 148.02 40.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.005 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.36 127.53 35.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.762 0.315 . . . . 0.0 110.835 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.16 -50.46 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.344 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -105.66 167.6 9.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.637 0.732 . . . . 0.0 111.95 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.33 -40.74 71.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.159 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -64.09 -40.94 97.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.288 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -58.98 -37.66 77.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.57 -40.36 96.77 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.342 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -58.26 -34.02 70.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.267 . . . . 0.0 111.211 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.62 1.82 7.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.92 23.55 63.77 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.986 -0.341 . . . . 0.0 113.227 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -88.24 125.99 62.12 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.219 172.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.68 152.48 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 CA-C-N 120.614 1.255 . . . . 0.0 111.372 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.07 158.01 30.45 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.357 1.371 . . . . 0.0 112.344 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 115' ' ' ILE . 85.3 mt -62.04 -11.18 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.993 -0.527 . . . . 0.0 112.291 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.436 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.7 t -44.09 -39.64 6.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -172.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.436 ' HD3' HG22 ' A' ' 113' ' ' THR . 24.5 Cg_exo -59.68 -32.45 95.8 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 CA-C-N 122.296 1.856 . . . . 0.0 112.401 -175.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.437 HD11 HG23 ' A' ' 112' ' ' ILE . 17.8 pt -98.82 7.69 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -77.8 139.95 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.458 0.572 . . . . 0.0 110.398 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.93 143.11 29.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 111.412 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -91.66 139.97 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.849 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.5 168.83 19.95 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 m -58.39 -38.79 78.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.733 0.301 . . . . 0.0 110.709 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.49 166.43 26.48 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.61 29.67 59.28 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.127 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.27 -120.04 19.37 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -104.21 157.77 16.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 0.0 111.031 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.1 mt -79.05 132.81 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.514 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.1 m -64.63 140.99 58.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.109 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -93.9 8.53 40.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.16 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.88 -44.16 31.27 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 121.808 -0.557 . . . . 0.0 112.764 -173.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.18 82.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.136 0.468 . . . . 0.0 110.759 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 90' ' ' PHE . 32.8 tp -59.5 -41.99 91.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.454 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.98 -44.25 94.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.464 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.7 m -59.18 -43.52 92.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.597 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.2 m -61.02 -47.5 86.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.651 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.638 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 18.9 m -62.99 -40.08 96.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.815 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.65 -39.67 89.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -58.65 -42.41 88.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.951 0.405 . . . . 0.0 110.342 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.97 -39.2 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.025 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.9 m -60.01 -25.22 65.12 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.938 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.77 23.0 43.95 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.644 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -77.27 134.26 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.455 0.627 . . . . 0.0 110.359 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.818 0 CA-C-O 117.968 -1.462 . . . . 0.0 111.024 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.98 133.7 53.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -128.01 141.85 51.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.406 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -123.22 140.49 52.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.505 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -111.38 138.59 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -123.99 132.52 53.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.4 t -120.34 142.61 48.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.499 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.8 t -120.27 141.31 50.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.0 -176.39 50.0 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.6 mp -92.37 140.86 29.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.754 0.312 . . . . 0.0 110.425 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.02 142.83 97.56 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.47 -174.95 0.81 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.741 1.628 . . . . 0.0 112.14 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -58.91 148.76 29.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.315 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.66 124.22 32.93 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -147.84 163.53 36.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 110.427 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 115.68 8.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 71.4 mtm -133.97 162.14 32.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -78.6 165.67 23.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.948 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -61.53 143.1 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.314 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.3 p -122.34 164.8 17.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.493 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.47 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.617 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.24 147.85 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.537 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.13 146.86 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.92 150.61 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.66 142.64 38.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.68 154.21 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.62 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -70.21 146.14 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -86.5 138.31 31.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -117.13 142.27 47.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.462 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.42 146.0 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.641 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -144.68 160.69 40.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.555 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -56.73 154.28 18.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.51 136.48 31.11 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.359 1.373 . . . . 0.0 112.083 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -137.41 169.23 18.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.481 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.82 145.03 26.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.19 -174.37 50.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.0 t -134.24 165.64 24.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 110.618 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -63.2 168.79 3.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.603 ' CG ' ' HH ' ' A' ' 69' ' ' TYR . 80.2 m-20 -70.22 138.42 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -150.0 155.14 39.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.335 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -73.19 169.95 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.439 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -94.95 113.06 24.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.845 0.355 . . . . 0.0 110.634 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.6 p -131.74 162.68 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.51 137.57 30.99 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.0 -169.63 33.43 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.94 -149.92 0.46 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.42 150.46 11.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.921 0.391 . . . . 0.0 110.942 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.27 162.3 6.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -54.12 163.85 1.13 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.05 168.81 5.48 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.403 1.402 . . . . 0.0 112.243 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.95 156.28 28.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.796 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -113.84 174.62 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -56.84 145.43 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.724 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -65.04 112.69 8.73 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.52 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.12 159.77 45.16 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.266 1.311 . . . . 0.0 111.636 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -90.31 140.96 27.18 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.359 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.36 134.96 53.2 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.083 1.188 . . . . 0.0 111.561 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.0 152.4 87.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.437 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.99 142.93 99.02 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.248 1.299 . . . . 0.0 111.201 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.0 p -55.88 137.05 72.57 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.098 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.21 119.91 3.97 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.123 1.216 . . . . 0.0 113.334 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -85.19 157.04 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -57.32 125.54 23.26 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.794 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.58 21.12 12.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.82 173.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -159.69 142.71 14.02 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.336 0.516 . . . . 0.0 112.274 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -146.46 153.04 39.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.917 171.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' HG23 ' A' ' 79' ' ' THR . 80.0 m-20 -91.98 125.6 36.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 67' ' ' LEU . 5.2 tp -123.26 144.31 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -175.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.3 p -150.06 160.51 43.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.614 0.721 . . . . 0.0 112.299 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.57 -34.28 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.545 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.75 -44.25 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.059 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -70.74 -46.66 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.193 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 62' ' ' ILE . 7.6 mp -73.57 -23.24 59.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 69.25 -150.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.603 ' HH ' ' CG ' ' A' ' 33' ' ' ASP . 58.2 t80 -54.08 -26.59 27.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.112 0.869 . . . . 0.0 111.797 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -53.06 -28.28 24.02 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.436 ' HE3' HD22 ' A' ' 67' ' ' LEU . 59.4 t-105 -55.77 107.13 0.79 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.189 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.22 -13.29 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.757 1.638 . . . . 0.0 114.113 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -85.31 144.43 28.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.202 0.525 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -68.17 -37.13 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.777 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.4 m -67.16 129.76 31.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -61.76 -32.95 73.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -147.1 174.55 11.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.75 162.07 34.34 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.474 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.2 m -107.51 138.46 43.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.659 -0.318 . . . . 0.0 110.145 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -108.98 132.83 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -148.07 144.91 28.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.38 0.61 . . . . 0.0 112.27 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 40.4 m -102.45 118.73 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -87.65 158.06 51.58 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.545 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.37 -18.26 5.19 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.417 1.411 . . . . 0.0 113.327 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.6 p -77.5 3.03 14.48 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 63.18 45.53 5.07 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.073 0.463 . . . . 0.0 110.638 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -135.2 144.66 47.07 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.571 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.84 120.46 40.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.72 158.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.614 0.721 . . . . 0.0 111.921 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.504 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.1 t80 -114.15 129.18 56.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.879 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.88 131.73 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -99.66 155.15 36.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.666 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -48.85 -25.75 8.88 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.487 1.458 . . . . 0.0 113.104 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.1 p30 -65.27 -11.74 44.44 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.38 67.6 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.847 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.9 m -99.4 138.63 36.23 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 m -103.18 129.37 50.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.231 0.538 . . . . 0.0 110.067 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -114.14 148.83 36.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.024 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 125.93 34.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.325 . . . . 0.0 110.409 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.05 -51.38 7.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.451 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HB3' HD11 ' A' ' 131' ' ' LEU . 51.7 p30 -112.38 167.59 10.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.658 0.742 . . . . 0.0 112.012 -175.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -52.32 -34.02 45.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.777 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -61.71 -47.43 85.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.619 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.9 -34.29 74.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.424 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.594 ' OE2' ' HB3' ' A' ' 99' ' ' ALA . 76.9 mm-40 -62.31 -41.14 98.28 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.131 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -59.08 -34.01 71.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.064 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.09 -3.35 12.95 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.01 23.46 63.71 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.65 -0.309 . . . . 0.0 113.242 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -89.75 143.2 29.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.393 0.597 . . . . 0.0 109.593 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 150.17 47.42 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.242 1.295 . . . . 0.0 111.265 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.97 158.94 30.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.373 1.382 . . . . 0.0 112.783 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 115' ' ' ILE . 92.5 mt -60.02 -14.0 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.159 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.438 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.5 t -42.97 -41.33 6.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -170.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD3' HG22 ' A' ' 113' ' ' THR . 19.1 Cg_exo -61.76 -27.41 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 CA-C-N 122.039 1.764 . . . . 0.0 112.656 -173.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 112' ' ' ILE . 9.5 pt -98.8 6.64 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HD3' HD11 ' A' ' 127' ' ' LEU . 78.6 mtm180 -75.87 143.38 41.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.884 0.766 . . . . 0.0 110.828 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -79.73 150.99 30.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.812 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -81.28 139.79 35.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.066 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.98 172.58 34.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 m -62.83 -35.9 81.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.643 0.259 . . . . 0.0 111.535 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.76 110.06 3.24 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.864 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 49.98 26.9 9.15 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.617 -0.325 . . . . 0.0 112.639 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.6 -60.07 4.73 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.14 145.87 35.02 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.639 -0.33 . . . . 0.0 110.361 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 117' ' ' ALA . 87.3 mt -73.07 133.47 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.15 0.5 . . . . 0.0 110.476 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -64.08 140.88 58.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.238 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.403 HD11 ' HD3' ' A' ' 116' ' ' ARG . 67.3 mt -95.11 10.86 34.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.053 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.7 -45.44 30.76 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.8 -0.563 . . . . 0.0 112.877 -173.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.85 -48.48 81.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.263 0.531 . . . . 0.0 110.835 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 90' ' ' PHE . 31.2 tp -59.31 -42.1 90.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 101' ' ' ASN . 27.8 tp -59.59 -44.17 93.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.562 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -59.82 -44.2 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.599 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.9 m -60.27 -46.29 90.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.565 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.6 m -62.35 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.976 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.0 -39.61 86.39 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.677 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.51 -41.97 91.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.05 -39.72 93.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.97 -25.21 65.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.0 60.0 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.794 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -53.65 141.74 25.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.487 0.643 . . . . 0.0 111.416 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.985 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -122.5 129.18 51.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.423 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -135.14 157.71 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.541 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -111.88 138.89 47.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.41 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.72 138.91 50.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -126.01 134.95 51.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.325 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.7 t -118.52 141.78 48.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.603 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 t -126.22 144.15 50.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.369 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 179.76 52.73 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.3 mt -98.6 139.28 34.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.53 142.98 84.59 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -89.16 132.16 2.23 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.573 1.515 . . . . 0.0 112.151 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -150.01 162.48 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.51 -166.44 41.73 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.8 p -132.0 156.77 45.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.496 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.67 -174.89 50.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.6 mtt -107.69 160.09 15.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.383 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -68.33 125.21 25.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.423 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -126.68 143.61 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.512 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 t -75.23 152.86 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.302 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.09 56.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.596 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.08 155.25 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.563 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.4 144.75 56.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.436 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -80.13 138.1 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.634 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.88 154.89 36.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.517 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.02 146.0 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.511 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -143.62 160.17 41.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.007 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -116.72 157.26 25.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.556 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -106.13 134.21 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -99.18 146.77 25.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.7 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -74.8 179.58 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.726 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.9 p -61.05 157.49 41.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.473 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.96 159.84 24.08 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.289 1.326 . . . . 0.0 112.041 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -76.06 -174.57 2.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 30' ' ' GLY . 6.0 tt -91.66 130.03 37.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.911 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -53.46 138.45 36.68 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -176.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t -136.49 161.14 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.618 0.247 . . . . 0.0 110.658 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -81.63 108.52 15.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.654 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -145.1 176.31 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.444 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.14 147.21 48.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.339 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -57.67 136.47 56.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 110.638 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -140.64 -173.28 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.584 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -56.58 177.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.494 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.44 179.98 32.12 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.37 -155.83 7.5 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.16 -174.95 44.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.96 142.47 55.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.85 151.23 42.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.648 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.85 161.94 4.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.91 145.5 98.14 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.322 1.348 . . . . 0.0 112.003 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.78 161.06 40.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.505 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.43 133.21 36.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -126.08 152.41 45.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.9 m -61.44 157.71 43.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.38 137.01 25.36 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.306 1.338 . . . . 0.0 112.238 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -90.34 142.64 28.51 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.717 -0.658 . . . . 0.0 109.646 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.33 160.92 3.03 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.221 1.281 . . . . 0.0 111.377 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.3 mt -63.9 153.3 84.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -82.74 150.5 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.42 1.414 . . . . 0.0 111.172 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.3 p -55.99 134.85 73.77 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.066 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.05 119.8 4.01 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.236 1.291 . . . . 0.0 113.059 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -75.97 157.59 32.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 168.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.1 m -54.74 125.58 20.56 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.239 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.2 p30 63.31 16.28 9.34 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.295 171.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -153.83 140.65 19.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -143.95 150.01 37.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.0 m-20 -97.01 125.56 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.69 HD11 HD11 ' A' ' 67' ' ' LEU . 9.2 tp -126.87 146.69 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.713 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.7 p -150.52 160.55 43.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.691 0.758 . . . . 0.0 112.305 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -55.48 -34.84 64.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.477 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.14 90.54 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.183 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -70.08 -46.58 64.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.287 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 62' ' ' ILE . 7.9 mp -72.12 -25.7 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.23 -148.64 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.25 -20.06 16.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.3 0.954 . . . . 0.0 112.429 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.5 -24.17 63.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.503 ' HE3' HD22 ' A' ' 67' ' ' LEU . 45.4 t-105 -55.88 112.59 4.49 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.32 -176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 125' ' ' ILE . 64.1 Cg_endo -89.52 -13.24 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.754 1.636 . . . . 0.0 114.166 -175.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.3 mt -90.9 145.21 24.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.532 . . . . 0.0 111.883 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -69.03 -37.5 78.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.58 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.88 129.94 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -62.34 -33.59 75.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -147.95 174.49 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.765 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.06 34.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.4 m -108.09 140.07 41.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.16 136.53 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.74 144.12 39.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.325 0.583 . . . . 0.0 111.988 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.18 118.53 36.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.695 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -83.12 156.77 66.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.061 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.01 -18.29 16.59 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.403 1.402 . . . . 0.0 113.055 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -80.11 3.1 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 64.1 40.78 6.75 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.178 0.514 . . . . 0.0 110.559 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -115.68 128.11 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -96.78 124.22 40.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.262 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.36 156.77 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.367 0.603 . . . . 0.0 111.306 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.516 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.6 t80 -114.08 126.47 55.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.048 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -106.27 130.49 57.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.448 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.28 155.83 35.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.819 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.52 -26.68 9.28 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.588 1.525 . . . . 0.0 113.105 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.448 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 33.3 p30 -64.74 -11.91 41.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.45 9.23 67.12 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 122.123 -0.361 . . . . 0.0 112.913 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.6 m -99.39 140.14 34.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.3 m -103.85 130.46 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.17 0.509 . . . . 0.0 110.102 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.69 149.06 38.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.106 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.28 126.93 35.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.696 0.284 . . . . 0.0 110.805 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.36 -50.52 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.965 0.412 . . . . 0.0 110.226 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.34 167.6 9.64 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 111.687 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -56.75 -38.37 72.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.062 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -64.79 -41.79 95.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.548 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.613 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.86 -37.88 83.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.811 175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.05 -52.09 57.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.338 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.67 -20.27 66.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.06 9.85 3.37 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.55 63.32 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 122.28 -0.262 . . . . 0.0 113.456 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -96.98 112.97 62.18 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -54.27 152.72 24.43 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 CA-C-N 120.577 1.242 . . . . 0.0 111.7 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.02 158.98 30.7 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.457 1.438 . . . . 0.0 112.75 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 115' ' ' ILE . 93.9 mt -61.29 -10.68 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.302 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 114' ' ' PRO . 2.3 t -42.19 -41.81 5.47 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -172.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.447 ' HD3' HG22 ' A' ' 113' ' ' THR . 19.0 Cg_exo -62.14 -30.19 81.91 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 122.004 1.752 . . . . 0.0 112.612 -173.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 112' ' ' ILE . 15.7 pt -98.87 5.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.485 ' HD2' HD11 ' A' ' 127' ' ' LEU . 83.0 mtp180 -75.63 143.03 42.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.835 0.743 . . . . 0.0 110.555 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 125' ' ' ILE . . . -86.91 138.53 31.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.897 0.379 . . . . 0.0 111.105 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -92.56 139.89 30.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.53 169.52 19.47 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -58.33 -39.07 78.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.706 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -141.35 165.65 26.3 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.32 28.68 59.51 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.204 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.53 -121.44 25.19 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.67 155.11 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.991 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 117' ' ' ALA . 45.4 mt -74.58 129.94 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.019 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.3 m -63.49 140.63 58.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.015 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.485 HD11 ' HD2' ' A' ' 116' ' ' ARG . 70.6 mt -93.16 9.81 34.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.121 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.78 -44.14 30.51 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.858 -0.526 . . . . 0.0 112.757 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.17 82.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.161 0.481 . . . . 0.0 110.707 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.516 HD21 ' CD1' ' A' ' 90' ' ' PHE . 37.5 tp -59.21 -41.89 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.034 0.445 . . . . 0.0 110.458 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.48 -44.47 95.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.7 p -59.76 -40.86 89.58 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.649 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.9 m -61.66 -48.57 80.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.601 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.516 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 21.9 m -62.6 -40.28 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.727 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.44 -39.49 87.69 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -58.58 -43.0 89.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.315 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.07 -39.47 92.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.91 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -60.1 -25.23 65.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.794 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.94 22.95 24.22 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.643 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -88.71 145.9 25.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.474 0.637 . . . . 0.0 110.311 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.911 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.42 139.71 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.466 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -120.67 141.83 50.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -114.67 137.67 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.453 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -128.17 137.05 51.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.467 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -119.68 141.44 49.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.419 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.1 m -119.19 149.3 41.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.561 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 t -70.71 149.54 46.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.67 141.46 43.99 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.67 135.07 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.352 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 142.5 83.59 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -90.97 111.29 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.744 1.629 . . . . 0.0 112.494 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.94 132.75 43.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.312 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.16 -173.06 35.96 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -119.92 147.82 44.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.692 0.282 . . . . 0.0 110.459 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.78 -178.1 51.13 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt -127.65 155.38 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.81 0.338 . . . . 0.0 110.484 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -80.23 133.47 36.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.507 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -68.22 142.94 55.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.51 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -136.14 157.06 47.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.836 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.83 146.66 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.645 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.93 146.78 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.57 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.1 144.18 54.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.61 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -98.1 152.68 19.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -132.94 164.03 27.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.404 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.57 143.24 36.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -63.74 145.7 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -99.55 125.62 45.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -127.93 138.79 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.5 mtp -126.39 162.62 25.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.599 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -72.33 -175.42 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.611 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 p -57.15 153.11 26.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 176.05 9.33 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.459 1.439 . . . . 0.0 112.271 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.87 123.97 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 29' ' ' LEU . 5.7 mp -76.8 152.92 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.415 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.24 150.95 14.36 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.7 p -121.07 170.13 9.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.744 0.307 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.82 127.64 33.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.471 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.0 145.17 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -137.86 175.31 9.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -59.7 150.42 27.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.461 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.16 141.48 49.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.547 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -124.81 168.35 13.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.538 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.73 -165.99 19.2 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 147.93 19.13 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.33 -158.29 9.3 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.74 146.35 31.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.423 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 147.4 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.02 153.61 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.491 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.28 174.24 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.349 1.366 . . . . 0.0 112.194 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.58 150.24 24.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -109.06 138.66 45.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.591 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -63.35 147.79 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 m -116.82 156.09 48.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.375 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.23 135.46 59.93 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.227 1.285 . . . . 0.0 111.858 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.34 141.39 32.54 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.246 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.33 149.97 21.4 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.15 1.233 . . . . 0.0 111.636 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.97 154.58 81.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.01 146.82 42.23 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.196 1.264 . . . . 0.0 111.174 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.5 m -55.82 139.81 69.18 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.241 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.17 119.92 3.99 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.142 1.228 . . . . 0.0 113.131 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -88.42 159.85 17.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 168.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 p -54.71 125.61 20.62 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.702 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 63.72 15.66 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 170.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -159.8 158.81 31.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -148.05 153.21 38.63 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.576 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.498 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.2 m-20 -90.53 125.21 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 67' ' ' LEU . 9.4 tp -126.05 147.12 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.6 p -150.23 162.1 41.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.783 0.801 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -55.62 -35.05 65.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.414 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.05 92.22 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.134 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.0 -46.64 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.257 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 HD11 ' A' ' 62' ' ' ILE . 8.3 mp -73.56 -26.61 60.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -175.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 70.46 -146.23 0.08 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -56.18 -20.12 16.54 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.495 1.043 . . . . 0.0 112.463 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.27 -25.13 63.83 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.49 ' HE3' HD22 ' A' ' 67' ' ' LEU . 36.1 t-105 -55.87 111.76 3.52 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.572 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.63 -13.23 2.8 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.858 1.705 . . . . 0.0 114.096 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.8 mt -90.6 145.57 24.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.177 0.513 . . . . 0.0 111.953 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.8 p -69.71 -37.43 76.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.555 174.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.76 128.8 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.75 -33.99 75.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.068 -169.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -147.25 174.82 11.26 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.503 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.76 162.04 34.29 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.1 m -106.76 139.72 40.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.9 pt -108.16 135.77 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -146.19 141.03 27.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.375 0.607 . . . . 0.0 112.181 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.0 m -103.52 118.5 36.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.055 170.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.8 mt -81.78 153.62 70.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.064 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.42 -17.85 7.15 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.25 1.3 . . . . 0.0 113.25 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 m -79.74 3.18 20.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 63.91 48.42 3.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.122 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -130.88 133.45 45.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.271 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.86 120.48 37.28 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.678 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.567 HG12 ' HB1' ' A' ' 104' ' ' ALA . 35.5 m -132.06 155.81 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.554 0.692 . . . . 0.0 111.783 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CD1' HD21 ' A' ' 130' ' ' LEU . 88.3 t80 -114.18 130.24 56.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.81 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.6 t -109.51 131.9 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.47 155.35 36.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.851 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.68 -27.33 10.73 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.605 1.537 . . . . 0.0 113.09 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 30.6 p30 -64.04 -12.03 34.78 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.12 10.24 66.49 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 122.153 -0.342 . . . . 0.0 112.896 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 57.4 m -99.43 139.11 35.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -102.48 130.49 49.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.285 0.564 . . . . 0.0 109.993 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.62 150.88 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.141 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.34 124.9 33.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 mt -79.85 -47.13 15.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 109.793 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -114.89 166.27 11.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.358 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -52.9 -34.53 55.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.735 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -61.01 -49.05 78.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.747 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.6 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -59.21 -37.12 76.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -61.66 -42.31 98.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.998 0.427 . . . . 0.0 110.089 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -58.23 -33.17 69.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.358 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.16 9.77 2.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.1 23.51 63.42 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 122.18 -0.325 . . . . 0.0 113.38 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -97.55 111.96 60.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.339 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -54.46 150.94 32.29 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.116 1.21 . . . . 0.0 111.654 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.81 158.9 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.325 1.35 . . . . 0.0 112.477 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.5 HG23 HD11 ' A' ' 115' ' ' ILE . 75.3 mt -61.9 -10.62 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.6 t -44.41 -38.83 5.89 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.424 ' HD3' HG22 ' A' ' 113' ' ' THR . 30.1 Cg_exo -58.79 -32.49 97.22 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 CA-C-N 122.472 1.919 . . . . 0.0 112.462 -175.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 112' ' ' ILE . 19.0 pt -98.83 7.55 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -76.45 137.34 39.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.495 0.588 . . . . 0.0 110.478 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -85.75 153.24 22.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.401 . . . . 0.0 111.636 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -84.23 148.32 26.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.833 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.98 26.17 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.621 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.1 m -57.67 -37.88 74.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.683 0.277 . . . . 0.0 111.077 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.97 177.62 20.77 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.98 12.41 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.17 -119.93 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -104.94 161.96 13.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 111.075 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.53 133.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.469 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.2 m -63.1 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.842 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.52 9.27 35.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.098 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.8 31.52 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.838 -0.539 . . . . 0.0 112.852 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.11 82.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.323 0.562 . . . . 0.0 110.752 -176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.8 tp -59.1 -42.35 90.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.5 tp -60.17 -43.24 95.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.473 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.7 m -59.24 -43.64 92.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.628 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.2 m -60.75 -47.63 85.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.538 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.5 m -63.22 -39.69 95.33 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.088 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.11 -39.49 86.36 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.724 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -58.75 -43.09 90.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.04 -38.62 89.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 10.8 m -59.89 -25.33 65.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.997 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.47 22.99 57.58 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.648 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.39 143.46 29.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.496 0.648 . . . . 0.0 110.444 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 CA-C-O 117.955 -1.469 . . . . 0.0 111.009 -179.831 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -124.45 136.06 53.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.342 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -127.24 145.8 50.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.598 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -112.82 141.57 46.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -110.01 135.76 50.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.458 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -130.91 152.39 50.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.522 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m -119.41 147.79 43.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.348 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -120.06 147.03 45.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.546 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -175.36 47.65 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.2 tp -99.5 128.71 45.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.748 0.309 . . . . 0.0 110.388 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.26 142.87 90.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.22 143.24 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.657 1.571 . . . . 0.0 112.184 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -61.4 143.8 55.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.4 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.16 -171.58 42.52 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 94.2 p -117.31 154.54 31.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.16 -178.49 52.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.3 mtp -129.26 161.82 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -88.19 143.98 26.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -112.97 160.83 17.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.59 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -71.46 137.57 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.46 143.58 55.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.723 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.8 151.92 45.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.53 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 146.71 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.26 142.07 29.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.744 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.14 157.65 29.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.295 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -90.63 136.02 33.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.475 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -126.08 153.04 45.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -69.16 147.73 50.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.504 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -111.49 142.04 44.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 mtt -117.03 163.35 16.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.504 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -64.14 144.54 57.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.65 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.4 m -120.31 165.64 17.61 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.406 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -59.92 109.98 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.287 1.325 . . . . 0.0 111.876 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -68.44 144.43 54.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 29' ' ' LEU . 9.2 tt -97.96 129.18 44.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.241 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.0 102.12 0.11 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 m -126.56 145.53 50.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.777 0.323 . . . . 0.0 110.312 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.41 115.61 18.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -150.07 166.71 28.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.59 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -56.96 156.04 7.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.53 121.32 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.687 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -134.54 -176.57 4.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.841 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.3 p -71.51 163.39 27.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.365 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.91 179.68 52.51 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.24 -175.11 49.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.59 42.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -55.55 153.71 7.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.68 146.95 15.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.98 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.11 153.74 72.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.873 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.83 -169.93 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.612 1.541 . . . . 0.0 112.146 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.53 155.05 4.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -62.23 153.09 31.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -120.95 170.53 9.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.29 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -54.04 160.86 2.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 68' ' ' ALA . 65.8 Cg_exo -48.32 128.14 16.86 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.314 1.342 . . . . 0.0 112.351 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.29 143.11 29.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.525 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.23 160.93 2.92 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.151 1.234 . . . . 0.0 111.362 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.8 mt -63.98 154.5 81.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.686 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.62 147.74 32.08 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.311 1.341 . . . . 0.0 111.444 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 p -55.91 125.91 64.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.005 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.19 119.99 4.0 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.22 1.28 . . . . 0.0 113.289 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.7 p -76.35 158.72 31.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.1 m -56.41 125.46 22.09 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.992 -172.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 63.68 22.94 13.33 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.616 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -157.4 139.73 14.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -147.01 146.82 30.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.835 169.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.4 m-20 -93.75 125.71 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 67' ' ' LEU . 4.6 tp -126.2 144.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.514 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.3 p -150.42 158.9 44.67 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.566 0.698 . . . . 0.0 112.388 -173.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -55.54 -34.6 64.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.438 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.74 89.41 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.09 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -70.39 -46.64 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.259 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.528 HD11 HD11 ' A' ' 62' ' ' ILE . 6.9 mp -71.68 -26.27 62.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . 69.66 -147.17 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -55.85 -22.03 22.95 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.38 0.991 . . . . 0.0 112.286 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 70' ' ' LEU . 7.2 mp -61.53 -20.53 63.34 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.469 ' HE3' HD22 ' A' ' 67' ' ' LEU . 51.6 t-105 -55.82 118.45 20.15 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.247 -176.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HB3' HG22 ' A' ' 125' ' ' ILE . 58.8 Cg_endo -89.69 -13.3 2.75 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.807 1.671 . . . . 0.0 114.157 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.62 145.21 27.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.34 0.59 . . . . 0.0 112.101 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.2 p -67.31 -37.8 83.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.464 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.77 128.6 26.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -62.11 -33.91 75.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -147.99 173.87 12.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.778 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.81 162.01 34.23 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.481 HG23 ' OD1' ' A' ' 61' ' ' ASP . 5.1 m -108.92 139.09 44.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.611 -0.347 . . . . 0.0 110.105 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.51 134.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.11 144.56 38.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.233 0.54 . . . . 0.0 111.995 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.21 118.6 37.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.396 172.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.85 155.8 67.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.07 -20.6 10.88 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.323 1.349 . . . . 0.0 113.221 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -80.84 2.97 24.2 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 t0 69.26 35.12 2.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -112.53 128.88 56.47 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.603 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -96.52 122.29 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.8 m -133.1 158.31 43.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.353 0.596 . . . . 0.0 111.557 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.2 t80 -114.1 126.85 55.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.039 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -107.47 129.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.5 155.45 36.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.647 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.49 -26.59 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.589 1.526 . . . . 0.0 113.115 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 33.4 p30 -63.95 -12.77 40.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.88 67.09 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 122.09 -0.381 . . . . 0.0 112.924 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 m -99.34 139.38 35.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 m -104.87 130.18 53.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 109.972 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -114.9 148.65 38.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.9 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.4 127.74 35.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.694 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -86.82 -50.53 6.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.285 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.402 ' HB3' HD11 ' A' ' 131' ' ' LEU . 44.9 p-10 -103.43 167.12 10.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.627 0.727 . . . . 0.0 111.956 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.37 -39.88 73.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.999 -173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.18 -41.89 99.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.271 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.29 -37.19 79.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.899 0.381 . . . . 0.0 110.968 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.97 -40.55 98.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.43 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -58.63 -34.04 70.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.721 0.296 . . . . 0.0 111.329 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.21 0.96 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.49 63.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.969 -0.35 . . . . 0.0 113.191 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -83.21 143.15 44.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.03 152.66 68.01 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.262 1.308 . . . . 0.0 111.752 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.1 153.54 28.55 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.454 1.436 . . . . 0.0 112.725 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 115' ' ' ILE . 90.1 mt -64.02 -18.98 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.779 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 t -46.6 -36.82 7.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.57 -29.01 83.58 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 CA-C-N 122.997 2.106 . . . . 0.0 112.103 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 112' ' ' ILE . 17.6 pt -98.89 2.17 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 143.3 45.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.103 0.865 . . . . 0.0 110.204 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.12 152.51 18.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.776 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -85.13 140.95 30.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.305 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.66 175.66 26.79 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.9 m -58.27 -38.73 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.784 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.9 31.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.2 36.04 56.45 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.37 -123.04 19.63 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -109.04 161.88 14.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.051 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' A' ' 72' ' ' PRO . 46.7 mt -75.04 133.32 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.425 -173.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.7 m -72.25 141.37 48.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.694 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.9 mt -91.68 8.5 36.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.163 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.54 -43.15 36.09 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.749 -0.595 . . . . 0.0 112.327 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.72 88.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.788 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 90' ' ' PHE . 36.4 tp -59.01 -41.68 88.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.035 0.445 . . . . 0.0 110.463 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 101' ' ' ASN . 33.8 tp -59.64 -45.2 92.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.474 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.3 p -59.73 -41.05 90.06 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.69 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.2 m -61.62 -47.76 83.96 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.707 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.603 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 24.0 m -62.67 -40.35 96.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.839 -177.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.3 mt -60.18 -39.87 88.0 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.751 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -59.44 -42.05 91.04 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.424 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.05 -38.72 89.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.107 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.1 m -59.97 -25.28 65.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.867 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.46 22.89 38.69 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.703 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.26 145.63 29.95 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.483 0.641 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.789 0 CA-C-O 118.044 -1.42 . . . . 0.0 110.975 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -118.15 140.37 49.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -118.03 140.23 50.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.45 139.2 50.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.375 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -129.58 156.7 43.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.613 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -114.44 140.31 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.35 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.9 t -112.83 142.42 45.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.674 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -120.76 146.14 46.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.334 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.43 142.78 39.5 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -93.62 143.16 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.823 0.344 . . . . 0.0 110.624 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.2 153.3 86.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.1 114.34 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.386 1.391 . . . . 0.0 112.223 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -123.34 146.49 47.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.39 133.29 23.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -139.71 144.93 37.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.16 132.29 28.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.8 mtt -133.0 158.25 43.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.835 0.35 . . . . 0.0 110.552 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.37 146.77 23.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -101.6 149.65 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.595 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -124.09 163.28 21.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.1 155.04 45.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.48 144.13 56.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.489 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.23 145.64 29.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.558 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -91.44 145.77 24.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.522 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -106.02 134.92 48.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.623 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -103.08 142.26 34.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -66.69 140.4 57.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.485 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -101.94 131.7 48.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -116.09 138.68 51.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.352 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.5 mtm -112.25 145.07 40.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -70.82 143.7 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.575 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.3 m -64.07 153.53 84.84 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.58 109.95 2.88 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.285 1.323 . . . . 0.0 112.086 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -149.96 170.26 19.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.1 140.44 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.36 133.79 26.17 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -126.74 163.01 24.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 110.362 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.17 114.29 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -149.93 175.19 11.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -63.95 149.87 46.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.501 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -61.38 142.53 56.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.548 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -92.32 153.27 19.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.701 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.1 p -118.59 162.79 17.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.224 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.4 -178.05 51.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.82 -171.59 48.35 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.48 -176.92 49.6 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -121.43 151.9 39.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 0.0 110.437 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.41 152.75 20.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.477 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.02 153.95 16.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.63 169.56 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.27 1.313 . . . . 0.0 111.975 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.01 158.33 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -83.53 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.443 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.07 164.2 33.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.074 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -63.27 160.51 40.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.769 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.33 128.27 17.12 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.343 1.362 . . . . 0.0 112.159 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.28 139.66 27.0 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.11 150.44 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.095 1.197 . . . . 0.0 111.609 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.06 153.92 83.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.21 151.44 54.88 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.236 1.29 . . . . 0.0 111.496 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 p -55.95 136.49 73.15 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.037 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.04 119.87 4.03 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.225 1.283 . . . . 0.0 113.225 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.7 p -80.43 157.79 26.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -57.37 125.39 22.62 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.79 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 63.58 19.22 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.84 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -159.61 144.53 15.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.543 0.611 . . . . 0.0 112.384 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -142.34 153.21 43.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.763 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 79' ' ' THR . 79.6 m-20 -94.88 126.0 39.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 173.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 67' ' ' LEU . 4.7 tp -124.79 141.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.5 p -143.46 163.37 33.29 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.594 0.711 . . . . 0.0 111.755 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.54 -35.53 65.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.216 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -40.19 85.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.729 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.44 -46.65 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.826 -176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.627 HD12 ' CE3' ' A' ' 71' ' ' TRP . 36.5 mt -87.02 -8.69 56.91 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 61.66 -145.37 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.0 -28.44 37.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.29 0.95 . . . . 0.0 111.92 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.33 -25.58 35.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.627 ' CE3' HD12 ' A' ' 67' ' ' LEU . 49.2 t-105 -55.92 107.17 0.8 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.372 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.02 -13.17 3.89 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.833 1.689 . . . . 0.0 114.129 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.2 mt -89.67 145.89 24.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.315 0.579 . . . . 0.0 111.821 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.1 p -69.63 -37.1 76.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.723 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.77 129.64 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -64.31 -30.14 71.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -150.26 174.62 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.662 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.82 161.96 34.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.456 HG23 ' OD1' ' A' ' 61' ' ' ASP . 4.5 m -107.89 140.94 40.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.629 -0.336 . . . . 0.0 110.102 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 pt -108.87 136.08 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -143.55 143.88 31.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 111.824 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.2 m -107.4 122.23 46.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.701 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.1 mt -82.7 158.83 64.87 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.03 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.0 -22.07 13.71 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.401 1.401 . . . . 0.0 113.191 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -79.54 3.05 19.97 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.2 40.09 7.03 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.196 0.522 . . . . 0.0 110.638 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -113.24 129.11 56.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HB1' ' CG2' ' A' ' 134' ' ' THR . . . -95.01 121.93 37.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.202 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.06 156.73 42.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.599 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 130' ' ' LEU . 92.4 t80 -114.06 126.95 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.06 130.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' OD1' ' A' ' 94' ' ' ASP . . . -100.4 156.22 35.49 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.658 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.2 -26.73 8.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.509 1.473 . . . . 0.0 113.105 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 92' ' ' ALA . 31.0 p30 -65.11 -11.46 40.13 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.61 8.51 67.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.85 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -99.47 138.48 36.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.1 m -103.7 131.0 51.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 109.865 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -115.97 149.76 38.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.979 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -87.38 127.23 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.674 0.273 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -86.68 -51.02 6.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.941 0.4 . . . . 0.0 110.181 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.404 ' HB3' HD11 ' A' ' 131' ' ' LEU . 43.2 p-10 -103.25 167.61 9.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.644 0.735 . . . . 0.0 111.944 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -57.79 -39.04 76.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.944 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -62.76 -41.27 99.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.151 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.607 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . . . -60.7 -35.87 77.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.072 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.2 -40.55 97.81 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.389 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -58.86 -34.01 71.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.689 0.281 . . . . 0.0 111.241 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.21 -1.79 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.54 63.41 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.07 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 5.1 m-70 -82.09 143.19 48.8 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 109.516 173.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 153.47 73.84 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.366 1.378 . . . . 0.0 111.811 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.12 151.89 27.32 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.538 1.492 . . . . 0.0 112.66 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 115' ' ' ILE . 90.2 mt -64.28 -18.62 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 119.015 -0.517 . . . . 0.0 111.672 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.422 HG22 ' HD3' ' A' ' 114' ' ' PRO . 3.3 t -45.12 -37.34 4.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -171.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.422 ' HD3' HG22 ' A' ' 113' ' ' THR . 39.3 Cg_exo -59.01 -32.11 96.95 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 CA-C-N 122.529 1.939 . . . . 0.0 112.102 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 112' ' ' ILE . 15.8 pt -97.06 3.68 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -77.38 139.37 39.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.439 0.563 . . . . 0.0 110.331 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -83.0 142.3 31.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 111.38 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -90.75 139.85 30.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.684 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.19 168.32 19.94 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.551 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -57.81 -39.22 77.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 110.673 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.14 166.04 26.82 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.12 30.21 57.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.048 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.72 -120.26 19.61 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.31 158.13 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.936 0.398 . . . . 0.0 111.134 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.3 mt -79.0 130.64 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.533 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -63.29 140.8 58.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.236 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.5 mt -94.41 9.87 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.059 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.02 -45.26 32.94 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.845 -0.534 . . . . 0.0 112.735 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.3 85.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.175 0.488 . . . . 0.0 110.759 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 90' ' ' PHE . 35.8 tp -59.47 -41.95 90.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.602 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 101' ' ' ASN . 30.0 tp -59.64 -44.61 93.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -59.07 -43.37 91.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.66 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.3 m -60.59 -47.28 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 110.626 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.622 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 19.9 m -62.7 -41.53 99.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.794 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.16 -37.43 82.88 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.69 -43.86 90.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 110.197 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -36.24 82.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.84 -25.16 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 97.88 23.04 14.11 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.86 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -48.78 147.07 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.493 0.646 . . . . 0.0 112.137 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.908 -179.967 . . . . . . . . 0 0 . 1 stop_ save_